data_1mvg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mvg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -51.75 131.08 30.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.462 1.105 . . . . 0.0 111.506 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.58 -173.88 35.64 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.9 m -120.85 148.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -143.94 155.8 44.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.74 1.216 . . . . 0.0 109.05 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -138.96 130.45 27.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.378 1.071 . . . . 0.0 108.227 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.57 136.7 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.389 1.076 . . . . 0.0 110.132 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.26 -57.17 2.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.796 1.639 . . . . 0.0 109.922 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.31 172.28 16.13 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.702 0.801 . . . . 0.0 110.617 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.67 143.86 26.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.269 1.028 . . . . 0.0 110.651 -170.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -141.39 118.38 11.21 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.074 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 62.8 6.12 2.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.722 2.009 . . . . 0.0 113.342 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -62.87 -47.79 81.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.913 0.885 . . . . 0.0 110.093 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -33.46 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.074 0.55 . . . . 0.0 111.526 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -67.71 -43.13 80.77 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.333 0.653 . . . . 0.0 110.232 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.4 -53.25 60.3 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.731 0.812 . . . . 0.0 110.994 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.71 -39.78 85.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.768 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -75.35 -23.72 57.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.048 0.84 . . . . 0.0 112.567 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -34.26 74.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.279 0.49 . . . . 0.0 110.283 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.9 tp -73.37 162.01 29.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.677 1.191 . . . . 0.0 108.719 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.69 -34.49 26.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.481 1.113 . . . . 0.0 113.038 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.3 111.92 1.29 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.119 1.768 . . . . 0.0 110.637 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.17 149.64 19.81 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.197 2.598 . . . . 0.0 110.192 -169.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -54.85 -32.3 60.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.22 -47.85 71.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.709 0.803 . . . . 0.0 111.889 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.7 mt -80.54 -31.52 36.99 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.984 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.15 -29.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.57 1.077 . . . . 0.0 111.246 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -53.43 -29.93 37.76 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 111.591 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 90.4 mtp -61.4 -66.93 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.88 -39.07 65.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.029 1.331 . . . . 0.0 112.769 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -43.34 -49.08 6.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.838 2.055 . . . . 0.0 112.25 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -123.8 40.74 3.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.905 0.882 . . . . 0.0 110.71 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.4 mt -130.99 136.93 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -112.79 97.72 42.36 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 107.906 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.13 159.42 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.334 2.69 . . . . 0.0 112.893 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.1 mm -75.29 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.138 0.975 . . . . 0.0 109.159 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.4 t -128.61 144.55 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 126.023 1.729 . . . . 0.0 107.19 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -156.04 143.28 19.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.343 0.657 . . . . 0.0 110.072 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.74 142.82 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.455 1.102 . . . . 0.0 110.383 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -118.81 107.23 13.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.45 1.9 . . . . 0.0 108.412 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -89.31 134.69 33.95 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.28 1.432 . . . . 0.0 108.061 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -151.33 59.54 0.9 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.1 81.55 0.24 Allowed Glycine 0 C--N 1.339 0.721 0 C-N-CA 124.076 0.846 . . . . 0.0 112.029 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 76.93 -43.96 0.45 Allowed 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.071 2.148 . . . . 0.0 112.657 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.6 146.03 25.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.64 163.06 32.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 111.17 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.18 139.66 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.391 1.076 . . . . 0.0 108.714 -171.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.03 137.4 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 125.902 1.681 . . . . 0.0 106.812 174.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.1 m -131.08 135.53 47.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 t -129.04 144.79 51.31 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.288 1.035 . . . . 0.0 109.144 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -122.76 122.23 38.21 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 p -122.94 154.56 64.35 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.59 56.37 6.02 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.548 2.832 . . . . 0.0 110.732 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -162.35 -41.89 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.564 . . . . 0.0 110.173 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -161.96 157.38 23.64 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.31 1.044 . . . . 0.0 109.127 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.0 p -109.77 140.93 43.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.015 0.926 . . . . 0.0 109.049 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.2 t -136.2 149.13 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.328 1.051 . . . . 0.0 109.968 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 m -144.98 146.9 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.337 1.455 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.35 151.79 33.42 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 p -122.14 153.07 39.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.654 1.982 . . . . 0.0 110.947 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.29 169.22 10.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.073 0.949 . . . . 0.0 110.625 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.1 m -141.75 145.56 34.95 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.938 1.295 . . . . 0.0 109.091 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.19 136.5 53.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.338 0.655 . . . . 0.0 111.544 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.83 45.38 95.82 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.607 1.099 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -157.43 148.97 21.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.165 0.482 . . . . 0.0 110.168 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.07 124.28 23.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.641 1.176 . . . . 0.0 109.163 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.76 147.72 47.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.295 1.038 . . . . 0.0 110.477 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.1 132.66 36.42 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.687 1.195 . . . . 0.0 108.48 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.8 tt -133.59 153.77 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 124.976 1.31 . . . . 0.0 109.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.528 0.099 0 C-N-CA 124.362 1.065 . . . . 0.0 109.559 -171.992 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.1 pttt . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 120.851 0.358 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.1 -175.32 5.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.72 1.608 . . . . 0.0 107.851 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 157.51 43.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.915 0.325 . . . . 0.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.5 p -159.79 160.94 34.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.499 1.119 . . . . 0.0 109.807 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -84.03 112.48 20.23 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.5 t -84.9 136.52 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -154.98 159.19 40.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.255 1.022 . . . . 0.0 110.266 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -124.86 128.66 49.02 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 126.861 2.064 . . . . 0.0 108.645 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.08 -134.02 0.34 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.232 1.413 . . . . 0.0 108.89 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.97 79.98 2.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.137 0.975 . . . . 0.0 110.641 -176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.51 40.27 77.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.292 0.949 . . . . 0.0 111.642 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.96 126.34 6.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.774 0.83 . . . . 0.0 109.892 -174.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.0 mt -74.19 142.57 45.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.78 127.63 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.02 152.5 46.3 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.385 1.074 . . . . 0.0 109.242 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.21 140.25 41.59 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.495 1.118 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -125.27 -160.61 0.97 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.896 1.278 . . . . 0.0 108.642 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.35 -54.08 42.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.498 1.119 . . . . 0.0 110.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -133.99 -6.09 2.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.745 1.218 . . . . 0.0 112.764 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.69 153.03 19.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.713 0.805 . . . . 0.0 109.334 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 p -145.82 160.23 42.07 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -143.79 121.84 12.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -137.1 107.18 6.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.441 1.096 . . . . 0.0 108.837 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.04 145.38 40.96 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.533 1.133 . . . . 0.0 108.988 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.99 145.88 29.88 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.051 0.541 . . . . 0.0 110.422 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.97 134.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 C-N-CA 125.127 1.371 . . . . 0.0 108.951 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 133.76 19.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.125 1.37 . . . . 0.0 108.69 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.85 -112.03 4.04 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.084 0.85 . . . . 0.0 111.638 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.32 37.02 4.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.895 1.278 . . . . 0.0 109.146 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -142.9 145.46 33.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.289 1.036 . . . . 0.0 109.112 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 ttt -138.88 116.47 11.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.136 1.374 . . . . 0.0 108.335 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.95 137.12 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -128.7 93.02 3.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.868 1.267 . . . . 0.0 108.839 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -97.02 139.4 33.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.879 1.272 . . . . 0.0 109.604 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.5 mt -143.13 147.89 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.682 1.193 . . . . 0.0 107.945 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 165.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -131.5 84.07 2.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.381 1.872 . . . . 0.0 107.395 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.72 -117.34 9.88 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.32 11.39 58.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.481 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -128.19 138.23 55.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 118.649 1.225 . . . . 0.0 108.009 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.8 m -123.04 136.11 54.7 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.745 1.218 . . . . 0.0 107.764 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 163.33 32.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.03 0.532 . . . . 0.0 111.835 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.7 139.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -138.02 157.7 45.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.04 145.97 47.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.747 1.219 . . . . 0.0 109.376 -169.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.1 m -143.42 161.86 37.27 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.115 1.366 . . . . 0.0 109.798 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.7 145.79 51.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.61 1.564 . . . . 0.0 109.483 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -71.66 146.74 48.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.869 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 C--O 1.25 1.108 0 C-N-CA 126.085 1.754 . . . . 0.0 107.505 174.055 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t 50.77 75.63 0.18 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.566 1.547 . . . . 0.0 112.226 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.4 -167.22 37.09 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.6 m -117.69 147.64 42.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -142.42 138.65 31.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.517 1.127 . . . . 0.0 109.584 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -112.65 112.03 23.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.06 139.72 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -125.62 -34.65 2.63 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.456 0.702 . . . . 0.0 111.726 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.95 144.06 50.56 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.703 0.801 . . . . 0.0 110.43 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -144.83 121.28 11.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.551 1.541 . . . . 0.0 107.908 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -140.34 139.96 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.913 0.885 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.24 18.32 10.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.702 1.601 . . . . 0.0 111.758 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -84.46 -47.33 10.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.008 1.323 . . . . 0.0 109.721 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.75 -36.89 67.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.601 0.761 . . . . 0.0 111.79 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.7 -46.64 89.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.429 1.092 . . . . 0.0 110.47 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.41 -50.77 68.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.937 0.495 . . . . 0.0 111.072 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.7 mt -55.2 -40.92 71.32 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.903 0.319 . . . . 0.0 111.076 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.05 -37.5 85.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.248 0.619 . . . . 0.0 111.122 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.13 66.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.057 -0.497 . . . . 0.0 111.851 173.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -75.76 171.27 14.65 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 121.579 0.704 . . . . 0.0 110.752 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.56 76.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.147 1.379 . . . . 0.0 112.959 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.91 130.62 92.7 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.63 -0.224 . . . . 0.0 110.574 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.16 168.17 23.64 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.389 2.726 . . . . 0.0 110.897 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -48.24 -36.69 14.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.425 1.49 . . . . 0.0 113.487 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.72 -38.26 81.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.929 0.492 . . . . 0.0 111.596 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.87 -31.67 20.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.567 -0.73 . . . . 0.0 112.027 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.86 -36.94 77.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.597 1.09 . . . . 0.0 109.817 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -52.83 -38.09 60.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 111.559 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 66.8 mtt -72.35 -17.94 61.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.248 0.619 . . . . 0.0 112.43 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.86 26.52 4.3 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.525 1.13 . . . . 0.0 111.801 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -69.45 -70.69 0.26 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.427 0.691 . . . . 0.0 109.765 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -121.59 52.08 1.27 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.343 1.457 . . . . 0.0 107.111 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.16 124.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -107.7 93.68 10.78 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 125.883 1.673 . . . . 0.0 108.249 -165.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.32 172.28 16.25 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.119 2.546 . . . . 0.0 112.686 -164.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.61 135.43 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.69 143.15 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.928 1.291 . . . . 0.0 107.66 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -152.36 113.48 4.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mp -109.6 140.21 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -140.59 139.53 34.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -115.76 166.94 11.38 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.134 0.973 . . . . 0.0 111.089 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -147.7 56.25 1.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.87 -143.79 16.06 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.45 1.5 . . . . 0.0 109.799 -173.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.03 -35.98 78.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.567 1.147 . . . . 0.0 111.357 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.5 138.14 46.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.02 157.28 37.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.914 0.759 . . . . 0.0 112.561 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.47 138.71 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.395 -167.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -108.62 126.22 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.518 1.927 . . . . 0.0 106.553 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.3 m -123.65 138.22 54.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.607 1.163 . . . . 0.0 107.965 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.3 m -133.57 129.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 108.703 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.9 121.46 35.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.66 1.184 . . . . 0.0 108.113 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -122.28 155.29 61.98 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.19 40.42 0.97 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.425 2.75 . . . . 0.0 111.292 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -142.94 -50.72 0.35 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.899 2.079 . . . . 0.0 108.088 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -159.17 159.8 34.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.298 1.439 . . . . 0.0 108.981 -175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -111.87 146.47 37.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.065 0.946 . . . . 0.0 109.721 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.3 t -141.25 146.55 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.125 1.37 . . . . 0.0 108.419 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -149.92 157.81 43.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.247 0.619 . . . . 0.0 110.098 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -153.13 150.42 29.07 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.186 0.994 . . . . 0.0 109.923 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -122.53 150.52 42.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.145 1.778 . . . . 0.0 110.603 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -164.67 -179.52 5.95 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.188 0.995 . . . . 0.0 110.205 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.6 m -136.3 134.66 38.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.516 1.126 . . . . 0.0 108.877 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.17 142.69 50.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.489 0.316 . . . . 0.0 110.551 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.23 -39.99 2.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.001 1.286 . . . . 0.0 112.207 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -124.39 177.85 5.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.598 1.159 . . . . 0.0 111.292 -170.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -73.76 155.75 38.56 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.713 0.805 . . . . 0.0 111.009 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.14 149.48 28.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.28 1.032 . . . . 0.0 109.176 171.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -85.11 138.3 32.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.484 0.713 . . . . 0.0 109.167 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -127.99 147.65 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.798 1.239 . . . . 0.0 107.843 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 124.706 1.202 . . . . 0.0 108.662 179.257 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.301 0.572 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.95 178.47 8.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.549 1.94 . . . . 0.0 108.462 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.34 158.16 35.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.302 0.641 . . . . 0.0 110.393 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.7 p -157.98 160.84 37.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.759 1.223 . . . . 0.0 109.155 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.6 m -74.62 100.17 3.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.5 t -74.38 97.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -133.89 153.5 51.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.724 0.81 . . . . 0.0 109.756 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -135.44 131.54 36.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.368 1.067 . . . . 0.0 109.269 -165.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.11 88.97 3.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.559 1.543 . . . . 0.0 109.606 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.95 67.06 0.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.901 1.28 . . . . 0.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.17 31.93 82.29 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.283 0.944 . . . . 0.0 113.077 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.01 112.13 5.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.083 0.953 . . . . 0.0 108.559 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -74.9 125.67 29.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.53 114.37 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.1 p -130.11 162.78 28.05 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.844 0.858 . . . . 0.0 109.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.1 142.94 18.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 168.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 t -137.67 168.56 19.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.026 1.73 . . . . 0.0 108.103 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -84.77 50.05 1.84 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.454 0.702 . . . . 0.0 110.695 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? 178.51 -23.0 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.948 2.099 . . . . 0.0 111.429 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -150.24 161.56 42.2 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.886 0.766 . . . . 0.0 111.049 -166.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.9 t -149.01 141.94 24.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.379 1.071 . . . . 0.0 108.842 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -122.9 102.46 8.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.453 1.901 . . . . 0.0 106.513 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -121.72 94.35 4.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.29 1.436 . . . . 0.0 109.51 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -121.71 112.33 18.27 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.67 147.83 45.37 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.51 0.724 . . . . 0.0 110.255 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.47 149.95 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.605 1.162 . . . . 0.0 109.915 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -125.12 -155.09 0.65 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.147 . . . . 0.0 108.287 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.48 -59.36 8.93 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.616 0.627 . . . . 0.0 111.884 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -136.22 22.3 3.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.378 1.071 . . . . 0.0 111.207 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -142.53 155.0 44.97 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.066 0.946 . . . . 0.0 108.976 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.7 ttt -146.03 133.78 21.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.667 1.187 . . . . 0.0 108.731 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.2 t -102.86 122.44 55.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.64 91.93 3.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.289 1.836 . . . . 0.0 108.441 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.8 m -103.46 133.75 47.99 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 109.11 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 34.2 mm -125.63 153.29 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.0 m -133.08 143.59 49.43 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -129.61 92.47 3.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 106.337 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -9.13 83.81 0.0 OUTLIER Glycine 0 C--N 1.342 0.867 0 C-N-CA 129.296 3.331 . . . . 0.0 115.068 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.19 -46.24 1.02 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.232 0.92 . . . . 0.0 110.947 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.69 150.78 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 125.417 1.487 . . . . 0.0 108.767 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -122.39 155.96 34.98 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.313 1.445 . . . . 0.0 108.987 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp -125.44 136.03 52.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.74 115.43 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 165.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -126.92 156.33 41.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.958 1.703 . . . . 0.0 106.637 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -141.62 147.0 36.9 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.771 0.429 . . . . 0.0 110.365 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -134.64 160.83 36.89 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.435 1.494 . . . . 0.0 110.83 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -121.96 144.95 48.57 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.26 1.424 . . . . 0.0 109.539 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -75.21 140.45 43.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.656 1.182 . . . . 0.0 110.862 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.432 1.493 . . . . 0.0 107.932 177.131 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.3 p -51.09 135.12 25.9 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.138 0.975 . . . . 0.0 111.127 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.06 -170.65 35.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 m -121.69 146.09 47.36 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.763 1.225 . . . . 0.0 108.704 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -145.0 161.9 38.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.95 1.3 . . . . 0.0 110.062 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 123.87 23.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.938 1.295 . . . . 0.0 107.781 172.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.71 137.63 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -122.63 -43.66 2.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.043 0.937 . . . . 0.0 110.707 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.01 146.91 46.19 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.631 0.772 . . . . 0.0 110.685 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.28 138.18 21.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.5 1.92 . . . . 0.0 107.808 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -151.41 139.6 20.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.508 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t30 64.64 28.13 13.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.586 2.354 . . . . 0.0 112.164 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -79.91 -50.54 10.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 109.977 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -53.99 -38.76 65.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 111.729 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -57.65 -52.57 64.88 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.095 0.958 . . . . 0.0 110.482 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.14 -46.77 89.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.039 0.536 . . . . 0.0 111.453 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.4 mt -55.69 -42.39 75.1 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.604 0.362 . . . . 0.0 111.406 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -65.89 -38.54 89.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.221 0.208 . . . . 0.0 110.669 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -23.17 65.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.86 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.78 -71.82 0.2 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.311 0.96 . . . . 0.0 109.596 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.47 -54.53 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.291 1.036 . . . . 0.0 110.527 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.9 134.93 47.66 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.238 1.015 . . . . 0.0 111.774 -170.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.06 168.05 23.98 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.491 2.794 . . . . 0.0 111.196 -171.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -50.43 -35.32 28.07 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 113.531 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.76 -36.94 82.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.486 0.714 . . . . 0.0 112.001 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.0 mt -86.84 -33.14 19.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.716 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -35.34 69.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 119.647 1.112 . . . . 0.0 110.434 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -46.98 -44.19 19.93 Favored 'General case' 0 C--N 1.345 0.403 0 C-N-CA 124.508 1.123 . . . . 0.0 111.192 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.6 ttt -71.21 -16.59 62.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.142 0.977 . . . . 0.0 112.008 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.71 -34.79 9.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.657 1.183 . . . . 0.0 111.12 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.75 -57.65 1.86 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 127.023 2.129 . . . . 0.0 111.821 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -118.14 35.41 4.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.853 0.861 . . . . 0.0 109.981 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.59 122.64 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -112.22 100.05 48.26 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 109.255 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.72 166.65 23.41 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.281 -166.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mm -68.25 140.97 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.07 147.1 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -148.47 128.55 13.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.59 143.52 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 107.931 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -141.61 77.06 1.57 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.549 1.14 . . . . 0.0 108.901 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -81.55 128.93 34.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.926 0.89 . . . . 0.0 108.906 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -125.99 79.68 1.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.03 -120.28 5.25 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.095 0.855 . . . . 0.0 111.497 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -68.95 -40.7 78.78 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.168 0.987 . . . . 0.0 111.69 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.76 138.07 39.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.058 0.543 . . . . 0.0 109.876 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -127.51 117.31 21.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.138 1.775 . . . . 0.0 107.572 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.1 t -110.04 126.21 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.27 141.6 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.173 1.389 . . . . 0.0 108.028 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.2 m -141.86 152.41 43.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 108.812 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.7 p -147.93 143.32 27.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.372 1.069 . . . . 0.0 109.093 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -125.8 136.93 53.68 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.28 1.032 . . . . 0.0 109.402 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.52 168.73 12.34 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.957 1.303 . . . . 0.0 108.175 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.07 -25.01 32.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.429 2.086 . . . . 0.0 113.0 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -138.17 33.59 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.504 0.722 . . . . 0.0 110.566 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.81 173.16 1.97 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.091 . . . . 0.0 109.588 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.6 t -170.63 151.47 3.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 108.295 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -144.58 148.42 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.088 1.355 . . . . 0.0 108.872 -173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 156.89 43.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.966 0.906 . . . . 0.0 110.381 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -150.67 143.93 24.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.253 1.421 . . . . 0.0 109.422 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m -130.86 130.33 43.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.847 1.259 . . . . 0.0 109.639 -172.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -158.19 173.64 16.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.974 0.91 . . . . 0.0 110.032 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 m -145.28 147.71 32.66 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.549 1.139 . . . . 0.0 108.463 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.91 168.87 19.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 111.644 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.87 -39.99 3.03 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.89 0.757 . . . . 0.0 113.207 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -120.28 -173.34 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.491 1.116 . . . . 0.0 109.887 -168.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -57.66 145.12 35.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.508 1.123 . . . . 0.0 109.997 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 105.16 3.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.444 0.698 . . . . 0.0 110.338 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.08 127.86 34.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 165.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.73 144.59 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.874 0.47 . . . . 0.0 110.365 174.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.455 -0.218 0 C-N-CA 124.139 0.976 . . . . 0.0 109.502 -179.709 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.2 pttm . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.23 162.82 34.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.517 1.527 . . . . 0.0 109.304 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -103.92 140.67 37.37 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.353 1.061 . . . . 0.0 109.048 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.6 p -152.27 174.99 13.11 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.705 1.202 . . . . 0.0 108.812 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -110.12 97.62 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.71 137.58 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -151.54 157.22 41.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 109.628 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.86 123.05 49.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.18 -68.56 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.001 0.921 . . . . 0.0 110.434 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -156.96 78.1 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.27 28.95 65.12 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.12 0.867 . . . . 0.0 112.089 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -152.27 140.75 20.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.111 2.164 . . . . 0.0 106.559 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.71 135.54 33.65 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.54 122.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 p -133.68 142.11 47.88 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -150.62 145.27 25.78 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.644 0.378 . . . . 0.0 110.874 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -126.16 -168.6 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.611 1.565 . . . . 0.0 108.542 166.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -36.41 68.4 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.166 0.986 . . . . 0.0 113.211 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -133.75 -37.12 0.93 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.548 1.139 . . . . 0.0 112.407 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.65 149.69 47.83 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.9 m -150.24 157.92 43.6 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.107 0.963 . . . . 0.0 108.951 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -166.69 149.37 6.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -154.98 123.59 6.07 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -118.2 141.47 48.47 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.793 0.837 . . . . 0.0 109.499 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -141.5 127.2 19.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.278 1.431 . . . . 0.0 107.759 -173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.08 133.84 64.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 124.531 1.133 . . . . 0.0 108.574 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.53 164.38 29.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.073 2.149 . . . . 0.0 107.838 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.98 -85.9 0.01 OUTLIER Glycine 0 C--N 1.344 0.987 0 C-N-CA 128.337 2.875 . . . . 0.0 115.119 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -125.59 40.59 3.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.271 1.028 . . . . 0.0 110.008 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -152.03 128.41 10.62 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 ttt -122.26 121.07 35.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.996 1.318 . . . . 0.0 108.591 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.77 135.04 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -130.85 89.29 2.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.923 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.9 m -95.44 133.87 38.92 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.419 0.687 . . . . 0.0 109.441 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.63 143.68 38.08 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.9 m -136.13 133.87 37.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.61 1.164 . . . . 0.0 108.669 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -123.78 72.02 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.509 1.923 . . . . 0.0 107.207 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 14.43 67.93 0.01 OUTLIER Glycine 0 C--N 1.344 1.014 0 C-N-CA 129.063 3.22 . . . . 0.0 115.407 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.4 -43.34 1.1 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.38 148.53 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.4 t -121.19 164.67 16.56 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.32 1.048 . . . . 0.0 110.323 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -145.44 140.97 27.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.002 1.321 . . . . 0.0 108.183 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -124.77 129.32 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -111.68 146.49 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 165.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -135.56 128.89 32.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.4 m -121.58 156.07 33.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.994 1.318 . . . . 0.0 110.788 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -121.37 137.95 54.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.111 1.764 . . . . 0.0 107.809 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -70.46 145.31 51.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.553 0.216 . . . . 0.0 111.098 -170.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.545 1.538 . . . . 0.0 107.754 179.397 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 t -53.44 114.03 1.37 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.504 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 -177.55 43.43 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -120.5 156.07 32.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.882 1.273 . . . . 0.0 108.923 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -149.59 152.94 36.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.224 1.41 . . . . 0.0 109.893 -169.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -129.59 120.13 24.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.321 1.448 . . . . 0.0 107.311 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.15 121.14 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.333 0.653 . . . . 0.0 109.545 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -89.58 -51.34 5.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.815 1.646 . . . . 0.0 109.735 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.06 161.99 37.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.135 0.574 . . . . 0.0 110.581 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -156.23 137.55 13.87 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.009 1.324 . . . . 0.0 109.422 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -151.77 142.01 22.35 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.965 0.906 . . . . 0.0 110.54 -171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.46 31.46 12.25 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.944 1.698 . . . . 0.0 111.415 -167.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -94.78 -49.65 5.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.609 1.963 . . . . 0.0 108.627 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -53.55 -34.48 58.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.716 1.207 . . . . 0.0 111.677 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -57.49 -49.86 74.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.608 0.763 . . . . 0.0 111.089 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -68.34 -42.84 78.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.915 0.325 . . . . 0.0 111.428 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.01 -42.4 85.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.53 0.332 . . . . 0.0 110.853 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.08 -41.28 99.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 110.754 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.61 -25.85 66.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.151 0.58 . . . . 0.0 112.157 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.82 172.3 13.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.477 0.581 . . . . 0.0 110.709 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.93 76.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.267 1.427 . . . . 0.0 113.283 -175.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.12 132.97 90.12 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.913 -175.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.45 164.39 34.06 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.195 2.597 . . . . 0.0 110.578 -174.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -54.16 -31.28 52.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.713 1.205 . . . . 0.0 112.216 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -56.71 -44.11 81.25 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.056 0.942 . . . . 0.0 111.39 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.92 -29.7 26.92 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.18 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.74 -34.11 60.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 119.501 1.046 . . . . 0.0 109.716 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -52.66 -37.07 58.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.037 0.935 . . . . 0.0 111.618 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.73 -58.4 3.51 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.33 61.55 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.546 1.138 . . . . 0.0 112.595 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -53.26 -34.48 57.38 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.119 1.367 . . . . 0.0 112.008 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -121.04 40.23 3.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.28 1.032 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.0 mt -125.68 134.96 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 166.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.87 102.28 26.27 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.451 1.1 . . . . 0.0 108.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 138.3 20.85 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.062 1.841 . . . . 0.0 109.996 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.43 141.46 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.8 t -123.88 147.17 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.34 144.11 25.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.76 144.64 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -141.9 143.75 33.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 170.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.83 152.08 27.95 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.092 0.557 . . . . 0.0 109.977 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -147.05 58.04 1.16 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.072 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.74 -135.72 12.9 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.84 -27.9 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.251 1.02 . . . . 0.0 112.001 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.11 140.07 43.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.222 1.409 . . . . 0.0 110.856 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -141.49 127.37 19.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.824 1.249 . . . . 0.0 108.234 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.73 138.04 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.56 128.9 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.1 m -124.56 151.95 44.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.384 1.474 . . . . 0.0 109.274 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 p -125.29 151.42 46.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.788 1.635 . . . . 0.0 108.415 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -136.65 107.36 6.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.35 140.39 14.81 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.11 -9.65 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.959 2.439 . . . . 0.0 113.637 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -128.77 10.7 6.06 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.106 0.962 . . . . 0.0 111.917 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -166.21 79.82 0.26 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.022 0.828 . . . . 0.0 110.426 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.9 m -110.81 101.52 10.12 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -136.78 152.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.913 1.285 . . . . 0.0 110.126 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.7 m -124.74 147.65 48.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.507 1.523 . . . . 0.0 109.981 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.19 131.6 38.78 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 126.726 2.01 . . . . 0.0 107.018 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 p -122.41 132.03 54.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.241 1.016 . . . . 0.0 109.761 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.75 176.35 11.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 111.609 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -145.43 145.03 30.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.8 1.64 . . . . 0.0 107.936 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.84 137.41 55.29 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.986 0.514 . . . . 0.0 110.842 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.82 48.14 84.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -157.74 166.38 32.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -60.19 116.78 4.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.58 101.58 7.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.159 0.984 . . . . 0.0 109.225 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -79.72 112.73 17.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.336 1.054 . . . . 0.0 109.583 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -127.35 140.53 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.228 1.011 . . . . 0.0 108.415 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 m . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 123.901 0.881 . . . . 0.0 109.872 -178.604 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 153.66 51.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.379 1.472 . . . . 0.0 109.107 170.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.43 142.6 27.52 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.985 0.914 . . . . 0.0 109.99 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.6 m -142.79 175.17 10.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 109.589 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 m -132.18 84.91 2.19 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.7 1.2 . . . . 0.0 107.845 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.63 149.89 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.922 0.889 . . . . 0.0 110.602 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -134.62 157.72 45.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.458 1.503 . . . . 0.0 108.513 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.35 112.29 24.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.42 -66.26 0.93 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.885 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.66 83.82 0.61 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.2 35.03 82.63 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.558 0.599 . . . . 0.0 111.709 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -161.52 141.38 10.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.75 0.82 . . . . 0.0 110.004 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.42 133.89 34.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.05 136.64 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 108.065 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 m -148.27 148.63 30.67 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.6 1.16 . . . . 0.0 108.353 -172.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -144.89 154.52 42.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.948 1.299 . . . . 0.0 109.634 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 -172.48 3.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.721 1.608 . . . . 0.0 107.328 167.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -63.03 -56.49 16.5 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.561 0.744 . . . . 0.0 110.141 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -96.76 -36.89 10.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.562 1.145 . . . . 0.0 111.268 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -99.75 156.7 16.96 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.234 1.014 . . . . 0.0 110.823 -170.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.7 t -147.36 156.2 42.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.052 0.941 . . . . 0.0 108.54 165.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.17 127.99 8.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -172.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -147.19 120.86 9.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.15 131.08 54.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.314 1.046 . . . . 0.0 108.865 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.41 129.99 54.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.48 2.312 . . . . 0.0 107.447 -175.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.5 t -120.51 144.79 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.955 0.902 . . . . 0.0 109.42 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -137.09 -176.06 4.25 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.186 1.795 . . . . 0.0 108.582 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.29 -61.32 6.74 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.623 1.106 . . . . 0.0 113.403 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -129.55 31.92 4.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.772 1.229 . . . . 0.0 110.905 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -159.49 150.11 19.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 16.0 ttt -144.93 134.61 23.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.786 1.234 . . . . 0.0 107.903 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.22 139.22 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -134.63 137.08 43.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.191 0.996 . . . . 0.0 108.94 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -143.32 133.31 24.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.789 0.836 . . . . 0.0 109.239 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.47 152.66 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.2 m -136.47 137.33 40.28 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -133.09 95.04 3.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.81 1.644 . . . . 0.0 106.566 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.66 -125.29 39.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.14 24.84 23.06 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.078 -0.845 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.6 136.71 58.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.9 m -121.53 145.27 48.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.158 1.383 . . . . 0.0 107.98 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.93 131.59 54.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -125.56 136.03 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -157.07 174.89 14.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -157.69 150.81 23.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m -130.83 162.34 29.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.93 1.292 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -122.65 139.6 53.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.463 1.505 . . . . 0.0 108.415 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -70.88 148.62 47.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.678 0.791 . . . . 0.0 111.072 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 C--O 1.252 1.235 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.474 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 N--CA 1.458 -0.074 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.7 p -52.92 100.29 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.11 1.364 . . . . 0.0 110.669 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.32 -168.48 36.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.5 m -119.51 151.73 38.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.187 1.395 . . . . 0.0 108.69 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -148.85 129.41 13.99 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 110.208 -162.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -113.07 106.8 15.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.567 1.547 . . . . 0.0 109.17 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.52 117.96 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.121 0.968 . . . . 0.0 109.551 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -99.51 -40.67 7.72 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.811 0.844 . . . . 0.0 111.09 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.41 148.2 43.5 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.927 0.891 . . . . 0.0 110.625 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.49 134.97 14.29 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.544 1.538 . . . . 0.0 108.346 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -156.14 137.87 14.26 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.099 0.959 . . . . 0.0 109.483 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.31 -35.66 0.33 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.459 1.904 . . . . 0.0 111.352 -172.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -32.23 -49.69 0.2 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.428 2.691 . . . . 0.0 112.115 156.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.79 -52.03 67.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.835 0.854 . . . . 0.0 111.016 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.94 -41.5 91.95 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.161 . . . . 0.0 110.664 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.28 -50.37 74.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.329 0.652 . . . . 0.0 111.584 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.94 -42.78 85.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.094 0.406 . . . . 0.0 111.123 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -38.44 80.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -27.25 67.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.957 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.01 -65.17 0.73 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.445 0.566 . . . . 0.0 111.348 -167.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.99 -58.31 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.427 1.091 . . . . 0.0 109.466 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -55.9 130.53 72.9 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.189 0.596 . . . . 0.0 110.508 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.75 170.12 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.299 2.666 . . . . 0.0 111.332 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.57 -28.57 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.876 1.67 . . . . 0.0 113.282 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.14 -42.51 96.77 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.433 0.693 . . . . 0.0 111.868 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.5 mt -83.98 -34.1 24.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.771 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.46 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.276 0.944 . . . . 0.0 111.047 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -49.11 -35.88 17.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 111.629 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.5 mtt -71.24 -60.23 2.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.23 -41.76 69.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.525 1.13 . . . . 0.0 112.168 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -51.36 -37.26 47.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.465 1.506 . . . . 0.0 111.521 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.28 37.58 4.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.032 0.933 . . . . 0.0 110.934 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.5 mt -133.15 136.92 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 168.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -103.1 89.57 2.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.615 1.166 . . . . 0.0 108.293 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.33 148.23 88.2 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.052 1.835 . . . . 0.0 110.923 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 tp -96.26 124.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 t -123.76 136.89 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -168.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -126.97 121.02 30.52 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.795 1.238 . . . . 0.0 108.46 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 98.4 mt -110.62 135.13 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -124.12 88.7 2.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.655 1.582 . . . . 0.0 108.627 -171.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -85.18 128.78 34.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 166.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -132.2 77.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 163.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.82 -128.33 8.44 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.846 1.212 . . . . 0.0 111.174 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.1 -33.05 74.63 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.544 1.138 . . . . 0.0 112.06 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.38 142.46 28.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.185 0.994 . . . . 0.0 110.85 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.65 137.01 45.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.458 1.903 . . . . 0.0 108.264 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.35 124.4 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.26 125.79 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -122.64 135.78 54.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.771 1.228 . . . . 0.0 108.239 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -125.77 128.87 48.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -124.88 114.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 165.79 31.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.78 -3.54 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.277 1.985 . . . . 0.0 113.223 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -139.77 -17.93 0.96 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -130.17 98.6 4.78 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.592 1.157 . . . . 0.0 109.151 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -110.91 113.4 25.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 172.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.16 150.25 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.229 . . . . 0.0 109.394 -173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -135.93 147.06 47.95 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.833 1.253 . . . . 0.0 109.615 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -132.76 149.25 52.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.668 1.187 . . . . 0.0 109.875 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -128.07 138.79 52.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.371 1.868 . . . . 0.0 109.738 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.42 176.33 11.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.082 0.953 . . . . 0.0 110.132 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.2 m -138.39 146.27 42.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.052 1.341 . . . . 0.0 108.196 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 pp -66.8 148.78 51.48 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.967 0.167 . . . . 0.0 111.269 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.43 43.23 44.15 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.855 1.217 . . . . 0.0 112.877 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -156.37 140.15 16.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.11 116.79 7.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.481 0.712 . . . . 0.0 110.566 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.31 160.22 25.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.133 1.373 . . . . 0.0 109.327 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.11 139.74 38.23 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 tt -137.25 168.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.523 1.529 . . . . 0.0 108.17 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.6 m . . . . . 0 N--CA 1.457 -0.118 0 C-N-CA 123.36 0.664 . . . . 0.0 109.849 -174.796 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.75 161.27 39.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.87 1.268 . . . . 0.0 109.136 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -89.07 154.3 20.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.336 0.654 . . . . 0.0 109.797 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p -155.05 165.66 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.397 1.079 . . . . 0.0 109.939 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.1 m -135.32 76.73 1.63 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 137.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -150.95 153.23 34.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.947 0.899 . . . . 0.0 109.44 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.49 162.0 19.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.178 0.991 . . . . 0.0 110.274 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.63 49.3 0.87 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.585 1.154 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.9 t30 68.09 95.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.578 1.951 . . . . 0.0 111.979 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.79 24.54 75.53 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.105 0.86 . . . . 0.0 112.854 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -163.06 147.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.203 . . . . 0.0 108.694 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -103.68 151.25 23.2 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.035 1.334 . . . . 0.0 108.205 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.3 t -121.63 95.08 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -71.25 144.81 49.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.736 0.814 . . . . 0.0 109.526 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -164.86 128.2 2.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.933 0.493 . . . . 0.0 111.928 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -141.71 -149.03 0.26 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.269 2.228 . . . . 0.0 106.115 166.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.64 -73.92 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -78.76 -37.7 40.5 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 111.723 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -95.71 81.76 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.579 0.752 . . . . 0.0 111.054 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.6 p -140.91 144.17 35.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.212 1.005 . . . . 0.0 110.904 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 180.0 -145.74 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.17 1.788 . . . . 0.0 110.124 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.78 170.41 15.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.439 1.496 . . . . 0.0 110.378 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -160.0 127.51 4.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 109.615 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -122.27 149.73 43.3 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.801 1.64 . . . . 0.0 109.86 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.02 146.39 33.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.026 0.931 . . . . 0.0 110.422 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -136.55 171.7 14.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.516 1.926 . . . . 0.0 108.474 168.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -3.22 -76.0 0.01 OUTLIER Glycine 0 C--N 1.343 0.929 0 C-N-CA 128.906 3.146 . . . . 0.0 116.264 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.58 35.43 2.93 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.47 1.108 . . . . 0.0 110.269 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.21 147.29 31.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.201 0.6 . . . . 0.0 110.884 -172.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.14 130.24 38.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.593 1.557 . . . . 0.0 108.63 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.71 116.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -129.8 136.8 50.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 109.794 -169.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 t -142.3 157.73 44.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.201 0.524 . . . . 0.0 110.645 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.4 128.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.78 171.55 9.88 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -150.81 80.68 1.33 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.51 -113.19 5.58 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -175.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.95 68.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.37 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.98 160.41 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.745 1.218 . . . . 0.0 107.871 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.2 m -134.39 155.46 50.24 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.274 1.03 . . . . 0.0 110.311 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 mp -127.1 129.04 47.19 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 158.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.94 142.57 39.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 164.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -158.18 147.93 19.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -128.26 136.08 50.54 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 t -125.04 162.93 23.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.525 1.13 . . . . 0.0 110.583 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.71 133.96 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.52 1.528 . . . . 0.0 107.499 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 ttp85 -68.82 150.92 47.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.054 0.541 . . . . 0.0 109.918 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--O 1.249 1.038 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 172.654 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.3 p -168.7 155.01 6.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.58 1.152 . . . . 0.0 110.026 -173.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.34 -169.76 16.74 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.161 0.886 . . . . 0.0 112.449 165.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -121.95 134.13 54.84 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.939 1.295 . . . . 0.0 108.849 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -144.02 165.0 29.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.167 0.987 . . . . 0.0 111.281 -166.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -148.15 122.64 9.75 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.762 1.225 . . . . 0.0 108.943 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.01 139.63 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.67 1.188 . . . . 0.0 109.783 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -124.06 -37.67 2.55 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.331 0.652 . . . . 0.0 112.187 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.51 149.4 51.71 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 110.161 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.38 148.46 14.77 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.7 0.8 . . . . 0.0 111.536 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.08 140.54 21.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.334 1.454 . . . . 0.0 108.184 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 59.24 89.96 0.06 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.381 1.472 . . . . 0.0 109.268 -171.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -148.64 -51.41 0.17 Allowed 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -47.65 -50.73 23.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.049 1.34 . . . . 0.0 111.375 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.84 -47.49 82.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.819 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -61.66 -53.36 57.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.948 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -62.99 -35.37 79.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.948 0.34 . . . . 0.0 111.51 -174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -75.81 -36.3 59.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.291 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.84 65.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.314 0.506 . . . . 0.0 111.147 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -74.11 -64.52 1.0 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.424 1.089 . . . . 0.0 109.543 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.11 -65.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.353 0.661 . . . . 0.0 111.135 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -56.33 136.77 75.66 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.7 0.8 . . . . 0.0 112.684 -165.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.48 171.47 16.77 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.572 2.848 . . . . 0.0 111.889 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.22 -34.63 4.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.842 2.057 . . . . 0.0 113.532 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.43 -31.85 71.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.949 0.9 . . . . 0.0 112.104 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -93.78 -32.17 14.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.8 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pp -66.89 -20.7 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 119.078 0.854 . . . . 0.0 111.296 173.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -49.87 -38.31 34.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.61 0.641 . . . . 0.0 110.582 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -96.2 46.75 1.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.362 1.065 . . . . 0.0 109.683 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -156.9 -52.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.321 1.048 . . . . 0.0 110.634 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -52.46 -46.38 66.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.62 1.968 . . . . 0.0 112.341 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -120.51 35.21 4.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 109.328 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.82 144.73 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -111.88 90.32 12.98 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.64 137.29 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.184 1.923 . . . . 0.0 109.426 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.55 137.52 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.36 142.02 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.38 129.75 22.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.171 1.388 . . . . 0.0 108.11 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.14 138.43 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.289 1.436 . . . . 0.0 108.505 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -126.15 125.49 42.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.32 1.048 . . . . 0.0 108.648 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.95 142.99 29.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.62 1.568 . . . . 0.0 111.559 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -140.85 42.09 1.83 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.858 1.663 . . . . 0.0 110.829 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 96.71 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.16 0.886 . . . . 0.0 112.771 170.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 57.29 18.52 4.35 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.352 1.461 . . . . 0.0 112.56 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -150.8 143.5 24.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.75 2.02 . . . . 0.0 105.783 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.81 150.89 30.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.819 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.0 131.64 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.437 1.095 . . . . 0.0 108.441 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.95 134.04 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.955 1.702 . . . . 0.0 107.337 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.1 m -132.72 137.42 46.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.704 1.202 . . . . 0.0 107.986 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 t -127.09 140.12 52.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.975 1.71 . . . . 0.0 107.737 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -123.35 116.7 23.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.05 159.97 56.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.27 -4.39 14.27 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.008 1.805 . . . . 0.0 112.445 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -119.42 29.11 7.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.233 1.413 . . . . 0.0 110.932 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 127.83 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.303 3.441 . . . . 0.0 110.389 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 p -108.79 138.08 45.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.2 135.71 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.336 1.454 . . . . 0.0 108.099 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -144.43 151.4 39.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 111.524 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.17 140.98 9.26 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.557 1.543 . . . . 0.0 109.751 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -124.91 151.64 45.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.868 1.267 . . . . 0.0 109.828 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -166.2 152.99 9.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.24 0.543 . . . . 0.0 110.984 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -122.42 144.52 48.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.434 1.894 . . . . 0.0 108.016 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.34 131.73 46.76 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.343 0.257 . . . . 0.0 111.476 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.26 50.34 51.45 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -160.46 139.27 10.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.47 142.28 49.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.97 150.67 27.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.649 0.779 . . . . 0.0 109.892 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -89.43 132.38 35.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.303 1.041 . . . . 0.0 109.219 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.74 147.14 25.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.319 1.048 . . . . 0.0 108.273 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.454 -0.238 0 C-N-CA 124.945 1.298 . . . . 0.0 107.975 -175.199 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 121.187 0.517 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.7 -173.8 2.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.536 2.334 . . . . 0.0 107.633 166.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.81 146.33 37.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.79 0.836 . . . . 0.0 110.68 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.9 p -166.23 162.6 17.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.777 1.231 . . . . 0.0 109.094 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -116.26 61.31 0.72 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 111.894 -173.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.63 138.06 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.381 1.073 . . . . 0.0 112.396 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -151.22 153.96 35.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.291 1.037 . . . . 0.0 110.303 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -85.15 125.49 32.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.059 1.344 . . . . 0.0 108.906 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.28 -68.38 0.8 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.212 1.005 . . . . 0.0 109.387 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -164.51 88.52 0.5 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.93 24.23 64.52 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.198 0.904 . . . . 0.0 112.797 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -157.43 138.8 13.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 109.337 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.37 139.79 36.37 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.2 t -133.45 139.58 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.228 1.411 . . . . 0.0 107.376 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.82 156.11 37.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -143.56 141.49 30.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.309 1.044 . . . . 0.0 109.049 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 t -151.55 166.94 29.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.868 1.267 . . . . 0.0 107.883 163.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -85.72 12.32 9.17 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.157 0.983 . . . . 0.0 111.857 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -126.97 -30.33 2.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.21 1.804 . . . . 0.0 109.854 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -157.12 157.24 34.13 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.913 0.885 . . . . 0.0 109.682 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -136.15 150.91 49.26 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -143.95 92.67 2.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.369 1.468 . . . . 0.0 108.07 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -130.3 124.16 31.7 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.68 139.8 11.8 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -121.07 136.02 55.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.944 2.098 . . . . 0.0 107.948 -172.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.0 133.72 56.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -160.84 127.7 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.628 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.34 -96.34 0.48 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.138 0.875 . . . . 0.0 110.949 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -138.8 18.46 2.67 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.251 1.02 . . . . 0.0 110.757 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -148.65 130.92 15.55 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.4 ptp -123.97 155.56 37.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.428 1.091 . . . . 0.0 111.488 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.55 131.7 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -131.61 140.54 49.43 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.29 0.636 . . . . 0.0 110.898 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -131.17 129.34 41.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.982 1.713 . . . . 0.0 108.181 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 48.0 mm -123.48 152.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 53.2 m -134.99 145.84 48.49 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 163.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -130.5 105.44 7.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 170.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -15.69 89.05 0.01 OUTLIER Glycine 0 C--N 1.342 0.864 0 C-N-CA 128.562 2.982 . . . . 0.0 115.016 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.8 -47.88 0.95 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.93 137.35 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 109.183 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 36.6 m -120.19 133.51 55.48 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.172 1.389 . . . . 0.0 109.179 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.92 140.12 51.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.951 2.101 . . . . 0.0 108.73 -170.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.19 141.73 40.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm85 -162.77 160.72 25.67 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 109.761 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -135.64 143.91 45.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.457 1.103 . . . . 0.0 109.344 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 m -133.21 155.73 48.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.427 1.091 . . . . 0.0 109.417 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -124.71 142.11 51.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.074 1.35 . . . . 0.0 108.158 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -65.95 141.75 58.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.554 0.741 . . . . 0.0 109.859 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 C--O 1.251 1.18 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 CA--C 1.527 0.095 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 p -48.34 112.06 0.54 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.281 1.433 . . . . 0.0 110.793 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.58 -177.31 41.48 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -119.28 140.62 49.98 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.842 1.257 . . . . 0.0 107.922 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -142.29 150.26 40.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.007 0.923 . . . . 0.0 109.759 -163.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -137.33 121.63 18.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -53.25 117.31 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.214 1.006 . . . . 0.0 108.613 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.11 -35.06 9.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.525 0.73 . . . . 0.0 110.209 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 147.08 39.68 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.507 1.123 . . . . 0.0 108.652 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.8 147.08 22.59 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.005 0.922 . . . . 0.0 109.99 -175.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.74 155.73 36.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.296 0.57 . . . . 0.0 111.532 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.22 35.11 25.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.237 1.815 . . . . 0.0 110.494 -169.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -99.88 -45.41 5.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.866 1.666 . . . . 0.0 110.139 -167.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.25 -40.03 46.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.008 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.29 -48.31 82.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.493 1.117 . . . . 0.0 110.772 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.47 -46.5 89.86 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 122.889 0.476 . . . . 0.0 110.828 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.56 -45.37 85.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.662 0.21 . . . . 0.0 111.136 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -65.51 -34.48 78.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.984 0.514 . . . . 0.0 111.74 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.73 -25.35 67.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.79 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.4 mt -76.46 170.49 16.29 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.088 0.858 . . . . 0.0 110.64 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.54 94.27 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.74 1.216 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 139.85 97.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 111.516 -173.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.47 169.01 17.58 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.914 3.076 . . . . 0.0 111.191 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -48.92 -41.0 32.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.275 1.43 . . . . 0.0 112.631 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -53.85 -38.52 64.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.881 0.473 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.62 -24.12 19.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.607 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -32.56 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.832 1.196 . . . . 0.0 109.62 170.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -50.94 -43.27 60.17 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.336 1.054 . . . . 0.0 110.551 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 56.7 mtt -69.65 -52.18 28.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.244 0.618 . . . . 0.0 110.046 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.46 -35.7 70.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.768 0.827 . . . . 0.0 112.832 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -32.05 67.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.885 0.874 . . . . 0.0 111.186 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -119.39 49.03 1.4 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.175 0.99 . . . . 0.0 109.353 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.39 146.59 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 126.042 1.737 . . . . 0.0 106.472 165.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 106.5 40.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.334 1.054 . . . . 0.0 109.547 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.05 113.49 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.378 2.052 . . . . 0.0 109.392 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.31 139.29 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.06 148.36 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.598 1.559 . . . . 0.0 108.306 -171.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.87 130.11 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -109.1 129.14 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -119.14 101.4 7.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -126.12 141.76 51.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.639 1.176 . . . . 0.0 109.351 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -145.96 73.12 1.32 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.929 0.892 . . . . 0.0 108.953 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.89 -115.09 3.95 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.19 -42.67 88.53 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.53 0.732 . . . . 0.0 111.208 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -76.68 131.83 39.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.449 0.7 . . . . 0.0 110.432 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -129.84 120.85 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.058 1.743 . . . . 0.0 108.16 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -109.53 131.96 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.05 135.23 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -134.48 142.15 46.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.8 t -144.45 137.19 26.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.958 0.503 . . . . 0.0 109.804 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -124.1 153.84 40.86 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.736 1.214 . . . . 0.0 109.514 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.08 159.21 29.23 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.72 39.93 0.92 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.407 2.738 . . . . 0.0 111.577 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -144.55 -41.6 0.25 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.49 1.516 . . . . 0.0 110.129 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.0 169.82 23.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.206 1.802 . . . . 0.0 109.217 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.4 m -150.41 143.33 24.74 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.987 1.315 . . . . 0.0 107.681 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.16 146.56 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.59 1.156 . . . . 0.0 109.711 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.5 m -134.21 145.65 49.39 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.121 1.768 . . . . 0.0 107.529 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.85 130.52 24.17 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.556 1.542 . . . . 0.0 106.847 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 p -125.01 127.29 46.77 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.475 1.11 . . . . 0.0 109.249 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -164.39 -176.46 4.4 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.458 0.703 . . . . 0.0 110.613 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.5 m -140.25 148.22 41.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.131 1.372 . . . . 0.0 107.847 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 165.54 25.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.109 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.24 -29.05 5.35 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.055 0.836 . . . . 0.0 112.84 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -121.81 -177.03 3.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.144 1.378 . . . . 0.0 109.345 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.71 142.57 57.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.453 0.701 . . . . 0.0 109.791 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.4 125.64 16.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.367 1.067 . . . . 0.0 108.871 -175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.33 139.16 32.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.599 0.76 . . . . 0.0 109.27 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.2 mt -135.39 142.07 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.6 m . . . . . 0 CA--C 1.532 0.27 0 C-N-CA 125.779 1.632 . . . . 0.0 108.771 -177.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 mttm . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.915 0.388 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.15 168.08 24.19 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.229 1.412 . . . . 0.0 109.993 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -118.14 144.33 45.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.87 1.268 . . . . 0.0 108.994 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.4 p -157.79 150.1 22.42 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.489 1.115 . . . . 0.0 109.182 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.5 m -88.08 87.34 7.3 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.14 132.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.434 0.694 . . . . 0.0 109.518 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -150.37 164.53 35.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.812 1.245 . . . . 0.0 108.637 172.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.83 127.16 52.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.663 1.185 . . . . 0.0 108.105 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.25 142.54 25.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.427 1.091 . . . . 0.0 109.537 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.72 41.63 31.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.923 1.289 . . . . 0.0 111.781 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.43 31.44 79.51 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.133 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -154.79 151.6 28.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.98 0.89 . . . . 0.0 110.387 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.51 141.41 50.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.43 129.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.25 28.31 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -157.45 143.18 17.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.827 0.851 . . . . 0.0 109.192 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -109.82 -118.36 0.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.57 -47.8 5.23 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.463 1.505 . . . . 0.0 108.945 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 -44.25 2.11 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.9 1.28 . . . . 0.0 111.186 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -70.7 139.87 51.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 m -141.04 162.92 34.36 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.272 0.629 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.04 123.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.946 1.299 . . . . 0.0 107.877 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -136.69 110.84 8.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -118.98 120.2 36.56 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -121.02 150.96 40.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.338 1.455 . . . . 0.0 109.406 -170.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.45 136.19 57.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 125.792 1.637 . . . . 0.0 109.534 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.91 103.41 2.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.31 1.044 . . . . 0.0 109.931 170.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.64 -105.83 1.1 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.419 1.009 . . . . 0.0 111.429 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -122.58 24.65 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.931 1.293 . . . . 0.0 110.25 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -143.8 135.0 25.73 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 122.891 0.476 . . . . 0.0 110.723 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 mmt -100.74 129.23 46.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.1 123.51 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -135.87 141.94 44.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.241 -174.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -134.97 143.17 46.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.84 0.856 . . . . 0.0 109.414 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.41 142.83 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.843 1.657 . . . . 0.0 106.779 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.4 m -113.62 144.71 42.44 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.63 108.4 4.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.37 -125.3 39.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.21 29.11 13.23 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.03 0.824 . . . . 0.0 111.848 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.88 145.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 C-N-CA 124.906 1.282 . . . . 0.0 107.616 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.4 m -123.56 149.78 44.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.701 1.201 . . . . 0.0 107.89 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.0 133.67 53.62 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.64 128.82 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 ptt-85 -158.64 168.11 27.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.341 0.591 . . . . 0.0 111.048 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -138.39 132.8 32.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.353 -171.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 162.24 15.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.971 0.908 . . . . 0.0 110.139 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -126.52 147.57 49.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.332 1.453 . . . . 0.0 109.471 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -63.08 105.97 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.918 0.887 . . . . 0.0 110.045 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--O 1.253 1.244 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.078 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 119.796 -0.145 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 p -50.72 116.23 1.85 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.815 1.646 . . . . 0.0 111.022 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.84 -178.99 40.92 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -118.91 130.66 55.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -134.42 144.69 48.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.777 1.631 . . . . 0.0 109.166 -167.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -119.53 118.96 32.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -52.87 124.62 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.067 0.947 . . . . 0.0 108.966 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -103.49 -44.14 5.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.772 1.629 . . . . 0.0 109.777 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 155.5 41.64 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.095 0.958 . . . . 0.0 109.439 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -151.31 122.4 7.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.401 1.08 . . . . 0.0 109.319 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.87 136.52 38.78 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.772 0.829 . . . . 0.0 111.582 -165.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 65.02 14.75 9.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.808 2.443 . . . . 0.0 112.022 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -81.21 -50.98 8.91 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.509 1.524 . . . . 0.0 110.663 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.54 -47.75 75.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.374 0.67 . . . . 0.0 110.854 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -59.73 -47.41 85.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.58 1.552 . . . . 0.0 110.134 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -55.16 -53.11 60.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.034 0.533 . . . . 0.0 111.899 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.93 -41.35 82.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -62.24 -38.77 90.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.242 0.617 . . . . 0.0 110.974 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.89 -20.15 61.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.716 0.806 . . . . 0.0 112.218 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.0 tp -75.34 -59.35 2.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.756 0.707 . . . . 0.0 111.22 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.03 -46.0 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.905 1.282 . . . . 0.0 110.097 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.65 135.56 71.44 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.643 1.177 . . . . 0.0 110.848 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -79.29 169.77 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.461 2.774 . . . . 0.0 110.639 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -44.56 -38.09 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.115 1.766 . . . . 0.0 112.474 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.1 -46.04 68.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.299 1.04 . . . . 0.0 111.757 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -81.15 -34.66 32.29 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.335 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.03 -22.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 118.815 0.734 . . . . 0.0 112.036 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.44 -33.16 19.98 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.855 0.862 . . . . 0.0 111.904 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.4 ttp -60.87 -30.56 70.21 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 123.607 0.763 . . . . 0.0 112.095 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.99 -36.14 9.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.897 1.279 . . . . 0.0 111.387 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -34.88 18.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.753 2.021 . . . . 0.0 113.561 -170.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -120.08 6.92 10.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.417 1.087 . . . . 0.0 111.859 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.98 122.91 71.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -106.33 100.73 31.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.354 1.462 . . . . 0.0 108.182 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.12 156.32 51.64 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.685 2.257 . . . . 0.0 110.96 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 tt -83.46 147.96 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -131.87 151.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.038 1.735 . . . . 0.0 108.316 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -154.47 127.94 8.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.53 148.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 125.108 1.363 . . . . 0.0 107.714 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.45 141.05 37.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.13 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.82 152.08 0.33 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.469 1.908 . . . . 0.0 110.64 172.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -135.25 58.42 1.76 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.322 1.449 . . . . 0.0 107.786 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.66 -131.98 6.12 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.729 1.157 . . . . 0.0 110.23 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.86 -33.84 76.95 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.926 1.29 . . . . 0.0 113.349 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.72 171.92 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.485 0.714 . . . . 0.0 110.843 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -157.56 121.56 4.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.641 1.576 . . . . 0.0 108.463 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.8 129.89 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 158.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.44 130.49 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.522 1.529 . . . . 0.0 107.221 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.1 m -128.68 145.81 51.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.238 1.415 . . . . 0.0 108.155 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.7 t -139.87 136.21 33.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -123.25 134.59 54.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -130.57 151.51 78.79 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 125.694 1.598 . . . . 0.0 107.125 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.43 -19.09 49.75 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.788 2.325 . . . . 0.0 114.068 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -138.79 32.4 2.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.087 0.858 . . . . 0.0 111.941 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -171.31 156.2 4.53 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.629 1.172 . . . . 0.0 108.871 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.3 m -148.2 143.97 27.4 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.33 151.5 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 109.519 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.4 m -148.31 146.27 28.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.456 1.102 . . . . 0.0 108.665 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.31 155.14 42.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.396 1.478 . . . . 0.0 108.893 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 p -138.6 145.7 40.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.682 0.793 . . . . 0.0 109.93 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -163.03 172.71 14.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.955 1.302 . . . . 0.0 109.429 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -144.6 139.12 27.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.21 152.54 44.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.25 0.547 . . . . 0.0 111.715 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.69 75.31 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.071 1.32 . . . . 0.0 112.049 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -160.01 157.69 29.22 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.416 1.108 . . . . 0.0 111.576 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.74 144.55 50.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.912 1.685 . . . . 0.0 111.048 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.87 161.73 42.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.867 1.267 . . . . 0.0 109.385 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.7 144.85 25.64 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.4 mt -129.3 136.19 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 109.054 -175.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.4 3.66 2.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.547 1.139 . . . . 0.0 113.193 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 69.72 134.22 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.0 2.12 . . . . 0.0 112.759 171.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.7 125.3 13.27 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.928 1.291 . . . . 0.0 110.214 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -91.7 104.35 16.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.857 1.663 . . . . 0.0 108.719 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.11 150.47 3.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.077 0.951 . . . . 0.0 110.145 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -150.8 167.12 28.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.435 1.494 . . . . 0.0 109.117 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.91 115.16 16.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.57 -114.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.015 1.326 . . . . 0.0 110.555 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -83.91 56.95 3.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.426 1.49 . . . . 0.0 110.639 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.47 37.37 94.69 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -140.32 140.55 35.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.671 1.188 . . . . 0.0 107.946 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 tt -79.3 109.71 13.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.8 t -119.24 117.25 53.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 m -123.89 152.13 42.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.508 1.523 . . . . 0.0 109.404 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -128.9 135.44 49.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.352 1.461 . . . . 0.0 108.32 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t -110.17 168.27 9.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.695 1.198 . . . . 0.0 108.748 170.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.46 -43.47 84.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 111.045 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -96.68 -23.71 16.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.822 0.849 . . . . 0.0 113.162 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.9 -168.3 3.0 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.44 1.018 . . . . 0.0 112.373 -168.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -143.9 162.27 36.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.596 1.159 . . . . 0.0 111.502 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -149.54 120.9 7.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.589 1.556 . . . . 0.0 108.336 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -128.48 133.57 48.51 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.68 1.192 . . . . 0.0 108.423 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -152.07 135.95 16.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -165.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.0 152.78 30.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.385 0.274 . . . . 0.0 110.446 -166.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.3 t -119.3 139.36 46.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.854 1.261 . . . . 0.0 108.817 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -133.77 101.63 5.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.172 1.789 . . . . 0.0 109.321 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.71 -101.84 0.57 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.27 11.14 10.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.203 1.401 . . . . 0.0 111.377 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -114.88 145.74 41.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.322 1.449 . . . . 0.0 107.45 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.2 ttt -127.72 133.4 49.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.2 t -115.56 136.96 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.47 119.26 21.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.3 1.44 . . . . 0.0 108.657 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -129.28 114.57 16.41 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.84 140.27 44.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.9 t -119.68 172.23 7.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.065 0.393 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -158.11 103.17 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.86 1.664 . . . . 0.0 107.503 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.02 -113.71 5.36 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.03 28.44 13.01 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.17 0.89 . . . . 0.0 112.084 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.14 118.96 51.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -120.33 128.44 53.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.965 0.906 . . . . 0.0 109.246 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.91 138.78 50.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 107.861 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.81 130.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -151.95 164.57 36.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -151.69 155.89 39.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.0 m -136.13 166.05 24.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.558 1.143 . . . . 0.0 109.549 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -132.45 137.48 47.28 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.021 0.928 . . . . 0.0 109.341 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -58.13 132.55 53.85 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.508 0.723 . . . . 0.0 109.479 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.3 178.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 p -51.94 116.81 2.35 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.0 111.156 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.09 177.73 42.56 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.3 m -118.41 138.54 52.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.172 1.389 . . . . 0.0 107.669 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -143.48 155.18 44.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.53 1.132 . . . . 0.0 109.761 -163.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -142.39 128.17 19.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.63 134.14 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 124.042 0.937 . . . . 0.0 109.61 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -109.61 -33.97 6.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.435 0.694 . . . . 0.0 111.339 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.51 46.58 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.137 0.575 . . . . 0.0 110.828 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -148.79 144.3 26.9 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 109.09 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -156.65 144.12 19.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.222 1.009 . . . . 0.0 109.645 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.9 26.05 12.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.035 1.334 . . . . 0.0 110.855 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -99.98 -48.44 4.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.69 2.396 . . . . 0.0 107.711 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.02 -43.65 50.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.126 1.37 . . . . 0.0 110.572 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -60.13 -50.3 74.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.891 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -57.61 -50.03 74.49 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.297 0.639 . . . . 0.0 110.934 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.45 -44.25 95.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -62.87 -30.57 71.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.046 0.539 . . . . 0.0 111.626 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.47 66.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 0.0 111.389 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.02 -176.94 5.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.375 0.534 . . . . 0.0 110.094 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.12 -32.99 37.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.528 1.531 . . . . 0.0 113.606 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.48 111.38 1.8 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.104 1.362 . . . . 0.0 111.013 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.81 167.89 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.075 2.517 . . . . 0.0 110.065 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -46.04 -36.66 5.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.772 1.629 . . . . 0.0 113.059 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -72.4 -57.46 4.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.288 1.035 . . . . 0.0 111.622 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.28 -33.74 63.35 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.342 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -39.52 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -33.67 18.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.518 0.599 . . . . 0.0 112.267 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.22 -55.77 5.27 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.81 65.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.57 1.148 . . . . 0.0 112.9 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -45.34 -39.55 6.87 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.75 1.62 . . . . 0.0 111.974 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -118.2 47.36 1.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.334 1.054 . . . . 0.0 109.238 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.0 mt -127.12 135.16 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -109.47 99.15 35.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.868 1.667 . . . . 0.0 108.354 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.49 145.23 26.32 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.123 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.5 tp -80.81 137.13 21.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.95 148.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.285 1.434 . . . . 0.0 108.078 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -153.26 123.56 7.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mp -110.16 140.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -129.37 137.26 50.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.177 1.391 . . . . 0.0 107.393 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.77 166.66 32.82 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.514 0.726 . . . . 0.0 109.529 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -156.17 65.84 0.57 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.363 0.665 . . . . 0.0 109.54 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.1 -85.3 1.04 Allowed Glycine 0 C--N 1.337 0.631 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -92.88 -49.48 6.03 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.501 0.72 . . . . 0.0 111.709 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.64 142.73 31.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.273 0.488 . . . . 0.0 110.485 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.83 142.34 48.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.924 1.689 . . . . 0.0 108.424 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.2 t -130.3 126.97 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.774 1.63 . . . . 0.0 106.77 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.3 t -110.41 126.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.9 m -132.26 141.07 48.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.448 1.099 . . . . 0.0 108.533 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.1 m -142.85 134.13 26.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 108.157 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -123.48 146.84 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 108.651 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -144.59 151.73 51.1 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.78 -13.38 36.62 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.448 2.099 . . . . 0.0 113.27 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -144.1 41.56 1.4 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.859 0.864 . . . . 0.0 111.365 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -177.19 154.98 1.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.224 1.41 . . . . 0.0 108.143 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.6 m -154.53 130.8 10.4 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 167.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -127.18 131.26 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 107.864 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -140.02 133.53 30.14 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.268 1.027 . . . . 0.0 108.333 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.12 158.81 37.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.42 1.488 . . . . 0.0 109.609 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.3 p -152.27 159.96 43.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.465 0.706 . . . . 0.0 110.529 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -167.4 171.21 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.66 1.184 . . . . 0.0 109.061 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.1 m -139.93 155.13 47.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.566 1.146 . . . . 0.0 107.959 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.0 mt -59.05 112.37 1.66 Allowed 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.686 0.394 . . . . 0.0 111.883 -171.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.8 41.03 95.87 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.787 1.184 . . . . 0.0 111.251 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -130.87 132.09 44.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.548 0.739 . . . . 0.0 110.183 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.48 124.81 12.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.886 1.675 . . . . 0.0 110.754 172.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.81 173.88 13.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.887 1.275 . . . . 0.0 110.107 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -116.31 146.84 42.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.044 1.738 . . . . 0.0 108.162 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.29 136.26 60.55 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 173.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 N--CA 1.454 -0.26 0 C-N-CA 123.503 0.721 . . . . 0.0 109.484 -172.323 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.557 0.218 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp -144.84 13.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.284 1.034 . . . . 0.0 113.093 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 66.51 143.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.928 2.091 . . . . 0.0 113.357 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.9 t -155.66 147.42 23.14 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.636 -0.665 . . . . 0.0 110.748 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 m -156.21 71.97 0.74 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.719 0.808 . . . . 0.0 111.036 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.26 -161.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.793 0.724 . . . . 0.0 111.173 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -157.79 -174.88 5.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.584 1.554 . . . . 0.0 111.884 -161.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -104.89 139.55 39.46 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 109.345 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.16 112.91 5.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.838 1.255 . . . . 0.0 108.918 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 56.58 64.99 1.52 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.053 1.341 . . . . 0.0 111.394 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.88 37.23 77.05 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.716 1.151 . . . . 0.0 113.117 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -154.75 118.33 4.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.11 0.964 . . . . 0.0 108.497 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.63 122.05 44.2 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.502 1.121 . . . . 0.0 108.302 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.73 70.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.451 -163.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.45 127.2 32.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -144.98 152.13 39.69 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.072 0.949 . . . . 0.0 110.16 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -141.63 -164.88 1.87 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.697 1.199 . . . . 0.0 109.799 -174.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -46.93 -57.27 5.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.24 1.816 . . . . 0.0 112.045 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -127.84 -24.59 3.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.296 1.038 . . . . 0.0 111.648 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -72.87 145.9 46.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.162 0.437 . . . . 0.0 110.117 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.9 m -134.65 152.17 51.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.374 1.07 . . . . 0.0 108.287 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -146.07 93.41 2.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -107.0 105.73 15.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.045 1.738 . . . . 0.0 106.956 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 125.55 50.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.314 1.046 . . . . 0.0 109.104 -170.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -122.37 130.46 53.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.563 1.545 . . . . 0.0 107.723 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -121.46 149.48 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 109.304 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -143.22 -150.3 0.31 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.018 1.327 . . . . 0.0 108.414 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.76 -65.96 2.1 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -126.73 31.45 5.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.602 1.161 . . . . 0.0 109.958 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -155.44 143.78 20.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.161 0.984 . . . . 0.0 108.716 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 11.4 ttt -146.66 124.07 11.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.69 1.196 . . . . 0.0 108.101 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.75 137.29 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.666 1.186 . . . . 0.0 107.932 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -132.61 125.87 31.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.032 0.933 . . . . 0.0 108.779 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -132.68 122.65 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mm -119.12 157.02 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -134.05 149.26 51.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.58 112.98 5.28 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.623 1.169 . . . . 0.0 108.748 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.5 -91.24 0.25 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 124.333 0.968 . . . . 0.0 111.028 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.46 37.19 1.49 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.837 1.208 . . . . 0.0 110.152 172.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.44 144.89 35.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 106.956 174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -121.49 134.74 55.07 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.836 1.254 . . . . 0.0 108.038 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.28 141.53 49.91 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.61 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -161.71 161.29 29.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.017 0.927 . . . . 0.0 108.684 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -139.95 143.61 36.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.1 m -119.08 163.74 16.56 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.408 1.483 . . . . 0.0 110.618 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -123.32 151.13 42.76 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.16 1.384 . . . . 0.0 108.342 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -71.92 146.34 47.88 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.406 0.683 . . . . 0.0 109.618 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--O 1.255 1.349 0 CA-C-O 116.857 -1.544 . . . . 0.0 106.92 174.453 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 119.051 -0.499 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.3 p -43.62 112.92 0.44 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 126.116 1.766 . . . . 0.0 111.261 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.85 -175.79 39.97 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -120.5 142.69 49.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -142.56 139.39 31.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.201 1.0 . . . . 0.0 109.622 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -120.6 109.46 15.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.49 1.116 . . . . 0.0 108.521 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.24 137.54 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.592 1.157 . . . . 0.0 109.618 167.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -125.03 -52.7 1.65 Allowed 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.607 0.763 . . . . 0.0 109.38 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.09 148.29 25.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.987 0.915 . . . . 0.0 110.284 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.44 147.61 12.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.618 1.167 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -147.53 143.49 27.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.973 0.909 . . . . 0.0 109.263 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.46 28.2 17.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.507 1.523 . . . . 0.0 111.092 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -89.71 -61.55 1.67 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.034 2.134 . . . . 0.0 109.524 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -55.28 -36.87 66.59 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.196 0.999 . . . . 0.0 111.098 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.29 -39.8 71.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.162 0.985 . . . . 0.0 110.635 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.64 -52.89 63.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.459 171.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.89 -42.45 75.98 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 123.244 0.34 . . . . 0.0 110.548 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.78 -43.39 98.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.784 0.434 . . . . 0.0 111.108 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.29 -17.19 61.89 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.7 tp -69.57 -70.3 0.29 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.841 0.746 . . . . 0.0 112.311 -165.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.82 -58.0 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.381 1.072 . . . . 0.0 110.482 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.48 154.34 44.62 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.203 1.001 . . . . 0.0 111.84 -176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.94 165.25 28.71 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.502 2.135 . . . . 0.0 111.227 -172.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.16 -23.83 62.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.029 1.331 . . . . 0.0 112.17 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.04 -37.55 83.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.931 0.492 . . . . 0.0 111.355 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.41 -29.57 26.05 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.426 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -36.53 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.487 1.04 . . . . 0.0 110.217 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.39 -41.38 76.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.951 1.3 . . . . 0.0 110.246 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 ttt -68.64 -38.97 80.91 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.669 0.213 . . . . 0.0 111.252 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.49 -18.05 49.78 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.288 1.035 . . . . 0.0 113.189 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -38.69 -60.79 0.79 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.174 2.19 . . . . 0.0 114.427 -165.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -119.31 34.49 5.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.268 1.027 . . . . 0.0 109.505 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.46 126.87 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -104.04 98.23 13.19 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 126.176 1.79 . . . . 0.0 108.396 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.29 124.31 10.33 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.065 2.51 . . . . 0.0 110.005 -172.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.37 141.63 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.89 144.93 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.078 1.351 . . . . 0.0 109.037 -169.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -135.8 132.47 36.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.325 1.05 . . . . 0.0 109.02 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mm -110.6 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.014 1.726 . . . . 0.0 106.911 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 -179.72 2.31 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.109 1.364 . . . . 0.0 110.856 168.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -152.67 39.8 0.56 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.615 0.766 . . . . 0.0 110.365 168.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.04 -133.8 3.53 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.67 -31.19 72.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.855 1.262 . . . . 0.0 112.731 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.16 156.98 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.188 0.595 . . . . 0.0 109.688 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -148.64 110.14 4.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.752 1.621 . . . . 0.0 107.101 173.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.38 141.47 24.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.35 133.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.553 1.141 . . . . 0.0 108.063 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -126.27 143.31 51.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.636 1.175 . . . . 0.0 108.435 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.8 p -124.81 141.74 51.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.571 1.148 . . . . 0.0 108.989 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -133.5 137.27 45.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.87 1.268 . . . . 0.0 108.519 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -153.12 148.41 20.08 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.22 32.51 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.64 2.226 . . . . 0.0 112.402 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -174.6 20.27 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.947 2.099 . . . . 0.0 111.403 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.97 147.08 0.44 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.517 1.127 . . . . 0.0 108.952 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.9 t -170.06 152.58 4.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.184 0.594 . . . . 0.0 109.639 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -162.44 164.34 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.517 1.127 . . . . 0.0 109.078 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 m -136.79 146.14 45.36 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.487 1.115 . . . . 0.0 108.52 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.64 155.94 45.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.083 1.353 . . . . 0.0 110.417 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.6 p -138.6 121.97 17.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.65 1.58 . . . . 0.0 109.009 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -144.51 175.11 10.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.639 0.775 . . . . 0.0 110.487 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -153.18 148.49 26.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.7 0.8 . . . . 0.0 110.24 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.65 123.52 21.1 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.857 0.863 . . . . 0.0 110.791 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.96 37.46 93.24 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.367 0.984 . . . . 0.0 111.885 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -160.3 175.3 13.01 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -50.73 140.09 15.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.741 1.216 . . . . 0.0 111.638 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.69 91.06 2.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 110.097 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.7 130.65 41.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 mt -129.84 140.94 47.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 123.342 0.657 . . . . 0.0 109.437 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.366 4.9 t . . . . . 0 CA--C 1.533 0.314 0 C-N-CA 128.119 2.567 . . . . 0.0 115.362 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.34 -179.89 4.1 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.418 1.487 . . . . 0.0 109.708 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -153.46 120.73 5.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.693 1.597 . . . . 0.0 107.541 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.3 m -136.08 -172.13 3.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.633 1.173 . . . . 0.0 109.241 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.0 m -135.68 85.37 2.16 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.92 132.14 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.689 0.796 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -144.44 151.93 39.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.192 1.397 . . . . 0.0 108.368 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tp -92.24 137.88 31.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.032 0.933 . . . . 0.0 108.703 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.7 72.06 1.46 Allowed 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.312 1.445 . . . . 0.0 108.911 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.6 t30 65.47 75.42 0.35 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.662 1.585 . . . . 0.0 111.286 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.38 32.68 84.99 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.961 0.791 . . . . 0.0 113.198 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -157.84 139.89 14.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.721 0.76 . . . . 0.0 110.828 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.42 146.14 34.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.595 1.158 . . . . 0.0 108.651 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -143.29 138.51 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.242 1.017 . . . . 0.0 109.214 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.0 p -144.82 169.73 17.48 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.673 1.589 . . . . 0.0 109.863 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -144.58 141.86 29.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.515 1.126 . . . . 0.0 108.197 158.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -120.06 -159.05 0.77 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 107.999 164.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.32 -50.21 68.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.415 0.686 . . . . 0.0 111.158 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -127.58 -25.78 3.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.036 1.334 . . . . 0.0 111.581 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -91.08 144.05 26.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 109.321 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.7 m -149.29 125.36 10.68 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -109.0 112.08 24.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.857 1.663 . . . . 0.0 109.195 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -137.26 128.89 28.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.983 1.313 . . . . 0.0 108.542 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -162.15 149.35 13.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.82 157.44 46.78 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.744 1.218 . . . . 0.0 111.094 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.67 140.72 47.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.695 1.198 . . . . 0.0 109.488 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.87 162.26 30.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.013 1.725 . . . . 0.0 107.858 165.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -10.4 -79.87 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 128.368 2.89 . . . . 0.0 115.077 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -123.69 29.13 6.66 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.503 1.121 . . . . 0.0 111.184 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -152.01 115.76 4.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 ttt -101.92 141.41 34.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.959 1.304 . . . . 0.0 107.574 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.49 138.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.55 151.91 47.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.357 0.663 . . . . 0.0 110.739 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 152.45 51.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.085 0.954 . . . . 0.0 108.782 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.47 138.36 29.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.1 m -97.97 154.37 17.73 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.572 1.149 . . . . 0.0 109.143 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.28 67.27 1.08 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.577 1.551 . . . . 0.0 107.24 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.73 8.38 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.728 1.156 . . . . 0.0 110.937 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.05 15.36 27.79 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.296 -0.724 . . . . 0.0 113.046 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.6 154.1 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.28 1.432 . . . . 0.0 107.534 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -136.46 160.64 38.15 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.56 1.144 . . . . 0.0 108.75 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.55 143.52 50.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.478 1.511 . . . . 0.0 107.323 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.19 143.88 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 160.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -141.07 161.73 37.16 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.952 0.901 . . . . 0.0 109.476 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -141.81 138.45 32.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.924 0.89 . . . . 0.0 109.708 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.6 m -134.38 159.93 39.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.947 1.699 . . . . 0.0 110.712 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -122.71 148.99 44.66 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.269 1.428 . . . . 0.0 109.207 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -66.02 147.34 53.5 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.234 0.614 . . . . 0.0 110.171 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.8 1.64 . . . . 0.0 107.025 169.916 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.267 0.079 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.49 -6.64 6.96 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.802 0.841 . . . . 0.0 113.208 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -51.75 131.08 30.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.462 1.105 . . . . 0.0 111.506 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.58 -173.88 35.64 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.9 m -120.85 148.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -143.94 155.8 44.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.74 1.216 . . . . 0.0 109.05 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -138.96 130.45 27.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.378 1.071 . . . . 0.0 108.227 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.57 136.7 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.389 1.076 . . . . 0.0 110.132 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.26 -57.17 2.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.796 1.639 . . . . 0.0 109.922 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.31 172.28 16.13 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.702 0.801 . . . . 0.0 110.617 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.67 143.86 26.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.269 1.028 . . . . 0.0 110.651 -170.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -141.39 118.38 11.21 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.074 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 62.8 6.12 2.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.722 2.009 . . . . 0.0 113.342 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -62.87 -47.79 81.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.913 0.885 . . . . 0.0 110.093 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -33.46 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.074 0.55 . . . . 0.0 111.526 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -67.71 -43.13 80.77 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.333 0.653 . . . . 0.0 110.232 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.4 -53.25 60.3 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.731 0.812 . . . . 0.0 110.994 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.71 -39.78 85.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.768 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -75.35 -23.72 57.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.048 0.84 . . . . 0.0 112.567 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -34.26 74.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.279 0.49 . . . . 0.0 110.283 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.9 tp -73.37 162.01 29.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.677 1.191 . . . . 0.0 108.719 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.69 -34.49 26.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.481 1.113 . . . . 0.0 113.038 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.3 111.92 1.29 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.119 1.768 . . . . 0.0 110.637 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.17 149.64 19.81 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.197 2.598 . . . . 0.0 110.192 -169.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -54.85 -32.3 60.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.22 -47.85 71.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.709 0.803 . . . . 0.0 111.889 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.7 mt -80.54 -31.52 36.99 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.984 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.15 -29.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.57 1.077 . . . . 0.0 111.246 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -53.43 -29.93 37.76 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 111.591 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 90.4 mtp -61.4 -66.93 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.88 -39.07 65.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.029 1.331 . . . . 0.0 112.769 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -43.34 -49.08 6.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.838 2.055 . . . . 0.0 112.25 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -123.8 40.74 3.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.905 0.882 . . . . 0.0 110.71 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.4 mt -130.99 136.93 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -112.79 97.72 42.36 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 107.906 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.13 159.42 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.334 2.69 . . . . 0.0 112.893 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.1 mm -75.29 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.138 0.975 . . . . 0.0 109.159 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.4 t -128.61 144.55 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 126.023 1.729 . . . . 0.0 107.19 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -156.04 143.28 19.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.343 0.657 . . . . 0.0 110.072 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.74 142.82 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.455 1.102 . . . . 0.0 110.383 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -118.81 107.23 13.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.45 1.9 . . . . 0.0 108.412 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -89.31 134.69 33.95 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.28 1.432 . . . . 0.0 108.061 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -151.33 59.54 0.9 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.1 81.55 0.24 Allowed Glycine 0 C--N 1.339 0.721 0 C-N-CA 124.076 0.846 . . . . 0.0 112.029 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 76.93 -43.96 0.45 Allowed 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.071 2.148 . . . . 0.0 112.657 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.6 146.03 25.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.64 163.06 32.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 111.17 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.18 139.66 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.391 1.076 . . . . 0.0 108.714 -171.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.03 137.4 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 125.902 1.681 . . . . 0.0 106.812 174.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.1 m -131.08 135.53 47.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 t -129.04 144.79 51.31 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.288 1.035 . . . . 0.0 109.144 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -122.76 122.23 38.21 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 p -122.94 154.56 64.35 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.59 56.37 6.02 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.548 2.832 . . . . 0.0 110.732 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -162.35 -41.89 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.564 . . . . 0.0 110.173 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -161.96 157.38 23.64 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.31 1.044 . . . . 0.0 109.127 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.0 p -109.77 140.93 43.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.015 0.926 . . . . 0.0 109.049 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.2 t -136.2 149.13 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.328 1.051 . . . . 0.0 109.968 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 m -144.98 146.9 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.337 1.455 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.35 151.79 33.42 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 p -122.14 153.07 39.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.654 1.982 . . . . 0.0 110.947 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.29 169.22 10.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.073 0.949 . . . . 0.0 110.625 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.1 m -141.75 145.56 34.95 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.938 1.295 . . . . 0.0 109.091 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.19 136.5 53.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.338 0.655 . . . . 0.0 111.544 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.83 45.38 95.82 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.607 1.099 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -157.43 148.97 21.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.165 0.482 . . . . 0.0 110.168 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.07 124.28 23.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.641 1.176 . . . . 0.0 109.163 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.76 147.72 47.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.295 1.038 . . . . 0.0 110.477 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.1 132.66 36.42 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.687 1.195 . . . . 0.0 108.48 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.8 tt -133.59 153.77 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 124.976 1.31 . . . . 0.0 109.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.9 m -124.72 126.31 45.47 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 124.362 1.065 . . . . 0.0 109.559 -171.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -70.22 152.24 44.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.134 0.973 . . . . 0.0 109.706 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 48.3 ttm -51.47 -42.86 61.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.033 1.333 . . . . 0.0 113.101 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.43 -49.21 78.46 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.053 0.541 . . . . 0.0 110.986 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.98 66.88 0.1 OUTLIER Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -139.54 116.25 10.8 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.154 0.982 . . . . 0.0 108.396 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -74.75 149.19 39.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.851 0.358 . . . . 0.0 111.035 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.1 -175.32 5.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.72 1.608 . . . . 0.0 107.851 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 157.51 43.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.915 0.325 . . . . 0.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.5 p -159.79 160.94 34.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.499 1.119 . . . . 0.0 109.807 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -84.03 112.48 20.23 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.5 t -84.9 136.52 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -154.98 159.19 40.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.255 1.022 . . . . 0.0 110.266 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -124.86 128.66 49.02 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 126.861 2.064 . . . . 0.0 108.645 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.08 -134.02 0.34 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.232 1.413 . . . . 0.0 108.89 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.97 79.98 2.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.137 0.975 . . . . 0.0 110.641 -176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.51 40.27 77.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.292 0.949 . . . . 0.0 111.642 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.96 126.34 6.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.774 0.83 . . . . 0.0 109.892 -174.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.0 mt -74.19 142.57 45.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.78 127.63 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.02 152.5 46.3 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.385 1.074 . . . . 0.0 109.242 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.21 140.25 41.59 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.495 1.118 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -125.27 -160.61 0.97 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.896 1.278 . . . . 0.0 108.642 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.35 -54.08 42.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.498 1.119 . . . . 0.0 110.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -133.99 -6.09 2.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.745 1.218 . . . . 0.0 112.764 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.69 153.03 19.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.713 0.805 . . . . 0.0 109.334 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 p -145.82 160.23 42.07 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -143.79 121.84 12.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -137.1 107.18 6.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.441 1.096 . . . . 0.0 108.837 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.04 145.38 40.96 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.533 1.133 . . . . 0.0 108.988 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.99 145.88 29.88 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.051 0.541 . . . . 0.0 110.422 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.97 134.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 C-N-CA 125.127 1.371 . . . . 0.0 108.951 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 133.76 19.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.125 1.37 . . . . 0.0 108.69 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.85 -112.03 4.04 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.084 0.85 . . . . 0.0 111.638 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.32 37.02 4.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.895 1.278 . . . . 0.0 109.146 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -142.9 145.46 33.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.289 1.036 . . . . 0.0 109.112 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 ttt -138.88 116.47 11.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.136 1.374 . . . . 0.0 108.335 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.95 137.12 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -128.7 93.02 3.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.868 1.267 . . . . 0.0 108.839 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -97.02 139.4 33.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.879 1.272 . . . . 0.0 109.604 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.5 mt -143.13 147.89 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.682 1.193 . . . . 0.0 107.945 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 165.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -131.5 84.07 2.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.381 1.872 . . . . 0.0 107.395 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.72 -117.34 9.88 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.32 11.39 58.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.481 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -128.19 138.23 55.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 118.649 1.225 . . . . 0.0 108.009 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.8 m -123.04 136.11 54.7 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.745 1.218 . . . . 0.0 107.764 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 163.33 32.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.03 0.532 . . . . 0.0 111.835 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.7 139.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -138.02 157.7 45.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.04 145.97 47.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.747 1.219 . . . . 0.0 109.376 -169.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.1 m -143.42 161.86 37.27 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.115 1.366 . . . . 0.0 109.798 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.7 145.79 51.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.61 1.564 . . . . 0.0 109.483 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -71.66 146.74 48.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.869 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 C--O 1.25 1.108 0 C-N-CA 126.085 1.754 . . . . 0.0 107.505 174.055 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -65.12 -50.29 66.62 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.495 0.718 . . . . 0.0 110.053 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t 50.77 75.63 0.18 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.566 1.547 . . . . 0.0 112.226 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.4 -167.22 37.09 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.6 m -117.69 147.64 42.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -142.42 138.65 31.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.517 1.127 . . . . 0.0 109.584 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -112.65 112.03 23.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.06 139.72 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -125.62 -34.65 2.63 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.456 0.702 . . . . 0.0 111.726 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.95 144.06 50.56 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.703 0.801 . . . . 0.0 110.43 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -144.83 121.28 11.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.551 1.541 . . . . 0.0 107.908 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -140.34 139.96 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.913 0.885 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.24 18.32 10.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.702 1.601 . . . . 0.0 111.758 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -84.46 -47.33 10.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.008 1.323 . . . . 0.0 109.721 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.75 -36.89 67.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.601 0.761 . . . . 0.0 111.79 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.7 -46.64 89.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.429 1.092 . . . . 0.0 110.47 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.41 -50.77 68.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.937 0.495 . . . . 0.0 111.072 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.7 mt -55.2 -40.92 71.32 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.903 0.319 . . . . 0.0 111.076 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.05 -37.5 85.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.248 0.619 . . . . 0.0 111.122 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.13 66.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.057 -0.497 . . . . 0.0 111.851 173.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -75.76 171.27 14.65 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 121.579 0.704 . . . . 0.0 110.752 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.56 76.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.147 1.379 . . . . 0.0 112.959 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.91 130.62 92.7 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.63 -0.224 . . . . 0.0 110.574 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.16 168.17 23.64 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.389 2.726 . . . . 0.0 110.897 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -48.24 -36.69 14.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.425 1.49 . . . . 0.0 113.487 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.72 -38.26 81.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.929 0.492 . . . . 0.0 111.596 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.87 -31.67 20.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.567 -0.73 . . . . 0.0 112.027 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.86 -36.94 77.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.597 1.09 . . . . 0.0 109.817 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -52.83 -38.09 60.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 111.559 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 66.8 mtt -72.35 -17.94 61.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.248 0.619 . . . . 0.0 112.43 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.86 26.52 4.3 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.525 1.13 . . . . 0.0 111.801 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -69.45 -70.69 0.26 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.427 0.691 . . . . 0.0 109.765 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -121.59 52.08 1.27 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.343 1.457 . . . . 0.0 107.111 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.16 124.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -107.7 93.68 10.78 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 125.883 1.673 . . . . 0.0 108.249 -165.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.32 172.28 16.25 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.119 2.546 . . . . 0.0 112.686 -164.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.61 135.43 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.69 143.15 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.928 1.291 . . . . 0.0 107.66 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -152.36 113.48 4.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mp -109.6 140.21 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -140.59 139.53 34.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -115.76 166.94 11.38 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.134 0.973 . . . . 0.0 111.089 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -147.7 56.25 1.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.87 -143.79 16.06 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.45 1.5 . . . . 0.0 109.799 -173.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.03 -35.98 78.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.567 1.147 . . . . 0.0 111.357 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.5 138.14 46.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.02 157.28 37.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.914 0.759 . . . . 0.0 112.561 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.47 138.71 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.395 -167.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -108.62 126.22 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.518 1.927 . . . . 0.0 106.553 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.3 m -123.65 138.22 54.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.607 1.163 . . . . 0.0 107.965 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.3 m -133.57 129.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 108.703 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.9 121.46 35.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.66 1.184 . . . . 0.0 108.113 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -122.28 155.29 61.98 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.19 40.42 0.97 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.425 2.75 . . . . 0.0 111.292 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -142.94 -50.72 0.35 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.899 2.079 . . . . 0.0 108.088 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -159.17 159.8 34.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.298 1.439 . . . . 0.0 108.981 -175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -111.87 146.47 37.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.065 0.946 . . . . 0.0 109.721 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.3 t -141.25 146.55 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.125 1.37 . . . . 0.0 108.419 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -149.92 157.81 43.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.247 0.619 . . . . 0.0 110.098 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -153.13 150.42 29.07 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.186 0.994 . . . . 0.0 109.923 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -122.53 150.52 42.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.145 1.778 . . . . 0.0 110.603 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -164.67 -179.52 5.95 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.188 0.995 . . . . 0.0 110.205 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.6 m -136.3 134.66 38.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.516 1.126 . . . . 0.0 108.877 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.17 142.69 50.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.489 0.316 . . . . 0.0 110.551 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.23 -39.99 2.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.001 1.286 . . . . 0.0 112.207 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -124.39 177.85 5.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.598 1.159 . . . . 0.0 111.292 -170.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -73.76 155.75 38.56 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.713 0.805 . . . . 0.0 111.009 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.14 149.48 28.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.28 1.032 . . . . 0.0 109.176 171.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -85.11 138.3 32.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.484 0.713 . . . . 0.0 109.167 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -127.99 147.65 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.798 1.239 . . . . 0.0 107.843 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.1 m -116.23 134.65 54.68 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.706 1.202 . . . . 0.0 108.662 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -65.03 -80.64 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.602 0.761 . . . . 0.0 110.495 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 92.8 mtp -150.58 -66.4 0.2 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.487 1.115 . . . . 0.0 109.275 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -68.65 -71.64 0.21 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.747 1.219 . . . . 0.0 110.651 -173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.75 50.35 0.07 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -121.03 75.28 1.14 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -75.06 150.47 38.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.027 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.95 178.47 8.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.549 1.94 . . . . 0.0 108.462 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.34 158.16 35.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.302 0.641 . . . . 0.0 110.393 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.7 p -157.98 160.84 37.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.759 1.223 . . . . 0.0 109.155 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.6 m -74.62 100.17 3.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.5 t -74.38 97.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -133.89 153.5 51.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.724 0.81 . . . . 0.0 109.756 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -135.44 131.54 36.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.368 1.067 . . . . 0.0 109.269 -165.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.11 88.97 3.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.559 1.543 . . . . 0.0 109.606 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.95 67.06 0.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.901 1.28 . . . . 0.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.17 31.93 82.29 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.283 0.944 . . . . 0.0 113.077 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.01 112.13 5.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.083 0.953 . . . . 0.0 108.559 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -74.9 125.67 29.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.53 114.37 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.1 p -130.11 162.78 28.05 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.844 0.858 . . . . 0.0 109.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.1 142.94 18.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 168.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 t -137.67 168.56 19.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.026 1.73 . . . . 0.0 108.103 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -84.77 50.05 1.84 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.454 0.702 . . . . 0.0 110.695 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? 178.51 -23.0 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.948 2.099 . . . . 0.0 111.429 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -150.24 161.56 42.2 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.886 0.766 . . . . 0.0 111.049 -166.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.9 t -149.01 141.94 24.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.379 1.071 . . . . 0.0 108.842 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -122.9 102.46 8.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.453 1.901 . . . . 0.0 106.513 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -121.72 94.35 4.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.29 1.436 . . . . 0.0 109.51 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -121.71 112.33 18.27 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.67 147.83 45.37 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.51 0.724 . . . . 0.0 110.255 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.47 149.95 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.605 1.162 . . . . 0.0 109.915 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -125.12 -155.09 0.65 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.147 . . . . 0.0 108.287 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.48 -59.36 8.93 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.616 0.627 . . . . 0.0 111.884 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -136.22 22.3 3.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.378 1.071 . . . . 0.0 111.207 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -142.53 155.0 44.97 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.066 0.946 . . . . 0.0 108.976 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.7 ttt -146.03 133.78 21.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.667 1.187 . . . . 0.0 108.731 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.2 t -102.86 122.44 55.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.64 91.93 3.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.289 1.836 . . . . 0.0 108.441 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.8 m -103.46 133.75 47.99 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 109.11 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 34.2 mm -125.63 153.29 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.0 m -133.08 143.59 49.43 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -129.61 92.47 3.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 106.337 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -9.13 83.81 0.0 OUTLIER Glycine 0 C--N 1.342 0.867 0 C-N-CA 129.296 3.331 . . . . 0.0 115.068 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.19 -46.24 1.02 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.232 0.92 . . . . 0.0 110.947 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.69 150.78 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 125.417 1.487 . . . . 0.0 108.767 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -122.39 155.96 34.98 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.313 1.445 . . . . 0.0 108.987 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp -125.44 136.03 52.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.74 115.43 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 165.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -126.92 156.33 41.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.958 1.703 . . . . 0.0 106.637 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -141.62 147.0 36.9 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.771 0.429 . . . . 0.0 110.365 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -134.64 160.83 36.89 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.435 1.494 . . . . 0.0 110.83 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -121.96 144.95 48.57 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.26 1.424 . . . . 0.0 109.539 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -75.21 140.45 43.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.656 1.182 . . . . 0.0 110.862 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.432 1.493 . . . . 0.0 107.932 177.131 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.221 0.058 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -64.31 -34.0 77.13 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.262 0.625 . . . . 0.0 111.269 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.3 p -51.09 135.12 25.9 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.138 0.975 . . . . 0.0 111.127 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.06 -170.65 35.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 m -121.69 146.09 47.36 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.763 1.225 . . . . 0.0 108.704 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -145.0 161.9 38.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.95 1.3 . . . . 0.0 110.062 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 123.87 23.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.938 1.295 . . . . 0.0 107.781 172.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.71 137.63 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -122.63 -43.66 2.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.043 0.937 . . . . 0.0 110.707 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.01 146.91 46.19 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.631 0.772 . . . . 0.0 110.685 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.28 138.18 21.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.5 1.92 . . . . 0.0 107.808 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -151.41 139.6 20.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.508 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t30 64.64 28.13 13.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.586 2.354 . . . . 0.0 112.164 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -79.91 -50.54 10.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 109.977 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -53.99 -38.76 65.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 111.729 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -57.65 -52.57 64.88 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.095 0.958 . . . . 0.0 110.482 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.14 -46.77 89.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.039 0.536 . . . . 0.0 111.453 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.4 mt -55.69 -42.39 75.1 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.604 0.362 . . . . 0.0 111.406 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -65.89 -38.54 89.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.221 0.208 . . . . 0.0 110.669 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -23.17 65.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.86 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.78 -71.82 0.2 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.311 0.96 . . . . 0.0 109.596 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.47 -54.53 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.291 1.036 . . . . 0.0 110.527 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.9 134.93 47.66 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.238 1.015 . . . . 0.0 111.774 -170.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.06 168.05 23.98 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.491 2.794 . . . . 0.0 111.196 -171.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -50.43 -35.32 28.07 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 113.531 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.76 -36.94 82.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.486 0.714 . . . . 0.0 112.001 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.0 mt -86.84 -33.14 19.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.716 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -35.34 69.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 119.647 1.112 . . . . 0.0 110.434 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -46.98 -44.19 19.93 Favored 'General case' 0 C--N 1.345 0.403 0 C-N-CA 124.508 1.123 . . . . 0.0 111.192 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.6 ttt -71.21 -16.59 62.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.142 0.977 . . . . 0.0 112.008 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.71 -34.79 9.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.657 1.183 . . . . 0.0 111.12 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.75 -57.65 1.86 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 127.023 2.129 . . . . 0.0 111.821 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -118.14 35.41 4.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.853 0.861 . . . . 0.0 109.981 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.59 122.64 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -112.22 100.05 48.26 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 109.255 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.72 166.65 23.41 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.281 -166.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mm -68.25 140.97 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.07 147.1 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -148.47 128.55 13.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.59 143.52 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 107.931 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -141.61 77.06 1.57 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.549 1.14 . . . . 0.0 108.901 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -81.55 128.93 34.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.926 0.89 . . . . 0.0 108.906 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -125.99 79.68 1.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.03 -120.28 5.25 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.095 0.855 . . . . 0.0 111.497 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -68.95 -40.7 78.78 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.168 0.987 . . . . 0.0 111.69 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.76 138.07 39.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.058 0.543 . . . . 0.0 109.876 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -127.51 117.31 21.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.138 1.775 . . . . 0.0 107.572 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.1 t -110.04 126.21 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.27 141.6 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.173 1.389 . . . . 0.0 108.028 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.2 m -141.86 152.41 43.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 108.812 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.7 p -147.93 143.32 27.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.372 1.069 . . . . 0.0 109.093 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -125.8 136.93 53.68 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.28 1.032 . . . . 0.0 109.402 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.52 168.73 12.34 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.957 1.303 . . . . 0.0 108.175 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.07 -25.01 32.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.429 2.086 . . . . 0.0 113.0 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -138.17 33.59 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.504 0.722 . . . . 0.0 110.566 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.81 173.16 1.97 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.091 . . . . 0.0 109.588 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.6 t -170.63 151.47 3.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 108.295 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -144.58 148.42 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.088 1.355 . . . . 0.0 108.872 -173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 156.89 43.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.966 0.906 . . . . 0.0 110.381 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -150.67 143.93 24.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.253 1.421 . . . . 0.0 109.422 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m -130.86 130.33 43.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.847 1.259 . . . . 0.0 109.639 -172.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -158.19 173.64 16.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.974 0.91 . . . . 0.0 110.032 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 m -145.28 147.71 32.66 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.549 1.139 . . . . 0.0 108.463 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.91 168.87 19.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 111.644 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.87 -39.99 3.03 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.89 0.757 . . . . 0.0 113.207 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -120.28 -173.34 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.491 1.116 . . . . 0.0 109.887 -168.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -57.66 145.12 35.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.508 1.123 . . . . 0.0 109.997 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 105.16 3.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.444 0.698 . . . . 0.0 110.338 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.08 127.86 34.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 165.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.73 144.59 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.874 0.47 . . . . 0.0 110.365 174.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 m -90.35 146.47 24.16 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.139 0.976 . . . . 0.0 109.502 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.5 p -64.77 -177.64 0.35 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.055 0.942 . . . . 0.0 110.443 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.91 78.65 1.64 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.3 t0 62.43 83.91 0.15 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.313 1.845 . . . . 0.0 110.642 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.52 -85.13 0.06 OUTLIER Glycine 0 C--N 1.339 0.724 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.871 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -149.13 158.87 44.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.973 0.909 . . . . 0.0 109.557 -165.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -91.76 149.86 21.39 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.323 0.649 . . . . 0.0 111.64 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.23 162.82 34.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.517 1.527 . . . . 0.0 109.304 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -103.92 140.67 37.37 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.353 1.061 . . . . 0.0 109.048 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.6 p -152.27 174.99 13.11 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.705 1.202 . . . . 0.0 108.812 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -110.12 97.62 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.71 137.58 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -151.54 157.22 41.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 109.628 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.86 123.05 49.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.18 -68.56 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.001 0.921 . . . . 0.0 110.434 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -156.96 78.1 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.27 28.95 65.12 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.12 0.867 . . . . 0.0 112.089 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -152.27 140.75 20.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.111 2.164 . . . . 0.0 106.559 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.71 135.54 33.65 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.54 122.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 p -133.68 142.11 47.88 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -150.62 145.27 25.78 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.644 0.378 . . . . 0.0 110.874 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -126.16 -168.6 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.611 1.565 . . . . 0.0 108.542 166.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -36.41 68.4 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.166 0.986 . . . . 0.0 113.211 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -133.75 -37.12 0.93 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.548 1.139 . . . . 0.0 112.407 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.65 149.69 47.83 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.9 m -150.24 157.92 43.6 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.107 0.963 . . . . 0.0 108.951 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -166.69 149.37 6.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -154.98 123.59 6.07 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -118.2 141.47 48.47 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.793 0.837 . . . . 0.0 109.499 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -141.5 127.2 19.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.278 1.431 . . . . 0.0 107.759 -173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.08 133.84 64.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 124.531 1.133 . . . . 0.0 108.574 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.53 164.38 29.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.073 2.149 . . . . 0.0 107.838 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.98 -85.9 0.01 OUTLIER Glycine 0 C--N 1.344 0.987 0 C-N-CA 128.337 2.875 . . . . 0.0 115.119 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -125.59 40.59 3.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.271 1.028 . . . . 0.0 110.008 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -152.03 128.41 10.62 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 ttt -122.26 121.07 35.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.996 1.318 . . . . 0.0 108.591 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.77 135.04 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -130.85 89.29 2.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.923 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.9 m -95.44 133.87 38.92 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.419 0.687 . . . . 0.0 109.441 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.63 143.68 38.08 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.9 m -136.13 133.87 37.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.61 1.164 . . . . 0.0 108.669 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -123.78 72.02 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.509 1.923 . . . . 0.0 107.207 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 14.43 67.93 0.01 OUTLIER Glycine 0 C--N 1.344 1.014 0 C-N-CA 129.063 3.22 . . . . 0.0 115.407 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.4 -43.34 1.1 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.38 148.53 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.4 t -121.19 164.67 16.56 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.32 1.048 . . . . 0.0 110.323 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -145.44 140.97 27.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.002 1.321 . . . . 0.0 108.183 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -124.77 129.32 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -111.68 146.49 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 165.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -135.56 128.89 32.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.4 m -121.58 156.07 33.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.994 1.318 . . . . 0.0 110.788 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -121.37 137.95 54.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.111 1.764 . . . . 0.0 107.809 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -70.46 145.31 51.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.553 0.216 . . . . 0.0 111.098 -170.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.545 1.538 . . . . 0.0 107.754 179.397 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 120.009 -0.043 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -131.2 0.53 4.15 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.095 0.958 . . . . 0.0 113.054 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 t -53.44 114.03 1.37 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.504 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 -177.55 43.43 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -120.5 156.07 32.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.882 1.273 . . . . 0.0 108.923 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -149.59 152.94 36.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.224 1.41 . . . . 0.0 109.893 -169.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -129.59 120.13 24.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.321 1.448 . . . . 0.0 107.311 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.15 121.14 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.333 0.653 . . . . 0.0 109.545 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -89.58 -51.34 5.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.815 1.646 . . . . 0.0 109.735 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.06 161.99 37.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.135 0.574 . . . . 0.0 110.581 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -156.23 137.55 13.87 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.009 1.324 . . . . 0.0 109.422 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -151.77 142.01 22.35 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.965 0.906 . . . . 0.0 110.54 -171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.46 31.46 12.25 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.944 1.698 . . . . 0.0 111.415 -167.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -94.78 -49.65 5.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.609 1.963 . . . . 0.0 108.627 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -53.55 -34.48 58.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.716 1.207 . . . . 0.0 111.677 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -57.49 -49.86 74.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.608 0.763 . . . . 0.0 111.089 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -68.34 -42.84 78.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.915 0.325 . . . . 0.0 111.428 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.01 -42.4 85.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.53 0.332 . . . . 0.0 110.853 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.08 -41.28 99.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 110.754 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.61 -25.85 66.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.151 0.58 . . . . 0.0 112.157 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.82 172.3 13.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.477 0.581 . . . . 0.0 110.709 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.93 76.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.267 1.427 . . . . 0.0 113.283 -175.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.12 132.97 90.12 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.913 -175.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.45 164.39 34.06 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.195 2.597 . . . . 0.0 110.578 -174.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -54.16 -31.28 52.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.713 1.205 . . . . 0.0 112.216 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -56.71 -44.11 81.25 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.056 0.942 . . . . 0.0 111.39 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.92 -29.7 26.92 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.18 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.74 -34.11 60.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 119.501 1.046 . . . . 0.0 109.716 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -52.66 -37.07 58.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.037 0.935 . . . . 0.0 111.618 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.73 -58.4 3.51 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.33 61.55 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.546 1.138 . . . . 0.0 112.595 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -53.26 -34.48 57.38 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.119 1.367 . . . . 0.0 112.008 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -121.04 40.23 3.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.28 1.032 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.0 mt -125.68 134.96 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 166.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.87 102.28 26.27 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.451 1.1 . . . . 0.0 108.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 138.3 20.85 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.062 1.841 . . . . 0.0 109.996 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.43 141.46 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.8 t -123.88 147.17 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.34 144.11 25.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.76 144.64 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -141.9 143.75 33.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 170.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.83 152.08 27.95 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.092 0.557 . . . . 0.0 109.977 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -147.05 58.04 1.16 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.072 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.74 -135.72 12.9 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.84 -27.9 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.251 1.02 . . . . 0.0 112.001 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.11 140.07 43.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.222 1.409 . . . . 0.0 110.856 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -141.49 127.37 19.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.824 1.249 . . . . 0.0 108.234 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.73 138.04 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.56 128.9 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.1 m -124.56 151.95 44.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.384 1.474 . . . . 0.0 109.274 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 p -125.29 151.42 46.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.788 1.635 . . . . 0.0 108.415 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -136.65 107.36 6.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.35 140.39 14.81 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.11 -9.65 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.959 2.439 . . . . 0.0 113.637 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -128.77 10.7 6.06 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.106 0.962 . . . . 0.0 111.917 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -166.21 79.82 0.26 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.022 0.828 . . . . 0.0 110.426 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.9 m -110.81 101.52 10.12 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -136.78 152.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.913 1.285 . . . . 0.0 110.126 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.7 m -124.74 147.65 48.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.507 1.523 . . . . 0.0 109.981 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.19 131.6 38.78 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 126.726 2.01 . . . . 0.0 107.018 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 p -122.41 132.03 54.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.241 1.016 . . . . 0.0 109.761 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.75 176.35 11.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 111.609 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -145.43 145.03 30.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.8 1.64 . . . . 0.0 107.936 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.84 137.41 55.29 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.986 0.514 . . . . 0.0 110.842 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.82 48.14 84.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -157.74 166.38 32.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -60.19 116.78 4.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.58 101.58 7.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.159 0.984 . . . . 0.0 109.225 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -79.72 112.73 17.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.336 1.054 . . . . 0.0 109.583 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -127.35 140.53 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.228 1.011 . . . . 0.0 108.415 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 m -77.52 136.31 38.3 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.901 0.881 . . . . 0.0 109.872 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 t -61.88 -49.67 75.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.606 0.362 . . . . 0.0 111.094 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.16 -69.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.702 1.201 . . . . 0.0 108.929 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -65.14 -55.87 16.21 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.867 1.267 . . . . 0.0 111.888 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.84 54.93 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -147.43 115.1 6.39 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 152.86 23.67 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -169.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 153.66 51.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.379 1.472 . . . . 0.0 109.107 170.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.43 142.6 27.52 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.985 0.914 . . . . 0.0 109.99 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.6 m -142.79 175.17 10.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 109.589 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 m -132.18 84.91 2.19 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.7 1.2 . . . . 0.0 107.845 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.63 149.89 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.922 0.889 . . . . 0.0 110.602 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -134.62 157.72 45.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.458 1.503 . . . . 0.0 108.513 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.35 112.29 24.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.42 -66.26 0.93 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.885 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.66 83.82 0.61 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.2 35.03 82.63 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.558 0.599 . . . . 0.0 111.709 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -161.52 141.38 10.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.75 0.82 . . . . 0.0 110.004 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.42 133.89 34.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.05 136.64 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 108.065 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 m -148.27 148.63 30.67 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.6 1.16 . . . . 0.0 108.353 -172.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -144.89 154.52 42.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.948 1.299 . . . . 0.0 109.634 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 -172.48 3.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.721 1.608 . . . . 0.0 107.328 167.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -63.03 -56.49 16.5 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.561 0.744 . . . . 0.0 110.141 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -96.76 -36.89 10.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.562 1.145 . . . . 0.0 111.268 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -99.75 156.7 16.96 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.234 1.014 . . . . 0.0 110.823 -170.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.7 t -147.36 156.2 42.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.052 0.941 . . . . 0.0 108.54 165.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.17 127.99 8.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -172.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -147.19 120.86 9.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.15 131.08 54.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.314 1.046 . . . . 0.0 108.865 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.41 129.99 54.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.48 2.312 . . . . 0.0 107.447 -175.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.5 t -120.51 144.79 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.955 0.902 . . . . 0.0 109.42 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -137.09 -176.06 4.25 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.186 1.795 . . . . 0.0 108.582 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.29 -61.32 6.74 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.623 1.106 . . . . 0.0 113.403 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -129.55 31.92 4.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.772 1.229 . . . . 0.0 110.905 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -159.49 150.11 19.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 16.0 ttt -144.93 134.61 23.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.786 1.234 . . . . 0.0 107.903 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.22 139.22 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -134.63 137.08 43.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.191 0.996 . . . . 0.0 108.94 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -143.32 133.31 24.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.789 0.836 . . . . 0.0 109.239 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.47 152.66 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.2 m -136.47 137.33 40.28 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -133.09 95.04 3.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.81 1.644 . . . . 0.0 106.566 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.66 -125.29 39.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.14 24.84 23.06 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.078 -0.845 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.6 136.71 58.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.9 m -121.53 145.27 48.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.158 1.383 . . . . 0.0 107.98 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.93 131.59 54.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -125.56 136.03 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -157.07 174.89 14.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -157.69 150.81 23.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m -130.83 162.34 29.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.93 1.292 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -122.65 139.6 53.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.463 1.505 . . . . 0.0 108.415 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -70.88 148.62 47.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.678 0.791 . . . . 0.0 111.072 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 C--O 1.252 1.235 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.474 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 119.662 -0.209 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -152.26 -55.18 0.13 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.296 1.039 . . . . 0.0 108.934 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.7 p -52.92 100.29 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.11 1.364 . . . . 0.0 110.669 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.32 -168.48 36.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.5 m -119.51 151.73 38.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.187 1.395 . . . . 0.0 108.69 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -148.85 129.41 13.99 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 110.208 -162.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -113.07 106.8 15.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.567 1.547 . . . . 0.0 109.17 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.52 117.96 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.121 0.968 . . . . 0.0 109.551 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -99.51 -40.67 7.72 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.811 0.844 . . . . 0.0 111.09 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.41 148.2 43.5 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.927 0.891 . . . . 0.0 110.625 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.49 134.97 14.29 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.544 1.538 . . . . 0.0 108.346 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -156.14 137.87 14.26 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.099 0.959 . . . . 0.0 109.483 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.31 -35.66 0.33 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.459 1.904 . . . . 0.0 111.352 -172.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -32.23 -49.69 0.2 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.428 2.691 . . . . 0.0 112.115 156.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.79 -52.03 67.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.835 0.854 . . . . 0.0 111.016 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.94 -41.5 91.95 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.161 . . . . 0.0 110.664 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.28 -50.37 74.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.329 0.652 . . . . 0.0 111.584 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.94 -42.78 85.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.094 0.406 . . . . 0.0 111.123 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -38.44 80.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -27.25 67.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.957 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.01 -65.17 0.73 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.445 0.566 . . . . 0.0 111.348 -167.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.99 -58.31 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.427 1.091 . . . . 0.0 109.466 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -55.9 130.53 72.9 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.189 0.596 . . . . 0.0 110.508 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.75 170.12 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.299 2.666 . . . . 0.0 111.332 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.57 -28.57 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.876 1.67 . . . . 0.0 113.282 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.14 -42.51 96.77 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.433 0.693 . . . . 0.0 111.868 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.5 mt -83.98 -34.1 24.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.771 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.46 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.276 0.944 . . . . 0.0 111.047 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -49.11 -35.88 17.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 111.629 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.5 mtt -71.24 -60.23 2.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.23 -41.76 69.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.525 1.13 . . . . 0.0 112.168 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -51.36 -37.26 47.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.465 1.506 . . . . 0.0 111.521 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.28 37.58 4.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.032 0.933 . . . . 0.0 110.934 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.5 mt -133.15 136.92 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 168.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -103.1 89.57 2.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.615 1.166 . . . . 0.0 108.293 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.33 148.23 88.2 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.052 1.835 . . . . 0.0 110.923 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 tp -96.26 124.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 t -123.76 136.89 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -168.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -126.97 121.02 30.52 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.795 1.238 . . . . 0.0 108.46 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 98.4 mt -110.62 135.13 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -124.12 88.7 2.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.655 1.582 . . . . 0.0 108.627 -171.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -85.18 128.78 34.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 166.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -132.2 77.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 163.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.82 -128.33 8.44 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.846 1.212 . . . . 0.0 111.174 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.1 -33.05 74.63 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.544 1.138 . . . . 0.0 112.06 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.38 142.46 28.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.185 0.994 . . . . 0.0 110.85 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.65 137.01 45.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.458 1.903 . . . . 0.0 108.264 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.35 124.4 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.26 125.79 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -122.64 135.78 54.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.771 1.228 . . . . 0.0 108.239 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -125.77 128.87 48.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -124.88 114.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 165.79 31.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.78 -3.54 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.277 1.985 . . . . 0.0 113.223 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -139.77 -17.93 0.96 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -130.17 98.6 4.78 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.592 1.157 . . . . 0.0 109.151 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -110.91 113.4 25.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 172.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.16 150.25 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.229 . . . . 0.0 109.394 -173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -135.93 147.06 47.95 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.833 1.253 . . . . 0.0 109.615 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -132.76 149.25 52.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.668 1.187 . . . . 0.0 109.875 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -128.07 138.79 52.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.371 1.868 . . . . 0.0 109.738 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.42 176.33 11.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.082 0.953 . . . . 0.0 110.132 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.2 m -138.39 146.27 42.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.052 1.341 . . . . 0.0 108.196 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 pp -66.8 148.78 51.48 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.967 0.167 . . . . 0.0 111.269 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.43 43.23 44.15 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.855 1.217 . . . . 0.0 112.877 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -156.37 140.15 16.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.11 116.79 7.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.481 0.712 . . . . 0.0 110.566 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.31 160.22 25.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.133 1.373 . . . . 0.0 109.327 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.11 139.74 38.23 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 tt -137.25 168.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.523 1.529 . . . . 0.0 108.17 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.6 m -137.05 144.56 43.24 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.36 0.664 . . . . 0.0 109.849 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -67.22 -177.35 0.66 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.946 1.298 . . . . 0.0 110.771 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -70.72 85.1 0.65 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.311 0.644 . . . . 0.0 109.402 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 52.9 63.41 2.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.442 1.897 . . . . 0.0 110.671 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.14 -104.27 0.46 Allowed Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.481 -0.647 . . . . 0.0 111.481 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -128.06 155.87 43.67 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.626 1.171 . . . . 0.0 110.308 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.95 160.06 18.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.471 1.109 . . . . 0.0 111.605 -177.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.75 161.27 39.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.87 1.268 . . . . 0.0 109.136 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -89.07 154.3 20.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.336 0.654 . . . . 0.0 109.797 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p -155.05 165.66 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.397 1.079 . . . . 0.0 109.939 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.1 m -135.32 76.73 1.63 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 137.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -150.95 153.23 34.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.947 0.899 . . . . 0.0 109.44 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.49 162.0 19.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.178 0.991 . . . . 0.0 110.274 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.63 49.3 0.87 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.585 1.154 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.9 t30 68.09 95.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.578 1.951 . . . . 0.0 111.979 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.79 24.54 75.53 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.105 0.86 . . . . 0.0 112.854 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -163.06 147.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.203 . . . . 0.0 108.694 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -103.68 151.25 23.2 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.035 1.334 . . . . 0.0 108.205 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.3 t -121.63 95.08 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -71.25 144.81 49.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.736 0.814 . . . . 0.0 109.526 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -164.86 128.2 2.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.933 0.493 . . . . 0.0 111.928 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -141.71 -149.03 0.26 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.269 2.228 . . . . 0.0 106.115 166.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.64 -73.92 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -78.76 -37.7 40.5 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 111.723 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -95.71 81.76 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.579 0.752 . . . . 0.0 111.054 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.6 p -140.91 144.17 35.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.212 1.005 . . . . 0.0 110.904 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 180.0 -145.74 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.17 1.788 . . . . 0.0 110.124 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.78 170.41 15.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.439 1.496 . . . . 0.0 110.378 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -160.0 127.51 4.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 109.615 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -122.27 149.73 43.3 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.801 1.64 . . . . 0.0 109.86 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.02 146.39 33.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.026 0.931 . . . . 0.0 110.422 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -136.55 171.7 14.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.516 1.926 . . . . 0.0 108.474 168.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -3.22 -76.0 0.01 OUTLIER Glycine 0 C--N 1.343 0.929 0 C-N-CA 128.906 3.146 . . . . 0.0 116.264 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.58 35.43 2.93 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.47 1.108 . . . . 0.0 110.269 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.21 147.29 31.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.201 0.6 . . . . 0.0 110.884 -172.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.14 130.24 38.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.593 1.557 . . . . 0.0 108.63 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.71 116.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -129.8 136.8 50.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 109.794 -169.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 t -142.3 157.73 44.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.201 0.524 . . . . 0.0 110.645 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.4 128.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.78 171.55 9.88 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -150.81 80.68 1.33 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.51 -113.19 5.58 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -175.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.95 68.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.37 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.98 160.41 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.745 1.218 . . . . 0.0 107.871 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.2 m -134.39 155.46 50.24 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.274 1.03 . . . . 0.0 110.311 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 mp -127.1 129.04 47.19 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 158.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.94 142.57 39.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 164.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -158.18 147.93 19.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -128.26 136.08 50.54 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 t -125.04 162.93 23.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.525 1.13 . . . . 0.0 110.583 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.71 133.96 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.52 1.528 . . . . 0.0 107.499 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 ttp85 -68.82 150.92 47.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.054 0.541 . . . . 0.0 109.918 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--O 1.249 1.038 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 172.654 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.62 -52.99 4.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.277 1.031 . . . . 0.0 112.151 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.3 p -168.7 155.01 6.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.58 1.152 . . . . 0.0 110.026 -173.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.34 -169.76 16.74 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.161 0.886 . . . . 0.0 112.449 165.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -121.95 134.13 54.84 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.939 1.295 . . . . 0.0 108.849 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -144.02 165.0 29.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.167 0.987 . . . . 0.0 111.281 -166.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -148.15 122.64 9.75 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.762 1.225 . . . . 0.0 108.943 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.01 139.63 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.67 1.188 . . . . 0.0 109.783 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -124.06 -37.67 2.55 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.331 0.652 . . . . 0.0 112.187 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.51 149.4 51.71 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 110.161 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.38 148.46 14.77 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.7 0.8 . . . . 0.0 111.536 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.08 140.54 21.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.334 1.454 . . . . 0.0 108.184 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 59.24 89.96 0.06 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.381 1.472 . . . . 0.0 109.268 -171.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -148.64 -51.41 0.17 Allowed 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -47.65 -50.73 23.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.049 1.34 . . . . 0.0 111.375 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.84 -47.49 82.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.819 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -61.66 -53.36 57.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.948 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -62.99 -35.37 79.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.948 0.34 . . . . 0.0 111.51 -174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -75.81 -36.3 59.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.291 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.84 65.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.314 0.506 . . . . 0.0 111.147 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -74.11 -64.52 1.0 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.424 1.089 . . . . 0.0 109.543 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.11 -65.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.353 0.661 . . . . 0.0 111.135 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -56.33 136.77 75.66 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.7 0.8 . . . . 0.0 112.684 -165.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.48 171.47 16.77 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.572 2.848 . . . . 0.0 111.889 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.22 -34.63 4.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.842 2.057 . . . . 0.0 113.532 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.43 -31.85 71.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.949 0.9 . . . . 0.0 112.104 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -93.78 -32.17 14.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.8 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pp -66.89 -20.7 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 119.078 0.854 . . . . 0.0 111.296 173.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -49.87 -38.31 34.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.61 0.641 . . . . 0.0 110.582 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -96.2 46.75 1.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.362 1.065 . . . . 0.0 109.683 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -156.9 -52.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.321 1.048 . . . . 0.0 110.634 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -52.46 -46.38 66.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.62 1.968 . . . . 0.0 112.341 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -120.51 35.21 4.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 109.328 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.82 144.73 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -111.88 90.32 12.98 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.64 137.29 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.184 1.923 . . . . 0.0 109.426 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.55 137.52 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.36 142.02 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.38 129.75 22.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.171 1.388 . . . . 0.0 108.11 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.14 138.43 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.289 1.436 . . . . 0.0 108.505 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -126.15 125.49 42.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.32 1.048 . . . . 0.0 108.648 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.95 142.99 29.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.62 1.568 . . . . 0.0 111.559 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -140.85 42.09 1.83 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.858 1.663 . . . . 0.0 110.829 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 96.71 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.16 0.886 . . . . 0.0 112.771 170.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 57.29 18.52 4.35 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.352 1.461 . . . . 0.0 112.56 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -150.8 143.5 24.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.75 2.02 . . . . 0.0 105.783 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.81 150.89 30.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.819 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.0 131.64 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.437 1.095 . . . . 0.0 108.441 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.95 134.04 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.955 1.702 . . . . 0.0 107.337 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.1 m -132.72 137.42 46.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.704 1.202 . . . . 0.0 107.986 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 t -127.09 140.12 52.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.975 1.71 . . . . 0.0 107.737 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -123.35 116.7 23.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.05 159.97 56.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.27 -4.39 14.27 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.008 1.805 . . . . 0.0 112.445 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -119.42 29.11 7.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.233 1.413 . . . . 0.0 110.932 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 127.83 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.303 3.441 . . . . 0.0 110.389 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 p -108.79 138.08 45.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.2 135.71 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.336 1.454 . . . . 0.0 108.099 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -144.43 151.4 39.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 111.524 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.17 140.98 9.26 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.557 1.543 . . . . 0.0 109.751 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -124.91 151.64 45.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.868 1.267 . . . . 0.0 109.828 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -166.2 152.99 9.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.24 0.543 . . . . 0.0 110.984 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -122.42 144.52 48.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.434 1.894 . . . . 0.0 108.016 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.34 131.73 46.76 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.343 0.257 . . . . 0.0 111.476 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.26 50.34 51.45 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -160.46 139.27 10.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.47 142.28 49.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.97 150.67 27.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.649 0.779 . . . . 0.0 109.892 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -89.43 132.38 35.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.303 1.041 . . . . 0.0 109.219 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.74 147.14 25.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.319 1.048 . . . . 0.0 108.273 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 m -113.03 95.95 5.68 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.945 1.298 . . . . 0.0 107.975 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 m -149.09 47.44 0.99 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.191 0.451 . . . . 0.0 110.579 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 54.3 mtm -148.05 56.57 1.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.639 0.776 . . . . 0.0 109.599 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 56.37 67.69 0.96 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.445 0.698 . . . . 0.0 109.485 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.76 39.99 78.59 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.145 1.355 . . . . 0.0 113.164 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -139.28 143.33 37.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.4 143.31 27.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.285 -161.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.7 -173.8 2.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.536 2.334 . . . . 0.0 107.633 166.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.81 146.33 37.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.79 0.836 . . . . 0.0 110.68 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.9 p -166.23 162.6 17.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.777 1.231 . . . . 0.0 109.094 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -116.26 61.31 0.72 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 111.894 -173.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.63 138.06 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.381 1.073 . . . . 0.0 112.396 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -151.22 153.96 35.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.291 1.037 . . . . 0.0 110.303 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -85.15 125.49 32.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.059 1.344 . . . . 0.0 108.906 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.28 -68.38 0.8 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.212 1.005 . . . . 0.0 109.387 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -164.51 88.52 0.5 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.93 24.23 64.52 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.198 0.904 . . . . 0.0 112.797 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -157.43 138.8 13.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 109.337 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.37 139.79 36.37 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.2 t -133.45 139.58 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.228 1.411 . . . . 0.0 107.376 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.82 156.11 37.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -143.56 141.49 30.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.309 1.044 . . . . 0.0 109.049 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 t -151.55 166.94 29.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.868 1.267 . . . . 0.0 107.883 163.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -85.72 12.32 9.17 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.157 0.983 . . . . 0.0 111.857 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -126.97 -30.33 2.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.21 1.804 . . . . 0.0 109.854 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -157.12 157.24 34.13 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.913 0.885 . . . . 0.0 109.682 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -136.15 150.91 49.26 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -143.95 92.67 2.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.369 1.468 . . . . 0.0 108.07 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -130.3 124.16 31.7 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.68 139.8 11.8 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -121.07 136.02 55.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.944 2.098 . . . . 0.0 107.948 -172.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.0 133.72 56.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -160.84 127.7 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.628 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.34 -96.34 0.48 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.138 0.875 . . . . 0.0 110.949 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -138.8 18.46 2.67 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.251 1.02 . . . . 0.0 110.757 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -148.65 130.92 15.55 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.4 ptp -123.97 155.56 37.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.428 1.091 . . . . 0.0 111.488 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.55 131.7 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -131.61 140.54 49.43 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.29 0.636 . . . . 0.0 110.898 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -131.17 129.34 41.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.982 1.713 . . . . 0.0 108.181 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 48.0 mm -123.48 152.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 53.2 m -134.99 145.84 48.49 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 163.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -130.5 105.44 7.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 170.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -15.69 89.05 0.01 OUTLIER Glycine 0 C--N 1.342 0.864 0 C-N-CA 128.562 2.982 . . . . 0.0 115.016 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.8 -47.88 0.95 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.93 137.35 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 109.183 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 36.6 m -120.19 133.51 55.48 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.172 1.389 . . . . 0.0 109.179 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.92 140.12 51.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.951 2.101 . . . . 0.0 108.73 -170.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.19 141.73 40.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm85 -162.77 160.72 25.67 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 109.761 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -135.64 143.91 45.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.457 1.103 . . . . 0.0 109.344 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 m -133.21 155.73 48.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.427 1.091 . . . . 0.0 109.417 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -124.71 142.11 51.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.074 1.35 . . . . 0.0 108.158 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -65.95 141.75 58.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.554 0.741 . . . . 0.0 109.859 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 C--O 1.251 1.18 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 120.221 0.058 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.62 -50.37 0.72 Allowed 'General case' 0 C--N 1.339 0.11 0 C-N-CA 124.498 1.119 . . . . 0.0 109.72 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 p -48.34 112.06 0.54 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.281 1.433 . . . . 0.0 110.793 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.58 -177.31 41.48 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -119.28 140.62 49.98 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.842 1.257 . . . . 0.0 107.922 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -142.29 150.26 40.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.007 0.923 . . . . 0.0 109.759 -163.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -137.33 121.63 18.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -53.25 117.31 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.214 1.006 . . . . 0.0 108.613 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.11 -35.06 9.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.525 0.73 . . . . 0.0 110.209 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 147.08 39.68 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.507 1.123 . . . . 0.0 108.652 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.8 147.08 22.59 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.005 0.922 . . . . 0.0 109.99 -175.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.74 155.73 36.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.296 0.57 . . . . 0.0 111.532 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.22 35.11 25.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.237 1.815 . . . . 0.0 110.494 -169.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -99.88 -45.41 5.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.866 1.666 . . . . 0.0 110.139 -167.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.25 -40.03 46.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.008 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.29 -48.31 82.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.493 1.117 . . . . 0.0 110.772 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.47 -46.5 89.86 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 122.889 0.476 . . . . 0.0 110.828 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.56 -45.37 85.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.662 0.21 . . . . 0.0 111.136 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -65.51 -34.48 78.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.984 0.514 . . . . 0.0 111.74 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.73 -25.35 67.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.79 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.4 mt -76.46 170.49 16.29 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.088 0.858 . . . . 0.0 110.64 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.54 94.27 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.74 1.216 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 139.85 97.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 111.516 -173.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.47 169.01 17.58 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.914 3.076 . . . . 0.0 111.191 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -48.92 -41.0 32.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.275 1.43 . . . . 0.0 112.631 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -53.85 -38.52 64.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.881 0.473 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.62 -24.12 19.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.607 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -32.56 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.832 1.196 . . . . 0.0 109.62 170.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -50.94 -43.27 60.17 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.336 1.054 . . . . 0.0 110.551 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 56.7 mtt -69.65 -52.18 28.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.244 0.618 . . . . 0.0 110.046 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.46 -35.7 70.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.768 0.827 . . . . 0.0 112.832 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -32.05 67.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.885 0.874 . . . . 0.0 111.186 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -119.39 49.03 1.4 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.175 0.99 . . . . 0.0 109.353 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.39 146.59 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 126.042 1.737 . . . . 0.0 106.472 165.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 106.5 40.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.334 1.054 . . . . 0.0 109.547 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.05 113.49 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.378 2.052 . . . . 0.0 109.392 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.31 139.29 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.06 148.36 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.598 1.559 . . . . 0.0 108.306 -171.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.87 130.11 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -109.1 129.14 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -119.14 101.4 7.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -126.12 141.76 51.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.639 1.176 . . . . 0.0 109.351 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -145.96 73.12 1.32 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.929 0.892 . . . . 0.0 108.953 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.89 -115.09 3.95 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.19 -42.67 88.53 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.53 0.732 . . . . 0.0 111.208 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -76.68 131.83 39.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.449 0.7 . . . . 0.0 110.432 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -129.84 120.85 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.058 1.743 . . . . 0.0 108.16 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -109.53 131.96 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.05 135.23 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -134.48 142.15 46.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.8 t -144.45 137.19 26.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.958 0.503 . . . . 0.0 109.804 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -124.1 153.84 40.86 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.736 1.214 . . . . 0.0 109.514 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.08 159.21 29.23 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.72 39.93 0.92 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.407 2.738 . . . . 0.0 111.577 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -144.55 -41.6 0.25 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.49 1.516 . . . . 0.0 110.129 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.0 169.82 23.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.206 1.802 . . . . 0.0 109.217 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.4 m -150.41 143.33 24.74 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.987 1.315 . . . . 0.0 107.681 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.16 146.56 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.59 1.156 . . . . 0.0 109.711 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.5 m -134.21 145.65 49.39 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.121 1.768 . . . . 0.0 107.529 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.85 130.52 24.17 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.556 1.542 . . . . 0.0 106.847 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 p -125.01 127.29 46.77 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.475 1.11 . . . . 0.0 109.249 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -164.39 -176.46 4.4 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.458 0.703 . . . . 0.0 110.613 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.5 m -140.25 148.22 41.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.131 1.372 . . . . 0.0 107.847 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 165.54 25.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.109 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.24 -29.05 5.35 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.055 0.836 . . . . 0.0 112.84 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -121.81 -177.03 3.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.144 1.378 . . . . 0.0 109.345 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.71 142.57 57.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.453 0.701 . . . . 0.0 109.791 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.4 125.64 16.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.367 1.067 . . . . 0.0 108.871 -175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.33 139.16 32.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.599 0.76 . . . . 0.0 109.27 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.2 mt -135.39 142.07 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.6 m -102.83 120.59 40.88 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.779 1.632 . . . . 0.0 108.771 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 m -73.48 152.22 40.79 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -79.79 55.74 2.12 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.135 0.974 . . . . 0.0 110.826 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -159.03 23.78 0.21 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.996 1.718 . . . . 0.0 109.715 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.27 53.83 42.56 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.115 0.864 . . . . 0.0 112.171 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -145.52 118.45 8.76 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.66 0.784 . . . . 0.0 108.95 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -91.12 162.95 14.46 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.817 0.447 . . . . 0.0 111.798 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.15 168.08 24.19 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.229 1.412 . . . . 0.0 109.993 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -118.14 144.33 45.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.87 1.268 . . . . 0.0 108.994 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.4 p -157.79 150.1 22.42 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.489 1.115 . . . . 0.0 109.182 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.5 m -88.08 87.34 7.3 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.14 132.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.434 0.694 . . . . 0.0 109.518 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -150.37 164.53 35.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.812 1.245 . . . . 0.0 108.637 172.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.83 127.16 52.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.663 1.185 . . . . 0.0 108.105 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.25 142.54 25.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.427 1.091 . . . . 0.0 109.537 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.72 41.63 31.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.923 1.289 . . . . 0.0 111.781 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.43 31.44 79.51 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.133 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -154.79 151.6 28.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.98 0.89 . . . . 0.0 110.387 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.51 141.41 50.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.43 129.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.25 28.31 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -157.45 143.18 17.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.827 0.851 . . . . 0.0 109.192 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -109.82 -118.36 0.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.57 -47.8 5.23 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.463 1.505 . . . . 0.0 108.945 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 -44.25 2.11 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.9 1.28 . . . . 0.0 111.186 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -70.7 139.87 51.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 m -141.04 162.92 34.36 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.272 0.629 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.04 123.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.946 1.299 . . . . 0.0 107.877 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -136.69 110.84 8.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -118.98 120.2 36.56 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -121.02 150.96 40.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.338 1.455 . . . . 0.0 109.406 -170.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.45 136.19 57.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 125.792 1.637 . . . . 0.0 109.534 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.91 103.41 2.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.31 1.044 . . . . 0.0 109.931 170.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.64 -105.83 1.1 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.419 1.009 . . . . 0.0 111.429 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -122.58 24.65 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.931 1.293 . . . . 0.0 110.25 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -143.8 135.0 25.73 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 122.891 0.476 . . . . 0.0 110.723 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 mmt -100.74 129.23 46.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.1 123.51 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -135.87 141.94 44.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.241 -174.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -134.97 143.17 46.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.84 0.856 . . . . 0.0 109.414 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.41 142.83 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.843 1.657 . . . . 0.0 106.779 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.4 m -113.62 144.71 42.44 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.63 108.4 4.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.37 -125.3 39.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.21 29.11 13.23 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.03 0.824 . . . . 0.0 111.848 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.88 145.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 C-N-CA 124.906 1.282 . . . . 0.0 107.616 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.4 m -123.56 149.78 44.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.701 1.201 . . . . 0.0 107.89 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.0 133.67 53.62 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.64 128.82 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 ptt-85 -158.64 168.11 27.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.341 0.591 . . . . 0.0 111.048 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -138.39 132.8 32.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.353 -171.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 162.24 15.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.971 0.908 . . . . 0.0 110.139 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -126.52 147.57 49.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.332 1.453 . . . . 0.0 109.471 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -63.08 105.97 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.918 0.887 . . . . 0.0 110.045 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--O 1.253 1.244 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.078 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.305 0.098 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -73.0 -19.31 61.23 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.051 0.94 . . . . 0.0 110.757 168.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 p -50.72 116.23 1.85 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.815 1.646 . . . . 0.0 111.022 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.84 -178.99 40.92 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -118.91 130.66 55.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -134.42 144.69 48.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.777 1.631 . . . . 0.0 109.166 -167.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -119.53 118.96 32.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -52.87 124.62 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.067 0.947 . . . . 0.0 108.966 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -103.49 -44.14 5.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.772 1.629 . . . . 0.0 109.777 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 155.5 41.64 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.095 0.958 . . . . 0.0 109.439 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -151.31 122.4 7.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.401 1.08 . . . . 0.0 109.319 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.87 136.52 38.78 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.772 0.829 . . . . 0.0 111.582 -165.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 65.02 14.75 9.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.808 2.443 . . . . 0.0 112.022 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -81.21 -50.98 8.91 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.509 1.524 . . . . 0.0 110.663 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.54 -47.75 75.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.374 0.67 . . . . 0.0 110.854 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -59.73 -47.41 85.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.58 1.552 . . . . 0.0 110.134 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -55.16 -53.11 60.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.034 0.533 . . . . 0.0 111.899 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.93 -41.35 82.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -62.24 -38.77 90.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.242 0.617 . . . . 0.0 110.974 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.89 -20.15 61.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.716 0.806 . . . . 0.0 112.218 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.0 tp -75.34 -59.35 2.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.756 0.707 . . . . 0.0 111.22 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.03 -46.0 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.905 1.282 . . . . 0.0 110.097 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.65 135.56 71.44 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.643 1.177 . . . . 0.0 110.848 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -79.29 169.77 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.461 2.774 . . . . 0.0 110.639 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -44.56 -38.09 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.115 1.766 . . . . 0.0 112.474 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.1 -46.04 68.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.299 1.04 . . . . 0.0 111.757 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -81.15 -34.66 32.29 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.335 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.03 -22.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 118.815 0.734 . . . . 0.0 112.036 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.44 -33.16 19.98 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.855 0.862 . . . . 0.0 111.904 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.4 ttp -60.87 -30.56 70.21 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 123.607 0.763 . . . . 0.0 112.095 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.99 -36.14 9.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.897 1.279 . . . . 0.0 111.387 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -34.88 18.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.753 2.021 . . . . 0.0 113.561 -170.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -120.08 6.92 10.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.417 1.087 . . . . 0.0 111.859 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.98 122.91 71.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -106.33 100.73 31.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.354 1.462 . . . . 0.0 108.182 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.12 156.32 51.64 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.685 2.257 . . . . 0.0 110.96 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 tt -83.46 147.96 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -131.87 151.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.038 1.735 . . . . 0.0 108.316 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -154.47 127.94 8.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.53 148.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 125.108 1.363 . . . . 0.0 107.714 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.45 141.05 37.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.13 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.82 152.08 0.33 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.469 1.908 . . . . 0.0 110.64 172.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -135.25 58.42 1.76 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.322 1.449 . . . . 0.0 107.786 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.66 -131.98 6.12 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.729 1.157 . . . . 0.0 110.23 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.86 -33.84 76.95 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.926 1.29 . . . . 0.0 113.349 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.72 171.92 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.485 0.714 . . . . 0.0 110.843 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -157.56 121.56 4.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.641 1.576 . . . . 0.0 108.463 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.8 129.89 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 158.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.44 130.49 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.522 1.529 . . . . 0.0 107.221 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.1 m -128.68 145.81 51.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.238 1.415 . . . . 0.0 108.155 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.7 t -139.87 136.21 33.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -123.25 134.59 54.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -130.57 151.51 78.79 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 125.694 1.598 . . . . 0.0 107.125 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.43 -19.09 49.75 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.788 2.325 . . . . 0.0 114.068 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -138.79 32.4 2.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.087 0.858 . . . . 0.0 111.941 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -171.31 156.2 4.53 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.629 1.172 . . . . 0.0 108.871 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.3 m -148.2 143.97 27.4 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.33 151.5 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 109.519 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.4 m -148.31 146.27 28.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.456 1.102 . . . . 0.0 108.665 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.31 155.14 42.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.396 1.478 . . . . 0.0 108.893 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 p -138.6 145.7 40.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.682 0.793 . . . . 0.0 109.93 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -163.03 172.71 14.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.955 1.302 . . . . 0.0 109.429 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -144.6 139.12 27.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.21 152.54 44.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.25 0.547 . . . . 0.0 111.715 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.69 75.31 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.071 1.32 . . . . 0.0 112.049 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -160.01 157.69 29.22 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.416 1.108 . . . . 0.0 111.576 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.74 144.55 50.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.912 1.685 . . . . 0.0 111.048 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.87 161.73 42.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.867 1.267 . . . . 0.0 109.385 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.7 144.85 25.64 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.4 mt -129.3 136.19 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.3 m -80.75 89.35 5.77 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 109.054 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.4 m -81.52 154.79 26.1 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.439 1.096 . . . . 0.0 109.844 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -54.11 152.43 6.0 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.488 1.515 . . . . 0.0 111.156 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.2 t70 63.58 33.43 13.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.166 1.386 . . . . 0.0 111.024 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 49.23 69.85 0.92 Allowed Glycine 0 C--N 1.343 0.934 0 C-N-CA 126.293 1.901 . . . . 0.0 113.529 170.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -146.81 160.62 42.05 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.696 0.748 . . . . 0.0 112.208 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -116.25 138.69 51.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.237 1.415 . . . . 0.0 108.544 170.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.4 3.66 2.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.547 1.139 . . . . 0.0 113.193 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 69.72 134.22 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.0 2.12 . . . . 0.0 112.759 171.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.7 125.3 13.27 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.928 1.291 . . . . 0.0 110.214 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -91.7 104.35 16.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.857 1.663 . . . . 0.0 108.719 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.11 150.47 3.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.077 0.951 . . . . 0.0 110.145 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -150.8 167.12 28.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.435 1.494 . . . . 0.0 109.117 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.91 115.16 16.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.57 -114.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.015 1.326 . . . . 0.0 110.555 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -83.91 56.95 3.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.426 1.49 . . . . 0.0 110.639 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.47 37.37 94.69 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -140.32 140.55 35.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.671 1.188 . . . . 0.0 107.946 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 tt -79.3 109.71 13.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.8 t -119.24 117.25 53.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 m -123.89 152.13 42.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.508 1.523 . . . . 0.0 109.404 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -128.9 135.44 49.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.352 1.461 . . . . 0.0 108.32 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t -110.17 168.27 9.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.695 1.198 . . . . 0.0 108.748 170.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.46 -43.47 84.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 111.045 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -96.68 -23.71 16.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.822 0.849 . . . . 0.0 113.162 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.9 -168.3 3.0 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.44 1.018 . . . . 0.0 112.373 -168.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -143.9 162.27 36.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.596 1.159 . . . . 0.0 111.502 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -149.54 120.9 7.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.589 1.556 . . . . 0.0 108.336 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -128.48 133.57 48.51 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.68 1.192 . . . . 0.0 108.423 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -152.07 135.95 16.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -165.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.0 152.78 30.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.385 0.274 . . . . 0.0 110.446 -166.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.3 t -119.3 139.36 46.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.854 1.261 . . . . 0.0 108.817 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -133.77 101.63 5.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.172 1.789 . . . . 0.0 109.321 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.71 -101.84 0.57 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.27 11.14 10.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.203 1.401 . . . . 0.0 111.377 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -114.88 145.74 41.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.322 1.449 . . . . 0.0 107.45 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.2 ttt -127.72 133.4 49.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.2 t -115.56 136.96 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.47 119.26 21.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.3 1.44 . . . . 0.0 108.657 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -129.28 114.57 16.41 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.84 140.27 44.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.9 t -119.68 172.23 7.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.065 0.393 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -158.11 103.17 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.86 1.664 . . . . 0.0 107.503 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.02 -113.71 5.36 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.03 28.44 13.01 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.17 0.89 . . . . 0.0 112.084 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.14 118.96 51.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -120.33 128.44 53.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.965 0.906 . . . . 0.0 109.246 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.91 138.78 50.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 107.861 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.81 130.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -151.95 164.57 36.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -151.69 155.89 39.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.0 m -136.13 166.05 24.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.558 1.143 . . . . 0.0 109.549 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -132.45 137.48 47.28 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.021 0.928 . . . . 0.0 109.341 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -58.13 132.55 53.85 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.508 0.723 . . . . 0.0 109.479 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.3 178.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -89.62 -10.04 47.44 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.501 0.72 . . . . 0.0 111.944 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 p -51.94 116.81 2.35 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.0 111.156 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.09 177.73 42.56 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.3 m -118.41 138.54 52.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.172 1.389 . . . . 0.0 107.669 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -143.48 155.18 44.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.53 1.132 . . . . 0.0 109.761 -163.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -142.39 128.17 19.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.63 134.14 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 124.042 0.937 . . . . 0.0 109.61 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -109.61 -33.97 6.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.435 0.694 . . . . 0.0 111.339 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.51 46.58 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.137 0.575 . . . . 0.0 110.828 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -148.79 144.3 26.9 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 109.09 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -156.65 144.12 19.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.222 1.009 . . . . 0.0 109.645 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.9 26.05 12.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.035 1.334 . . . . 0.0 110.855 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -99.98 -48.44 4.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.69 2.396 . . . . 0.0 107.711 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.02 -43.65 50.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.126 1.37 . . . . 0.0 110.572 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -60.13 -50.3 74.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.891 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -57.61 -50.03 74.49 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.297 0.639 . . . . 0.0 110.934 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.45 -44.25 95.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -62.87 -30.57 71.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.046 0.539 . . . . 0.0 111.626 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.47 66.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 0.0 111.389 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.02 -176.94 5.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.375 0.534 . . . . 0.0 110.094 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.12 -32.99 37.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.528 1.531 . . . . 0.0 113.606 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.48 111.38 1.8 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.104 1.362 . . . . 0.0 111.013 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.81 167.89 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.075 2.517 . . . . 0.0 110.065 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -46.04 -36.66 5.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.772 1.629 . . . . 0.0 113.059 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -72.4 -57.46 4.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.288 1.035 . . . . 0.0 111.622 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.28 -33.74 63.35 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.342 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -39.52 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -33.67 18.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.518 0.599 . . . . 0.0 112.267 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.22 -55.77 5.27 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.81 65.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.57 1.148 . . . . 0.0 112.9 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -45.34 -39.55 6.87 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.75 1.62 . . . . 0.0 111.974 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -118.2 47.36 1.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.334 1.054 . . . . 0.0 109.238 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.0 mt -127.12 135.16 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -109.47 99.15 35.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.868 1.667 . . . . 0.0 108.354 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.49 145.23 26.32 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.123 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.5 tp -80.81 137.13 21.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.95 148.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.285 1.434 . . . . 0.0 108.078 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -153.26 123.56 7.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mp -110.16 140.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -129.37 137.26 50.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.177 1.391 . . . . 0.0 107.393 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.77 166.66 32.82 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.514 0.726 . . . . 0.0 109.529 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -156.17 65.84 0.57 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.363 0.665 . . . . 0.0 109.54 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.1 -85.3 1.04 Allowed Glycine 0 C--N 1.337 0.631 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -92.88 -49.48 6.03 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.501 0.72 . . . . 0.0 111.709 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.64 142.73 31.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.273 0.488 . . . . 0.0 110.485 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.83 142.34 48.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.924 1.689 . . . . 0.0 108.424 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.2 t -130.3 126.97 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.774 1.63 . . . . 0.0 106.77 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.3 t -110.41 126.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.9 m -132.26 141.07 48.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.448 1.099 . . . . 0.0 108.533 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.1 m -142.85 134.13 26.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 108.157 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -123.48 146.84 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 108.651 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -144.59 151.73 51.1 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.78 -13.38 36.62 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.448 2.099 . . . . 0.0 113.27 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -144.1 41.56 1.4 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.859 0.864 . . . . 0.0 111.365 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -177.19 154.98 1.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.224 1.41 . . . . 0.0 108.143 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.6 m -154.53 130.8 10.4 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 167.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -127.18 131.26 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 107.864 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -140.02 133.53 30.14 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.268 1.027 . . . . 0.0 108.333 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.12 158.81 37.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.42 1.488 . . . . 0.0 109.609 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.3 p -152.27 159.96 43.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.465 0.706 . . . . 0.0 110.529 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -167.4 171.21 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.66 1.184 . . . . 0.0 109.061 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.1 m -139.93 155.13 47.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.566 1.146 . . . . 0.0 107.959 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.0 mt -59.05 112.37 1.66 Allowed 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.686 0.394 . . . . 0.0 111.883 -171.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.8 41.03 95.87 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.787 1.184 . . . . 0.0 111.251 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -130.87 132.09 44.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.548 0.739 . . . . 0.0 110.183 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.48 124.81 12.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.886 1.675 . . . . 0.0 110.754 172.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.81 173.88 13.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.887 1.275 . . . . 0.0 110.107 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -116.31 146.84 42.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.044 1.738 . . . . 0.0 108.162 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.29 136.26 60.55 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 173.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m -85.1 103.49 14.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.503 0.721 . . . . 0.0 109.484 -172.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -65.08 153.68 40.09 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.605 1.162 . . . . 0.0 108.999 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 58.3 mtt -78.6 50.35 0.96 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.803 0.841 . . . . 0.0 110.654 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -152.8 37.09 0.5 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.751 1.621 . . . . 0.0 108.716 169.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 47.87 46.85 25.58 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.717 2.103 . . . . 0.0 114.869 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -160.67 -177.27 6.06 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.052 0.941 . . . . 0.0 109.166 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.34 171.4 10.45 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 124.532 1.133 . . . . 0.0 110.7 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp -144.84 13.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.284 1.034 . . . . 0.0 113.093 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 66.51 143.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.928 2.091 . . . . 0.0 113.357 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.9 t -155.66 147.42 23.14 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.636 -0.665 . . . . 0.0 110.748 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 m -156.21 71.97 0.74 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.719 0.808 . . . . 0.0 111.036 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.26 -161.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.793 0.724 . . . . 0.0 111.173 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -157.79 -174.88 5.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.584 1.554 . . . . 0.0 111.884 -161.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -104.89 139.55 39.46 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 109.345 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.16 112.91 5.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.838 1.255 . . . . 0.0 108.918 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 56.58 64.99 1.52 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.053 1.341 . . . . 0.0 111.394 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.88 37.23 77.05 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.716 1.151 . . . . 0.0 113.117 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -154.75 118.33 4.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.11 0.964 . . . . 0.0 108.497 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.63 122.05 44.2 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.502 1.121 . . . . 0.0 108.302 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.73 70.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.451 -163.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.45 127.2 32.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -144.98 152.13 39.69 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.072 0.949 . . . . 0.0 110.16 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -141.63 -164.88 1.87 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.697 1.199 . . . . 0.0 109.799 -174.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -46.93 -57.27 5.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.24 1.816 . . . . 0.0 112.045 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -127.84 -24.59 3.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.296 1.038 . . . . 0.0 111.648 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -72.87 145.9 46.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.162 0.437 . . . . 0.0 110.117 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.9 m -134.65 152.17 51.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.374 1.07 . . . . 0.0 108.287 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -146.07 93.41 2.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -107.0 105.73 15.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.045 1.738 . . . . 0.0 106.956 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 125.55 50.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.314 1.046 . . . . 0.0 109.104 -170.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -122.37 130.46 53.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.563 1.545 . . . . 0.0 107.723 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -121.46 149.48 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 109.304 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -143.22 -150.3 0.31 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.018 1.327 . . . . 0.0 108.414 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.76 -65.96 2.1 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -126.73 31.45 5.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.602 1.161 . . . . 0.0 109.958 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -155.44 143.78 20.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.161 0.984 . . . . 0.0 108.716 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 11.4 ttt -146.66 124.07 11.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.69 1.196 . . . . 0.0 108.101 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.75 137.29 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.666 1.186 . . . . 0.0 107.932 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -132.61 125.87 31.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.032 0.933 . . . . 0.0 108.779 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -132.68 122.65 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mm -119.12 157.02 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -134.05 149.26 51.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.58 112.98 5.28 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.623 1.169 . . . . 0.0 108.748 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.5 -91.24 0.25 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 124.333 0.968 . . . . 0.0 111.028 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.46 37.19 1.49 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.837 1.208 . . . . 0.0 110.152 172.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.44 144.89 35.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 106.956 174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -121.49 134.74 55.07 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.836 1.254 . . . . 0.0 108.038 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.28 141.53 49.91 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.61 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -161.71 161.29 29.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.017 0.927 . . . . 0.0 108.684 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -139.95 143.61 36.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.1 m -119.08 163.74 16.56 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.408 1.483 . . . . 0.0 110.618 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -123.32 151.13 42.76 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.16 1.384 . . . . 0.0 108.342 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -71.92 146.34 47.88 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.406 0.683 . . . . 0.0 109.618 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--O 1.255 1.349 0 CA-C-O 116.857 -1.544 . . . . 0.0 106.92 174.453 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 119.814 -0.136 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -72.85 -18.95 61.4 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 119.051 -0.499 . . . . 0.0 109.688 168.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.3 p -43.62 112.92 0.44 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 126.116 1.766 . . . . 0.0 111.261 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.85 -175.79 39.97 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -120.5 142.69 49.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -142.56 139.39 31.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.201 1.0 . . . . 0.0 109.622 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -120.6 109.46 15.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.49 1.116 . . . . 0.0 108.521 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.24 137.54 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.592 1.157 . . . . 0.0 109.618 167.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -125.03 -52.7 1.65 Allowed 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.607 0.763 . . . . 0.0 109.38 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.09 148.29 25.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.987 0.915 . . . . 0.0 110.284 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.44 147.61 12.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.618 1.167 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -147.53 143.49 27.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.973 0.909 . . . . 0.0 109.263 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.46 28.2 17.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.507 1.523 . . . . 0.0 111.092 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -89.71 -61.55 1.67 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.034 2.134 . . . . 0.0 109.524 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -55.28 -36.87 66.59 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.196 0.999 . . . . 0.0 111.098 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.29 -39.8 71.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.162 0.985 . . . . 0.0 110.635 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.64 -52.89 63.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.459 171.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.89 -42.45 75.98 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 123.244 0.34 . . . . 0.0 110.548 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.78 -43.39 98.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.784 0.434 . . . . 0.0 111.108 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.29 -17.19 61.89 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.7 tp -69.57 -70.3 0.29 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.841 0.746 . . . . 0.0 112.311 -165.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.82 -58.0 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.381 1.072 . . . . 0.0 110.482 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.48 154.34 44.62 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.203 1.001 . . . . 0.0 111.84 -176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.94 165.25 28.71 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.502 2.135 . . . . 0.0 111.227 -172.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.16 -23.83 62.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.029 1.331 . . . . 0.0 112.17 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.04 -37.55 83.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.931 0.492 . . . . 0.0 111.355 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.41 -29.57 26.05 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.426 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -36.53 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.487 1.04 . . . . 0.0 110.217 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.39 -41.38 76.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.951 1.3 . . . . 0.0 110.246 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 ttt -68.64 -38.97 80.91 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.669 0.213 . . . . 0.0 111.252 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.49 -18.05 49.78 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.288 1.035 . . . . 0.0 113.189 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -38.69 -60.79 0.79 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.174 2.19 . . . . 0.0 114.427 -165.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -119.31 34.49 5.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.268 1.027 . . . . 0.0 109.505 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.46 126.87 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -104.04 98.23 13.19 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 126.176 1.79 . . . . 0.0 108.396 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.29 124.31 10.33 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.065 2.51 . . . . 0.0 110.005 -172.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.37 141.63 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.89 144.93 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.078 1.351 . . . . 0.0 109.037 -169.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -135.8 132.47 36.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.325 1.05 . . . . 0.0 109.02 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mm -110.6 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.014 1.726 . . . . 0.0 106.911 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 -179.72 2.31 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.109 1.364 . . . . 0.0 110.856 168.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -152.67 39.8 0.56 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.615 0.766 . . . . 0.0 110.365 168.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.04 -133.8 3.53 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.67 -31.19 72.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.855 1.262 . . . . 0.0 112.731 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.16 156.98 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.188 0.595 . . . . 0.0 109.688 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -148.64 110.14 4.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.752 1.621 . . . . 0.0 107.101 173.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.38 141.47 24.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.35 133.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.553 1.141 . . . . 0.0 108.063 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -126.27 143.31 51.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.636 1.175 . . . . 0.0 108.435 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.8 p -124.81 141.74 51.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.571 1.148 . . . . 0.0 108.989 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -133.5 137.27 45.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.87 1.268 . . . . 0.0 108.519 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -153.12 148.41 20.08 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.22 32.51 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.64 2.226 . . . . 0.0 112.402 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -174.6 20.27 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.947 2.099 . . . . 0.0 111.403 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.97 147.08 0.44 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.517 1.127 . . . . 0.0 108.952 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.9 t -170.06 152.58 4.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.184 0.594 . . . . 0.0 109.639 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -162.44 164.34 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.517 1.127 . . . . 0.0 109.078 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 m -136.79 146.14 45.36 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.487 1.115 . . . . 0.0 108.52 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.64 155.94 45.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.083 1.353 . . . . 0.0 110.417 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.6 p -138.6 121.97 17.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.65 1.58 . . . . 0.0 109.009 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -144.51 175.11 10.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.639 0.775 . . . . 0.0 110.487 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -153.18 148.49 26.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.7 0.8 . . . . 0.0 110.24 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.65 123.52 21.1 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.857 0.863 . . . . 0.0 110.791 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.96 37.46 93.24 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.367 0.984 . . . . 0.0 111.885 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -160.3 175.3 13.01 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -50.73 140.09 15.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.741 1.216 . . . . 0.0 111.638 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.69 91.06 2.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 110.097 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.7 130.65 41.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 mt -129.84 140.94 47.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 123.342 0.657 . . . . 0.0 109.437 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.366 4.9 t 47.89 -171.68 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 128.119 2.567 . . . . 0.0 115.362 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 t 168.73 -78.1 0.0 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.935 2.894 . . . . 0.0 109.315 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.0 ttt -91.22 62.1 4.66 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.125 0.97 . . . . 0.0 109.939 -170.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -171.33 -68.48 0.02 OUTLIER 'General case' 0 C--N 1.338 0.102 0 C-N-CA 126.284 1.834 . . . . 0.0 107.283 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.9 -98.34 1.32 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -163.15 119.17 1.78 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -51.1 138.92 19.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.503 1.121 . . . . 0.0 109.811 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.34 -179.89 4.1 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.418 1.487 . . . . 0.0 109.708 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -153.46 120.73 5.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.693 1.597 . . . . 0.0 107.541 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.3 m -136.08 -172.13 3.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.633 1.173 . . . . 0.0 109.241 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.0 m -135.68 85.37 2.16 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.92 132.14 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.689 0.796 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -144.44 151.93 39.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.192 1.397 . . . . 0.0 108.368 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tp -92.24 137.88 31.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.032 0.933 . . . . 0.0 108.703 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.7 72.06 1.46 Allowed 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.312 1.445 . . . . 0.0 108.911 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.6 t30 65.47 75.42 0.35 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.662 1.585 . . . . 0.0 111.286 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.38 32.68 84.99 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.961 0.791 . . . . 0.0 113.198 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -157.84 139.89 14.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.721 0.76 . . . . 0.0 110.828 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.42 146.14 34.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.595 1.158 . . . . 0.0 108.651 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -143.29 138.51 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.242 1.017 . . . . 0.0 109.214 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.0 p -144.82 169.73 17.48 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.673 1.589 . . . . 0.0 109.863 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -144.58 141.86 29.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.515 1.126 . . . . 0.0 108.197 158.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -120.06 -159.05 0.77 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 107.999 164.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.32 -50.21 68.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.415 0.686 . . . . 0.0 111.158 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -127.58 -25.78 3.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.036 1.334 . . . . 0.0 111.581 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -91.08 144.05 26.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 109.321 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.7 m -149.29 125.36 10.68 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -109.0 112.08 24.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.857 1.663 . . . . 0.0 109.195 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -137.26 128.89 28.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.983 1.313 . . . . 0.0 108.542 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -162.15 149.35 13.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.82 157.44 46.78 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.744 1.218 . . . . 0.0 111.094 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.67 140.72 47.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.695 1.198 . . . . 0.0 109.488 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.87 162.26 30.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.013 1.725 . . . . 0.0 107.858 165.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -10.4 -79.87 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 128.368 2.89 . . . . 0.0 115.077 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -123.69 29.13 6.66 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.503 1.121 . . . . 0.0 111.184 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -152.01 115.76 4.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 ttt -101.92 141.41 34.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.959 1.304 . . . . 0.0 107.574 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.49 138.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.55 151.91 47.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.357 0.663 . . . . 0.0 110.739 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 152.45 51.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.085 0.954 . . . . 0.0 108.782 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.47 138.36 29.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.1 m -97.97 154.37 17.73 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.572 1.149 . . . . 0.0 109.143 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.28 67.27 1.08 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.577 1.551 . . . . 0.0 107.24 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.73 8.38 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.728 1.156 . . . . 0.0 110.937 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.05 15.36 27.79 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.296 -0.724 . . . . 0.0 113.046 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.6 154.1 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.28 1.432 . . . . 0.0 107.534 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -136.46 160.64 38.15 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.56 1.144 . . . . 0.0 108.75 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.55 143.52 50.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.478 1.511 . . . . 0.0 107.323 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.19 143.88 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 160.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -141.07 161.73 37.16 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.952 0.901 . . . . 0.0 109.476 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -141.81 138.45 32.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.924 0.89 . . . . 0.0 109.708 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.6 m -134.38 159.93 39.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.947 1.699 . . . . 0.0 110.712 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -122.71 148.99 44.66 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.269 1.428 . . . . 0.0 109.207 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -66.02 147.34 53.5 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.234 0.614 . . . . 0.0 110.171 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.8 1.64 . . . . 0.0 107.025 169.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -51.75 131.08 30.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.462 1.105 . . . . 0.0 111.506 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.58 -173.88 35.64 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.9 m -120.85 148.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -143.94 155.8 44.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.74 1.216 . . . . 0.0 109.05 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -138.96 130.45 27.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.378 1.071 . . . . 0.0 108.227 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.57 136.7 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.389 1.076 . . . . 0.0 110.132 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.26 -57.17 2.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.796 1.639 . . . . 0.0 109.922 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.31 172.28 16.13 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.702 0.801 . . . . 0.0 110.617 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.67 143.86 26.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.269 1.028 . . . . 0.0 110.651 -170.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -141.39 118.38 11.21 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.074 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 62.8 6.12 2.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.722 2.009 . . . . 0.0 113.342 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -62.87 -47.79 81.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.913 0.885 . . . . 0.0 110.093 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -33.46 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.074 0.55 . . . . 0.0 111.526 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -67.71 -43.13 80.77 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.333 0.653 . . . . 0.0 110.232 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.4 -53.25 60.3 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.731 0.812 . . . . 0.0 110.994 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.71 -39.78 85.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.768 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -75.35 -23.72 57.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.048 0.84 . . . . 0.0 112.567 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -34.26 74.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.279 0.49 . . . . 0.0 110.283 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.9 tp -73.37 162.01 29.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.677 1.191 . . . . 0.0 108.719 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.69 -34.49 26.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.481 1.113 . . . . 0.0 113.038 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -44.3 111.92 1.29 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.119 1.768 . . . . 0.0 110.637 174.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' HD23 ' A' ' 23' ' ' LEU . 71.4 Cg_endo -80.17 149.64 19.81 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.197 2.598 . . . . 0.0 110.192 -169.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -54.85 -32.3 60.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.22 -47.85 71.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.709 0.803 . . . . 0.0 111.889 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.7 mt -80.54 -31.52 36.99 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.984 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.15 -29.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.57 1.077 . . . . 0.0 111.246 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -53.43 -29.93 37.76 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 111.591 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 90.4 mtp -61.4 -66.93 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.88 -39.07 65.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.029 1.331 . . . . 0.0 112.769 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -43.34 -49.08 6.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.838 2.055 . . . . 0.0 112.25 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -123.8 40.74 3.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.905 0.882 . . . . 0.0 110.71 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.4 mt -130.99 136.93 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -112.79 97.72 42.36 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 107.906 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.13 159.42 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.334 2.69 . . . . 0.0 112.893 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.1 mm -75.29 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.138 0.975 . . . . 0.0 109.159 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.4 t -128.61 144.55 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 126.023 1.729 . . . . 0.0 107.19 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -156.04 143.28 19.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.343 0.657 . . . . 0.0 110.072 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.74 142.82 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.455 1.102 . . . . 0.0 110.383 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -118.81 107.23 13.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.45 1.9 . . . . 0.0 108.412 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -89.31 134.69 33.95 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.28 1.432 . . . . 0.0 108.061 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -151.33 59.54 0.9 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.1 81.55 0.24 Allowed Glycine 0 C--N 1.339 0.721 0 C-N-CA 124.076 0.846 . . . . 0.0 112.029 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 76.93 -43.96 0.45 Allowed 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.071 2.148 . . . . 0.0 112.657 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.6 146.03 25.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.64 163.06 32.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 111.17 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.18 139.66 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.391 1.076 . . . . 0.0 108.714 -171.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.03 137.4 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 125.902 1.681 . . . . 0.0 106.812 174.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.1 m -131.08 135.53 47.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 t -129.04 144.79 51.31 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.288 1.035 . . . . 0.0 109.144 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -122.76 122.23 38.21 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 p -122.94 154.56 64.35 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.59 56.37 6.02 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.548 2.832 . . . . 0.0 110.732 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -162.35 -41.89 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.564 . . . . 0.0 110.173 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -161.96 157.38 23.64 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.31 1.044 . . . . 0.0 109.127 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.0 p -109.77 140.93 43.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.015 0.926 . . . . 0.0 109.049 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.2 t -136.2 149.13 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.328 1.051 . . . . 0.0 109.968 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 m -144.98 146.9 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.337 1.455 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.35 151.79 33.42 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 p -122.14 153.07 39.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.654 1.982 . . . . 0.0 110.947 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.29 169.22 10.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.073 0.949 . . . . 0.0 110.625 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.1 m -141.75 145.56 34.95 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.938 1.295 . . . . 0.0 109.091 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.19 136.5 53.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.338 0.655 . . . . 0.0 111.544 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.83 45.38 95.82 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.607 1.099 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -157.43 148.97 21.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.165 0.482 . . . . 0.0 110.168 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.07 124.28 23.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.641 1.176 . . . . 0.0 109.163 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.76 147.72 47.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.295 1.038 . . . . 0.0 110.477 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.1 132.66 36.42 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.687 1.195 . . . . 0.0 108.48 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.8 tt -133.59 153.77 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 124.976 1.31 . . . . 0.0 109.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.528 0.099 0 C-N-CA 124.362 1.065 . . . . 0.0 109.559 -171.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.1 pttt . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 120.851 0.358 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.1 -175.32 5.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.72 1.608 . . . . 0.0 107.851 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 157.51 43.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.915 0.325 . . . . 0.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.5 p -159.79 160.94 34.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.499 1.119 . . . . 0.0 109.807 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -84.03 112.48 20.23 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.5 t -84.9 136.52 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -154.98 159.19 40.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.255 1.022 . . . . 0.0 110.266 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -124.86 128.66 49.02 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 126.861 2.064 . . . . 0.0 108.645 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.08 -134.02 0.34 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.232 1.413 . . . . 0.0 108.89 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.97 79.98 2.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.137 0.975 . . . . 0.0 110.641 -176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.51 40.27 77.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.292 0.949 . . . . 0.0 111.642 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.96 126.34 6.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.774 0.83 . . . . 0.0 109.892 -174.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.0 mt -74.19 142.57 45.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.78 127.63 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.02 152.5 46.3 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.385 1.074 . . . . 0.0 109.242 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.21 140.25 41.59 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.495 1.118 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -125.27 -160.61 0.97 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.896 1.278 . . . . 0.0 108.642 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.35 -54.08 42.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.498 1.119 . . . . 0.0 110.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -133.99 -6.09 2.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.745 1.218 . . . . 0.0 112.764 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.69 153.03 19.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.713 0.805 . . . . 0.0 109.334 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 p -145.82 160.23 42.07 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -143.79 121.84 12.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -137.1 107.18 6.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.441 1.096 . . . . 0.0 108.837 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.04 145.38 40.96 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.533 1.133 . . . . 0.0 108.988 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.99 145.88 29.88 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.051 0.541 . . . . 0.0 110.422 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.97 134.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 C-N-CA 125.127 1.371 . . . . 0.0 108.951 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 133.76 19.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.125 1.37 . . . . 0.0 108.69 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.85 -112.03 4.04 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.084 0.85 . . . . 0.0 111.638 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.32 37.02 4.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.895 1.278 . . . . 0.0 109.146 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -142.9 145.46 33.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.289 1.036 . . . . 0.0 109.112 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 ttt -138.88 116.47 11.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.136 1.374 . . . . 0.0 108.335 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.95 137.12 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -128.7 93.02 3.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.868 1.267 . . . . 0.0 108.839 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -97.02 139.4 33.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.879 1.272 . . . . 0.0 109.604 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.5 mt -143.13 147.89 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.682 1.193 . . . . 0.0 107.945 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 165.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -131.5 84.07 2.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.381 1.872 . . . . 0.0 107.395 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.72 -117.34 9.88 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.32 11.39 58.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.481 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -128.19 138.23 55.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 118.649 1.225 . . . . 0.0 108.009 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.8 m -123.04 136.11 54.7 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.745 1.218 . . . . 0.0 107.764 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 163.33 32.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.03 0.532 . . . . 0.0 111.835 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.7 139.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -138.02 157.7 45.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.04 145.97 47.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.747 1.219 . . . . 0.0 109.376 -169.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.1 m -143.42 161.86 37.27 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.115 1.366 . . . . 0.0 109.798 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.7 145.79 51.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.61 1.564 . . . . 0.0 109.483 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -71.66 146.74 48.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.869 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 C--O 1.25 1.108 0 C-N-CA 126.085 1.754 . . . . 0.0 107.505 174.055 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t 50.77 75.63 0.18 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.566 1.547 . . . . 0.0 112.226 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.4 -167.22 37.09 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.6 m -117.69 147.64 42.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -142.42 138.65 31.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.517 1.127 . . . . 0.0 109.584 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -112.65 112.03 23.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.06 139.72 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -125.62 -34.65 2.63 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.456 0.702 . . . . 0.0 111.726 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.95 144.06 50.56 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.703 0.801 . . . . 0.0 110.43 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -144.83 121.28 11.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.551 1.541 . . . . 0.0 107.908 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -140.34 139.96 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.913 0.885 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.24 18.32 10.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.702 1.601 . . . . 0.0 111.758 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -84.46 -47.33 10.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.008 1.323 . . . . 0.0 109.721 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.75 -36.89 67.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.601 0.761 . . . . 0.0 111.79 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.7 -46.64 89.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.429 1.092 . . . . 0.0 110.47 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.46 ' CG ' HD11 ' A' ' 118' ' ' LEU . 65.5 t80 -63.41 -50.77 68.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.937 0.495 . . . . 0.0 111.072 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.7 mt -55.2 -40.92 71.32 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.903 0.319 . . . . 0.0 111.076 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.05 -37.5 85.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.248 0.619 . . . . 0.0 111.122 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.13 66.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.057 -0.497 . . . . 0.0 111.851 173.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -75.76 171.27 14.65 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 121.579 0.704 . . . . 0.0 110.752 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.56 76.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.147 1.379 . . . . 0.0 112.959 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.91 130.62 92.7 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.63 -0.224 . . . . 0.0 110.574 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.16 168.17 23.64 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.389 2.726 . . . . 0.0 110.897 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -48.24 -36.69 14.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.425 1.49 . . . . 0.0 113.487 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.72 -38.26 81.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.929 0.492 . . . . 0.0 111.596 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.87 -31.67 20.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.567 -0.73 . . . . 0.0 112.027 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.86 -36.94 77.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.597 1.09 . . . . 0.0 109.817 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -52.83 -38.09 60.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 111.559 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 66.8 mtt -72.35 -17.94 61.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.248 0.619 . . . . 0.0 112.43 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.86 26.52 4.3 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.525 1.13 . . . . 0.0 111.801 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -69.45 -70.69 0.26 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.427 0.691 . . . . 0.0 109.765 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -121.59 52.08 1.27 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.343 1.457 . . . . 0.0 107.111 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.16 124.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -107.7 93.68 10.78 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 125.883 1.673 . . . . 0.0 108.249 -165.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.32 172.28 16.25 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.119 2.546 . . . . 0.0 112.686 -164.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.61 135.43 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.69 143.15 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.928 1.291 . . . . 0.0 107.66 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -152.36 113.48 4.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mp -109.6 140.21 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -140.59 139.53 34.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -115.76 166.94 11.38 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.134 0.973 . . . . 0.0 111.089 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -147.7 56.25 1.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.87 -143.79 16.06 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.45 1.5 . . . . 0.0 109.799 -173.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.03 -35.98 78.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.567 1.147 . . . . 0.0 111.357 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.5 138.14 46.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.02 157.28 37.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.914 0.759 . . . . 0.0 112.561 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.47 138.71 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.395 -167.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -108.62 126.22 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.518 1.927 . . . . 0.0 106.553 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.3 m -123.65 138.22 54.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.607 1.163 . . . . 0.0 107.965 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.3 m -133.57 129.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 108.703 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.9 121.46 35.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.66 1.184 . . . . 0.0 108.113 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -122.28 155.29 61.98 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.19 40.42 0.97 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.425 2.75 . . . . 0.0 111.292 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -142.94 -50.72 0.35 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.899 2.079 . . . . 0.0 108.088 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -159.17 159.8 34.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.298 1.439 . . . . 0.0 108.981 -175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -111.87 146.47 37.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.065 0.946 . . . . 0.0 109.721 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.3 t -141.25 146.55 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.125 1.37 . . . . 0.0 108.419 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -149.92 157.81 43.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.247 0.619 . . . . 0.0 110.098 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -153.13 150.42 29.07 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.186 0.994 . . . . 0.0 109.923 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -122.53 150.52 42.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.145 1.778 . . . . 0.0 110.603 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -164.67 -179.52 5.95 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.188 0.995 . . . . 0.0 110.205 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.6 m -136.3 134.66 38.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.516 1.126 . . . . 0.0 108.877 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.17 142.69 50.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.489 0.316 . . . . 0.0 110.551 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.23 -39.99 2.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.001 1.286 . . . . 0.0 112.207 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -124.39 177.85 5.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.598 1.159 . . . . 0.0 111.292 -170.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -73.76 155.75 38.56 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.713 0.805 . . . . 0.0 111.009 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.14 149.48 28.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.28 1.032 . . . . 0.0 109.176 171.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -85.11 138.3 32.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.484 0.713 . . . . 0.0 109.167 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -127.99 147.65 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.798 1.239 . . . . 0.0 107.843 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 124.706 1.202 . . . . 0.0 108.662 179.257 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.301 0.572 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.95 178.47 8.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.549 1.94 . . . . 0.0 108.462 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.34 158.16 35.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.302 0.641 . . . . 0.0 110.393 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.7 p -157.98 160.84 37.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.759 1.223 . . . . 0.0 109.155 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.6 m -74.62 100.17 3.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.5 t -74.38 97.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -133.89 153.5 51.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.724 0.81 . . . . 0.0 109.756 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -135.44 131.54 36.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.368 1.067 . . . . 0.0 109.269 -165.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.11 88.97 3.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.559 1.543 . . . . 0.0 109.606 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.95 67.06 0.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.901 1.28 . . . . 0.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.17 31.93 82.29 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.283 0.944 . . . . 0.0 113.077 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.01 112.13 5.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.083 0.953 . . . . 0.0 108.559 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -74.9 125.67 29.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.53 114.37 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.1 p -130.11 162.78 28.05 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.844 0.858 . . . . 0.0 109.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.1 142.94 18.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 168.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 t -137.67 168.56 19.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.026 1.73 . . . . 0.0 108.103 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -84.77 50.05 1.84 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.454 0.702 . . . . 0.0 110.695 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? 178.51 -23.0 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.948 2.099 . . . . 0.0 111.429 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -150.24 161.56 42.2 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.886 0.766 . . . . 0.0 111.049 -166.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.9 t -149.01 141.94 24.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.379 1.071 . . . . 0.0 108.842 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -122.9 102.46 8.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.453 1.901 . . . . 0.0 106.513 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -121.72 94.35 4.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.29 1.436 . . . . 0.0 109.51 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -121.71 112.33 18.27 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.67 147.83 45.37 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.51 0.724 . . . . 0.0 110.255 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.47 149.95 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.605 1.162 . . . . 0.0 109.915 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -125.12 -155.09 0.65 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.147 . . . . 0.0 108.287 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.48 -59.36 8.93 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.616 0.627 . . . . 0.0 111.884 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -136.22 22.3 3.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.378 1.071 . . . . 0.0 111.207 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -142.53 155.0 44.97 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.066 0.946 . . . . 0.0 108.976 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.7 ttt -146.03 133.78 21.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.667 1.187 . . . . 0.0 108.731 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.2 t -102.86 122.44 55.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.64 91.93 3.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.289 1.836 . . . . 0.0 108.441 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.8 m -103.46 133.75 47.99 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 109.11 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 34.2 mm -125.63 153.29 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.0 m -133.08 143.59 49.43 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -129.61 92.47 3.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 106.337 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -9.13 83.81 0.0 OUTLIER Glycine 0 C--N 1.342 0.867 0 C-N-CA 129.296 3.331 . . . . 0.0 115.068 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.19 -46.24 1.02 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.232 0.92 . . . . 0.0 110.947 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.69 150.78 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 125.417 1.487 . . . . 0.0 108.767 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -122.39 155.96 34.98 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.313 1.445 . . . . 0.0 108.987 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 17' ' ' PHE . 2.0 mp -125.44 136.03 52.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.74 115.43 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 165.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -126.92 156.33 41.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.958 1.703 . . . . 0.0 106.637 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -141.62 147.0 36.9 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.771 0.429 . . . . 0.0 110.365 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -134.64 160.83 36.89 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.435 1.494 . . . . 0.0 110.83 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -121.96 144.95 48.57 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.26 1.424 . . . . 0.0 109.539 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -75.21 140.45 43.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.656 1.182 . . . . 0.0 110.862 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.432 1.493 . . . . 0.0 107.932 177.131 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.3 p -51.09 135.12 25.9 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.138 0.975 . . . . 0.0 111.127 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.06 -170.65 35.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 m -121.69 146.09 47.36 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.763 1.225 . . . . 0.0 108.704 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -145.0 161.9 38.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.95 1.3 . . . . 0.0 110.062 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 123.87 23.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.938 1.295 . . . . 0.0 107.781 172.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.71 137.63 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -122.63 -43.66 2.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.043 0.937 . . . . 0.0 110.707 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.01 146.91 46.19 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.631 0.772 . . . . 0.0 110.685 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.28 138.18 21.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.5 1.92 . . . . 0.0 107.808 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -151.41 139.6 20.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.508 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t30 64.64 28.13 13.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.586 2.354 . . . . 0.0 112.164 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -79.91 -50.54 10.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 109.977 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -53.99 -38.76 65.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 111.729 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -57.65 -52.57 64.88 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.095 0.958 . . . . 0.0 110.482 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.14 -46.77 89.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.039 0.536 . . . . 0.0 111.453 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.4 mt -55.69 -42.39 75.1 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.604 0.362 . . . . 0.0 111.406 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -65.89 -38.54 89.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.221 0.208 . . . . 0.0 110.669 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -23.17 65.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.86 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.78 -71.82 0.2 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.311 0.96 . . . . 0.0 109.596 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.47 -54.53 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.291 1.036 . . . . 0.0 110.527 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.9 134.93 47.66 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.238 1.015 . . . . 0.0 111.774 -170.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.06 168.05 23.98 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.491 2.794 . . . . 0.0 111.196 -171.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -50.43 -35.32 28.07 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 113.531 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.76 -36.94 82.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.486 0.714 . . . . 0.0 112.001 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.0 mt -86.84 -33.14 19.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.716 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -35.34 69.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 119.647 1.112 . . . . 0.0 110.434 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -46.98 -44.19 19.93 Favored 'General case' 0 C--N 1.345 0.403 0 C-N-CA 124.508 1.123 . . . . 0.0 111.192 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.6 ttt -71.21 -16.59 62.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.142 0.977 . . . . 0.0 112.008 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.71 -34.79 9.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.657 1.183 . . . . 0.0 111.12 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.75 -57.65 1.86 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 127.023 2.129 . . . . 0.0 111.821 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.421 ' C ' HD12 ' A' ' 34' ' ' ILE . 19.8 t70 -118.14 35.41 4.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.853 0.861 . . . . 0.0 109.981 -172.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 33' ' ' ASP . 1.9 mp -118.59 122.64 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -112.22 100.05 48.26 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 109.255 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.72 166.65 23.41 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.281 -166.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mm -68.25 140.97 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.07 147.1 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -148.47 128.55 13.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.59 143.52 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 107.931 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -141.61 77.06 1.57 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.549 1.14 . . . . 0.0 108.901 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -81.55 128.93 34.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.926 0.89 . . . . 0.0 108.906 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -125.99 79.68 1.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.03 -120.28 5.25 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.095 0.855 . . . . 0.0 111.497 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -68.95 -40.7 78.78 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.168 0.987 . . . . 0.0 111.69 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.76 138.07 39.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.058 0.543 . . . . 0.0 109.876 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -127.51 117.31 21.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.138 1.775 . . . . 0.0 107.572 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.1 t -110.04 126.21 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.27 141.6 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.173 1.389 . . . . 0.0 108.028 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.2 m -141.86 152.41 43.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 108.812 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.7 p -147.93 143.32 27.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.372 1.069 . . . . 0.0 109.093 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -125.8 136.93 53.68 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.28 1.032 . . . . 0.0 109.402 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.52 168.73 12.34 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.957 1.303 . . . . 0.0 108.175 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.07 -25.01 32.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.429 2.086 . . . . 0.0 113.0 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -138.17 33.59 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.504 0.722 . . . . 0.0 110.566 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.81 173.16 1.97 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.091 . . . . 0.0 109.588 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.6 t -170.63 151.47 3.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 108.295 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -144.58 148.42 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.088 1.355 . . . . 0.0 108.872 -173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 156.89 43.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.966 0.906 . . . . 0.0 110.381 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -150.67 143.93 24.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.253 1.421 . . . . 0.0 109.422 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m -130.86 130.33 43.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.847 1.259 . . . . 0.0 109.639 -172.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -158.19 173.64 16.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.974 0.91 . . . . 0.0 110.032 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 m -145.28 147.71 32.66 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.549 1.139 . . . . 0.0 108.463 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.91 168.87 19.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 111.644 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.87 -39.99 3.03 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.89 0.757 . . . . 0.0 113.207 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -120.28 -173.34 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.491 1.116 . . . . 0.0 109.887 -168.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -57.66 145.12 35.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.508 1.123 . . . . 0.0 109.997 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 105.16 3.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.444 0.698 . . . . 0.0 110.338 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.08 127.86 34.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 165.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.73 144.59 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.874 0.47 . . . . 0.0 110.365 174.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.455 -0.218 0 C-N-CA 124.139 0.976 . . . . 0.0 109.502 -179.709 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.2 pttm . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.23 162.82 34.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.517 1.527 . . . . 0.0 109.304 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -103.92 140.67 37.37 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.353 1.061 . . . . 0.0 109.048 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.6 p -152.27 174.99 13.11 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.705 1.202 . . . . 0.0 108.812 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -110.12 97.62 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.71 137.58 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -151.54 157.22 41.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 109.628 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.86 123.05 49.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.18 -68.56 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.001 0.921 . . . . 0.0 110.434 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -156.96 78.1 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.27 28.95 65.12 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.12 0.867 . . . . 0.0 112.089 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -152.27 140.75 20.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.111 2.164 . . . . 0.0 106.559 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.71 135.54 33.65 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.54 122.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 p -133.68 142.11 47.88 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -150.62 145.27 25.78 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.644 0.378 . . . . 0.0 110.874 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -126.16 -168.6 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.611 1.565 . . . . 0.0 108.542 166.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -36.41 68.4 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.166 0.986 . . . . 0.0 113.211 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -133.75 -37.12 0.93 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.548 1.139 . . . . 0.0 112.407 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.65 149.69 47.83 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.9 m -150.24 157.92 43.6 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.107 0.963 . . . . 0.0 108.951 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -166.69 149.37 6.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -154.98 123.59 6.07 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -118.2 141.47 48.47 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.793 0.837 . . . . 0.0 109.499 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -141.5 127.2 19.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.278 1.431 . . . . 0.0 107.759 -173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.08 133.84 64.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 124.531 1.133 . . . . 0.0 108.574 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.53 164.38 29.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.073 2.149 . . . . 0.0 107.838 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.98 -85.9 0.01 OUTLIER Glycine 0 C--N 1.344 0.987 0 C-N-CA 128.337 2.875 . . . . 0.0 115.119 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -125.59 40.59 3.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.271 1.028 . . . . 0.0 110.008 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -152.03 128.41 10.62 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 ttt -122.26 121.07 35.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.996 1.318 . . . . 0.0 108.591 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.77 135.04 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -130.85 89.29 2.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.923 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.9 m -95.44 133.87 38.92 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.419 0.687 . . . . 0.0 109.441 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.63 143.68 38.08 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.9 m -136.13 133.87 37.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.61 1.164 . . . . 0.0 108.669 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -123.78 72.02 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.509 1.923 . . . . 0.0 107.207 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 14.43 67.93 0.01 OUTLIER Glycine 0 C--N 1.344 1.014 0 C-N-CA 129.063 3.22 . . . . 0.0 115.407 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.4 -43.34 1.1 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.38 148.53 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.4 t -121.19 164.67 16.56 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.32 1.048 . . . . 0.0 110.323 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -145.44 140.97 27.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.002 1.321 . . . . 0.0 108.183 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -124.77 129.32 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -111.68 146.49 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 165.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -135.56 128.89 32.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.4 m -121.58 156.07 33.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.994 1.318 . . . . 0.0 110.788 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -121.37 137.95 54.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.111 1.764 . . . . 0.0 107.809 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -70.46 145.31 51.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.553 0.216 . . . . 0.0 111.098 -170.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.545 1.538 . . . . 0.0 107.754 179.397 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 t -53.44 114.03 1.37 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.504 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 -177.55 43.43 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -120.5 156.07 32.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.882 1.273 . . . . 0.0 108.923 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -149.59 152.94 36.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.224 1.41 . . . . 0.0 109.893 -169.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -129.59 120.13 24.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.321 1.448 . . . . 0.0 107.311 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.15 121.14 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.333 0.653 . . . . 0.0 109.545 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -89.58 -51.34 5.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.815 1.646 . . . . 0.0 109.735 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.06 161.99 37.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.135 0.574 . . . . 0.0 110.581 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -156.23 137.55 13.87 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.009 1.324 . . . . 0.0 109.422 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -151.77 142.01 22.35 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.965 0.906 . . . . 0.0 110.54 -171.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.46 31.46 12.25 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.944 1.698 . . . . 0.0 111.415 -167.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -94.78 -49.65 5.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.609 1.963 . . . . 0.0 108.627 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -53.55 -34.48 58.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.716 1.207 . . . . 0.0 111.677 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -57.49 -49.86 74.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.608 0.763 . . . . 0.0 111.089 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -68.34 -42.84 78.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.915 0.325 . . . . 0.0 111.428 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.01 -42.4 85.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.53 0.332 . . . . 0.0 110.853 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.08 -41.28 99.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 110.754 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.61 -25.85 66.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.151 0.58 . . . . 0.0 112.157 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.82 172.3 13.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.477 0.581 . . . . 0.0 110.709 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.93 76.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.267 1.427 . . . . 0.0 113.283 -175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.12 132.97 90.12 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.913 -175.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.45 164.39 34.06 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.195 2.597 . . . . 0.0 110.578 -174.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -54.16 -31.28 52.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.713 1.205 . . . . 0.0 112.216 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -56.71 -44.11 81.25 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.056 0.942 . . . . 0.0 111.39 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.92 -29.7 26.92 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.18 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.74 -34.11 60.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 119.501 1.046 . . . . 0.0 109.716 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -52.66 -37.07 58.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.037 0.935 . . . . 0.0 111.618 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.73 -58.4 3.51 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.33 61.55 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.546 1.138 . . . . 0.0 112.595 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -53.26 -34.48 57.38 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.119 1.367 . . . . 0.0 112.008 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -121.04 40.23 3.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.28 1.032 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.0 mt -125.68 134.96 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 166.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.87 102.28 26.27 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.451 1.1 . . . . 0.0 108.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 138.3 20.85 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.062 1.841 . . . . 0.0 109.996 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.43 141.46 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.8 t -123.88 147.17 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.34 144.11 25.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.76 144.64 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -141.9 143.75 33.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 170.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.83 152.08 27.95 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.092 0.557 . . . . 0.0 109.977 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -147.05 58.04 1.16 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.072 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.74 -135.72 12.9 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.84 -27.9 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.251 1.02 . . . . 0.0 112.001 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.11 140.07 43.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.222 1.409 . . . . 0.0 110.856 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -141.49 127.37 19.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.824 1.249 . . . . 0.0 108.234 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.73 138.04 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.56 128.9 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.1 m -124.56 151.95 44.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.384 1.474 . . . . 0.0 109.274 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 p -125.29 151.42 46.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.788 1.635 . . . . 0.0 108.415 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -136.65 107.36 6.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.35 140.39 14.81 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.11 -9.65 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.959 2.439 . . . . 0.0 113.637 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -128.77 10.7 6.06 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.106 0.962 . . . . 0.0 111.917 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -166.21 79.82 0.26 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.022 0.828 . . . . 0.0 110.426 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.9 m -110.81 101.52 10.12 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -136.78 152.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.913 1.285 . . . . 0.0 110.126 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.7 m -124.74 147.65 48.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.507 1.523 . . . . 0.0 109.981 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.19 131.6 38.78 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 126.726 2.01 . . . . 0.0 107.018 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 p -122.41 132.03 54.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.241 1.016 . . . . 0.0 109.761 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.75 176.35 11.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 111.609 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -145.43 145.03 30.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.8 1.64 . . . . 0.0 107.936 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.84 137.41 55.29 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.986 0.514 . . . . 0.0 110.842 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.82 48.14 84.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -157.74 166.38 32.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -60.19 116.78 4.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.58 101.58 7.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.159 0.984 . . . . 0.0 109.225 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -79.72 112.73 17.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.336 1.054 . . . . 0.0 109.583 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -127.35 140.53 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.228 1.011 . . . . 0.0 108.415 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 m . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 123.901 0.881 . . . . 0.0 109.872 -178.604 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 153.66 51.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.379 1.472 . . . . 0.0 109.107 170.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.43 142.6 27.52 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.985 0.914 . . . . 0.0 109.99 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.6 m -142.79 175.17 10.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 109.589 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 m -132.18 84.91 2.19 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.7 1.2 . . . . 0.0 107.845 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.63 149.89 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.922 0.889 . . . . 0.0 110.602 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -134.62 157.72 45.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.458 1.503 . . . . 0.0 108.513 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.35 112.29 24.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.42 -66.26 0.93 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.885 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.66 83.82 0.61 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.2 35.03 82.63 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.558 0.599 . . . . 0.0 111.709 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -161.52 141.38 10.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.75 0.82 . . . . 0.0 110.004 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.42 133.89 34.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.05 136.64 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 108.065 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 m -148.27 148.63 30.67 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.6 1.16 . . . . 0.0 108.353 -172.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -144.89 154.52 42.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.948 1.299 . . . . 0.0 109.634 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 -172.48 3.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.721 1.608 . . . . 0.0 107.328 167.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -63.03 -56.49 16.5 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.561 0.744 . . . . 0.0 110.141 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -96.76 -36.89 10.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.562 1.145 . . . . 0.0 111.268 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -99.75 156.7 16.96 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.234 1.014 . . . . 0.0 110.823 -170.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.7 t -147.36 156.2 42.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.052 0.941 . . . . 0.0 108.54 165.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.17 127.99 8.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -172.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -147.19 120.86 9.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.15 131.08 54.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.314 1.046 . . . . 0.0 108.865 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.41 129.99 54.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.48 2.312 . . . . 0.0 107.447 -175.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.5 t -120.51 144.79 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.955 0.902 . . . . 0.0 109.42 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -137.09 -176.06 4.25 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.186 1.795 . . . . 0.0 108.582 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.29 -61.32 6.74 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.623 1.106 . . . . 0.0 113.403 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -129.55 31.92 4.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.772 1.229 . . . . 0.0 110.905 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -159.49 150.11 19.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 16.0 ttt -144.93 134.61 23.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.786 1.234 . . . . 0.0 107.903 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.22 139.22 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -134.63 137.08 43.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.191 0.996 . . . . 0.0 108.94 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -143.32 133.31 24.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.789 0.836 . . . . 0.0 109.239 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.47 152.66 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.2 m -136.47 137.33 40.28 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -133.09 95.04 3.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.81 1.644 . . . . 0.0 106.566 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.66 -125.29 39.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.14 24.84 23.06 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.078 -0.845 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.6 136.71 58.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.9 m -121.53 145.27 48.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.158 1.383 . . . . 0.0 107.98 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.93 131.59 54.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -125.56 136.03 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -157.07 174.89 14.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -157.69 150.81 23.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m -130.83 162.34 29.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.93 1.292 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -122.65 139.6 53.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.463 1.505 . . . . 0.0 108.415 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -70.88 148.62 47.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.678 0.791 . . . . 0.0 111.072 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 C--O 1.252 1.235 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.474 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 N--CA 1.458 -0.074 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.7 p -52.92 100.29 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.11 1.364 . . . . 0.0 110.669 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.32 -168.48 36.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.5 m -119.51 151.73 38.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.187 1.395 . . . . 0.0 108.69 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -148.85 129.41 13.99 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 110.208 -162.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -113.07 106.8 15.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.567 1.547 . . . . 0.0 109.17 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.52 117.96 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.121 0.968 . . . . 0.0 109.551 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -99.51 -40.67 7.72 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.811 0.844 . . . . 0.0 111.09 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.41 148.2 43.5 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.927 0.891 . . . . 0.0 110.625 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.49 134.97 14.29 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.544 1.538 . . . . 0.0 108.346 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -156.14 137.87 14.26 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.099 0.959 . . . . 0.0 109.483 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.31 -35.66 0.33 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.459 1.904 . . . . 0.0 111.352 -172.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -32.23 -49.69 0.2 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.428 2.691 . . . . 0.0 112.115 156.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.79 -52.03 67.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.835 0.854 . . . . 0.0 111.016 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.94 -41.5 91.95 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.161 . . . . 0.0 110.664 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.28 -50.37 74.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.329 0.652 . . . . 0.0 111.584 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.94 -42.78 85.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.094 0.406 . . . . 0.0 111.123 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -38.44 80.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -27.25 67.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.957 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.01 -65.17 0.73 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.445 0.566 . . . . 0.0 111.348 -167.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.99 -58.31 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.427 1.091 . . . . 0.0 109.466 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -55.9 130.53 72.9 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.189 0.596 . . . . 0.0 110.508 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.75 170.12 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.299 2.666 . . . . 0.0 111.332 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.57 -28.57 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.876 1.67 . . . . 0.0 113.282 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.14 -42.51 96.77 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.433 0.693 . . . . 0.0 111.868 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.5 mt -83.98 -34.1 24.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.771 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.46 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.276 0.944 . . . . 0.0 111.047 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -49.11 -35.88 17.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 111.629 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.5 mtt -71.24 -60.23 2.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.23 -41.76 69.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.525 1.13 . . . . 0.0 112.168 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -51.36 -37.26 47.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.465 1.506 . . . . 0.0 111.521 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.28 37.58 4.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.032 0.933 . . . . 0.0 110.934 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.5 mt -133.15 136.92 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 168.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -103.1 89.57 2.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.615 1.166 . . . . 0.0 108.293 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.33 148.23 88.2 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.052 1.835 . . . . 0.0 110.923 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 tp -96.26 124.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 t -123.76 136.89 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -168.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -126.97 121.02 30.52 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.795 1.238 . . . . 0.0 108.46 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 98.4 mt -110.62 135.13 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -124.12 88.7 2.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.655 1.582 . . . . 0.0 108.627 -171.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -85.18 128.78 34.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 166.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -132.2 77.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 163.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.82 -128.33 8.44 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.846 1.212 . . . . 0.0 111.174 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.1 -33.05 74.63 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.544 1.138 . . . . 0.0 112.06 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.38 142.46 28.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.185 0.994 . . . . 0.0 110.85 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.65 137.01 45.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.458 1.903 . . . . 0.0 108.264 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.35 124.4 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.26 125.79 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -122.64 135.78 54.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.771 1.228 . . . . 0.0 108.239 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -125.77 128.87 48.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -124.88 114.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 165.79 31.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.78 -3.54 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.277 1.985 . . . . 0.0 113.223 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -139.77 -17.93 0.96 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -130.17 98.6 4.78 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.592 1.157 . . . . 0.0 109.151 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -110.91 113.4 25.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 172.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.16 150.25 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.229 . . . . 0.0 109.394 -173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -135.93 147.06 47.95 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.833 1.253 . . . . 0.0 109.615 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -132.76 149.25 52.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.668 1.187 . . . . 0.0 109.875 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -128.07 138.79 52.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.371 1.868 . . . . 0.0 109.738 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.42 176.33 11.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.082 0.953 . . . . 0.0 110.132 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.2 m -138.39 146.27 42.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.052 1.341 . . . . 0.0 108.196 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 pp -66.8 148.78 51.48 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.967 0.167 . . . . 0.0 111.269 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.43 43.23 44.15 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.855 1.217 . . . . 0.0 112.877 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -156.37 140.15 16.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.11 116.79 7.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.481 0.712 . . . . 0.0 110.566 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.31 160.22 25.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.133 1.373 . . . . 0.0 109.327 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.11 139.74 38.23 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 tt -137.25 168.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.523 1.529 . . . . 0.0 108.17 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.6 m . . . . . 0 N--CA 1.457 -0.118 0 C-N-CA 123.36 0.664 . . . . 0.0 109.849 -174.796 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.75 161.27 39.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.87 1.268 . . . . 0.0 109.136 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -89.07 154.3 20.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.336 0.654 . . . . 0.0 109.797 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p -155.05 165.66 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.397 1.079 . . . . 0.0 109.939 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.1 m -135.32 76.73 1.63 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 137.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -150.95 153.23 34.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.947 0.899 . . . . 0.0 109.44 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.49 162.0 19.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.178 0.991 . . . . 0.0 110.274 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.63 49.3 0.87 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.585 1.154 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.9 t30 68.09 95.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.578 1.951 . . . . 0.0 111.979 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.79 24.54 75.53 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.105 0.86 . . . . 0.0 112.854 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -163.06 147.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.203 . . . . 0.0 108.694 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -103.68 151.25 23.2 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.035 1.334 . . . . 0.0 108.205 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.3 t -121.63 95.08 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -71.25 144.81 49.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.736 0.814 . . . . 0.0 109.526 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -164.86 128.2 2.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.933 0.493 . . . . 0.0 111.928 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -141.71 -149.03 0.26 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.269 2.228 . . . . 0.0 106.115 166.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.64 -73.92 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -78.76 -37.7 40.5 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 111.723 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -95.71 81.76 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.579 0.752 . . . . 0.0 111.054 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.6 p -140.91 144.17 35.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.212 1.005 . . . . 0.0 110.904 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 180.0 -145.74 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.17 1.788 . . . . 0.0 110.124 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.78 170.41 15.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.439 1.496 . . . . 0.0 110.378 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -160.0 127.51 4.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 109.615 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -122.27 149.73 43.3 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.801 1.64 . . . . 0.0 109.86 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.02 146.39 33.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.026 0.931 . . . . 0.0 110.422 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -136.55 171.7 14.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.516 1.926 . . . . 0.0 108.474 168.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -3.22 -76.0 0.01 OUTLIER Glycine 0 C--N 1.343 0.929 0 C-N-CA 128.906 3.146 . . . . 0.0 116.264 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.58 35.43 2.93 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.47 1.108 . . . . 0.0 110.269 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.21 147.29 31.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.201 0.6 . . . . 0.0 110.884 -172.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.14 130.24 38.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.593 1.557 . . . . 0.0 108.63 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.71 116.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -129.8 136.8 50.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 109.794 -169.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 t -142.3 157.73 44.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.201 0.524 . . . . 0.0 110.645 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.4 128.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.78 171.55 9.88 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -150.81 80.68 1.33 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.51 -113.19 5.58 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -175.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.95 68.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.37 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.98 160.41 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.745 1.218 . . . . 0.0 107.871 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.2 m -134.39 155.46 50.24 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.274 1.03 . . . . 0.0 110.311 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 mp -127.1 129.04 47.19 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 158.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.94 142.57 39.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 164.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -158.18 147.93 19.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -128.26 136.08 50.54 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 t -125.04 162.93 23.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.525 1.13 . . . . 0.0 110.583 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.71 133.96 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.52 1.528 . . . . 0.0 107.499 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 ttp85 -68.82 150.92 47.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.054 0.541 . . . . 0.0 109.918 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--O 1.249 1.038 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 172.654 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.3 p -168.7 155.01 6.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.58 1.152 . . . . 0.0 110.026 -173.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.34 -169.76 16.74 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.161 0.886 . . . . 0.0 112.449 165.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -121.95 134.13 54.84 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.939 1.295 . . . . 0.0 108.849 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -144.02 165.0 29.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.167 0.987 . . . . 0.0 111.281 -166.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -148.15 122.64 9.75 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.762 1.225 . . . . 0.0 108.943 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.01 139.63 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.67 1.188 . . . . 0.0 109.783 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -124.06 -37.67 2.55 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.331 0.652 . . . . 0.0 112.187 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.51 149.4 51.71 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 110.161 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.38 148.46 14.77 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.7 0.8 . . . . 0.0 111.536 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.08 140.54 21.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.334 1.454 . . . . 0.0 108.184 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 59.24 89.96 0.06 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.381 1.472 . . . . 0.0 109.268 -171.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -148.64 -51.41 0.17 Allowed 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -47.65 -50.73 23.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.049 1.34 . . . . 0.0 111.375 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.84 -47.49 82.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.819 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -61.66 -53.36 57.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.948 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -62.99 -35.37 79.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.948 0.34 . . . . 0.0 111.51 -174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -75.81 -36.3 59.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.291 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.84 65.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.314 0.506 . . . . 0.0 111.147 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -74.11 -64.52 1.0 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.424 1.089 . . . . 0.0 109.543 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.11 -65.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.353 0.661 . . . . 0.0 111.135 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -56.33 136.77 75.66 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.7 0.8 . . . . 0.0 112.684 -165.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.48 171.47 16.77 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.572 2.848 . . . . 0.0 111.889 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.22 -34.63 4.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.842 2.057 . . . . 0.0 113.532 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.43 -31.85 71.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.949 0.9 . . . . 0.0 112.104 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -93.78 -32.17 14.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.8 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pp -66.89 -20.7 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 119.078 0.854 . . . . 0.0 111.296 173.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -49.87 -38.31 34.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.61 0.641 . . . . 0.0 110.582 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -96.2 46.75 1.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.362 1.065 . . . . 0.0 109.683 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -156.9 -52.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.321 1.048 . . . . 0.0 110.634 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -52.46 -46.38 66.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.62 1.968 . . . . 0.0 112.341 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -120.51 35.21 4.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 109.328 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.82 144.73 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -111.88 90.32 12.98 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.64 137.29 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.184 1.923 . . . . 0.0 109.426 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.55 137.52 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.36 142.02 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.38 129.75 22.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.171 1.388 . . . . 0.0 108.11 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.14 138.43 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.289 1.436 . . . . 0.0 108.505 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -126.15 125.49 42.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.32 1.048 . . . . 0.0 108.648 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.95 142.99 29.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.62 1.568 . . . . 0.0 111.559 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -140.85 42.09 1.83 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.858 1.663 . . . . 0.0 110.829 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 96.71 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.16 0.886 . . . . 0.0 112.771 170.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 57.29 18.52 4.35 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.352 1.461 . . . . 0.0 112.56 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -150.8 143.5 24.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.75 2.02 . . . . 0.0 105.783 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.81 150.89 30.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.819 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.0 131.64 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.437 1.095 . . . . 0.0 108.441 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.95 134.04 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.955 1.702 . . . . 0.0 107.337 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.1 m -132.72 137.42 46.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.704 1.202 . . . . 0.0 107.986 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 t -127.09 140.12 52.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.975 1.71 . . . . 0.0 107.737 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -123.35 116.7 23.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.05 159.97 56.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.27 -4.39 14.27 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.008 1.805 . . . . 0.0 112.445 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -119.42 29.11 7.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.233 1.413 . . . . 0.0 110.932 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 127.83 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.303 3.441 . . . . 0.0 110.389 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 p -108.79 138.08 45.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.2 135.71 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.336 1.454 . . . . 0.0 108.099 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -144.43 151.4 39.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 111.524 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.17 140.98 9.26 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.557 1.543 . . . . 0.0 109.751 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -124.91 151.64 45.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.868 1.267 . . . . 0.0 109.828 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -166.2 152.99 9.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.24 0.543 . . . . 0.0 110.984 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -122.42 144.52 48.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.434 1.894 . . . . 0.0 108.016 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.34 131.73 46.76 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.343 0.257 . . . . 0.0 111.476 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.26 50.34 51.45 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -160.46 139.27 10.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.47 142.28 49.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.97 150.67 27.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.649 0.779 . . . . 0.0 109.892 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -89.43 132.38 35.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.303 1.041 . . . . 0.0 109.219 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.74 147.14 25.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.319 1.048 . . . . 0.0 108.273 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.454 -0.238 0 C-N-CA 124.945 1.298 . . . . 0.0 107.975 -175.199 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 121.187 0.517 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.7 -173.8 2.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.536 2.334 . . . . 0.0 107.633 166.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.81 146.33 37.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.79 0.836 . . . . 0.0 110.68 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.9 p -166.23 162.6 17.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.777 1.231 . . . . 0.0 109.094 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -116.26 61.31 0.72 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 111.894 -173.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.63 138.06 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.381 1.073 . . . . 0.0 112.396 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -151.22 153.96 35.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.291 1.037 . . . . 0.0 110.303 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -85.15 125.49 32.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.059 1.344 . . . . 0.0 108.906 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.28 -68.38 0.8 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.212 1.005 . . . . 0.0 109.387 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -164.51 88.52 0.5 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.93 24.23 64.52 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.198 0.904 . . . . 0.0 112.797 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -157.43 138.8 13.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 109.337 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.37 139.79 36.37 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.2 t -133.45 139.58 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.228 1.411 . . . . 0.0 107.376 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.82 156.11 37.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -143.56 141.49 30.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.309 1.044 . . . . 0.0 109.049 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 t -151.55 166.94 29.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.868 1.267 . . . . 0.0 107.883 163.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -85.72 12.32 9.17 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.157 0.983 . . . . 0.0 111.857 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -126.97 -30.33 2.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.21 1.804 . . . . 0.0 109.854 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -157.12 157.24 34.13 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.913 0.885 . . . . 0.0 109.682 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -136.15 150.91 49.26 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -143.95 92.67 2.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.369 1.468 . . . . 0.0 108.07 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -130.3 124.16 31.7 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.68 139.8 11.8 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -121.07 136.02 55.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.944 2.098 . . . . 0.0 107.948 -172.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.0 133.72 56.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -160.84 127.7 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.628 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.34 -96.34 0.48 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.138 0.875 . . . . 0.0 110.949 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -138.8 18.46 2.67 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.251 1.02 . . . . 0.0 110.757 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -148.65 130.92 15.55 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.4 ptp -123.97 155.56 37.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.428 1.091 . . . . 0.0 111.488 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.55 131.7 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -131.61 140.54 49.43 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.29 0.636 . . . . 0.0 110.898 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -131.17 129.34 41.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.982 1.713 . . . . 0.0 108.181 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 48.0 mm -123.48 152.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 53.2 m -134.99 145.84 48.49 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 163.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -130.5 105.44 7.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 170.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -15.69 89.05 0.01 OUTLIER Glycine 0 C--N 1.342 0.864 0 C-N-CA 128.562 2.982 . . . . 0.0 115.016 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.8 -47.88 0.95 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.93 137.35 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 109.183 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 36.6 m -120.19 133.51 55.48 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.172 1.389 . . . . 0.0 109.179 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 118' ' ' LEU . 2.5 mp -119.92 140.12 51.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.951 2.101 . . . . 0.0 108.73 -170.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.19 141.73 40.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm85 -162.77 160.72 25.67 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 109.761 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -135.64 143.91 45.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.457 1.103 . . . . 0.0 109.344 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 m -133.21 155.73 48.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.427 1.091 . . . . 0.0 109.417 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -124.71 142.11 51.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.074 1.35 . . . . 0.0 108.158 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -65.95 141.75 58.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.554 0.741 . . . . 0.0 109.859 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 C--O 1.251 1.18 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.918 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 CA--C 1.527 0.095 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 p -48.34 112.06 0.54 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.281 1.433 . . . . 0.0 110.793 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.58 -177.31 41.48 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -119.28 140.62 49.98 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.842 1.257 . . . . 0.0 107.922 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -142.29 150.26 40.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.007 0.923 . . . . 0.0 109.759 -163.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -137.33 121.63 18.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -53.25 117.31 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.214 1.006 . . . . 0.0 108.613 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.11 -35.06 9.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.525 0.73 . . . . 0.0 110.209 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 147.08 39.68 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.507 1.123 . . . . 0.0 108.652 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.8 147.08 22.59 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.005 0.922 . . . . 0.0 109.99 -175.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.74 155.73 36.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.296 0.57 . . . . 0.0 111.532 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.22 35.11 25.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.237 1.815 . . . . 0.0 110.494 -169.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -99.88 -45.41 5.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.866 1.666 . . . . 0.0 110.139 -167.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.25 -40.03 46.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.008 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.29 -48.31 82.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.493 1.117 . . . . 0.0 110.772 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.47 -46.5 89.86 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 122.889 0.476 . . . . 0.0 110.828 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.56 -45.37 85.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.662 0.21 . . . . 0.0 111.136 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -65.51 -34.48 78.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.984 0.514 . . . . 0.0 111.74 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.73 -25.35 67.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.79 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.4 mt -76.46 170.49 16.29 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.088 0.858 . . . . 0.0 110.64 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.54 94.27 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.74 1.216 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 139.85 97.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 111.516 -173.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.47 169.01 17.58 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.914 3.076 . . . . 0.0 111.191 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -48.92 -41.0 32.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.275 1.43 . . . . 0.0 112.631 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -53.85 -38.52 64.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.881 0.473 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.62 -24.12 19.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.607 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -32.56 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.832 1.196 . . . . 0.0 109.62 170.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -50.94 -43.27 60.17 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.336 1.054 . . . . 0.0 110.551 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 56.7 mtt -69.65 -52.18 28.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.244 0.618 . . . . 0.0 110.046 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.46 -35.7 70.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.768 0.827 . . . . 0.0 112.832 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -32.05 67.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.885 0.874 . . . . 0.0 111.186 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -119.39 49.03 1.4 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.175 0.99 . . . . 0.0 109.353 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.39 146.59 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 126.042 1.737 . . . . 0.0 106.472 165.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 106.5 40.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.334 1.054 . . . . 0.0 109.547 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.05 113.49 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.378 2.052 . . . . 0.0 109.392 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.31 139.29 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.06 148.36 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.598 1.559 . . . . 0.0 108.306 -171.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.87 130.11 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -109.1 129.14 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -119.14 101.4 7.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -126.12 141.76 51.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.639 1.176 . . . . 0.0 109.351 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -145.96 73.12 1.32 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.929 0.892 . . . . 0.0 108.953 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.89 -115.09 3.95 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.19 -42.67 88.53 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.53 0.732 . . . . 0.0 111.208 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -76.68 131.83 39.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.449 0.7 . . . . 0.0 110.432 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -129.84 120.85 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.058 1.743 . . . . 0.0 108.16 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -109.53 131.96 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.05 135.23 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -134.48 142.15 46.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.8 t -144.45 137.19 26.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.958 0.503 . . . . 0.0 109.804 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -124.1 153.84 40.86 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.736 1.214 . . . . 0.0 109.514 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.08 159.21 29.23 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.72 39.93 0.92 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.407 2.738 . . . . 0.0 111.577 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -144.55 -41.6 0.25 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.49 1.516 . . . . 0.0 110.129 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.0 169.82 23.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.206 1.802 . . . . 0.0 109.217 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.4 m -150.41 143.33 24.74 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.987 1.315 . . . . 0.0 107.681 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.16 146.56 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.59 1.156 . . . . 0.0 109.711 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.5 m -134.21 145.65 49.39 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.121 1.768 . . . . 0.0 107.529 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.85 130.52 24.17 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.556 1.542 . . . . 0.0 106.847 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 p -125.01 127.29 46.77 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.475 1.11 . . . . 0.0 109.249 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -164.39 -176.46 4.4 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.458 0.703 . . . . 0.0 110.613 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.5 m -140.25 148.22 41.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.131 1.372 . . . . 0.0 107.847 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 165.54 25.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.109 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.24 -29.05 5.35 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.055 0.836 . . . . 0.0 112.84 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -121.81 -177.03 3.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.144 1.378 . . . . 0.0 109.345 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.71 142.57 57.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.453 0.701 . . . . 0.0 109.791 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.4 125.64 16.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.367 1.067 . . . . 0.0 108.871 -175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.33 139.16 32.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.599 0.76 . . . . 0.0 109.27 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.2 mt -135.39 142.07 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.6 m . . . . . 0 CA--C 1.532 0.27 0 C-N-CA 125.779 1.632 . . . . 0.0 108.771 -177.887 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 mttm . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.915 0.388 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.15 168.08 24.19 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.229 1.412 . . . . 0.0 109.993 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -118.14 144.33 45.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.87 1.268 . . . . 0.0 108.994 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.4 p -157.79 150.1 22.42 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.489 1.115 . . . . 0.0 109.182 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.5 m -88.08 87.34 7.3 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.14 132.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.434 0.694 . . . . 0.0 109.518 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -150.37 164.53 35.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.812 1.245 . . . . 0.0 108.637 172.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.83 127.16 52.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.663 1.185 . . . . 0.0 108.105 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.25 142.54 25.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.427 1.091 . . . . 0.0 109.537 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.72 41.63 31.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.923 1.289 . . . . 0.0 111.781 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.43 31.44 79.51 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.133 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -154.79 151.6 28.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.98 0.89 . . . . 0.0 110.387 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.51 141.41 50.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.43 129.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.25 28.31 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -157.45 143.18 17.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.827 0.851 . . . . 0.0 109.192 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -109.82 -118.36 0.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.57 -47.8 5.23 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.463 1.505 . . . . 0.0 108.945 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 -44.25 2.11 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.9 1.28 . . . . 0.0 111.186 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -70.7 139.87 51.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 m -141.04 162.92 34.36 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.272 0.629 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.04 123.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.946 1.299 . . . . 0.0 107.877 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -136.69 110.84 8.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -118.98 120.2 36.56 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -121.02 150.96 40.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.338 1.455 . . . . 0.0 109.406 -170.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.45 136.19 57.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 125.792 1.637 . . . . 0.0 109.534 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.91 103.41 2.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.31 1.044 . . . . 0.0 109.931 170.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.64 -105.83 1.1 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.419 1.009 . . . . 0.0 111.429 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -122.58 24.65 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.931 1.293 . . . . 0.0 110.25 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -143.8 135.0 25.73 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 122.891 0.476 . . . . 0.0 110.723 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 mmt -100.74 129.23 46.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.1 123.51 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -135.87 141.94 44.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.241 -174.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -134.97 143.17 46.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.84 0.856 . . . . 0.0 109.414 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.41 142.83 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.843 1.657 . . . . 0.0 106.779 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.4 m -113.62 144.71 42.44 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.63 108.4 4.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.37 -125.3 39.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.21 29.11 13.23 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.03 0.824 . . . . 0.0 111.848 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.88 145.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 C-N-CA 124.906 1.282 . . . . 0.0 107.616 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.4 m -123.56 149.78 44.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.701 1.201 . . . . 0.0 107.89 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.0 133.67 53.62 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.64 128.82 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 ptt-85 -158.64 168.11 27.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.341 0.591 . . . . 0.0 111.048 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -138.39 132.8 32.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.353 -171.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 162.24 15.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.971 0.908 . . . . 0.0 110.139 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -126.52 147.57 49.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.332 1.453 . . . . 0.0 109.471 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -63.08 105.97 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.918 0.887 . . . . 0.0 110.045 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--O 1.253 1.244 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.078 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 119.796 -0.145 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 p -50.72 116.23 1.85 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.815 1.646 . . . . 0.0 111.022 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.84 -178.99 40.92 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -118.91 130.66 55.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -134.42 144.69 48.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.777 1.631 . . . . 0.0 109.166 -167.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -119.53 118.96 32.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -52.87 124.62 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.067 0.947 . . . . 0.0 108.966 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -103.49 -44.14 5.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.772 1.629 . . . . 0.0 109.777 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 155.5 41.64 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.095 0.958 . . . . 0.0 109.439 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -151.31 122.4 7.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.401 1.08 . . . . 0.0 109.319 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.87 136.52 38.78 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.772 0.829 . . . . 0.0 111.582 -165.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 65.02 14.75 9.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.808 2.443 . . . . 0.0 112.022 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -81.21 -50.98 8.91 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.509 1.524 . . . . 0.0 110.663 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.54 -47.75 75.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.374 0.67 . . . . 0.0 110.854 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -59.73 -47.41 85.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.58 1.552 . . . . 0.0 110.134 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -55.16 -53.11 60.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.034 0.533 . . . . 0.0 111.899 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.93 -41.35 82.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -62.24 -38.77 90.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.242 0.617 . . . . 0.0 110.974 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.89 -20.15 61.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.716 0.806 . . . . 0.0 112.218 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.0 tp -75.34 -59.35 2.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.756 0.707 . . . . 0.0 111.22 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.03 -46.0 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.905 1.282 . . . . 0.0 110.097 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.65 135.56 71.44 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.643 1.177 . . . . 0.0 110.848 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -79.29 169.77 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.461 2.774 . . . . 0.0 110.639 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -44.56 -38.09 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.115 1.766 . . . . 0.0 112.474 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.1 -46.04 68.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.299 1.04 . . . . 0.0 111.757 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -81.15 -34.66 32.29 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.335 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.03 -22.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 118.815 0.734 . . . . 0.0 112.036 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.44 -33.16 19.98 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.855 0.862 . . . . 0.0 111.904 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.4 ttp -60.87 -30.56 70.21 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 123.607 0.763 . . . . 0.0 112.095 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.99 -36.14 9.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.897 1.279 . . . . 0.0 111.387 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -34.88 18.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.753 2.021 . . . . 0.0 113.561 -170.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -120.08 6.92 10.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.417 1.087 . . . . 0.0 111.859 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.98 122.91 71.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -106.33 100.73 31.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.354 1.462 . . . . 0.0 108.182 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.12 156.32 51.64 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.685 2.257 . . . . 0.0 110.96 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 tt -83.46 147.96 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -131.87 151.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.038 1.735 . . . . 0.0 108.316 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -154.47 127.94 8.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.53 148.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 125.108 1.363 . . . . 0.0 107.714 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.45 141.05 37.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.13 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.82 152.08 0.33 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.469 1.908 . . . . 0.0 110.64 172.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -135.25 58.42 1.76 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.322 1.449 . . . . 0.0 107.786 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.66 -131.98 6.12 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.729 1.157 . . . . 0.0 110.23 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.86 -33.84 76.95 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.926 1.29 . . . . 0.0 113.349 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.72 171.92 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.485 0.714 . . . . 0.0 110.843 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -157.56 121.56 4.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.641 1.576 . . . . 0.0 108.463 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.8 129.89 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 158.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.44 130.49 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.522 1.529 . . . . 0.0 107.221 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.1 m -128.68 145.81 51.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.238 1.415 . . . . 0.0 108.155 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.7 t -139.87 136.21 33.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -123.25 134.59 54.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -130.57 151.51 78.79 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 125.694 1.598 . . . . 0.0 107.125 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.43 -19.09 49.75 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.788 2.325 . . . . 0.0 114.068 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -138.79 32.4 2.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.087 0.858 . . . . 0.0 111.941 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -171.31 156.2 4.53 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.629 1.172 . . . . 0.0 108.871 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.3 m -148.2 143.97 27.4 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.33 151.5 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 109.519 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.4 m -148.31 146.27 28.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.456 1.102 . . . . 0.0 108.665 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -146.31 155.14 42.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.396 1.478 . . . . 0.0 108.893 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 p -138.6 145.7 40.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.682 0.793 . . . . 0.0 109.93 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -163.03 172.71 14.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.955 1.302 . . . . 0.0 109.429 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -144.6 139.12 27.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.21 152.54 44.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.25 0.547 . . . . 0.0 111.715 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.69 75.31 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.071 1.32 . . . . 0.0 112.049 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -160.01 157.69 29.22 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.416 1.108 . . . . 0.0 111.576 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.74 144.55 50.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.912 1.685 . . . . 0.0 111.048 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.87 161.73 42.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.867 1.267 . . . . 0.0 109.385 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.7 144.85 25.64 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.4 mt -129.3 136.19 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 109.054 -175.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.4 3.66 2.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.547 1.139 . . . . 0.0 113.193 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 69.72 134.22 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.0 2.12 . . . . 0.0 112.759 171.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.7 125.3 13.27 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.928 1.291 . . . . 0.0 110.214 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -91.7 104.35 16.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.857 1.663 . . . . 0.0 108.719 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.11 150.47 3.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.077 0.951 . . . . 0.0 110.145 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -150.8 167.12 28.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.435 1.494 . . . . 0.0 109.117 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.91 115.16 16.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.57 -114.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.015 1.326 . . . . 0.0 110.555 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -83.91 56.95 3.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.426 1.49 . . . . 0.0 110.639 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.47 37.37 94.69 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -140.32 140.55 35.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.671 1.188 . . . . 0.0 107.946 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 tt -79.3 109.71 13.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.8 t -119.24 117.25 53.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 m -123.89 152.13 42.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.508 1.523 . . . . 0.0 109.404 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -128.9 135.44 49.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.352 1.461 . . . . 0.0 108.32 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t -110.17 168.27 9.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.695 1.198 . . . . 0.0 108.748 170.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.46 -43.47 84.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 111.045 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -96.68 -23.71 16.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.822 0.849 . . . . 0.0 113.162 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.9 -168.3 3.0 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.44 1.018 . . . . 0.0 112.373 -168.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -143.9 162.27 36.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.596 1.159 . . . . 0.0 111.502 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -149.54 120.9 7.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.589 1.556 . . . . 0.0 108.336 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -128.48 133.57 48.51 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.68 1.192 . . . . 0.0 108.423 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -152.07 135.95 16.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -165.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.0 152.78 30.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.385 0.274 . . . . 0.0 110.446 -166.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.3 t -119.3 139.36 46.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.854 1.261 . . . . 0.0 108.817 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -133.77 101.63 5.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.172 1.789 . . . . 0.0 109.321 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.71 -101.84 0.57 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.27 11.14 10.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.203 1.401 . . . . 0.0 111.377 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -114.88 145.74 41.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.322 1.449 . . . . 0.0 107.45 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.2 ttt -127.72 133.4 49.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.2 t -115.56 136.96 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.47 119.26 21.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.3 1.44 . . . . 0.0 108.657 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -129.28 114.57 16.41 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.84 140.27 44.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.9 t -119.68 172.23 7.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.065 0.393 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -158.11 103.17 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.86 1.664 . . . . 0.0 107.503 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.02 -113.71 5.36 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.03 28.44 13.01 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.17 0.89 . . . . 0.0 112.084 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.14 118.96 51.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -120.33 128.44 53.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.965 0.906 . . . . 0.0 109.246 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.91 138.78 50.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 107.861 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.81 130.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -151.95 164.57 36.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -151.69 155.89 39.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.0 m -136.13 166.05 24.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.558 1.143 . . . . 0.0 109.549 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -132.45 137.48 47.28 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.021 0.928 . . . . 0.0 109.341 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -58.13 132.55 53.85 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.508 0.723 . . . . 0.0 109.479 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.3 178.939 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 p -51.94 116.81 2.35 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.0 111.156 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.09 177.73 42.56 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.3 m -118.41 138.54 52.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.172 1.389 . . . . 0.0 107.669 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -143.48 155.18 44.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.53 1.132 . . . . 0.0 109.761 -163.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -142.39 128.17 19.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.63 134.14 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 124.042 0.937 . . . . 0.0 109.61 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -109.61 -33.97 6.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.435 0.694 . . . . 0.0 111.339 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.51 46.58 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.137 0.575 . . . . 0.0 110.828 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -148.79 144.3 26.9 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 109.09 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -156.65 144.12 19.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.222 1.009 . . . . 0.0 109.645 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.9 26.05 12.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.035 1.334 . . . . 0.0 110.855 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -99.98 -48.44 4.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.69 2.396 . . . . 0.0 107.711 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.02 -43.65 50.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.126 1.37 . . . . 0.0 110.572 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -60.13 -50.3 74.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.891 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD2' HD21 ' A' ' 118' ' ' LEU . 8.9 t80 -57.61 -50.03 74.49 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.297 0.639 . . . . 0.0 110.934 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.45 -44.25 95.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -62.87 -30.57 71.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.046 0.539 . . . . 0.0 111.626 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.47 66.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 0.0 111.389 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.02 -176.94 5.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.375 0.534 . . . . 0.0 110.094 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.12 -32.99 37.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.528 1.531 . . . . 0.0 113.606 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.48 111.38 1.8 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.104 1.362 . . . . 0.0 111.013 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.81 167.89 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.075 2.517 . . . . 0.0 110.065 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -46.04 -36.66 5.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.772 1.629 . . . . 0.0 113.059 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -72.4 -57.46 4.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.288 1.035 . . . . 0.0 111.622 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.28 -33.74 63.35 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.342 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.433 ' O ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -63.72 -39.52 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.351 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -33.67 18.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.518 0.599 . . . . 0.0 112.267 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.22 -55.77 5.27 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.81 65.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.57 1.148 . . . . 0.0 112.9 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -45.34 -39.55 6.87 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.75 1.62 . . . . 0.0 111.974 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -118.2 47.36 1.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.334 1.054 . . . . 0.0 109.238 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.0 mt -127.12 135.16 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -109.47 99.15 35.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.868 1.667 . . . . 0.0 108.354 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.49 145.23 26.32 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.123 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.5 tp -80.81 137.13 21.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.95 148.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.285 1.434 . . . . 0.0 108.078 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -153.26 123.56 7.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mp -110.16 140.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -129.37 137.26 50.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.177 1.391 . . . . 0.0 107.393 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.77 166.66 32.82 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.514 0.726 . . . . 0.0 109.529 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -156.17 65.84 0.57 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.363 0.665 . . . . 0.0 109.54 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.1 -85.3 1.04 Allowed Glycine 0 C--N 1.337 0.631 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -92.88 -49.48 6.03 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.501 0.72 . . . . 0.0 111.709 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.64 142.73 31.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.273 0.488 . . . . 0.0 110.485 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.83 142.34 48.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.924 1.689 . . . . 0.0 108.424 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.2 t -130.3 126.97 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.774 1.63 . . . . 0.0 106.77 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.3 t -110.41 126.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.9 m -132.26 141.07 48.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.448 1.099 . . . . 0.0 108.533 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.1 m -142.85 134.13 26.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 108.157 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -123.48 146.84 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 108.651 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.4 HG22 ' HD2' ' A' ' 54' ' ' PRO . 1.3 m -144.59 151.73 51.1 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' HG22 ' A' ' 53' ' ' THR . 42.8 Cg_endo -63.78 -13.38 36.62 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.448 2.099 . . . . 0.0 113.27 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -144.1 41.56 1.4 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.859 0.864 . . . . 0.0 111.365 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -177.19 154.98 1.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.224 1.41 . . . . 0.0 108.143 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.6 m -154.53 130.8 10.4 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 167.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -127.18 131.26 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 107.864 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -140.02 133.53 30.14 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.268 1.027 . . . . 0.0 108.333 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.12 158.81 37.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.42 1.488 . . . . 0.0 109.609 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.3 p -152.27 159.96 43.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.465 0.706 . . . . 0.0 110.529 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -167.4 171.21 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.66 1.184 . . . . 0.0 109.061 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.1 m -139.93 155.13 47.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.566 1.146 . . . . 0.0 107.959 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.0 mt -59.05 112.37 1.66 Allowed 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.686 0.394 . . . . 0.0 111.883 -171.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.8 41.03 95.87 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.787 1.184 . . . . 0.0 111.251 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -130.87 132.09 44.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.548 0.739 . . . . 0.0 110.183 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.48 124.81 12.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.886 1.675 . . . . 0.0 110.754 172.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.81 173.88 13.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.887 1.275 . . . . 0.0 110.107 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -116.31 146.84 42.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.044 1.738 . . . . 0.0 108.162 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.29 136.26 60.55 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 173.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 N--CA 1.454 -0.26 0 C-N-CA 123.503 0.721 . . . . 0.0 109.484 -172.323 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.557 0.218 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp -144.84 13.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.284 1.034 . . . . 0.0 113.093 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 66.51 143.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.928 2.091 . . . . 0.0 113.357 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.9 t -155.66 147.42 23.14 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.636 -0.665 . . . . 0.0 110.748 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 m -156.21 71.97 0.74 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.719 0.808 . . . . 0.0 111.036 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.26 -161.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.793 0.724 . . . . 0.0 111.173 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -157.79 -174.88 5.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.584 1.554 . . . . 0.0 111.884 -161.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -104.89 139.55 39.46 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 109.345 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.16 112.91 5.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.838 1.255 . . . . 0.0 108.918 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 56.58 64.99 1.52 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.053 1.341 . . . . 0.0 111.394 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.88 37.23 77.05 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.716 1.151 . . . . 0.0 113.117 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -154.75 118.33 4.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.11 0.964 . . . . 0.0 108.497 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.63 122.05 44.2 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.502 1.121 . . . . 0.0 108.302 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.73 70.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.451 -163.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.45 127.2 32.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -144.98 152.13 39.69 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.072 0.949 . . . . 0.0 110.16 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -141.63 -164.88 1.87 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.697 1.199 . . . . 0.0 109.799 -174.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -46.93 -57.27 5.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.24 1.816 . . . . 0.0 112.045 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -127.84 -24.59 3.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.296 1.038 . . . . 0.0 111.648 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -72.87 145.9 46.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.162 0.437 . . . . 0.0 110.117 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.9 m -134.65 152.17 51.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.374 1.07 . . . . 0.0 108.287 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -146.07 93.41 2.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -107.0 105.73 15.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.045 1.738 . . . . 0.0 106.956 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.27 125.55 50.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.314 1.046 . . . . 0.0 109.104 -170.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -122.37 130.46 53.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.563 1.545 . . . . 0.0 107.723 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -121.46 149.48 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 109.304 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -143.22 -150.3 0.31 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.018 1.327 . . . . 0.0 108.414 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.76 -65.96 2.1 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -126.73 31.45 5.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.602 1.161 . . . . 0.0 109.958 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -155.44 143.78 20.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.161 0.984 . . . . 0.0 108.716 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 11.4 ttt -146.66 124.07 11.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.69 1.196 . . . . 0.0 108.101 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.75 137.29 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.666 1.186 . . . . 0.0 107.932 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -132.61 125.87 31.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.032 0.933 . . . . 0.0 108.779 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -132.68 122.65 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mm -119.12 157.02 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -134.05 149.26 51.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.58 112.98 5.28 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.623 1.169 . . . . 0.0 108.748 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.5 -91.24 0.25 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 124.333 0.968 . . . . 0.0 111.028 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.46 37.19 1.49 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.837 1.208 . . . . 0.0 110.152 172.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.44 144.89 35.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 106.956 174.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -121.49 134.74 55.07 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.836 1.254 . . . . 0.0 108.038 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -120.28 141.53 49.91 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.61 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -161.71 161.29 29.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.017 0.927 . . . . 0.0 108.684 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -139.95 143.61 36.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.1 m -119.08 163.74 16.56 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.408 1.483 . . . . 0.0 110.618 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -123.32 151.13 42.76 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.16 1.384 . . . . 0.0 108.342 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -71.92 146.34 47.88 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.406 0.683 . . . . 0.0 109.618 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--O 1.255 1.349 0 CA-C-O 116.857 -1.544 . . . . 0.0 106.92 174.453 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 119.051 -0.499 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.3 p -43.62 112.92 0.44 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 126.116 1.766 . . . . 0.0 111.261 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.85 -175.79 39.97 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -120.5 142.69 49.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -142.56 139.39 31.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.201 1.0 . . . . 0.0 109.622 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -120.6 109.46 15.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.49 1.116 . . . . 0.0 108.521 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.24 137.54 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.592 1.157 . . . . 0.0 109.618 167.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -125.03 -52.7 1.65 Allowed 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.607 0.763 . . . . 0.0 109.38 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.09 148.29 25.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.987 0.915 . . . . 0.0 110.284 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.44 147.61 12.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.618 1.167 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -147.53 143.49 27.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.973 0.909 . . . . 0.0 109.263 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.46 28.2 17.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.507 1.523 . . . . 0.0 111.092 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -89.71 -61.55 1.67 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.034 2.134 . . . . 0.0 109.524 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -55.28 -36.87 66.59 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.196 0.999 . . . . 0.0 111.098 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.29 -39.8 71.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.162 0.985 . . . . 0.0 110.635 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.64 -52.89 63.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.459 171.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.89 -42.45 75.98 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 123.244 0.34 . . . . 0.0 110.548 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.78 -43.39 98.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.784 0.434 . . . . 0.0 111.108 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.29 -17.19 61.89 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.7 tp -69.57 -70.3 0.29 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.841 0.746 . . . . 0.0 112.311 -165.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.82 -58.0 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.381 1.072 . . . . 0.0 110.482 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.48 154.34 44.62 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.203 1.001 . . . . 0.0 111.84 -176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.94 165.25 28.71 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.502 2.135 . . . . 0.0 111.227 -172.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.16 -23.83 62.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.029 1.331 . . . . 0.0 112.17 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.04 -37.55 83.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.931 0.492 . . . . 0.0 111.355 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.41 -29.57 26.05 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.426 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -36.53 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.487 1.04 . . . . 0.0 110.217 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.39 -41.38 76.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.951 1.3 . . . . 0.0 110.246 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 ttt -68.64 -38.97 80.91 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.669 0.213 . . . . 0.0 111.252 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.49 -18.05 49.78 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.288 1.035 . . . . 0.0 113.189 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -38.69 -60.79 0.79 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.174 2.19 . . . . 0.0 114.427 -165.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.447 ' C ' HD12 ' A' ' 34' ' ' ILE . 37.5 m-20 -119.31 34.49 5.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.268 1.027 . . . . 0.0 109.505 -171.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.447 HD12 ' C ' ' A' ' 33' ' ' ASP . 1.8 mp -116.46 126.87 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -104.04 98.23 13.19 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 126.176 1.79 . . . . 0.0 108.396 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.29 124.31 10.33 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.065 2.51 . . . . 0.0 110.005 -172.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.37 141.63 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.89 144.93 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.078 1.351 . . . . 0.0 109.037 -169.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -135.8 132.47 36.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.325 1.05 . . . . 0.0 109.02 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mm -110.6 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.014 1.726 . . . . 0.0 106.911 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 -179.72 2.31 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.109 1.364 . . . . 0.0 110.856 168.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -152.67 39.8 0.56 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.615 0.766 . . . . 0.0 110.365 168.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.04 -133.8 3.53 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.67 -31.19 72.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.855 1.262 . . . . 0.0 112.731 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.16 156.98 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.188 0.595 . . . . 0.0 109.688 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -148.64 110.14 4.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.752 1.621 . . . . 0.0 107.101 173.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.38 141.47 24.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.35 133.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.553 1.141 . . . . 0.0 108.063 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -126.27 143.31 51.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.636 1.175 . . . . 0.0 108.435 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.8 p -124.81 141.74 51.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.571 1.148 . . . . 0.0 108.989 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -133.5 137.27 45.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.87 1.268 . . . . 0.0 108.519 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -153.12 148.41 20.08 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.22 32.51 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.64 2.226 . . . . 0.0 112.402 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -174.6 20.27 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.947 2.099 . . . . 0.0 111.403 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.97 147.08 0.44 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.517 1.127 . . . . 0.0 108.952 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.9 t -170.06 152.58 4.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.184 0.594 . . . . 0.0 109.639 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -162.44 164.34 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.517 1.127 . . . . 0.0 109.078 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 m -136.79 146.14 45.36 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.487 1.115 . . . . 0.0 108.52 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.64 155.94 45.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.083 1.353 . . . . 0.0 110.417 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.6 p -138.6 121.97 17.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.65 1.58 . . . . 0.0 109.009 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -144.51 175.11 10.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.639 0.775 . . . . 0.0 110.487 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -153.18 148.49 26.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.7 0.8 . . . . 0.0 110.24 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.65 123.52 21.1 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.857 0.863 . . . . 0.0 110.791 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.96 37.46 93.24 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.367 0.984 . . . . 0.0 111.885 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -160.3 175.3 13.01 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -50.73 140.09 15.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.741 1.216 . . . . 0.0 111.638 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.69 91.06 2.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 110.097 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.7 130.65 41.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 mt -129.84 140.94 47.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 123.342 0.657 . . . . 0.0 109.437 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.366 4.9 t . . . . . 0 CA--C 1.533 0.314 0 C-N-CA 128.119 2.567 . . . . 0.0 115.362 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.34 -179.89 4.1 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.418 1.487 . . . . 0.0 109.708 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -153.46 120.73 5.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.693 1.597 . . . . 0.0 107.541 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.3 m -136.08 -172.13 3.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.633 1.173 . . . . 0.0 109.241 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.0 m -135.68 85.37 2.16 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.92 132.14 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.689 0.796 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -144.44 151.93 39.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.192 1.397 . . . . 0.0 108.368 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tp -92.24 137.88 31.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.032 0.933 . . . . 0.0 108.703 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.7 72.06 1.46 Allowed 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.312 1.445 . . . . 0.0 108.911 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.6 t30 65.47 75.42 0.35 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.662 1.585 . . . . 0.0 111.286 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.38 32.68 84.99 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.961 0.791 . . . . 0.0 113.198 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -157.84 139.89 14.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.721 0.76 . . . . 0.0 110.828 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.1 mp -78.42 146.14 34.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.595 1.158 . . . . 0.0 108.651 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -143.29 138.51 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.242 1.017 . . . . 0.0 109.214 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.0 p -144.82 169.73 17.48 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.673 1.589 . . . . 0.0 109.863 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -144.58 141.86 29.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.515 1.126 . . . . 0.0 108.197 158.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -120.06 -159.05 0.77 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 107.999 164.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.32 -50.21 68.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.415 0.686 . . . . 0.0 111.158 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -127.58 -25.78 3.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.036 1.334 . . . . 0.0 111.581 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -91.08 144.05 26.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 109.321 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.7 m -149.29 125.36 10.68 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -109.0 112.08 24.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.857 1.663 . . . . 0.0 109.195 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -137.26 128.89 28.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.983 1.313 . . . . 0.0 108.542 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -162.15 149.35 13.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.82 157.44 46.78 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.744 1.218 . . . . 0.0 111.094 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.67 140.72 47.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.695 1.198 . . . . 0.0 109.488 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.87 162.26 30.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.013 1.725 . . . . 0.0 107.858 165.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -10.4 -79.87 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 128.368 2.89 . . . . 0.0 115.077 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -123.69 29.13 6.66 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.503 1.121 . . . . 0.0 111.184 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -152.01 115.76 4.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 ttt -101.92 141.41 34.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.959 1.304 . . . . 0.0 107.574 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.49 138.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.55 151.91 47.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.357 0.663 . . . . 0.0 110.739 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 152.45 51.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.085 0.954 . . . . 0.0 108.782 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.47 138.36 29.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.1 m -97.97 154.37 17.73 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.572 1.149 . . . . 0.0 109.143 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.28 67.27 1.08 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.577 1.551 . . . . 0.0 107.24 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.73 8.38 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.728 1.156 . . . . 0.0 110.937 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.05 15.36 27.79 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.296 -0.724 . . . . 0.0 113.046 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.6 154.1 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.28 1.432 . . . . 0.0 107.534 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -136.46 160.64 38.15 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.56 1.144 . . . . 0.0 108.75 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.55 143.52 50.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.478 1.511 . . . . 0.0 107.323 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.19 143.88 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 160.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -141.07 161.73 37.16 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.952 0.901 . . . . 0.0 109.476 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -141.81 138.45 32.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.924 0.89 . . . . 0.0 109.708 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.6 m -134.38 159.93 39.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.947 1.699 . . . . 0.0 110.712 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -122.71 148.99 44.66 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.269 1.428 . . . . 0.0 109.207 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -66.02 147.34 53.5 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.234 0.614 . . . . 0.0 110.171 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.8 1.64 . . . . 0.0 107.025 169.916 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.267 0.079 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.49 -6.64 6.96 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.802 0.841 . . . . 0.0 113.208 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -51.75 131.08 30.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.462 1.105 . . . . 0.0 111.506 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.58 -173.88 35.64 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.9 m -120.85 148.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -143.94 155.8 44.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.74 1.216 . . . . 0.0 109.05 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -138.96 130.45 27.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.378 1.071 . . . . 0.0 108.227 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.57 136.7 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.389 1.076 . . . . 0.0 110.132 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.26 -57.17 2.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.796 1.639 . . . . 0.0 109.922 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.31 172.28 16.13 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.702 0.801 . . . . 0.0 110.617 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.67 143.86 26.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.269 1.028 . . . . 0.0 110.651 -170.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -141.39 118.38 11.21 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.074 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 62.8 6.12 2.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.722 2.009 . . . . 0.0 113.342 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -62.87 -47.79 81.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.913 0.885 . . . . 0.0 110.093 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -33.46 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.074 0.55 . . . . 0.0 111.526 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -67.71 -43.13 80.77 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.333 0.653 . . . . 0.0 110.232 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.4 -53.25 60.3 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.731 0.812 . . . . 0.0 110.994 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.71 -39.78 85.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.768 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -75.35 -23.72 57.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.048 0.84 . . . . 0.0 112.567 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -34.26 74.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.279 0.49 . . . . 0.0 110.283 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.9 tp -73.37 162.01 29.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.677 1.191 . . . . 0.0 108.719 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.69 -34.49 26.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.481 1.113 . . . . 0.0 113.038 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -44.3 111.92 1.29 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.119 1.768 . . . . 0.0 110.637 174.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' HD23 ' A' ' 23' ' ' LEU . 71.4 Cg_endo -80.17 149.64 19.81 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.197 2.598 . . . . 0.0 110.192 -169.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -54.85 -32.3 60.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.22 -47.85 71.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.709 0.803 . . . . 0.0 111.889 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.7 mt -80.54 -31.52 36.99 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.984 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.15 -29.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.57 1.077 . . . . 0.0 111.246 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -53.43 -29.93 37.76 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 111.591 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 90.4 mtp -61.4 -66.93 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.88 -39.07 65.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.029 1.331 . . . . 0.0 112.769 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -43.34 -49.08 6.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.838 2.055 . . . . 0.0 112.25 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -123.8 40.74 3.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.905 0.882 . . . . 0.0 110.71 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.4 mt -130.99 136.93 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -112.79 97.72 42.36 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 107.906 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.13 159.42 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.334 2.69 . . . . 0.0 112.893 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.1 mm -75.29 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.138 0.975 . . . . 0.0 109.159 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.4 t -128.61 144.55 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 126.023 1.729 . . . . 0.0 107.19 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -156.04 143.28 19.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.343 0.657 . . . . 0.0 110.072 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.74 142.82 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.455 1.102 . . . . 0.0 110.383 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -118.81 107.23 13.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.45 1.9 . . . . 0.0 108.412 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -89.31 134.69 33.95 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.28 1.432 . . . . 0.0 108.061 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -151.33 59.54 0.9 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.1 81.55 0.24 Allowed Glycine 0 C--N 1.339 0.721 0 C-N-CA 124.076 0.846 . . . . 0.0 112.029 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 76.93 -43.96 0.45 Allowed 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.071 2.148 . . . . 0.0 112.657 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.6 146.03 25.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.64 163.06 32.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 111.17 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.18 139.66 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.391 1.076 . . . . 0.0 108.714 -171.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.03 137.4 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 125.902 1.681 . . . . 0.0 106.812 174.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.1 m -131.08 135.53 47.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 t -129.04 144.79 51.31 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.288 1.035 . . . . 0.0 109.144 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -122.76 122.23 38.21 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 p -122.94 154.56 64.35 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.59 56.37 6.02 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.548 2.832 . . . . 0.0 110.732 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -162.35 -41.89 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.564 . . . . 0.0 110.173 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -161.96 157.38 23.64 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.31 1.044 . . . . 0.0 109.127 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.0 p -109.77 140.93 43.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.015 0.926 . . . . 0.0 109.049 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.2 t -136.2 149.13 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.328 1.051 . . . . 0.0 109.968 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 m -144.98 146.9 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.337 1.455 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.35 151.79 33.42 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 p -122.14 153.07 39.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.654 1.982 . . . . 0.0 110.947 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.29 169.22 10.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.073 0.949 . . . . 0.0 110.625 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.1 m -141.75 145.56 34.95 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.938 1.295 . . . . 0.0 109.091 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.19 136.5 53.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.338 0.655 . . . . 0.0 111.544 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.83 45.38 95.82 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.607 1.099 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -157.43 148.97 21.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.165 0.482 . . . . 0.0 110.168 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.07 124.28 23.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.641 1.176 . . . . 0.0 109.163 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.76 147.72 47.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.295 1.038 . . . . 0.0 110.477 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.1 132.66 36.42 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.687 1.195 . . . . 0.0 108.48 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.8 tt -133.59 153.77 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 124.976 1.31 . . . . 0.0 109.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.9 m -124.72 126.31 45.47 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 124.362 1.065 . . . . 0.0 109.559 -171.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -70.22 152.24 44.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.134 0.973 . . . . 0.0 109.706 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 48.3 ttm -51.47 -42.86 61.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.033 1.333 . . . . 0.0 113.101 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.43 -49.21 78.46 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.053 0.541 . . . . 0.0 110.986 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.98 66.88 0.1 OUTLIER Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -139.54 116.25 10.8 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.154 0.982 . . . . 0.0 108.396 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -74.75 149.19 39.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.851 0.358 . . . . 0.0 111.035 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.1 -175.32 5.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.72 1.608 . . . . 0.0 107.851 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 157.51 43.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.915 0.325 . . . . 0.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.5 p -159.79 160.94 34.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.499 1.119 . . . . 0.0 109.807 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -84.03 112.48 20.23 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.5 t -84.9 136.52 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -154.98 159.19 40.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.255 1.022 . . . . 0.0 110.266 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -124.86 128.66 49.02 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 126.861 2.064 . . . . 0.0 108.645 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.08 -134.02 0.34 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.232 1.413 . . . . 0.0 108.89 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.97 79.98 2.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.137 0.975 . . . . 0.0 110.641 -176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.51 40.27 77.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.292 0.949 . . . . 0.0 111.642 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.96 126.34 6.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.774 0.83 . . . . 0.0 109.892 -174.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.0 mt -74.19 142.57 45.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.78 127.63 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.02 152.5 46.3 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.385 1.074 . . . . 0.0 109.242 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.21 140.25 41.59 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.495 1.118 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -125.27 -160.61 0.97 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.896 1.278 . . . . 0.0 108.642 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.35 -54.08 42.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.498 1.119 . . . . 0.0 110.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -133.99 -6.09 2.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.745 1.218 . . . . 0.0 112.764 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.69 153.03 19.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.713 0.805 . . . . 0.0 109.334 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 p -145.82 160.23 42.07 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -143.79 121.84 12.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -137.1 107.18 6.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.441 1.096 . . . . 0.0 108.837 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.04 145.38 40.96 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.533 1.133 . . . . 0.0 108.988 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.99 145.88 29.88 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.051 0.541 . . . . 0.0 110.422 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.97 134.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 C-N-CA 125.127 1.371 . . . . 0.0 108.951 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 133.76 19.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.125 1.37 . . . . 0.0 108.69 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.85 -112.03 4.04 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.084 0.85 . . . . 0.0 111.638 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.32 37.02 4.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.895 1.278 . . . . 0.0 109.146 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -142.9 145.46 33.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.289 1.036 . . . . 0.0 109.112 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 ttt -138.88 116.47 11.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.136 1.374 . . . . 0.0 108.335 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.95 137.12 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -128.7 93.02 3.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.868 1.267 . . . . 0.0 108.839 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -97.02 139.4 33.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.879 1.272 . . . . 0.0 109.604 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.5 mt -143.13 147.89 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.682 1.193 . . . . 0.0 107.945 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 165.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -131.5 84.07 2.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.381 1.872 . . . . 0.0 107.395 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.72 -117.34 9.88 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.32 11.39 58.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.481 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -128.19 138.23 55.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 118.649 1.225 . . . . 0.0 108.009 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.8 m -123.04 136.11 54.7 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.745 1.218 . . . . 0.0 107.764 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 163.33 32.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.03 0.532 . . . . 0.0 111.835 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.7 139.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -138.02 157.7 45.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.04 145.97 47.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.747 1.219 . . . . 0.0 109.376 -169.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.1 m -143.42 161.86 37.27 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.115 1.366 . . . . 0.0 109.798 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.7 145.79 51.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.61 1.564 . . . . 0.0 109.483 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -71.66 146.74 48.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.869 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 C--O 1.25 1.108 0 C-N-CA 126.085 1.754 . . . . 0.0 107.505 174.055 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -65.12 -50.29 66.62 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.495 0.718 . . . . 0.0 110.053 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t 50.77 75.63 0.18 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.566 1.547 . . . . 0.0 112.226 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.4 -167.22 37.09 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.6 m -117.69 147.64 42.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -142.42 138.65 31.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.517 1.127 . . . . 0.0 109.584 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -112.65 112.03 23.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.06 139.72 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -125.62 -34.65 2.63 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.456 0.702 . . . . 0.0 111.726 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.95 144.06 50.56 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.703 0.801 . . . . 0.0 110.43 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -144.83 121.28 11.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.551 1.541 . . . . 0.0 107.908 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -140.34 139.96 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.913 0.885 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.24 18.32 10.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.702 1.601 . . . . 0.0 111.758 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -84.46 -47.33 10.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.008 1.323 . . . . 0.0 109.721 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.75 -36.89 67.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.601 0.761 . . . . 0.0 111.79 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.7 -46.64 89.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.429 1.092 . . . . 0.0 110.47 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.46 ' CG ' HD11 ' A' ' 118' ' ' LEU . 65.5 t80 -63.41 -50.77 68.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.937 0.495 . . . . 0.0 111.072 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.7 mt -55.2 -40.92 71.32 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.903 0.319 . . . . 0.0 111.076 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.05 -37.5 85.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.248 0.619 . . . . 0.0 111.122 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.13 66.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.057 -0.497 . . . . 0.0 111.851 173.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -75.76 171.27 14.65 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 121.579 0.704 . . . . 0.0 110.752 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.56 76.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.147 1.379 . . . . 0.0 112.959 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.91 130.62 92.7 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.63 -0.224 . . . . 0.0 110.574 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.16 168.17 23.64 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.389 2.726 . . . . 0.0 110.897 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -48.24 -36.69 14.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.425 1.49 . . . . 0.0 113.487 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.72 -38.26 81.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.929 0.492 . . . . 0.0 111.596 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.87 -31.67 20.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.567 -0.73 . . . . 0.0 112.027 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.86 -36.94 77.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.597 1.09 . . . . 0.0 109.817 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -52.83 -38.09 60.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 111.559 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 66.8 mtt -72.35 -17.94 61.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.248 0.619 . . . . 0.0 112.43 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.86 26.52 4.3 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.525 1.13 . . . . 0.0 111.801 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -69.45 -70.69 0.26 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.427 0.691 . . . . 0.0 109.765 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -121.59 52.08 1.27 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.343 1.457 . . . . 0.0 107.111 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.16 124.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -107.7 93.68 10.78 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 125.883 1.673 . . . . 0.0 108.249 -165.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.32 172.28 16.25 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.119 2.546 . . . . 0.0 112.686 -164.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.61 135.43 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.69 143.15 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.928 1.291 . . . . 0.0 107.66 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -152.36 113.48 4.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mp -109.6 140.21 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -140.59 139.53 34.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -115.76 166.94 11.38 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.134 0.973 . . . . 0.0 111.089 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -147.7 56.25 1.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.87 -143.79 16.06 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.45 1.5 . . . . 0.0 109.799 -173.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.03 -35.98 78.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.567 1.147 . . . . 0.0 111.357 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.5 138.14 46.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.02 157.28 37.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.914 0.759 . . . . 0.0 112.561 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.47 138.71 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.395 -167.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -108.62 126.22 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.518 1.927 . . . . 0.0 106.553 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.3 m -123.65 138.22 54.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.607 1.163 . . . . 0.0 107.965 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.3 m -133.57 129.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 108.703 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.9 121.46 35.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.66 1.184 . . . . 0.0 108.113 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -122.28 155.29 61.98 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.19 40.42 0.97 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.425 2.75 . . . . 0.0 111.292 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -142.94 -50.72 0.35 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.899 2.079 . . . . 0.0 108.088 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -159.17 159.8 34.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.298 1.439 . . . . 0.0 108.981 -175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -111.87 146.47 37.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.065 0.946 . . . . 0.0 109.721 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.3 t -141.25 146.55 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.125 1.37 . . . . 0.0 108.419 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -149.92 157.81 43.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.247 0.619 . . . . 0.0 110.098 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -153.13 150.42 29.07 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.186 0.994 . . . . 0.0 109.923 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -122.53 150.52 42.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.145 1.778 . . . . 0.0 110.603 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -164.67 -179.52 5.95 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.188 0.995 . . . . 0.0 110.205 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.6 m -136.3 134.66 38.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.516 1.126 . . . . 0.0 108.877 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.17 142.69 50.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.489 0.316 . . . . 0.0 110.551 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.23 -39.99 2.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.001 1.286 . . . . 0.0 112.207 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -124.39 177.85 5.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.598 1.159 . . . . 0.0 111.292 -170.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -73.76 155.75 38.56 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.713 0.805 . . . . 0.0 111.009 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.14 149.48 28.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.28 1.032 . . . . 0.0 109.176 171.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -85.11 138.3 32.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.484 0.713 . . . . 0.0 109.167 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -127.99 147.65 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.798 1.239 . . . . 0.0 107.843 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.1 m -116.23 134.65 54.68 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.706 1.202 . . . . 0.0 108.662 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -65.03 -80.64 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.602 0.761 . . . . 0.0 110.495 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 92.8 mtp -150.58 -66.4 0.2 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.487 1.115 . . . . 0.0 109.275 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -68.65 -71.64 0.21 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.747 1.219 . . . . 0.0 110.651 -173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.75 50.35 0.07 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -121.03 75.28 1.14 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -75.06 150.47 38.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.027 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.95 178.47 8.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.549 1.94 . . . . 0.0 108.462 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.34 158.16 35.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.302 0.641 . . . . 0.0 110.393 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.7 p -157.98 160.84 37.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.759 1.223 . . . . 0.0 109.155 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.6 m -74.62 100.17 3.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.5 t -74.38 97.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -133.89 153.5 51.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.724 0.81 . . . . 0.0 109.756 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -135.44 131.54 36.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.368 1.067 . . . . 0.0 109.269 -165.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.11 88.97 3.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.559 1.543 . . . . 0.0 109.606 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.95 67.06 0.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.901 1.28 . . . . 0.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.17 31.93 82.29 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.283 0.944 . . . . 0.0 113.077 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.01 112.13 5.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.083 0.953 . . . . 0.0 108.559 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -74.9 125.67 29.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.53 114.37 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.1 p -130.11 162.78 28.05 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.844 0.858 . . . . 0.0 109.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.1 142.94 18.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 168.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 t -137.67 168.56 19.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.026 1.73 . . . . 0.0 108.103 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -84.77 50.05 1.84 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.454 0.702 . . . . 0.0 110.695 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? 178.51 -23.0 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.948 2.099 . . . . 0.0 111.429 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -150.24 161.56 42.2 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.886 0.766 . . . . 0.0 111.049 -166.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.9 t -149.01 141.94 24.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.379 1.071 . . . . 0.0 108.842 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -122.9 102.46 8.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.453 1.901 . . . . 0.0 106.513 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -121.72 94.35 4.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.29 1.436 . . . . 0.0 109.51 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -121.71 112.33 18.27 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.67 147.83 45.37 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.51 0.724 . . . . 0.0 110.255 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.47 149.95 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.605 1.162 . . . . 0.0 109.915 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -125.12 -155.09 0.65 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.147 . . . . 0.0 108.287 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.48 -59.36 8.93 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.616 0.627 . . . . 0.0 111.884 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -136.22 22.3 3.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.378 1.071 . . . . 0.0 111.207 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -142.53 155.0 44.97 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.066 0.946 . . . . 0.0 108.976 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.7 ttt -146.03 133.78 21.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.667 1.187 . . . . 0.0 108.731 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.2 t -102.86 122.44 55.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.64 91.93 3.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.289 1.836 . . . . 0.0 108.441 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.8 m -103.46 133.75 47.99 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 109.11 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 34.2 mm -125.63 153.29 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.0 m -133.08 143.59 49.43 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -129.61 92.47 3.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 106.337 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -9.13 83.81 0.0 OUTLIER Glycine 0 C--N 1.342 0.867 0 C-N-CA 129.296 3.331 . . . . 0.0 115.068 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.19 -46.24 1.02 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.232 0.92 . . . . 0.0 110.947 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.69 150.78 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 125.417 1.487 . . . . 0.0 108.767 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -122.39 155.96 34.98 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.313 1.445 . . . . 0.0 108.987 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 17' ' ' PHE . 2.0 mp -125.44 136.03 52.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.74 115.43 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 165.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -126.92 156.33 41.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.958 1.703 . . . . 0.0 106.637 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -141.62 147.0 36.9 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.771 0.429 . . . . 0.0 110.365 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -134.64 160.83 36.89 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.435 1.494 . . . . 0.0 110.83 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -121.96 144.95 48.57 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.26 1.424 . . . . 0.0 109.539 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -75.21 140.45 43.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.656 1.182 . . . . 0.0 110.862 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.432 1.493 . . . . 0.0 107.932 177.131 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.221 0.058 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -64.31 -34.0 77.13 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.262 0.625 . . . . 0.0 111.269 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.3 p -51.09 135.12 25.9 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.138 0.975 . . . . 0.0 111.127 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.06 -170.65 35.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 m -121.69 146.09 47.36 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.763 1.225 . . . . 0.0 108.704 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -145.0 161.9 38.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.95 1.3 . . . . 0.0 110.062 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 123.87 23.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.938 1.295 . . . . 0.0 107.781 172.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.71 137.63 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -122.63 -43.66 2.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.043 0.937 . . . . 0.0 110.707 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.01 146.91 46.19 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.631 0.772 . . . . 0.0 110.685 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.28 138.18 21.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.5 1.92 . . . . 0.0 107.808 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -151.41 139.6 20.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.508 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t30 64.64 28.13 13.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.586 2.354 . . . . 0.0 112.164 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -79.91 -50.54 10.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 109.977 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -53.99 -38.76 65.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 111.729 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -57.65 -52.57 64.88 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.095 0.958 . . . . 0.0 110.482 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.14 -46.77 89.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.039 0.536 . . . . 0.0 111.453 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.4 mt -55.69 -42.39 75.1 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.604 0.362 . . . . 0.0 111.406 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -65.89 -38.54 89.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.221 0.208 . . . . 0.0 110.669 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -23.17 65.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.86 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.78 -71.82 0.2 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.311 0.96 . . . . 0.0 109.596 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.47 -54.53 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.291 1.036 . . . . 0.0 110.527 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.9 134.93 47.66 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.238 1.015 . . . . 0.0 111.774 -170.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.06 168.05 23.98 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.491 2.794 . . . . 0.0 111.196 -171.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -50.43 -35.32 28.07 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 113.531 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.76 -36.94 82.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.486 0.714 . . . . 0.0 112.001 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.0 mt -86.84 -33.14 19.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.716 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -35.34 69.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 119.647 1.112 . . . . 0.0 110.434 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -46.98 -44.19 19.93 Favored 'General case' 0 C--N 1.345 0.403 0 C-N-CA 124.508 1.123 . . . . 0.0 111.192 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.6 ttt -71.21 -16.59 62.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.142 0.977 . . . . 0.0 112.008 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.71 -34.79 9.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.657 1.183 . . . . 0.0 111.12 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.75 -57.65 1.86 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 127.023 2.129 . . . . 0.0 111.821 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.421 ' C ' HD12 ' A' ' 34' ' ' ILE . 19.8 t70 -118.14 35.41 4.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.853 0.861 . . . . 0.0 109.981 -172.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 33' ' ' ASP . 1.9 mp -118.59 122.64 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -112.22 100.05 48.26 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 109.255 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.72 166.65 23.41 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.281 -166.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mm -68.25 140.97 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.07 147.1 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -148.47 128.55 13.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.59 143.52 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 107.931 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -141.61 77.06 1.57 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.549 1.14 . . . . 0.0 108.901 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -81.55 128.93 34.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.926 0.89 . . . . 0.0 108.906 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -125.99 79.68 1.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.03 -120.28 5.25 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.095 0.855 . . . . 0.0 111.497 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -68.95 -40.7 78.78 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.168 0.987 . . . . 0.0 111.69 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.76 138.07 39.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.058 0.543 . . . . 0.0 109.876 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -127.51 117.31 21.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.138 1.775 . . . . 0.0 107.572 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.1 t -110.04 126.21 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.27 141.6 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.173 1.389 . . . . 0.0 108.028 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.2 m -141.86 152.41 43.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 108.812 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.7 p -147.93 143.32 27.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.372 1.069 . . . . 0.0 109.093 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -125.8 136.93 53.68 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.28 1.032 . . . . 0.0 109.402 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.52 168.73 12.34 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.957 1.303 . . . . 0.0 108.175 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.07 -25.01 32.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.429 2.086 . . . . 0.0 113.0 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -138.17 33.59 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.504 0.722 . . . . 0.0 110.566 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.81 173.16 1.97 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.091 . . . . 0.0 109.588 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.6 t -170.63 151.47 3.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 108.295 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -144.58 148.42 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.088 1.355 . . . . 0.0 108.872 -173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 156.89 43.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.966 0.906 . . . . 0.0 110.381 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -150.67 143.93 24.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.253 1.421 . . . . 0.0 109.422 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m -130.86 130.33 43.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.847 1.259 . . . . 0.0 109.639 -172.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -158.19 173.64 16.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.974 0.91 . . . . 0.0 110.032 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 m -145.28 147.71 32.66 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.549 1.139 . . . . 0.0 108.463 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.91 168.87 19.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 111.644 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.87 -39.99 3.03 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.89 0.757 . . . . 0.0 113.207 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -120.28 -173.34 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.491 1.116 . . . . 0.0 109.887 -168.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -57.66 145.12 35.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.508 1.123 . . . . 0.0 109.997 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 105.16 3.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.444 0.698 . . . . 0.0 110.338 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.08 127.86 34.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 165.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.73 144.59 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.874 0.47 . . . . 0.0 110.365 174.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 m -90.35 146.47 24.16 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.139 0.976 . . . . 0.0 109.502 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.5 p -64.77 -177.64 0.35 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.055 0.942 . . . . 0.0 110.443 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.91 78.65 1.64 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.3 t0 62.43 83.91 0.15 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.313 1.845 . . . . 0.0 110.642 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.52 -85.13 0.06 OUTLIER Glycine 0 C--N 1.339 0.724 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.871 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -149.13 158.87 44.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.973 0.909 . . . . 0.0 109.557 -165.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -91.76 149.86 21.39 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.323 0.649 . . . . 0.0 111.64 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.23 162.82 34.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.517 1.527 . . . . 0.0 109.304 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -103.92 140.67 37.37 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.353 1.061 . . . . 0.0 109.048 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.6 p -152.27 174.99 13.11 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.705 1.202 . . . . 0.0 108.812 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -110.12 97.62 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.71 137.58 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -151.54 157.22 41.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 109.628 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.86 123.05 49.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.18 -68.56 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.001 0.921 . . . . 0.0 110.434 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -156.96 78.1 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.27 28.95 65.12 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.12 0.867 . . . . 0.0 112.089 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -152.27 140.75 20.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.111 2.164 . . . . 0.0 106.559 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.71 135.54 33.65 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.54 122.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 p -133.68 142.11 47.88 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -150.62 145.27 25.78 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.644 0.378 . . . . 0.0 110.874 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -126.16 -168.6 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.611 1.565 . . . . 0.0 108.542 166.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -36.41 68.4 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.166 0.986 . . . . 0.0 113.211 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -133.75 -37.12 0.93 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.548 1.139 . . . . 0.0 112.407 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.65 149.69 47.83 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.9 m -150.24 157.92 43.6 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.107 0.963 . . . . 0.0 108.951 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -166.69 149.37 6.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -154.98 123.59 6.07 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -118.2 141.47 48.47 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.793 0.837 . . . . 0.0 109.499 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -141.5 127.2 19.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.278 1.431 . . . . 0.0 107.759 -173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.08 133.84 64.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 124.531 1.133 . . . . 0.0 108.574 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.53 164.38 29.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.073 2.149 . . . . 0.0 107.838 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.98 -85.9 0.01 OUTLIER Glycine 0 C--N 1.344 0.987 0 C-N-CA 128.337 2.875 . . . . 0.0 115.119 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -125.59 40.59 3.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.271 1.028 . . . . 0.0 110.008 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -152.03 128.41 10.62 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 ttt -122.26 121.07 35.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.996 1.318 . . . . 0.0 108.591 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.77 135.04 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -130.85 89.29 2.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.923 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.9 m -95.44 133.87 38.92 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.419 0.687 . . . . 0.0 109.441 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.63 143.68 38.08 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.9 m -136.13 133.87 37.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.61 1.164 . . . . 0.0 108.669 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -123.78 72.02 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.509 1.923 . . . . 0.0 107.207 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 14.43 67.93 0.01 OUTLIER Glycine 0 C--N 1.344 1.014 0 C-N-CA 129.063 3.22 . . . . 0.0 115.407 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.4 -43.34 1.1 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.38 148.53 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.4 t -121.19 164.67 16.56 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.32 1.048 . . . . 0.0 110.323 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -145.44 140.97 27.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.002 1.321 . . . . 0.0 108.183 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -124.77 129.32 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -111.68 146.49 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 165.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -135.56 128.89 32.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.4 m -121.58 156.07 33.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.994 1.318 . . . . 0.0 110.788 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -121.37 137.95 54.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.111 1.764 . . . . 0.0 107.809 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -70.46 145.31 51.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.553 0.216 . . . . 0.0 111.098 -170.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.545 1.538 . . . . 0.0 107.754 179.397 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 120.009 -0.043 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -131.2 0.53 4.15 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.095 0.958 . . . . 0.0 113.054 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 t -53.44 114.03 1.37 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.504 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 -177.55 43.43 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -120.5 156.07 32.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.882 1.273 . . . . 0.0 108.923 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -149.59 152.94 36.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.224 1.41 . . . . 0.0 109.893 -169.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -129.59 120.13 24.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.321 1.448 . . . . 0.0 107.311 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.15 121.14 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.333 0.653 . . . . 0.0 109.545 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -89.58 -51.34 5.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.815 1.646 . . . . 0.0 109.735 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.06 161.99 37.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.135 0.574 . . . . 0.0 110.581 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -156.23 137.55 13.87 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.009 1.324 . . . . 0.0 109.422 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -151.77 142.01 22.35 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.965 0.906 . . . . 0.0 110.54 -171.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.46 31.46 12.25 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.944 1.698 . . . . 0.0 111.415 -167.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -94.78 -49.65 5.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.609 1.963 . . . . 0.0 108.627 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -53.55 -34.48 58.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.716 1.207 . . . . 0.0 111.677 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -57.49 -49.86 74.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.608 0.763 . . . . 0.0 111.089 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -68.34 -42.84 78.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.915 0.325 . . . . 0.0 111.428 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.01 -42.4 85.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.53 0.332 . . . . 0.0 110.853 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.08 -41.28 99.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 110.754 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.61 -25.85 66.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.151 0.58 . . . . 0.0 112.157 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.82 172.3 13.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.477 0.581 . . . . 0.0 110.709 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.93 76.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.267 1.427 . . . . 0.0 113.283 -175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.12 132.97 90.12 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.913 -175.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.45 164.39 34.06 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.195 2.597 . . . . 0.0 110.578 -174.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -54.16 -31.28 52.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.713 1.205 . . . . 0.0 112.216 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -56.71 -44.11 81.25 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.056 0.942 . . . . 0.0 111.39 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.92 -29.7 26.92 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.18 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.74 -34.11 60.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 119.501 1.046 . . . . 0.0 109.716 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -52.66 -37.07 58.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.037 0.935 . . . . 0.0 111.618 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.73 -58.4 3.51 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.33 61.55 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.546 1.138 . . . . 0.0 112.595 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -53.26 -34.48 57.38 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.119 1.367 . . . . 0.0 112.008 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -121.04 40.23 3.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.28 1.032 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.0 mt -125.68 134.96 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 166.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.87 102.28 26.27 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.451 1.1 . . . . 0.0 108.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 138.3 20.85 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.062 1.841 . . . . 0.0 109.996 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.43 141.46 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.8 t -123.88 147.17 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.34 144.11 25.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.76 144.64 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -141.9 143.75 33.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 170.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.83 152.08 27.95 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.092 0.557 . . . . 0.0 109.977 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -147.05 58.04 1.16 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.072 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.74 -135.72 12.9 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.84 -27.9 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.251 1.02 . . . . 0.0 112.001 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.11 140.07 43.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.222 1.409 . . . . 0.0 110.856 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -141.49 127.37 19.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.824 1.249 . . . . 0.0 108.234 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.73 138.04 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.56 128.9 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.1 m -124.56 151.95 44.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.384 1.474 . . . . 0.0 109.274 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 p -125.29 151.42 46.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.788 1.635 . . . . 0.0 108.415 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -136.65 107.36 6.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.35 140.39 14.81 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.11 -9.65 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.959 2.439 . . . . 0.0 113.637 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -128.77 10.7 6.06 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.106 0.962 . . . . 0.0 111.917 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -166.21 79.82 0.26 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.022 0.828 . . . . 0.0 110.426 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.9 m -110.81 101.52 10.12 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -136.78 152.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.913 1.285 . . . . 0.0 110.126 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.7 m -124.74 147.65 48.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.507 1.523 . . . . 0.0 109.981 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.19 131.6 38.78 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 126.726 2.01 . . . . 0.0 107.018 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 p -122.41 132.03 54.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.241 1.016 . . . . 0.0 109.761 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.75 176.35 11.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 111.609 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -145.43 145.03 30.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.8 1.64 . . . . 0.0 107.936 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.84 137.41 55.29 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.986 0.514 . . . . 0.0 110.842 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.82 48.14 84.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -157.74 166.38 32.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -60.19 116.78 4.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.58 101.58 7.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.159 0.984 . . . . 0.0 109.225 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -79.72 112.73 17.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.336 1.054 . . . . 0.0 109.583 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -127.35 140.53 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.228 1.011 . . . . 0.0 108.415 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 m -77.52 136.31 38.3 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.901 0.881 . . . . 0.0 109.872 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 t -61.88 -49.67 75.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.606 0.362 . . . . 0.0 111.094 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.16 -69.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.702 1.201 . . . . 0.0 108.929 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -65.14 -55.87 16.21 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.867 1.267 . . . . 0.0 111.888 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.84 54.93 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -147.43 115.1 6.39 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 152.86 23.67 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -169.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 153.66 51.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.379 1.472 . . . . 0.0 109.107 170.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.43 142.6 27.52 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.985 0.914 . . . . 0.0 109.99 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.6 m -142.79 175.17 10.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 109.589 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 m -132.18 84.91 2.19 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.7 1.2 . . . . 0.0 107.845 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.63 149.89 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.922 0.889 . . . . 0.0 110.602 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -134.62 157.72 45.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.458 1.503 . . . . 0.0 108.513 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.35 112.29 24.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.42 -66.26 0.93 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.885 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.66 83.82 0.61 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.2 35.03 82.63 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.558 0.599 . . . . 0.0 111.709 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -161.52 141.38 10.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.75 0.82 . . . . 0.0 110.004 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.42 133.89 34.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.05 136.64 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 108.065 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 m -148.27 148.63 30.67 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.6 1.16 . . . . 0.0 108.353 -172.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -144.89 154.52 42.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.948 1.299 . . . . 0.0 109.634 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 -172.48 3.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.721 1.608 . . . . 0.0 107.328 167.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -63.03 -56.49 16.5 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.561 0.744 . . . . 0.0 110.141 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -96.76 -36.89 10.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.562 1.145 . . . . 0.0 111.268 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -99.75 156.7 16.96 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.234 1.014 . . . . 0.0 110.823 -170.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.7 t -147.36 156.2 42.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.052 0.941 . . . . 0.0 108.54 165.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.17 127.99 8.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -172.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -147.19 120.86 9.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.15 131.08 54.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.314 1.046 . . . . 0.0 108.865 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.41 129.99 54.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.48 2.312 . . . . 0.0 107.447 -175.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.5 t -120.51 144.79 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.955 0.902 . . . . 0.0 109.42 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -137.09 -176.06 4.25 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.186 1.795 . . . . 0.0 108.582 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.29 -61.32 6.74 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.623 1.106 . . . . 0.0 113.403 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -129.55 31.92 4.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.772 1.229 . . . . 0.0 110.905 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -159.49 150.11 19.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 16.0 ttt -144.93 134.61 23.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.786 1.234 . . . . 0.0 107.903 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.22 139.22 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -134.63 137.08 43.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.191 0.996 . . . . 0.0 108.94 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -143.32 133.31 24.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.789 0.836 . . . . 0.0 109.239 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.47 152.66 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.2 m -136.47 137.33 40.28 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -133.09 95.04 3.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.81 1.644 . . . . 0.0 106.566 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.66 -125.29 39.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.14 24.84 23.06 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.078 -0.845 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.6 136.71 58.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.9 m -121.53 145.27 48.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.158 1.383 . . . . 0.0 107.98 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.93 131.59 54.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -125.56 136.03 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -157.07 174.89 14.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -157.69 150.81 23.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m -130.83 162.34 29.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.93 1.292 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -122.65 139.6 53.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.463 1.505 . . . . 0.0 108.415 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -70.88 148.62 47.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.678 0.791 . . . . 0.0 111.072 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 C--O 1.252 1.235 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.474 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 119.662 -0.209 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -152.26 -55.18 0.13 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.296 1.039 . . . . 0.0 108.934 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.7 p -52.92 100.29 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.11 1.364 . . . . 0.0 110.669 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.32 -168.48 36.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.5 m -119.51 151.73 38.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.187 1.395 . . . . 0.0 108.69 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -148.85 129.41 13.99 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 110.208 -162.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -113.07 106.8 15.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.567 1.547 . . . . 0.0 109.17 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.52 117.96 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.121 0.968 . . . . 0.0 109.551 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -99.51 -40.67 7.72 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.811 0.844 . . . . 0.0 111.09 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.41 148.2 43.5 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.927 0.891 . . . . 0.0 110.625 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.49 134.97 14.29 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.544 1.538 . . . . 0.0 108.346 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -156.14 137.87 14.26 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.099 0.959 . . . . 0.0 109.483 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.31 -35.66 0.33 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.459 1.904 . . . . 0.0 111.352 -172.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -32.23 -49.69 0.2 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.428 2.691 . . . . 0.0 112.115 156.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.79 -52.03 67.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.835 0.854 . . . . 0.0 111.016 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.94 -41.5 91.95 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.161 . . . . 0.0 110.664 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.28 -50.37 74.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.329 0.652 . . . . 0.0 111.584 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.94 -42.78 85.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.094 0.406 . . . . 0.0 111.123 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -38.44 80.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -27.25 67.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.957 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.01 -65.17 0.73 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.445 0.566 . . . . 0.0 111.348 -167.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.99 -58.31 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.427 1.091 . . . . 0.0 109.466 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -55.9 130.53 72.9 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.189 0.596 . . . . 0.0 110.508 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.75 170.12 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.299 2.666 . . . . 0.0 111.332 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.57 -28.57 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.876 1.67 . . . . 0.0 113.282 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.14 -42.51 96.77 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.433 0.693 . . . . 0.0 111.868 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.5 mt -83.98 -34.1 24.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.771 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.46 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.276 0.944 . . . . 0.0 111.047 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -49.11 -35.88 17.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 111.629 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.5 mtt -71.24 -60.23 2.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.23 -41.76 69.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.525 1.13 . . . . 0.0 112.168 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -51.36 -37.26 47.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.465 1.506 . . . . 0.0 111.521 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.28 37.58 4.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.032 0.933 . . . . 0.0 110.934 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.5 mt -133.15 136.92 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 168.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -103.1 89.57 2.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.615 1.166 . . . . 0.0 108.293 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.33 148.23 88.2 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.052 1.835 . . . . 0.0 110.923 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 tp -96.26 124.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 t -123.76 136.89 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -168.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -126.97 121.02 30.52 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.795 1.238 . . . . 0.0 108.46 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 98.4 mt -110.62 135.13 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -124.12 88.7 2.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.655 1.582 . . . . 0.0 108.627 -171.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -85.18 128.78 34.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 166.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -132.2 77.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 163.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.82 -128.33 8.44 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.846 1.212 . . . . 0.0 111.174 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.1 -33.05 74.63 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.544 1.138 . . . . 0.0 112.06 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.38 142.46 28.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.185 0.994 . . . . 0.0 110.85 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.65 137.01 45.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.458 1.903 . . . . 0.0 108.264 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.35 124.4 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.26 125.79 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -122.64 135.78 54.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.771 1.228 . . . . 0.0 108.239 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -125.77 128.87 48.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -124.88 114.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 165.79 31.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.78 -3.54 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.277 1.985 . . . . 0.0 113.223 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -139.77 -17.93 0.96 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -130.17 98.6 4.78 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.592 1.157 . . . . 0.0 109.151 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -110.91 113.4 25.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 172.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.16 150.25 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.229 . . . . 0.0 109.394 -173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -135.93 147.06 47.95 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.833 1.253 . . . . 0.0 109.615 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -132.76 149.25 52.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.668 1.187 . . . . 0.0 109.875 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -128.07 138.79 52.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.371 1.868 . . . . 0.0 109.738 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.42 176.33 11.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.082 0.953 . . . . 0.0 110.132 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.2 m -138.39 146.27 42.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.052 1.341 . . . . 0.0 108.196 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 pp -66.8 148.78 51.48 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.967 0.167 . . . . 0.0 111.269 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.43 43.23 44.15 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.855 1.217 . . . . 0.0 112.877 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -156.37 140.15 16.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.11 116.79 7.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.481 0.712 . . . . 0.0 110.566 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.31 160.22 25.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.133 1.373 . . . . 0.0 109.327 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.11 139.74 38.23 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 tt -137.25 168.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.523 1.529 . . . . 0.0 108.17 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.6 m -137.05 144.56 43.24 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.36 0.664 . . . . 0.0 109.849 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -67.22 -177.35 0.66 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.946 1.298 . . . . 0.0 110.771 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -70.72 85.1 0.65 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.311 0.644 . . . . 0.0 109.402 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 52.9 63.41 2.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.442 1.897 . . . . 0.0 110.671 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.14 -104.27 0.46 Allowed Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.481 -0.647 . . . . 0.0 111.481 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -128.06 155.87 43.67 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.626 1.171 . . . . 0.0 110.308 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.95 160.06 18.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.471 1.109 . . . . 0.0 111.605 -177.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.75 161.27 39.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.87 1.268 . . . . 0.0 109.136 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -89.07 154.3 20.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.336 0.654 . . . . 0.0 109.797 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p -155.05 165.66 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.397 1.079 . . . . 0.0 109.939 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.1 m -135.32 76.73 1.63 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 137.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -150.95 153.23 34.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.947 0.899 . . . . 0.0 109.44 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.49 162.0 19.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.178 0.991 . . . . 0.0 110.274 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.63 49.3 0.87 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.585 1.154 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.9 t30 68.09 95.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.578 1.951 . . . . 0.0 111.979 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.79 24.54 75.53 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.105 0.86 . . . . 0.0 112.854 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -163.06 147.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.203 . . . . 0.0 108.694 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -103.68 151.25 23.2 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.035 1.334 . . . . 0.0 108.205 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.3 t -121.63 95.08 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -71.25 144.81 49.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.736 0.814 . . . . 0.0 109.526 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -164.86 128.2 2.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.933 0.493 . . . . 0.0 111.928 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -141.71 -149.03 0.26 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.269 2.228 . . . . 0.0 106.115 166.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.64 -73.92 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -78.76 -37.7 40.5 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 111.723 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -95.71 81.76 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.579 0.752 . . . . 0.0 111.054 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.6 p -140.91 144.17 35.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.212 1.005 . . . . 0.0 110.904 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 180.0 -145.74 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.17 1.788 . . . . 0.0 110.124 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.78 170.41 15.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.439 1.496 . . . . 0.0 110.378 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -160.0 127.51 4.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 109.615 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -122.27 149.73 43.3 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.801 1.64 . . . . 0.0 109.86 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.02 146.39 33.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.026 0.931 . . . . 0.0 110.422 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -136.55 171.7 14.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.516 1.926 . . . . 0.0 108.474 168.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -3.22 -76.0 0.01 OUTLIER Glycine 0 C--N 1.343 0.929 0 C-N-CA 128.906 3.146 . . . . 0.0 116.264 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.58 35.43 2.93 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.47 1.108 . . . . 0.0 110.269 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.21 147.29 31.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.201 0.6 . . . . 0.0 110.884 -172.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.14 130.24 38.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.593 1.557 . . . . 0.0 108.63 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.71 116.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -129.8 136.8 50.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 109.794 -169.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 t -142.3 157.73 44.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.201 0.524 . . . . 0.0 110.645 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.4 128.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.78 171.55 9.88 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -150.81 80.68 1.33 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.51 -113.19 5.58 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -175.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.95 68.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.37 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.98 160.41 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.745 1.218 . . . . 0.0 107.871 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.2 m -134.39 155.46 50.24 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.274 1.03 . . . . 0.0 110.311 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 mp -127.1 129.04 47.19 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 158.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.94 142.57 39.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 164.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -158.18 147.93 19.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -128.26 136.08 50.54 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 t -125.04 162.93 23.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.525 1.13 . . . . 0.0 110.583 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.71 133.96 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.52 1.528 . . . . 0.0 107.499 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 ttp85 -68.82 150.92 47.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.054 0.541 . . . . 0.0 109.918 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--O 1.249 1.038 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 172.654 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.62 -52.99 4.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.277 1.031 . . . . 0.0 112.151 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.3 p -168.7 155.01 6.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.58 1.152 . . . . 0.0 110.026 -173.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.34 -169.76 16.74 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.161 0.886 . . . . 0.0 112.449 165.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -121.95 134.13 54.84 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.939 1.295 . . . . 0.0 108.849 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -144.02 165.0 29.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.167 0.987 . . . . 0.0 111.281 -166.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -148.15 122.64 9.75 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.762 1.225 . . . . 0.0 108.943 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.01 139.63 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.67 1.188 . . . . 0.0 109.783 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -124.06 -37.67 2.55 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.331 0.652 . . . . 0.0 112.187 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.51 149.4 51.71 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 110.161 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.38 148.46 14.77 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.7 0.8 . . . . 0.0 111.536 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.08 140.54 21.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.334 1.454 . . . . 0.0 108.184 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 59.24 89.96 0.06 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.381 1.472 . . . . 0.0 109.268 -171.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -148.64 -51.41 0.17 Allowed 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -47.65 -50.73 23.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.049 1.34 . . . . 0.0 111.375 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.84 -47.49 82.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.819 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -61.66 -53.36 57.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.948 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -62.99 -35.37 79.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.948 0.34 . . . . 0.0 111.51 -174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -75.81 -36.3 59.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.291 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.84 65.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.314 0.506 . . . . 0.0 111.147 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -74.11 -64.52 1.0 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.424 1.089 . . . . 0.0 109.543 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.11 -65.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.353 0.661 . . . . 0.0 111.135 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -56.33 136.77 75.66 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.7 0.8 . . . . 0.0 112.684 -165.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.48 171.47 16.77 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.572 2.848 . . . . 0.0 111.889 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.22 -34.63 4.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.842 2.057 . . . . 0.0 113.532 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.43 -31.85 71.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.949 0.9 . . . . 0.0 112.104 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -93.78 -32.17 14.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.8 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pp -66.89 -20.7 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 119.078 0.854 . . . . 0.0 111.296 173.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -49.87 -38.31 34.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.61 0.641 . . . . 0.0 110.582 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -96.2 46.75 1.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.362 1.065 . . . . 0.0 109.683 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -156.9 -52.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.321 1.048 . . . . 0.0 110.634 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -52.46 -46.38 66.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.62 1.968 . . . . 0.0 112.341 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -120.51 35.21 4.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 109.328 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.82 144.73 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -111.88 90.32 12.98 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.64 137.29 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.184 1.923 . . . . 0.0 109.426 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.55 137.52 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.36 142.02 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.38 129.75 22.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.171 1.388 . . . . 0.0 108.11 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.14 138.43 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.289 1.436 . . . . 0.0 108.505 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -126.15 125.49 42.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.32 1.048 . . . . 0.0 108.648 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.95 142.99 29.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.62 1.568 . . . . 0.0 111.559 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -140.85 42.09 1.83 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.858 1.663 . . . . 0.0 110.829 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 96.71 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.16 0.886 . . . . 0.0 112.771 170.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 57.29 18.52 4.35 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.352 1.461 . . . . 0.0 112.56 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -150.8 143.5 24.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.75 2.02 . . . . 0.0 105.783 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.81 150.89 30.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.819 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.0 131.64 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.437 1.095 . . . . 0.0 108.441 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.95 134.04 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.955 1.702 . . . . 0.0 107.337 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.1 m -132.72 137.42 46.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.704 1.202 . . . . 0.0 107.986 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 t -127.09 140.12 52.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.975 1.71 . . . . 0.0 107.737 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -123.35 116.7 23.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.05 159.97 56.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.27 -4.39 14.27 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.008 1.805 . . . . 0.0 112.445 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -119.42 29.11 7.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.233 1.413 . . . . 0.0 110.932 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 127.83 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.303 3.441 . . . . 0.0 110.389 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 p -108.79 138.08 45.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.2 135.71 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.336 1.454 . . . . 0.0 108.099 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -144.43 151.4 39.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 111.524 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.17 140.98 9.26 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.557 1.543 . . . . 0.0 109.751 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -124.91 151.64 45.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.868 1.267 . . . . 0.0 109.828 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -166.2 152.99 9.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.24 0.543 . . . . 0.0 110.984 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -122.42 144.52 48.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.434 1.894 . . . . 0.0 108.016 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.34 131.73 46.76 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.343 0.257 . . . . 0.0 111.476 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.26 50.34 51.45 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -160.46 139.27 10.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.47 142.28 49.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.97 150.67 27.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.649 0.779 . . . . 0.0 109.892 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -89.43 132.38 35.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.303 1.041 . . . . 0.0 109.219 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.74 147.14 25.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.319 1.048 . . . . 0.0 108.273 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 m -113.03 95.95 5.68 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.945 1.298 . . . . 0.0 107.975 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 m -149.09 47.44 0.99 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.191 0.451 . . . . 0.0 110.579 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 54.3 mtm -148.05 56.57 1.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.639 0.776 . . . . 0.0 109.599 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 56.37 67.69 0.96 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.445 0.698 . . . . 0.0 109.485 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.76 39.99 78.59 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.145 1.355 . . . . 0.0 113.164 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -139.28 143.33 37.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.4 143.31 27.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.285 -161.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.7 -173.8 2.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.536 2.334 . . . . 0.0 107.633 166.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.81 146.33 37.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.79 0.836 . . . . 0.0 110.68 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.9 p -166.23 162.6 17.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.777 1.231 . . . . 0.0 109.094 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -116.26 61.31 0.72 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 111.894 -173.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.63 138.06 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.381 1.073 . . . . 0.0 112.396 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -151.22 153.96 35.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.291 1.037 . . . . 0.0 110.303 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -85.15 125.49 32.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.059 1.344 . . . . 0.0 108.906 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.28 -68.38 0.8 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.212 1.005 . . . . 0.0 109.387 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -164.51 88.52 0.5 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.93 24.23 64.52 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.198 0.904 . . . . 0.0 112.797 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -157.43 138.8 13.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 109.337 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.37 139.79 36.37 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.2 t -133.45 139.58 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.228 1.411 . . . . 0.0 107.376 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.82 156.11 37.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -143.56 141.49 30.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.309 1.044 . . . . 0.0 109.049 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 t -151.55 166.94 29.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.868 1.267 . . . . 0.0 107.883 163.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -85.72 12.32 9.17 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.157 0.983 . . . . 0.0 111.857 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -126.97 -30.33 2.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.21 1.804 . . . . 0.0 109.854 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -157.12 157.24 34.13 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.913 0.885 . . . . 0.0 109.682 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -136.15 150.91 49.26 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -143.95 92.67 2.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.369 1.468 . . . . 0.0 108.07 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -130.3 124.16 31.7 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.68 139.8 11.8 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -121.07 136.02 55.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.944 2.098 . . . . 0.0 107.948 -172.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.0 133.72 56.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -160.84 127.7 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.628 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.34 -96.34 0.48 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.138 0.875 . . . . 0.0 110.949 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -138.8 18.46 2.67 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.251 1.02 . . . . 0.0 110.757 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -148.65 130.92 15.55 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.4 ptp -123.97 155.56 37.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.428 1.091 . . . . 0.0 111.488 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.55 131.7 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -131.61 140.54 49.43 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.29 0.636 . . . . 0.0 110.898 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -131.17 129.34 41.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.982 1.713 . . . . 0.0 108.181 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 48.0 mm -123.48 152.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 53.2 m -134.99 145.84 48.49 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 163.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -130.5 105.44 7.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 170.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -15.69 89.05 0.01 OUTLIER Glycine 0 C--N 1.342 0.864 0 C-N-CA 128.562 2.982 . . . . 0.0 115.016 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.8 -47.88 0.95 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.93 137.35 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 109.183 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 36.6 m -120.19 133.51 55.48 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.172 1.389 . . . . 0.0 109.179 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 118' ' ' LEU . 2.5 mp -119.92 140.12 51.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.951 2.101 . . . . 0.0 108.73 -170.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.19 141.73 40.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm85 -162.77 160.72 25.67 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 109.761 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -135.64 143.91 45.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.457 1.103 . . . . 0.0 109.344 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 m -133.21 155.73 48.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.427 1.091 . . . . 0.0 109.417 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -124.71 142.11 51.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.074 1.35 . . . . 0.0 108.158 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -65.95 141.75 58.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.554 0.741 . . . . 0.0 109.859 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 C--O 1.251 1.18 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.918 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 120.221 0.058 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.62 -50.37 0.72 Allowed 'General case' 0 C--N 1.339 0.11 0 C-N-CA 124.498 1.119 . . . . 0.0 109.72 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 p -48.34 112.06 0.54 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.281 1.433 . . . . 0.0 110.793 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.58 -177.31 41.48 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -119.28 140.62 49.98 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.842 1.257 . . . . 0.0 107.922 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -142.29 150.26 40.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.007 0.923 . . . . 0.0 109.759 -163.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -137.33 121.63 18.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -53.25 117.31 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.214 1.006 . . . . 0.0 108.613 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.11 -35.06 9.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.525 0.73 . . . . 0.0 110.209 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 147.08 39.68 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.507 1.123 . . . . 0.0 108.652 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.8 147.08 22.59 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.005 0.922 . . . . 0.0 109.99 -175.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.74 155.73 36.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.296 0.57 . . . . 0.0 111.532 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.22 35.11 25.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.237 1.815 . . . . 0.0 110.494 -169.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -99.88 -45.41 5.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.866 1.666 . . . . 0.0 110.139 -167.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.25 -40.03 46.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.008 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.29 -48.31 82.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.493 1.117 . . . . 0.0 110.772 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.47 -46.5 89.86 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 122.889 0.476 . . . . 0.0 110.828 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.56 -45.37 85.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.662 0.21 . . . . 0.0 111.136 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -65.51 -34.48 78.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.984 0.514 . . . . 0.0 111.74 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.73 -25.35 67.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.79 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.4 mt -76.46 170.49 16.29 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.088 0.858 . . . . 0.0 110.64 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.54 94.27 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.74 1.216 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 139.85 97.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 111.516 -173.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.47 169.01 17.58 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.914 3.076 . . . . 0.0 111.191 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -48.92 -41.0 32.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.275 1.43 . . . . 0.0 112.631 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -53.85 -38.52 64.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.881 0.473 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.62 -24.12 19.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.607 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -32.56 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.832 1.196 . . . . 0.0 109.62 170.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -50.94 -43.27 60.17 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.336 1.054 . . . . 0.0 110.551 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 56.7 mtt -69.65 -52.18 28.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.244 0.618 . . . . 0.0 110.046 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.46 -35.7 70.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.768 0.827 . . . . 0.0 112.832 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -32.05 67.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.885 0.874 . . . . 0.0 111.186 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -119.39 49.03 1.4 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.175 0.99 . . . . 0.0 109.353 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.39 146.59 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 126.042 1.737 . . . . 0.0 106.472 165.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 106.5 40.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.334 1.054 . . . . 0.0 109.547 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.05 113.49 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.378 2.052 . . . . 0.0 109.392 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.31 139.29 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.06 148.36 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.598 1.559 . . . . 0.0 108.306 -171.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.87 130.11 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -109.1 129.14 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -119.14 101.4 7.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -126.12 141.76 51.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.639 1.176 . . . . 0.0 109.351 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -145.96 73.12 1.32 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.929 0.892 . . . . 0.0 108.953 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.89 -115.09 3.95 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.19 -42.67 88.53 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.53 0.732 . . . . 0.0 111.208 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -76.68 131.83 39.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.449 0.7 . . . . 0.0 110.432 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -129.84 120.85 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.058 1.743 . . . . 0.0 108.16 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -109.53 131.96 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.05 135.23 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -134.48 142.15 46.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.8 t -144.45 137.19 26.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.958 0.503 . . . . 0.0 109.804 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -124.1 153.84 40.86 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.736 1.214 . . . . 0.0 109.514 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.08 159.21 29.23 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.72 39.93 0.92 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.407 2.738 . . . . 0.0 111.577 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -144.55 -41.6 0.25 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.49 1.516 . . . . 0.0 110.129 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.0 169.82 23.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.206 1.802 . . . . 0.0 109.217 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.4 m -150.41 143.33 24.74 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.987 1.315 . . . . 0.0 107.681 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.16 146.56 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.59 1.156 . . . . 0.0 109.711 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.5 m -134.21 145.65 49.39 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.121 1.768 . . . . 0.0 107.529 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.85 130.52 24.17 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.556 1.542 . . . . 0.0 106.847 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 p -125.01 127.29 46.77 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.475 1.11 . . . . 0.0 109.249 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -164.39 -176.46 4.4 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.458 0.703 . . . . 0.0 110.613 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.5 m -140.25 148.22 41.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.131 1.372 . . . . 0.0 107.847 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 165.54 25.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.109 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.24 -29.05 5.35 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.055 0.836 . . . . 0.0 112.84 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -121.81 -177.03 3.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.144 1.378 . . . . 0.0 109.345 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.71 142.57 57.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.453 0.701 . . . . 0.0 109.791 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.4 125.64 16.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.367 1.067 . . . . 0.0 108.871 -175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.33 139.16 32.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.599 0.76 . . . . 0.0 109.27 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.2 mt -135.39 142.07 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.6 m -102.83 120.59 40.88 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.779 1.632 . . . . 0.0 108.771 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 m -73.48 152.22 40.79 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -79.79 55.74 2.12 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.135 0.974 . . . . 0.0 110.826 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -159.03 23.78 0.21 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.996 1.718 . . . . 0.0 109.715 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.27 53.83 42.56 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.115 0.864 . . . . 0.0 112.171 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -145.52 118.45 8.76 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.66 0.784 . . . . 0.0 108.95 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -91.12 162.95 14.46 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.817 0.447 . . . . 0.0 111.798 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.15 168.08 24.19 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.229 1.412 . . . . 0.0 109.993 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -118.14 144.33 45.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.87 1.268 . . . . 0.0 108.994 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.4 p -157.79 150.1 22.42 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.489 1.115 . . . . 0.0 109.182 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.5 m -88.08 87.34 7.3 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.14 132.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.434 0.694 . . . . 0.0 109.518 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -150.37 164.53 35.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.812 1.245 . . . . 0.0 108.637 172.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.83 127.16 52.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.663 1.185 . . . . 0.0 108.105 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.25 142.54 25.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.427 1.091 . . . . 0.0 109.537 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.72 41.63 31.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.923 1.289 . . . . 0.0 111.781 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.43 31.44 79.51 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.133 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -154.79 151.6 28.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.98 0.89 . . . . 0.0 110.387 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.51 141.41 50.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.43 129.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.25 28.31 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -157.45 143.18 17.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.827 0.851 . . . . 0.0 109.192 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -109.82 -118.36 0.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.57 -47.8 5.23 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.463 1.505 . . . . 0.0 108.945 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 -44.25 2.11 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.9 1.28 . . . . 0.0 111.186 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -70.7 139.87 51.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 m -141.04 162.92 34.36 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.272 0.629 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.04 123.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.946 1.299 . . . . 0.0 107.877 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -136.69 110.84 8.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -118.98 120.2 36.56 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -121.02 150.96 40.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.338 1.455 . . . . 0.0 109.406 -170.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.45 136.19 57.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 125.792 1.637 . . . . 0.0 109.534 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.91 103.41 2.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.31 1.044 . . . . 0.0 109.931 170.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.64 -105.83 1.1 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.419 1.009 . . . . 0.0 111.429 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -122.58 24.65 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.931 1.293 . . . . 0.0 110.25 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -143.8 135.0 25.73 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 122.891 0.476 . . . . 0.0 110.723 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 mmt -100.74 129.23 46.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.1 123.51 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -135.87 141.94 44.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.241 -174.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -134.97 143.17 46.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.84 0.856 . . . . 0.0 109.414 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.41 142.83 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.843 1.657 . . . . 0.0 106.779 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.4 m -113.62 144.71 42.44 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.63 108.4 4.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.37 -125.3 39.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.21 29.11 13.23 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.03 0.824 . . . . 0.0 111.848 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.88 145.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 C-N-CA 124.906 1.282 . . . . 0.0 107.616 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.4 m -123.56 149.78 44.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.701 1.201 . . . . 0.0 107.89 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.0 133.67 53.62 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.64 128.82 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 ptt-85 -158.64 168.11 27.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.341 0.591 . . . . 0.0 111.048 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -138.39 132.8 32.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.353 -171.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 162.24 15.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.971 0.908 . . . . 0.0 110.139 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -126.52 147.57 49.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.332 1.453 . . . . 0.0 109.471 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -63.08 105.97 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.918 0.887 . . . . 0.0 110.045 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--O 1.253 1.244 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.078 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.305 0.098 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -73.0 -19.31 61.23 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.051 0.94 . . . . 0.0 110.757 168.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 p -50.72 116.23 1.85 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.815 1.646 . . . . 0.0 111.022 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.84 -178.99 40.92 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -118.91 130.66 55.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -134.42 144.69 48.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.777 1.631 . . . . 0.0 109.166 -167.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -119.53 118.96 32.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -52.87 124.62 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.067 0.947 . . . . 0.0 108.966 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -103.49 -44.14 5.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.772 1.629 . . . . 0.0 109.777 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 155.5 41.64 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.095 0.958 . . . . 0.0 109.439 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -151.31 122.4 7.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.401 1.08 . . . . 0.0 109.319 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.87 136.52 38.78 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.772 0.829 . . . . 0.0 111.582 -165.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 65.02 14.75 9.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.808 2.443 . . . . 0.0 112.022 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -81.21 -50.98 8.91 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.509 1.524 . . . . 0.0 110.663 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.54 -47.75 75.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.374 0.67 . . . . 0.0 110.854 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -59.73 -47.41 85.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.58 1.552 . . . . 0.0 110.134 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -55.16 -53.11 60.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.034 0.533 . . . . 0.0 111.899 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.93 -41.35 82.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -62.24 -38.77 90.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.242 0.617 . . . . 0.0 110.974 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.89 -20.15 61.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.716 0.806 . . . . 0.0 112.218 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.0 tp -75.34 -59.35 2.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.756 0.707 . . . . 0.0 111.22 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.03 -46.0 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.905 1.282 . . . . 0.0 110.097 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.65 135.56 71.44 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.643 1.177 . . . . 0.0 110.848 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -79.29 169.77 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.461 2.774 . . . . 0.0 110.639 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -44.56 -38.09 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.115 1.766 . . . . 0.0 112.474 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.1 -46.04 68.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.299 1.04 . . . . 0.0 111.757 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -81.15 -34.66 32.29 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.335 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.03 -22.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 118.815 0.734 . . . . 0.0 112.036 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.44 -33.16 19.98 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.855 0.862 . . . . 0.0 111.904 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.4 ttp -60.87 -30.56 70.21 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 123.607 0.763 . . . . 0.0 112.095 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.99 -36.14 9.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.897 1.279 . . . . 0.0 111.387 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -34.88 18.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.753 2.021 . . . . 0.0 113.561 -170.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -120.08 6.92 10.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.417 1.087 . . . . 0.0 111.859 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.98 122.91 71.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -106.33 100.73 31.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.354 1.462 . . . . 0.0 108.182 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.12 156.32 51.64 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.685 2.257 . . . . 0.0 110.96 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 tt -83.46 147.96 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -131.87 151.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.038 1.735 . . . . 0.0 108.316 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -154.47 127.94 8.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.53 148.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 125.108 1.363 . . . . 0.0 107.714 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.45 141.05 37.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.13 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.82 152.08 0.33 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.469 1.908 . . . . 0.0 110.64 172.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -135.25 58.42 1.76 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.322 1.449 . . . . 0.0 107.786 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.66 -131.98 6.12 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.729 1.157 . . . . 0.0 110.23 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.86 -33.84 76.95 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.926 1.29 . . . . 0.0 113.349 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.72 171.92 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.485 0.714 . . . . 0.0 110.843 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -157.56 121.56 4.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.641 1.576 . . . . 0.0 108.463 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.8 129.89 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 158.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.44 130.49 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.522 1.529 . . . . 0.0 107.221 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.1 m -128.68 145.81 51.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.238 1.415 . . . . 0.0 108.155 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.7 t -139.87 136.21 33.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -123.25 134.59 54.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -130.57 151.51 78.79 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 125.694 1.598 . . . . 0.0 107.125 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.43 -19.09 49.75 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.788 2.325 . . . . 0.0 114.068 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -138.79 32.4 2.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.087 0.858 . . . . 0.0 111.941 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -171.31 156.2 4.53 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.629 1.172 . . . . 0.0 108.871 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.3 m -148.2 143.97 27.4 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.33 151.5 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 109.519 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.4 m -148.31 146.27 28.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.456 1.102 . . . . 0.0 108.665 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -146.31 155.14 42.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.396 1.478 . . . . 0.0 108.893 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 p -138.6 145.7 40.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.682 0.793 . . . . 0.0 109.93 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -163.03 172.71 14.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.955 1.302 . . . . 0.0 109.429 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -144.6 139.12 27.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.21 152.54 44.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.25 0.547 . . . . 0.0 111.715 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.69 75.31 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.071 1.32 . . . . 0.0 112.049 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -160.01 157.69 29.22 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.416 1.108 . . . . 0.0 111.576 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.74 144.55 50.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.912 1.685 . . . . 0.0 111.048 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.87 161.73 42.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.867 1.267 . . . . 0.0 109.385 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.7 144.85 25.64 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.4 mt -129.3 136.19 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.3 m -80.75 89.35 5.77 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 109.054 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.4 m -81.52 154.79 26.1 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.439 1.096 . . . . 0.0 109.844 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -54.11 152.43 6.0 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.488 1.515 . . . . 0.0 111.156 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.2 t70 63.58 33.43 13.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.166 1.386 . . . . 0.0 111.024 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 49.23 69.85 0.92 Allowed Glycine 0 C--N 1.343 0.934 0 C-N-CA 126.293 1.901 . . . . 0.0 113.529 170.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -146.81 160.62 42.05 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.696 0.748 . . . . 0.0 112.208 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -116.25 138.69 51.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.237 1.415 . . . . 0.0 108.544 170.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.4 3.66 2.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.547 1.139 . . . . 0.0 113.193 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 69.72 134.22 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.0 2.12 . . . . 0.0 112.759 171.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.7 125.3 13.27 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.928 1.291 . . . . 0.0 110.214 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -91.7 104.35 16.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.857 1.663 . . . . 0.0 108.719 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.11 150.47 3.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.077 0.951 . . . . 0.0 110.145 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -150.8 167.12 28.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.435 1.494 . . . . 0.0 109.117 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.91 115.16 16.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.57 -114.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.015 1.326 . . . . 0.0 110.555 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -83.91 56.95 3.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.426 1.49 . . . . 0.0 110.639 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.47 37.37 94.69 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -140.32 140.55 35.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.671 1.188 . . . . 0.0 107.946 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 tt -79.3 109.71 13.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.8 t -119.24 117.25 53.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 m -123.89 152.13 42.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.508 1.523 . . . . 0.0 109.404 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -128.9 135.44 49.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.352 1.461 . . . . 0.0 108.32 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t -110.17 168.27 9.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.695 1.198 . . . . 0.0 108.748 170.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.46 -43.47 84.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 111.045 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -96.68 -23.71 16.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.822 0.849 . . . . 0.0 113.162 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.9 -168.3 3.0 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.44 1.018 . . . . 0.0 112.373 -168.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -143.9 162.27 36.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.596 1.159 . . . . 0.0 111.502 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -149.54 120.9 7.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.589 1.556 . . . . 0.0 108.336 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -128.48 133.57 48.51 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.68 1.192 . . . . 0.0 108.423 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -152.07 135.95 16.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -165.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.0 152.78 30.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.385 0.274 . . . . 0.0 110.446 -166.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.3 t -119.3 139.36 46.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.854 1.261 . . . . 0.0 108.817 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -133.77 101.63 5.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.172 1.789 . . . . 0.0 109.321 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.71 -101.84 0.57 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.27 11.14 10.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.203 1.401 . . . . 0.0 111.377 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -114.88 145.74 41.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.322 1.449 . . . . 0.0 107.45 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.2 ttt -127.72 133.4 49.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.2 t -115.56 136.96 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.47 119.26 21.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.3 1.44 . . . . 0.0 108.657 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -129.28 114.57 16.41 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.84 140.27 44.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.9 t -119.68 172.23 7.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.065 0.393 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -158.11 103.17 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.86 1.664 . . . . 0.0 107.503 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.02 -113.71 5.36 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.03 28.44 13.01 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.17 0.89 . . . . 0.0 112.084 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.14 118.96 51.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -120.33 128.44 53.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.965 0.906 . . . . 0.0 109.246 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.91 138.78 50.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 107.861 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.81 130.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -151.95 164.57 36.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -151.69 155.89 39.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.0 m -136.13 166.05 24.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.558 1.143 . . . . 0.0 109.549 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -132.45 137.48 47.28 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.021 0.928 . . . . 0.0 109.341 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -58.13 132.55 53.85 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.508 0.723 . . . . 0.0 109.479 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.3 178.939 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -89.62 -10.04 47.44 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.501 0.72 . . . . 0.0 111.944 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 p -51.94 116.81 2.35 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.0 111.156 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.09 177.73 42.56 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.3 m -118.41 138.54 52.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.172 1.389 . . . . 0.0 107.669 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -143.48 155.18 44.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.53 1.132 . . . . 0.0 109.761 -163.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -142.39 128.17 19.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.63 134.14 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 124.042 0.937 . . . . 0.0 109.61 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -109.61 -33.97 6.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.435 0.694 . . . . 0.0 111.339 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.51 46.58 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.137 0.575 . . . . 0.0 110.828 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -148.79 144.3 26.9 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 109.09 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -156.65 144.12 19.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.222 1.009 . . . . 0.0 109.645 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.9 26.05 12.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.035 1.334 . . . . 0.0 110.855 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -99.98 -48.44 4.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.69 2.396 . . . . 0.0 107.711 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.02 -43.65 50.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.126 1.37 . . . . 0.0 110.572 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -60.13 -50.3 74.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.891 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD2' HD21 ' A' ' 118' ' ' LEU . 8.9 t80 -57.61 -50.03 74.49 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.297 0.639 . . . . 0.0 110.934 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.45 -44.25 95.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -62.87 -30.57 71.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.046 0.539 . . . . 0.0 111.626 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.47 66.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 0.0 111.389 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.02 -176.94 5.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.375 0.534 . . . . 0.0 110.094 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.12 -32.99 37.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.528 1.531 . . . . 0.0 113.606 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.48 111.38 1.8 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.104 1.362 . . . . 0.0 111.013 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.81 167.89 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.075 2.517 . . . . 0.0 110.065 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -46.04 -36.66 5.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.772 1.629 . . . . 0.0 113.059 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -72.4 -57.46 4.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.288 1.035 . . . . 0.0 111.622 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.28 -33.74 63.35 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.342 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.433 ' O ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -63.72 -39.52 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.351 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -33.67 18.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.518 0.599 . . . . 0.0 112.267 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.22 -55.77 5.27 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.81 65.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.57 1.148 . . . . 0.0 112.9 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -45.34 -39.55 6.87 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.75 1.62 . . . . 0.0 111.974 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -118.2 47.36 1.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.334 1.054 . . . . 0.0 109.238 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.0 mt -127.12 135.16 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -109.47 99.15 35.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.868 1.667 . . . . 0.0 108.354 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.49 145.23 26.32 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.123 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.5 tp -80.81 137.13 21.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.95 148.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.285 1.434 . . . . 0.0 108.078 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -153.26 123.56 7.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mp -110.16 140.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -129.37 137.26 50.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.177 1.391 . . . . 0.0 107.393 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.77 166.66 32.82 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.514 0.726 . . . . 0.0 109.529 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -156.17 65.84 0.57 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.363 0.665 . . . . 0.0 109.54 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.1 -85.3 1.04 Allowed Glycine 0 C--N 1.337 0.631 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -92.88 -49.48 6.03 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.501 0.72 . . . . 0.0 111.709 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.64 142.73 31.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.273 0.488 . . . . 0.0 110.485 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.83 142.34 48.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.924 1.689 . . . . 0.0 108.424 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.2 t -130.3 126.97 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.774 1.63 . . . . 0.0 106.77 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.3 t -110.41 126.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.9 m -132.26 141.07 48.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.448 1.099 . . . . 0.0 108.533 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.1 m -142.85 134.13 26.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 108.157 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -123.48 146.84 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 108.651 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.4 HG22 ' HD2' ' A' ' 54' ' ' PRO . 1.3 m -144.59 151.73 51.1 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' HG22 ' A' ' 53' ' ' THR . 42.8 Cg_endo -63.78 -13.38 36.62 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.448 2.099 . . . . 0.0 113.27 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -144.1 41.56 1.4 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.859 0.864 . . . . 0.0 111.365 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -177.19 154.98 1.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.224 1.41 . . . . 0.0 108.143 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.6 m -154.53 130.8 10.4 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 167.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -127.18 131.26 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 107.864 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -140.02 133.53 30.14 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.268 1.027 . . . . 0.0 108.333 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.12 158.81 37.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.42 1.488 . . . . 0.0 109.609 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.3 p -152.27 159.96 43.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.465 0.706 . . . . 0.0 110.529 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -167.4 171.21 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.66 1.184 . . . . 0.0 109.061 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.1 m -139.93 155.13 47.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.566 1.146 . . . . 0.0 107.959 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.0 mt -59.05 112.37 1.66 Allowed 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.686 0.394 . . . . 0.0 111.883 -171.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.8 41.03 95.87 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.787 1.184 . . . . 0.0 111.251 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -130.87 132.09 44.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.548 0.739 . . . . 0.0 110.183 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.48 124.81 12.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.886 1.675 . . . . 0.0 110.754 172.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.81 173.88 13.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.887 1.275 . . . . 0.0 110.107 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -116.31 146.84 42.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.044 1.738 . . . . 0.0 108.162 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.29 136.26 60.55 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 173.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m -85.1 103.49 14.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.503 0.721 . . . . 0.0 109.484 -172.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -65.08 153.68 40.09 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.605 1.162 . . . . 0.0 108.999 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 58.3 mtt -78.6 50.35 0.96 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.803 0.841 . . . . 0.0 110.654 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -152.8 37.09 0.5 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.751 1.621 . . . . 0.0 108.716 169.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 47.87 46.85 25.58 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.717 2.103 . . . . 0.0 114.869 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -160.67 -177.27 6.06 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.052 0.941 . . . . 0.0 109.166 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.34 171.4 10.45 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 124.532 1.133 . . . . 0.0 110.7 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp -144.84 13.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.284 1.034 . . . . 0.0 113.093 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 66.51 143.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.928 2.091 . . . . 0.0 113.357 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.9 t -155.66 147.42 23.14 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.636 -0.665 . . . . 0.0 110.748 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 m -156.21 71.97 0.74 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.719 0.808 . . . . 0.0 111.036 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.26 -161.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.793 0.724 . . . . 0.0 111.173 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -157.79 -174.88 5.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.584 1.554 . . . . 0.0 111.884 -161.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -104.89 139.55 39.46 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 109.345 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.16 112.91 5.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.838 1.255 . . . . 0.0 108.918 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 56.58 64.99 1.52 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.053 1.341 . . . . 0.0 111.394 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.88 37.23 77.05 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.716 1.151 . . . . 0.0 113.117 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -154.75 118.33 4.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.11 0.964 . . . . 0.0 108.497 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.63 122.05 44.2 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.502 1.121 . . . . 0.0 108.302 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.73 70.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.451 -163.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.45 127.2 32.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -144.98 152.13 39.69 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.072 0.949 . . . . 0.0 110.16 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -141.63 -164.88 1.87 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.697 1.199 . . . . 0.0 109.799 -174.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -46.93 -57.27 5.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.24 1.816 . . . . 0.0 112.045 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -127.84 -24.59 3.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.296 1.038 . . . . 0.0 111.648 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -72.87 145.9 46.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.162 0.437 . . . . 0.0 110.117 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.9 m -134.65 152.17 51.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.374 1.07 . . . . 0.0 108.287 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -146.07 93.41 2.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -107.0 105.73 15.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.045 1.738 . . . . 0.0 106.956 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.27 125.55 50.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.314 1.046 . . . . 0.0 109.104 -170.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -122.37 130.46 53.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.563 1.545 . . . . 0.0 107.723 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -121.46 149.48 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 109.304 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -143.22 -150.3 0.31 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.018 1.327 . . . . 0.0 108.414 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.76 -65.96 2.1 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -126.73 31.45 5.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.602 1.161 . . . . 0.0 109.958 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -155.44 143.78 20.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.161 0.984 . . . . 0.0 108.716 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 11.4 ttt -146.66 124.07 11.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.69 1.196 . . . . 0.0 108.101 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.75 137.29 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.666 1.186 . . . . 0.0 107.932 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -132.61 125.87 31.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.032 0.933 . . . . 0.0 108.779 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -132.68 122.65 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mm -119.12 157.02 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -134.05 149.26 51.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.58 112.98 5.28 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.623 1.169 . . . . 0.0 108.748 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.5 -91.24 0.25 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 124.333 0.968 . . . . 0.0 111.028 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.46 37.19 1.49 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.837 1.208 . . . . 0.0 110.152 172.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.44 144.89 35.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 106.956 174.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -121.49 134.74 55.07 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.836 1.254 . . . . 0.0 108.038 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -120.28 141.53 49.91 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.61 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -161.71 161.29 29.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.017 0.927 . . . . 0.0 108.684 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -139.95 143.61 36.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.1 m -119.08 163.74 16.56 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.408 1.483 . . . . 0.0 110.618 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -123.32 151.13 42.76 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.16 1.384 . . . . 0.0 108.342 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -71.92 146.34 47.88 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.406 0.683 . . . . 0.0 109.618 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--O 1.255 1.349 0 CA-C-O 116.857 -1.544 . . . . 0.0 106.92 174.453 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 119.814 -0.136 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -72.85 -18.95 61.4 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 119.051 -0.499 . . . . 0.0 109.688 168.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.3 p -43.62 112.92 0.44 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 126.116 1.766 . . . . 0.0 111.261 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.85 -175.79 39.97 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -120.5 142.69 49.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -142.56 139.39 31.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.201 1.0 . . . . 0.0 109.622 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -120.6 109.46 15.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.49 1.116 . . . . 0.0 108.521 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.24 137.54 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.592 1.157 . . . . 0.0 109.618 167.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -125.03 -52.7 1.65 Allowed 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.607 0.763 . . . . 0.0 109.38 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.09 148.29 25.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.987 0.915 . . . . 0.0 110.284 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.44 147.61 12.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.618 1.167 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -147.53 143.49 27.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.973 0.909 . . . . 0.0 109.263 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.46 28.2 17.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.507 1.523 . . . . 0.0 111.092 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -89.71 -61.55 1.67 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.034 2.134 . . . . 0.0 109.524 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -55.28 -36.87 66.59 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.196 0.999 . . . . 0.0 111.098 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.29 -39.8 71.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.162 0.985 . . . . 0.0 110.635 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.64 -52.89 63.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.459 171.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.89 -42.45 75.98 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 123.244 0.34 . . . . 0.0 110.548 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.78 -43.39 98.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.784 0.434 . . . . 0.0 111.108 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.29 -17.19 61.89 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.7 tp -69.57 -70.3 0.29 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.841 0.746 . . . . 0.0 112.311 -165.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.82 -58.0 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.381 1.072 . . . . 0.0 110.482 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.48 154.34 44.62 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.203 1.001 . . . . 0.0 111.84 -176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.94 165.25 28.71 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.502 2.135 . . . . 0.0 111.227 -172.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.16 -23.83 62.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.029 1.331 . . . . 0.0 112.17 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.04 -37.55 83.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.931 0.492 . . . . 0.0 111.355 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.41 -29.57 26.05 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.426 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -36.53 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.487 1.04 . . . . 0.0 110.217 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.39 -41.38 76.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.951 1.3 . . . . 0.0 110.246 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 ttt -68.64 -38.97 80.91 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.669 0.213 . . . . 0.0 111.252 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.49 -18.05 49.78 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.288 1.035 . . . . 0.0 113.189 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -38.69 -60.79 0.79 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.174 2.19 . . . . 0.0 114.427 -165.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.447 ' C ' HD12 ' A' ' 34' ' ' ILE . 37.5 m-20 -119.31 34.49 5.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.268 1.027 . . . . 0.0 109.505 -171.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.447 HD12 ' C ' ' A' ' 33' ' ' ASP . 1.8 mp -116.46 126.87 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -104.04 98.23 13.19 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 126.176 1.79 . . . . 0.0 108.396 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.29 124.31 10.33 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.065 2.51 . . . . 0.0 110.005 -172.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.37 141.63 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.89 144.93 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.078 1.351 . . . . 0.0 109.037 -169.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -135.8 132.47 36.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.325 1.05 . . . . 0.0 109.02 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mm -110.6 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.014 1.726 . . . . 0.0 106.911 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 -179.72 2.31 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.109 1.364 . . . . 0.0 110.856 168.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -152.67 39.8 0.56 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.615 0.766 . . . . 0.0 110.365 168.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.04 -133.8 3.53 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.67 -31.19 72.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.855 1.262 . . . . 0.0 112.731 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.16 156.98 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.188 0.595 . . . . 0.0 109.688 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -148.64 110.14 4.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.752 1.621 . . . . 0.0 107.101 173.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.38 141.47 24.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.35 133.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.553 1.141 . . . . 0.0 108.063 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -126.27 143.31 51.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.636 1.175 . . . . 0.0 108.435 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.8 p -124.81 141.74 51.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.571 1.148 . . . . 0.0 108.989 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -133.5 137.27 45.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.87 1.268 . . . . 0.0 108.519 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -153.12 148.41 20.08 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.22 32.51 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.64 2.226 . . . . 0.0 112.402 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -174.6 20.27 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.947 2.099 . . . . 0.0 111.403 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.97 147.08 0.44 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.517 1.127 . . . . 0.0 108.952 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.9 t -170.06 152.58 4.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.184 0.594 . . . . 0.0 109.639 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -162.44 164.34 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.517 1.127 . . . . 0.0 109.078 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 m -136.79 146.14 45.36 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.487 1.115 . . . . 0.0 108.52 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.64 155.94 45.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.083 1.353 . . . . 0.0 110.417 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.6 p -138.6 121.97 17.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.65 1.58 . . . . 0.0 109.009 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -144.51 175.11 10.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.639 0.775 . . . . 0.0 110.487 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -153.18 148.49 26.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.7 0.8 . . . . 0.0 110.24 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.65 123.52 21.1 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.857 0.863 . . . . 0.0 110.791 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.96 37.46 93.24 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.367 0.984 . . . . 0.0 111.885 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -160.3 175.3 13.01 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -50.73 140.09 15.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.741 1.216 . . . . 0.0 111.638 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.69 91.06 2.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 110.097 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.7 130.65 41.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 mt -129.84 140.94 47.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 123.342 0.657 . . . . 0.0 109.437 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.366 4.9 t 47.89 -171.68 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 128.119 2.567 . . . . 0.0 115.362 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 73' ' ' MET . 6.5 t 168.73 -78.1 0.0 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.935 2.894 . . . . 0.0 109.315 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.489 ' H ' HG23 ' A' ' 72' ' ' THR . 18.0 ttt -91.22 62.1 4.66 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.125 0.97 . . . . 0.0 109.939 -170.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -171.33 -68.48 0.02 OUTLIER 'General case' 0 C--N 1.338 0.102 0 C-N-CA 126.284 1.834 . . . . 0.0 107.283 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.9 -98.34 1.32 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -163.15 119.17 1.78 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -51.1 138.92 19.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.503 1.121 . . . . 0.0 109.811 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.34 -179.89 4.1 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.418 1.487 . . . . 0.0 109.708 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -153.46 120.73 5.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.693 1.597 . . . . 0.0 107.541 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.3 m -136.08 -172.13 3.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.633 1.173 . . . . 0.0 109.241 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.0 m -135.68 85.37 2.16 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.92 132.14 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.689 0.796 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -144.44 151.93 39.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.192 1.397 . . . . 0.0 108.368 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tp -92.24 137.88 31.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.032 0.933 . . . . 0.0 108.703 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.7 72.06 1.46 Allowed 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.312 1.445 . . . . 0.0 108.911 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.6 t30 65.47 75.42 0.35 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.662 1.585 . . . . 0.0 111.286 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.38 32.68 84.99 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.961 0.791 . . . . 0.0 113.198 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -157.84 139.89 14.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.721 0.76 . . . . 0.0 110.828 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.1 mp -78.42 146.14 34.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.595 1.158 . . . . 0.0 108.651 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -143.29 138.51 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.242 1.017 . . . . 0.0 109.214 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.0 p -144.82 169.73 17.48 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.673 1.589 . . . . 0.0 109.863 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -144.58 141.86 29.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.515 1.126 . . . . 0.0 108.197 158.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -120.06 -159.05 0.77 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 107.999 164.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.32 -50.21 68.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.415 0.686 . . . . 0.0 111.158 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -127.58 -25.78 3.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.036 1.334 . . . . 0.0 111.581 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -91.08 144.05 26.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 109.321 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.7 m -149.29 125.36 10.68 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -109.0 112.08 24.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.857 1.663 . . . . 0.0 109.195 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -137.26 128.89 28.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.983 1.313 . . . . 0.0 108.542 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -162.15 149.35 13.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.82 157.44 46.78 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.744 1.218 . . . . 0.0 111.094 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.67 140.72 47.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.695 1.198 . . . . 0.0 109.488 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.87 162.26 30.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.013 1.725 . . . . 0.0 107.858 165.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -10.4 -79.87 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 128.368 2.89 . . . . 0.0 115.077 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -123.69 29.13 6.66 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.503 1.121 . . . . 0.0 111.184 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -152.01 115.76 4.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 ttt -101.92 141.41 34.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.959 1.304 . . . . 0.0 107.574 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.49 138.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.55 151.91 47.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.357 0.663 . . . . 0.0 110.739 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 152.45 51.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.085 0.954 . . . . 0.0 108.782 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.47 138.36 29.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.1 m -97.97 154.37 17.73 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.572 1.149 . . . . 0.0 109.143 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.28 67.27 1.08 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.577 1.551 . . . . 0.0 107.24 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.73 8.38 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.728 1.156 . . . . 0.0 110.937 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.05 15.36 27.79 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.296 -0.724 . . . . 0.0 113.046 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.6 154.1 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.28 1.432 . . . . 0.0 107.534 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -136.46 160.64 38.15 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.56 1.144 . . . . 0.0 108.75 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.55 143.52 50.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.478 1.511 . . . . 0.0 107.323 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.19 143.88 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 160.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -141.07 161.73 37.16 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.952 0.901 . . . . 0.0 109.476 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -141.81 138.45 32.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.924 0.89 . . . . 0.0 109.708 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.6 m -134.38 159.93 39.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.947 1.699 . . . . 0.0 110.712 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -122.71 148.99 44.66 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.269 1.428 . . . . 0.0 109.207 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -66.02 147.34 53.5 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.234 0.614 . . . . 0.0 110.171 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.8 1.64 . . . . 0.0 107.025 169.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -51.75 131.08 30.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.462 1.105 . . . . 0.0 111.506 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.58 -173.88 35.64 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.9 m -120.85 148.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -143.94 155.8 44.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.74 1.216 . . . . 0.0 109.05 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -138.96 130.45 27.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.378 1.071 . . . . 0.0 108.227 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.57 136.7 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.389 1.076 . . . . 0.0 110.132 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.26 -57.17 2.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.796 1.639 . . . . 0.0 109.922 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.31 172.28 16.13 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.702 0.801 . . . . 0.0 110.617 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.67 143.86 26.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.269 1.028 . . . . 0.0 110.651 -170.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -141.39 118.38 11.21 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.074 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 62.8 6.12 2.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.722 2.009 . . . . 0.0 113.342 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -62.87 -47.79 81.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.913 0.885 . . . . 0.0 110.093 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -33.46 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.074 0.55 . . . . 0.0 111.526 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -67.71 -43.13 80.77 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.333 0.653 . . . . 0.0 110.232 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.4 -53.25 60.3 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.731 0.812 . . . . 0.0 110.994 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.71 -39.78 85.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.768 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -75.35 -23.72 57.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.048 0.84 . . . . 0.0 112.567 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -34.26 74.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.279 0.49 . . . . 0.0 110.283 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.9 tp -73.37 162.01 29.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.677 1.191 . . . . 0.0 108.719 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.69 -34.49 26.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.481 1.113 . . . . 0.0 113.038 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -44.3 111.92 1.29 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.119 1.768 . . . . 0.0 110.637 174.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' HD23 ' A' ' 23' ' ' LEU . 71.4 Cg_endo -80.17 149.64 19.81 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.197 2.598 . . . . 0.0 110.192 -169.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -54.85 -32.3 60.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.22 -47.85 71.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.709 0.803 . . . . 0.0 111.889 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.7 mt -80.54 -31.52 36.99 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.984 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.15 -29.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.57 1.077 . . . . 0.0 111.246 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -53.43 -29.93 37.76 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 111.591 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 90.4 mtp -61.4 -66.93 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.88 -39.07 65.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.029 1.331 . . . . 0.0 112.769 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -43.34 -49.08 6.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.838 2.055 . . . . 0.0 112.25 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -123.8 40.74 3.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.905 0.882 . . . . 0.0 110.71 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.4 mt -130.99 136.93 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -112.79 97.72 42.36 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 107.906 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.13 159.42 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.334 2.69 . . . . 0.0 112.893 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.1 mm -75.29 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.138 0.975 . . . . 0.0 109.159 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.4 t -128.61 144.55 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 126.023 1.729 . . . . 0.0 107.19 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -156.04 143.28 19.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.343 0.657 . . . . 0.0 110.072 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.74 142.82 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.455 1.102 . . . . 0.0 110.383 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -118.81 107.23 13.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.45 1.9 . . . . 0.0 108.412 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -89.31 134.69 33.95 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.28 1.432 . . . . 0.0 108.061 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -151.33 59.54 0.9 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.1 81.55 0.24 Allowed Glycine 0 C--N 1.339 0.721 0 C-N-CA 124.076 0.846 . . . . 0.0 112.029 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 76.93 -43.96 0.45 Allowed 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.071 2.148 . . . . 0.0 112.657 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.6 146.03 25.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.64 163.06 32.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 111.17 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.18 139.66 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.391 1.076 . . . . 0.0 108.714 -171.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.03 137.4 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 125.902 1.681 . . . . 0.0 106.812 174.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.1 m -131.08 135.53 47.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 t -129.04 144.79 51.31 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.288 1.035 . . . . 0.0 109.144 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -122.76 122.23 38.21 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 p -122.94 154.56 64.35 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.59 56.37 6.02 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.548 2.832 . . . . 0.0 110.732 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -162.35 -41.89 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.564 . . . . 0.0 110.173 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -161.96 157.38 23.64 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.31 1.044 . . . . 0.0 109.127 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.0 p -109.77 140.93 43.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.015 0.926 . . . . 0.0 109.049 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.2 t -136.2 149.13 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.328 1.051 . . . . 0.0 109.968 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 m -144.98 146.9 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.337 1.455 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.35 151.79 33.42 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 p -122.14 153.07 39.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.654 1.982 . . . . 0.0 110.947 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.29 169.22 10.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.073 0.949 . . . . 0.0 110.625 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.1 m -141.75 145.56 34.95 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.938 1.295 . . . . 0.0 109.091 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.19 136.5 53.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.338 0.655 . . . . 0.0 111.544 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.83 45.38 95.82 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.607 1.099 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -157.43 148.97 21.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.165 0.482 . . . . 0.0 110.168 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.07 124.28 23.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.641 1.176 . . . . 0.0 109.163 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.76 147.72 47.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.295 1.038 . . . . 0.0 110.477 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.1 132.66 36.42 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.687 1.195 . . . . 0.0 108.48 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.8 tt -133.59 153.77 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 124.976 1.31 . . . . 0.0 109.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.528 0.099 0 C-N-CA 124.362 1.065 . . . . 0.0 109.559 -171.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.1 pttt . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 120.851 0.358 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.1 -175.32 5.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.72 1.608 . . . . 0.0 107.851 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 157.51 43.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.915 0.325 . . . . 0.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.5 p -159.79 160.94 34.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.499 1.119 . . . . 0.0 109.807 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -84.03 112.48 20.23 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.5 t -84.9 136.52 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -154.98 159.19 40.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.255 1.022 . . . . 0.0 110.266 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -124.86 128.66 49.02 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 126.861 2.064 . . . . 0.0 108.645 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.08 -134.02 0.34 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.232 1.413 . . . . 0.0 108.89 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.97 79.98 2.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.137 0.975 . . . . 0.0 110.641 -176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.51 40.27 77.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.292 0.949 . . . . 0.0 111.642 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.96 126.34 6.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.774 0.83 . . . . 0.0 109.892 -174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.0 mt -74.19 142.57 45.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.78 127.63 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.02 152.5 46.3 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.385 1.074 . . . . 0.0 109.242 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.21 140.25 41.59 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.495 1.118 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -125.27 -160.61 0.97 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.896 1.278 . . . . 0.0 108.642 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.35 -54.08 42.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.498 1.119 . . . . 0.0 110.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -133.99 -6.09 2.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.745 1.218 . . . . 0.0 112.764 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.69 153.03 19.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.713 0.805 . . . . 0.0 109.334 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 p -145.82 160.23 42.07 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -143.79 121.84 12.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -137.1 107.18 6.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.441 1.096 . . . . 0.0 108.837 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.04 145.38 40.96 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.533 1.133 . . . . 0.0 108.988 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.99 145.88 29.88 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.051 0.541 . . . . 0.0 110.422 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.97 134.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 C-N-CA 125.127 1.371 . . . . 0.0 108.951 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 133.76 19.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.125 1.37 . . . . 0.0 108.69 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.85 -112.03 4.04 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.084 0.85 . . . . 0.0 111.638 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.32 37.02 4.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.895 1.278 . . . . 0.0 109.146 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -142.9 145.46 33.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.289 1.036 . . . . 0.0 109.112 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 ttt -138.88 116.47 11.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.136 1.374 . . . . 0.0 108.335 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.95 137.12 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -128.7 93.02 3.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.868 1.267 . . . . 0.0 108.839 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -97.02 139.4 33.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.879 1.272 . . . . 0.0 109.604 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.5 mt -143.13 147.89 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.682 1.193 . . . . 0.0 107.945 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 165.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -131.5 84.07 2.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.381 1.872 . . . . 0.0 107.395 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.72 -117.34 9.88 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.32 11.39 58.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.481 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -128.19 138.23 55.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 118.649 1.225 . . . . 0.0 108.009 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.8 m -123.04 136.11 54.7 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.745 1.218 . . . . 0.0 107.764 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 163.33 32.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.03 0.532 . . . . 0.0 111.835 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.7 139.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -138.02 157.7 45.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.04 145.97 47.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.747 1.219 . . . . 0.0 109.376 -169.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.1 m -143.42 161.86 37.27 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.115 1.366 . . . . 0.0 109.798 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.7 145.79 51.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.61 1.564 . . . . 0.0 109.483 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -71.66 146.74 48.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.869 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 C--O 1.25 1.108 0 C-N-CA 126.085 1.754 . . . . 0.0 107.505 174.055 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t 50.77 75.63 0.18 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.566 1.547 . . . . 0.0 112.226 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.4 -167.22 37.09 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.6 m -117.69 147.64 42.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -142.42 138.65 31.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.517 1.127 . . . . 0.0 109.584 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -112.65 112.03 23.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.06 139.72 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -125.62 -34.65 2.63 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.456 0.702 . . . . 0.0 111.726 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.95 144.06 50.56 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.703 0.801 . . . . 0.0 110.43 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -144.83 121.28 11.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.551 1.541 . . . . 0.0 107.908 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -140.34 139.96 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.913 0.885 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.24 18.32 10.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.702 1.601 . . . . 0.0 111.758 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -84.46 -47.33 10.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.008 1.323 . . . . 0.0 109.721 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.75 -36.89 67.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.601 0.761 . . . . 0.0 111.79 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.7 -46.64 89.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.429 1.092 . . . . 0.0 110.47 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.46 ' CG ' HD11 ' A' ' 118' ' ' LEU . 65.5 t80 -63.41 -50.77 68.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.937 0.495 . . . . 0.0 111.072 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.7 mt -55.2 -40.92 71.32 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.903 0.319 . . . . 0.0 111.076 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.05 -37.5 85.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.248 0.619 . . . . 0.0 111.122 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.13 66.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.057 -0.497 . . . . 0.0 111.851 173.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -75.76 171.27 14.65 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 121.579 0.704 . . . . 0.0 110.752 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.56 76.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.147 1.379 . . . . 0.0 112.959 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.91 130.62 92.7 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.63 -0.224 . . . . 0.0 110.574 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.16 168.17 23.64 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.389 2.726 . . . . 0.0 110.897 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -48.24 -36.69 14.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.425 1.49 . . . . 0.0 113.487 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.72 -38.26 81.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.929 0.492 . . . . 0.0 111.596 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.87 -31.67 20.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.567 -0.73 . . . . 0.0 112.027 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.86 -36.94 77.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.597 1.09 . . . . 0.0 109.817 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -52.83 -38.09 60.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 111.559 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 66.8 mtt -72.35 -17.94 61.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.248 0.619 . . . . 0.0 112.43 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.86 26.52 4.3 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.525 1.13 . . . . 0.0 111.801 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -69.45 -70.69 0.26 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.427 0.691 . . . . 0.0 109.765 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -121.59 52.08 1.27 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.343 1.457 . . . . 0.0 107.111 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.16 124.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -107.7 93.68 10.78 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 125.883 1.673 . . . . 0.0 108.249 -165.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.32 172.28 16.25 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.119 2.546 . . . . 0.0 112.686 -164.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.61 135.43 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.69 143.15 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.928 1.291 . . . . 0.0 107.66 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -152.36 113.48 4.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mp -109.6 140.21 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -140.59 139.53 34.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -115.76 166.94 11.38 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.134 0.973 . . . . 0.0 111.089 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -147.7 56.25 1.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.87 -143.79 16.06 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.45 1.5 . . . . 0.0 109.799 -173.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.03 -35.98 78.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.567 1.147 . . . . 0.0 111.357 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.5 138.14 46.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.02 157.28 37.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.914 0.759 . . . . 0.0 112.561 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.47 138.71 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.395 -167.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -108.62 126.22 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.518 1.927 . . . . 0.0 106.553 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.3 m -123.65 138.22 54.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.607 1.163 . . . . 0.0 107.965 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.3 m -133.57 129.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 108.703 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.9 121.46 35.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.66 1.184 . . . . 0.0 108.113 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -122.28 155.29 61.98 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.19 40.42 0.97 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.425 2.75 . . . . 0.0 111.292 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -142.94 -50.72 0.35 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.899 2.079 . . . . 0.0 108.088 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -159.17 159.8 34.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.298 1.439 . . . . 0.0 108.981 -175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -111.87 146.47 37.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.065 0.946 . . . . 0.0 109.721 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.3 t -141.25 146.55 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.125 1.37 . . . . 0.0 108.419 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -149.92 157.81 43.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.247 0.619 . . . . 0.0 110.098 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -153.13 150.42 29.07 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.186 0.994 . . . . 0.0 109.923 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -122.53 150.52 42.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.145 1.778 . . . . 0.0 110.603 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -164.67 -179.52 5.95 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.188 0.995 . . . . 0.0 110.205 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.6 m -136.3 134.66 38.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.516 1.126 . . . . 0.0 108.877 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.17 142.69 50.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.489 0.316 . . . . 0.0 110.551 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.23 -39.99 2.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.001 1.286 . . . . 0.0 112.207 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -124.39 177.85 5.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.598 1.159 . . . . 0.0 111.292 -170.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -73.76 155.75 38.56 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.713 0.805 . . . . 0.0 111.009 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.14 149.48 28.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.28 1.032 . . . . 0.0 109.176 171.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -85.11 138.3 32.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.484 0.713 . . . . 0.0 109.167 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -127.99 147.65 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.798 1.239 . . . . 0.0 107.843 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 124.706 1.202 . . . . 0.0 108.662 179.257 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.301 0.572 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.95 178.47 8.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.549 1.94 . . . . 0.0 108.462 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.34 158.16 35.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.302 0.641 . . . . 0.0 110.393 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.7 p -157.98 160.84 37.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.759 1.223 . . . . 0.0 109.155 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.6 m -74.62 100.17 3.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.5 t -74.38 97.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -133.89 153.5 51.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.724 0.81 . . . . 0.0 109.756 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -135.44 131.54 36.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.368 1.067 . . . . 0.0 109.269 -165.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.11 88.97 3.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.559 1.543 . . . . 0.0 109.606 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.95 67.06 0.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.901 1.28 . . . . 0.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.17 31.93 82.29 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.283 0.944 . . . . 0.0 113.077 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.01 112.13 5.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.083 0.953 . . . . 0.0 108.559 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -74.9 125.67 29.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.53 114.37 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.1 p -130.11 162.78 28.05 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.844 0.858 . . . . 0.0 109.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.1 142.94 18.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 168.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 t -137.67 168.56 19.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.026 1.73 . . . . 0.0 108.103 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -84.77 50.05 1.84 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.454 0.702 . . . . 0.0 110.695 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? 178.51 -23.0 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.948 2.099 . . . . 0.0 111.429 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -150.24 161.56 42.2 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.886 0.766 . . . . 0.0 111.049 -166.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.9 t -149.01 141.94 24.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.379 1.071 . . . . 0.0 108.842 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -122.9 102.46 8.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.453 1.901 . . . . 0.0 106.513 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -121.72 94.35 4.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.29 1.436 . . . . 0.0 109.51 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -121.71 112.33 18.27 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.67 147.83 45.37 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.51 0.724 . . . . 0.0 110.255 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.47 149.95 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.605 1.162 . . . . 0.0 109.915 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -125.12 -155.09 0.65 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.147 . . . . 0.0 108.287 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.48 -59.36 8.93 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.616 0.627 . . . . 0.0 111.884 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -136.22 22.3 3.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.378 1.071 . . . . 0.0 111.207 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -142.53 155.0 44.97 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.066 0.946 . . . . 0.0 108.976 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.7 ttt -146.03 133.78 21.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.667 1.187 . . . . 0.0 108.731 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.2 t -102.86 122.44 55.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.64 91.93 3.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.289 1.836 . . . . 0.0 108.441 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.8 m -103.46 133.75 47.99 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 109.11 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 34.2 mm -125.63 153.29 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.0 m -133.08 143.59 49.43 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -129.61 92.47 3.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 106.337 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -9.13 83.81 0.0 OUTLIER Glycine 0 C--N 1.342 0.867 0 C-N-CA 129.296 3.331 . . . . 0.0 115.068 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.19 -46.24 1.02 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.232 0.92 . . . . 0.0 110.947 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.69 150.78 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 125.417 1.487 . . . . 0.0 108.767 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -122.39 155.96 34.98 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.313 1.445 . . . . 0.0 108.987 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 17' ' ' PHE . 2.0 mp -125.44 136.03 52.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.74 115.43 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 165.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -126.92 156.33 41.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.958 1.703 . . . . 0.0 106.637 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -141.62 147.0 36.9 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.771 0.429 . . . . 0.0 110.365 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -134.64 160.83 36.89 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.435 1.494 . . . . 0.0 110.83 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -121.96 144.95 48.57 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.26 1.424 . . . . 0.0 109.539 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -75.21 140.45 43.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.656 1.182 . . . . 0.0 110.862 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.432 1.493 . . . . 0.0 107.932 177.131 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.3 p -51.09 135.12 25.9 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.138 0.975 . . . . 0.0 111.127 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.06 -170.65 35.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 m -121.69 146.09 47.36 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.763 1.225 . . . . 0.0 108.704 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -145.0 161.9 38.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.95 1.3 . . . . 0.0 110.062 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 123.87 23.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.938 1.295 . . . . 0.0 107.781 172.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.71 137.63 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -122.63 -43.66 2.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.043 0.937 . . . . 0.0 110.707 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.01 146.91 46.19 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.631 0.772 . . . . 0.0 110.685 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.28 138.18 21.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.5 1.92 . . . . 0.0 107.808 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -151.41 139.6 20.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.508 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t30 64.64 28.13 13.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.586 2.354 . . . . 0.0 112.164 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -79.91 -50.54 10.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 109.977 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -53.99 -38.76 65.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 111.729 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -57.65 -52.57 64.88 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.095 0.958 . . . . 0.0 110.482 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.14 -46.77 89.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.039 0.536 . . . . 0.0 111.453 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.4 mt -55.69 -42.39 75.1 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.604 0.362 . . . . 0.0 111.406 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -65.89 -38.54 89.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.221 0.208 . . . . 0.0 110.669 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -23.17 65.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.86 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.78 -71.82 0.2 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.311 0.96 . . . . 0.0 109.596 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.47 -54.53 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.291 1.036 . . . . 0.0 110.527 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.9 134.93 47.66 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.238 1.015 . . . . 0.0 111.774 -170.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.06 168.05 23.98 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.491 2.794 . . . . 0.0 111.196 -171.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -50.43 -35.32 28.07 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 113.531 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.76 -36.94 82.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.486 0.714 . . . . 0.0 112.001 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.0 mt -86.84 -33.14 19.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.716 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -35.34 69.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 119.647 1.112 . . . . 0.0 110.434 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -46.98 -44.19 19.93 Favored 'General case' 0 C--N 1.345 0.403 0 C-N-CA 124.508 1.123 . . . . 0.0 111.192 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.6 ttt -71.21 -16.59 62.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.142 0.977 . . . . 0.0 112.008 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.71 -34.79 9.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.657 1.183 . . . . 0.0 111.12 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.75 -57.65 1.86 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 127.023 2.129 . . . . 0.0 111.821 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.421 ' C ' HD12 ' A' ' 34' ' ' ILE . 19.8 t70 -118.14 35.41 4.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.853 0.861 . . . . 0.0 109.981 -172.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 33' ' ' ASP . 1.9 mp -118.59 122.64 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -112.22 100.05 48.26 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 109.255 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.72 166.65 23.41 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.281 -166.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mm -68.25 140.97 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.07 147.1 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -148.47 128.55 13.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.59 143.52 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 107.931 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -141.61 77.06 1.57 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.549 1.14 . . . . 0.0 108.901 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -81.55 128.93 34.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.926 0.89 . . . . 0.0 108.906 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -125.99 79.68 1.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.03 -120.28 5.25 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.095 0.855 . . . . 0.0 111.497 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -68.95 -40.7 78.78 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.168 0.987 . . . . 0.0 111.69 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.76 138.07 39.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.058 0.543 . . . . 0.0 109.876 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -127.51 117.31 21.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.138 1.775 . . . . 0.0 107.572 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.1 t -110.04 126.21 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.27 141.6 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.173 1.389 . . . . 0.0 108.028 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.2 m -141.86 152.41 43.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 108.812 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.7 p -147.93 143.32 27.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.372 1.069 . . . . 0.0 109.093 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -125.8 136.93 53.68 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.28 1.032 . . . . 0.0 109.402 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.52 168.73 12.34 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.957 1.303 . . . . 0.0 108.175 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.07 -25.01 32.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.429 2.086 . . . . 0.0 113.0 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -138.17 33.59 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.504 0.722 . . . . 0.0 110.566 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.81 173.16 1.97 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.091 . . . . 0.0 109.588 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.6 t -170.63 151.47 3.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 108.295 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -144.58 148.42 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.088 1.355 . . . . 0.0 108.872 -173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 156.89 43.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.966 0.906 . . . . 0.0 110.381 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -150.67 143.93 24.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.253 1.421 . . . . 0.0 109.422 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m -130.86 130.33 43.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.847 1.259 . . . . 0.0 109.639 -172.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -158.19 173.64 16.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.974 0.91 . . . . 0.0 110.032 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 m -145.28 147.71 32.66 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.549 1.139 . . . . 0.0 108.463 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.91 168.87 19.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 111.644 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.87 -39.99 3.03 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.89 0.757 . . . . 0.0 113.207 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -120.28 -173.34 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.491 1.116 . . . . 0.0 109.887 -168.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -57.66 145.12 35.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.508 1.123 . . . . 0.0 109.997 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 105.16 3.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.444 0.698 . . . . 0.0 110.338 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.08 127.86 34.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 165.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.73 144.59 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.874 0.47 . . . . 0.0 110.365 174.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.455 -0.218 0 C-N-CA 124.139 0.976 . . . . 0.0 109.502 -179.709 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.2 pttm . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.23 162.82 34.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.517 1.527 . . . . 0.0 109.304 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -103.92 140.67 37.37 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.353 1.061 . . . . 0.0 109.048 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.6 p -152.27 174.99 13.11 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.705 1.202 . . . . 0.0 108.812 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -110.12 97.62 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.71 137.58 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -151.54 157.22 41.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 109.628 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.86 123.05 49.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.18 -68.56 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.001 0.921 . . . . 0.0 110.434 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -156.96 78.1 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.27 28.95 65.12 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.12 0.867 . . . . 0.0 112.089 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -152.27 140.75 20.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.111 2.164 . . . . 0.0 106.559 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.71 135.54 33.65 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.54 122.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 p -133.68 142.11 47.88 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -150.62 145.27 25.78 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.644 0.378 . . . . 0.0 110.874 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -126.16 -168.6 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.611 1.565 . . . . 0.0 108.542 166.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -36.41 68.4 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.166 0.986 . . . . 0.0 113.211 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -133.75 -37.12 0.93 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.548 1.139 . . . . 0.0 112.407 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.65 149.69 47.83 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.9 m -150.24 157.92 43.6 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.107 0.963 . . . . 0.0 108.951 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -166.69 149.37 6.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -154.98 123.59 6.07 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -118.2 141.47 48.47 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.793 0.837 . . . . 0.0 109.499 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -141.5 127.2 19.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.278 1.431 . . . . 0.0 107.759 -173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.08 133.84 64.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 124.531 1.133 . . . . 0.0 108.574 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.53 164.38 29.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.073 2.149 . . . . 0.0 107.838 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.98 -85.9 0.01 OUTLIER Glycine 0 C--N 1.344 0.987 0 C-N-CA 128.337 2.875 . . . . 0.0 115.119 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -125.59 40.59 3.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.271 1.028 . . . . 0.0 110.008 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -152.03 128.41 10.62 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 ttt -122.26 121.07 35.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.996 1.318 . . . . 0.0 108.591 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.77 135.04 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -130.85 89.29 2.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.923 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.9 m -95.44 133.87 38.92 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.419 0.687 . . . . 0.0 109.441 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.63 143.68 38.08 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.9 m -136.13 133.87 37.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.61 1.164 . . . . 0.0 108.669 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -123.78 72.02 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.509 1.923 . . . . 0.0 107.207 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 14.43 67.93 0.01 OUTLIER Glycine 0 C--N 1.344 1.014 0 C-N-CA 129.063 3.22 . . . . 0.0 115.407 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.4 -43.34 1.1 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.38 148.53 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.4 t -121.19 164.67 16.56 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.32 1.048 . . . . 0.0 110.323 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -145.44 140.97 27.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.002 1.321 . . . . 0.0 108.183 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -124.77 129.32 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -111.68 146.49 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 165.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -135.56 128.89 32.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.4 m -121.58 156.07 33.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.994 1.318 . . . . 0.0 110.788 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -121.37 137.95 54.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.111 1.764 . . . . 0.0 107.809 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -70.46 145.31 51.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.553 0.216 . . . . 0.0 111.098 -170.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.545 1.538 . . . . 0.0 107.754 179.397 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 t -53.44 114.03 1.37 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.504 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 -177.55 43.43 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -120.5 156.07 32.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.882 1.273 . . . . 0.0 108.923 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -149.59 152.94 36.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.224 1.41 . . . . 0.0 109.893 -169.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -129.59 120.13 24.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.321 1.448 . . . . 0.0 107.311 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.15 121.14 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.333 0.653 . . . . 0.0 109.545 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -89.58 -51.34 5.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.815 1.646 . . . . 0.0 109.735 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.06 161.99 37.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.135 0.574 . . . . 0.0 110.581 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -156.23 137.55 13.87 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.009 1.324 . . . . 0.0 109.422 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -151.77 142.01 22.35 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.965 0.906 . . . . 0.0 110.54 -171.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.46 31.46 12.25 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.944 1.698 . . . . 0.0 111.415 -167.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -94.78 -49.65 5.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.609 1.963 . . . . 0.0 108.627 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -53.55 -34.48 58.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.716 1.207 . . . . 0.0 111.677 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -57.49 -49.86 74.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.608 0.763 . . . . 0.0 111.089 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -68.34 -42.84 78.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.915 0.325 . . . . 0.0 111.428 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.01 -42.4 85.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.53 0.332 . . . . 0.0 110.853 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.08 -41.28 99.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 110.754 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.61 -25.85 66.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.151 0.58 . . . . 0.0 112.157 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.82 172.3 13.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.477 0.581 . . . . 0.0 110.709 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.93 76.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.267 1.427 . . . . 0.0 113.283 -175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.12 132.97 90.12 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.913 -175.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.45 164.39 34.06 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.195 2.597 . . . . 0.0 110.578 -174.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -54.16 -31.28 52.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.713 1.205 . . . . 0.0 112.216 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -56.71 -44.11 81.25 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.056 0.942 . . . . 0.0 111.39 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.92 -29.7 26.92 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.18 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.74 -34.11 60.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 119.501 1.046 . . . . 0.0 109.716 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -52.66 -37.07 58.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.037 0.935 . . . . 0.0 111.618 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.73 -58.4 3.51 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.33 61.55 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.546 1.138 . . . . 0.0 112.595 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -53.26 -34.48 57.38 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.119 1.367 . . . . 0.0 112.008 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -121.04 40.23 3.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.28 1.032 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.0 mt -125.68 134.96 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 166.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.87 102.28 26.27 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.451 1.1 . . . . 0.0 108.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 138.3 20.85 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.062 1.841 . . . . 0.0 109.996 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.43 141.46 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.8 t -123.88 147.17 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.34 144.11 25.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.76 144.64 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -141.9 143.75 33.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 170.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.83 152.08 27.95 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.092 0.557 . . . . 0.0 109.977 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -147.05 58.04 1.16 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.072 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.74 -135.72 12.9 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.84 -27.9 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.251 1.02 . . . . 0.0 112.001 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.11 140.07 43.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.222 1.409 . . . . 0.0 110.856 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -141.49 127.37 19.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.824 1.249 . . . . 0.0 108.234 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.73 138.04 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.56 128.9 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.1 m -124.56 151.95 44.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.384 1.474 . . . . 0.0 109.274 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 p -125.29 151.42 46.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.788 1.635 . . . . 0.0 108.415 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -136.65 107.36 6.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.35 140.39 14.81 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.11 -9.65 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.959 2.439 . . . . 0.0 113.637 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -128.77 10.7 6.06 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.106 0.962 . . . . 0.0 111.917 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -166.21 79.82 0.26 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.022 0.828 . . . . 0.0 110.426 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.9 m -110.81 101.52 10.12 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -136.78 152.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.913 1.285 . . . . 0.0 110.126 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.7 m -124.74 147.65 48.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.507 1.523 . . . . 0.0 109.981 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.19 131.6 38.78 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 126.726 2.01 . . . . 0.0 107.018 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 p -122.41 132.03 54.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.241 1.016 . . . . 0.0 109.761 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.75 176.35 11.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 111.609 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -145.43 145.03 30.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.8 1.64 . . . . 0.0 107.936 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.84 137.41 55.29 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.986 0.514 . . . . 0.0 110.842 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.82 48.14 84.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -157.74 166.38 32.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -60.19 116.78 4.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.58 101.58 7.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.159 0.984 . . . . 0.0 109.225 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -79.72 112.73 17.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.336 1.054 . . . . 0.0 109.583 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -127.35 140.53 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.228 1.011 . . . . 0.0 108.415 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 m . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 123.901 0.881 . . . . 0.0 109.872 -178.604 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 153.66 51.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.379 1.472 . . . . 0.0 109.107 170.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.43 142.6 27.52 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.985 0.914 . . . . 0.0 109.99 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.6 m -142.79 175.17 10.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 109.589 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 m -132.18 84.91 2.19 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.7 1.2 . . . . 0.0 107.845 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.63 149.89 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.922 0.889 . . . . 0.0 110.602 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -134.62 157.72 45.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.458 1.503 . . . . 0.0 108.513 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.35 112.29 24.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.42 -66.26 0.93 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.885 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.66 83.82 0.61 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.2 35.03 82.63 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.558 0.599 . . . . 0.0 111.709 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -161.52 141.38 10.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.75 0.82 . . . . 0.0 110.004 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.42 133.89 34.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.05 136.64 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 108.065 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 m -148.27 148.63 30.67 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.6 1.16 . . . . 0.0 108.353 -172.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -144.89 154.52 42.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.948 1.299 . . . . 0.0 109.634 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 -172.48 3.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.721 1.608 . . . . 0.0 107.328 167.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -63.03 -56.49 16.5 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.561 0.744 . . . . 0.0 110.141 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -96.76 -36.89 10.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.562 1.145 . . . . 0.0 111.268 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -99.75 156.7 16.96 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.234 1.014 . . . . 0.0 110.823 -170.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.7 t -147.36 156.2 42.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.052 0.941 . . . . 0.0 108.54 165.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.17 127.99 8.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -172.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -147.19 120.86 9.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.15 131.08 54.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.314 1.046 . . . . 0.0 108.865 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.41 129.99 54.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.48 2.312 . . . . 0.0 107.447 -175.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.5 t -120.51 144.79 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.955 0.902 . . . . 0.0 109.42 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -137.09 -176.06 4.25 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.186 1.795 . . . . 0.0 108.582 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.29 -61.32 6.74 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.623 1.106 . . . . 0.0 113.403 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -129.55 31.92 4.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.772 1.229 . . . . 0.0 110.905 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -159.49 150.11 19.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 16.0 ttt -144.93 134.61 23.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.786 1.234 . . . . 0.0 107.903 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.22 139.22 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -134.63 137.08 43.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.191 0.996 . . . . 0.0 108.94 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -143.32 133.31 24.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.789 0.836 . . . . 0.0 109.239 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.47 152.66 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.2 m -136.47 137.33 40.28 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -133.09 95.04 3.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.81 1.644 . . . . 0.0 106.566 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.66 -125.29 39.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.14 24.84 23.06 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.078 -0.845 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.6 136.71 58.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.9 m -121.53 145.27 48.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.158 1.383 . . . . 0.0 107.98 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.93 131.59 54.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -125.56 136.03 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -157.07 174.89 14.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -157.69 150.81 23.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m -130.83 162.34 29.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.93 1.292 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -122.65 139.6 53.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.463 1.505 . . . . 0.0 108.415 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -70.88 148.62 47.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.678 0.791 . . . . 0.0 111.072 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 C--O 1.252 1.235 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.474 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 N--CA 1.458 -0.074 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.7 p -52.92 100.29 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.11 1.364 . . . . 0.0 110.669 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.32 -168.48 36.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.5 m -119.51 151.73 38.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.187 1.395 . . . . 0.0 108.69 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -148.85 129.41 13.99 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 110.208 -162.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -113.07 106.8 15.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.567 1.547 . . . . 0.0 109.17 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.52 117.96 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.121 0.968 . . . . 0.0 109.551 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -99.51 -40.67 7.72 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.811 0.844 . . . . 0.0 111.09 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.41 148.2 43.5 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.927 0.891 . . . . 0.0 110.625 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.49 134.97 14.29 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.544 1.538 . . . . 0.0 108.346 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -156.14 137.87 14.26 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.099 0.959 . . . . 0.0 109.483 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.31 -35.66 0.33 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.459 1.904 . . . . 0.0 111.352 -172.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -32.23 -49.69 0.2 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.428 2.691 . . . . 0.0 112.115 156.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.79 -52.03 67.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.835 0.854 . . . . 0.0 111.016 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.94 -41.5 91.95 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.161 . . . . 0.0 110.664 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.28 -50.37 74.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.329 0.652 . . . . 0.0 111.584 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.94 -42.78 85.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.094 0.406 . . . . 0.0 111.123 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -38.44 80.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -27.25 67.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.957 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.01 -65.17 0.73 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.445 0.566 . . . . 0.0 111.348 -167.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.99 -58.31 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.427 1.091 . . . . 0.0 109.466 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -55.9 130.53 72.9 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.189 0.596 . . . . 0.0 110.508 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.75 170.12 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.299 2.666 . . . . 0.0 111.332 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.57 -28.57 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.876 1.67 . . . . 0.0 113.282 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.14 -42.51 96.77 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.433 0.693 . . . . 0.0 111.868 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.5 mt -83.98 -34.1 24.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.771 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.46 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.276 0.944 . . . . 0.0 111.047 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -49.11 -35.88 17.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 111.629 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.5 mtt -71.24 -60.23 2.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.23 -41.76 69.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.525 1.13 . . . . 0.0 112.168 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -51.36 -37.26 47.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.465 1.506 . . . . 0.0 111.521 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.28 37.58 4.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.032 0.933 . . . . 0.0 110.934 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.5 mt -133.15 136.92 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 168.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -103.1 89.57 2.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.615 1.166 . . . . 0.0 108.293 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.33 148.23 88.2 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.052 1.835 . . . . 0.0 110.923 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 tp -96.26 124.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 t -123.76 136.89 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -168.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -126.97 121.02 30.52 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.795 1.238 . . . . 0.0 108.46 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 98.4 mt -110.62 135.13 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -124.12 88.7 2.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.655 1.582 . . . . 0.0 108.627 -171.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -85.18 128.78 34.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 166.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -132.2 77.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 163.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.82 -128.33 8.44 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.846 1.212 . . . . 0.0 111.174 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.1 -33.05 74.63 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.544 1.138 . . . . 0.0 112.06 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.38 142.46 28.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.185 0.994 . . . . 0.0 110.85 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.65 137.01 45.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.458 1.903 . . . . 0.0 108.264 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.35 124.4 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.26 125.79 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -122.64 135.78 54.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.771 1.228 . . . . 0.0 108.239 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -125.77 128.87 48.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -124.88 114.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 165.79 31.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.78 -3.54 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.277 1.985 . . . . 0.0 113.223 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -139.77 -17.93 0.96 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -130.17 98.6 4.78 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.592 1.157 . . . . 0.0 109.151 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -110.91 113.4 25.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 172.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.16 150.25 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.229 . . . . 0.0 109.394 -173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -135.93 147.06 47.95 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.833 1.253 . . . . 0.0 109.615 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -132.76 149.25 52.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.668 1.187 . . . . 0.0 109.875 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -128.07 138.79 52.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.371 1.868 . . . . 0.0 109.738 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.42 176.33 11.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.082 0.953 . . . . 0.0 110.132 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.2 m -138.39 146.27 42.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.052 1.341 . . . . 0.0 108.196 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 pp -66.8 148.78 51.48 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.967 0.167 . . . . 0.0 111.269 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.43 43.23 44.15 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.855 1.217 . . . . 0.0 112.877 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -156.37 140.15 16.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.11 116.79 7.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.481 0.712 . . . . 0.0 110.566 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.31 160.22 25.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.133 1.373 . . . . 0.0 109.327 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.11 139.74 38.23 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 tt -137.25 168.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.523 1.529 . . . . 0.0 108.17 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.6 m . . . . . 0 N--CA 1.457 -0.118 0 C-N-CA 123.36 0.664 . . . . 0.0 109.849 -174.796 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.75 161.27 39.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.87 1.268 . . . . 0.0 109.136 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -89.07 154.3 20.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.336 0.654 . . . . 0.0 109.797 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p -155.05 165.66 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.397 1.079 . . . . 0.0 109.939 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.1 m -135.32 76.73 1.63 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 137.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -150.95 153.23 34.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.947 0.899 . . . . 0.0 109.44 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.49 162.0 19.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.178 0.991 . . . . 0.0 110.274 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.63 49.3 0.87 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.585 1.154 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.9 t30 68.09 95.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.578 1.951 . . . . 0.0 111.979 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.79 24.54 75.53 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.105 0.86 . . . . 0.0 112.854 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -163.06 147.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.203 . . . . 0.0 108.694 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -103.68 151.25 23.2 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.035 1.334 . . . . 0.0 108.205 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.3 t -121.63 95.08 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -71.25 144.81 49.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.736 0.814 . . . . 0.0 109.526 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -164.86 128.2 2.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.933 0.493 . . . . 0.0 111.928 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -141.71 -149.03 0.26 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.269 2.228 . . . . 0.0 106.115 166.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.64 -73.92 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -78.76 -37.7 40.5 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 111.723 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -95.71 81.76 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.579 0.752 . . . . 0.0 111.054 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.6 p -140.91 144.17 35.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.212 1.005 . . . . 0.0 110.904 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 180.0 -145.74 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.17 1.788 . . . . 0.0 110.124 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.78 170.41 15.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.439 1.496 . . . . 0.0 110.378 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -160.0 127.51 4.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 109.615 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -122.27 149.73 43.3 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.801 1.64 . . . . 0.0 109.86 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.02 146.39 33.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.026 0.931 . . . . 0.0 110.422 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -136.55 171.7 14.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.516 1.926 . . . . 0.0 108.474 168.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -3.22 -76.0 0.01 OUTLIER Glycine 0 C--N 1.343 0.929 0 C-N-CA 128.906 3.146 . . . . 0.0 116.264 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.58 35.43 2.93 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.47 1.108 . . . . 0.0 110.269 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.21 147.29 31.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.201 0.6 . . . . 0.0 110.884 -172.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.14 130.24 38.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.593 1.557 . . . . 0.0 108.63 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.71 116.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -129.8 136.8 50.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 109.794 -169.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 t -142.3 157.73 44.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.201 0.524 . . . . 0.0 110.645 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.4 128.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.78 171.55 9.88 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -150.81 80.68 1.33 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.51 -113.19 5.58 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -175.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.95 68.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.37 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.98 160.41 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.745 1.218 . . . . 0.0 107.871 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.2 m -134.39 155.46 50.24 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.274 1.03 . . . . 0.0 110.311 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 mp -127.1 129.04 47.19 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 158.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.94 142.57 39.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 164.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -158.18 147.93 19.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -128.26 136.08 50.54 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 t -125.04 162.93 23.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.525 1.13 . . . . 0.0 110.583 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.71 133.96 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.52 1.528 . . . . 0.0 107.499 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 ttp85 -68.82 150.92 47.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.054 0.541 . . . . 0.0 109.918 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--O 1.249 1.038 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 172.654 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.3 p -168.7 155.01 6.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.58 1.152 . . . . 0.0 110.026 -173.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.34 -169.76 16.74 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.161 0.886 . . . . 0.0 112.449 165.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -121.95 134.13 54.84 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.939 1.295 . . . . 0.0 108.849 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -144.02 165.0 29.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.167 0.987 . . . . 0.0 111.281 -166.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -148.15 122.64 9.75 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.762 1.225 . . . . 0.0 108.943 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.01 139.63 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.67 1.188 . . . . 0.0 109.783 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -124.06 -37.67 2.55 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.331 0.652 . . . . 0.0 112.187 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.51 149.4 51.71 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 110.161 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.38 148.46 14.77 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.7 0.8 . . . . 0.0 111.536 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.08 140.54 21.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.334 1.454 . . . . 0.0 108.184 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 59.24 89.96 0.06 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.381 1.472 . . . . 0.0 109.268 -171.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -148.64 -51.41 0.17 Allowed 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -47.65 -50.73 23.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.049 1.34 . . . . 0.0 111.375 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.84 -47.49 82.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.819 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -61.66 -53.36 57.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.948 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -62.99 -35.37 79.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.948 0.34 . . . . 0.0 111.51 -174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -75.81 -36.3 59.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.291 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.84 65.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.314 0.506 . . . . 0.0 111.147 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -74.11 -64.52 1.0 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.424 1.089 . . . . 0.0 109.543 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.11 -65.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.353 0.661 . . . . 0.0 111.135 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -56.33 136.77 75.66 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.7 0.8 . . . . 0.0 112.684 -165.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.48 171.47 16.77 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.572 2.848 . . . . 0.0 111.889 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.22 -34.63 4.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.842 2.057 . . . . 0.0 113.532 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.43 -31.85 71.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.949 0.9 . . . . 0.0 112.104 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -93.78 -32.17 14.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.8 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pp -66.89 -20.7 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 119.078 0.854 . . . . 0.0 111.296 173.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -49.87 -38.31 34.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.61 0.641 . . . . 0.0 110.582 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -96.2 46.75 1.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.362 1.065 . . . . 0.0 109.683 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -156.9 -52.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.321 1.048 . . . . 0.0 110.634 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -52.46 -46.38 66.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.62 1.968 . . . . 0.0 112.341 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -120.51 35.21 4.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 109.328 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.82 144.73 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -111.88 90.32 12.98 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.64 137.29 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.184 1.923 . . . . 0.0 109.426 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.55 137.52 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.36 142.02 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.38 129.75 22.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.171 1.388 . . . . 0.0 108.11 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.14 138.43 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.289 1.436 . . . . 0.0 108.505 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -126.15 125.49 42.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.32 1.048 . . . . 0.0 108.648 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.95 142.99 29.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.62 1.568 . . . . 0.0 111.559 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -140.85 42.09 1.83 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.858 1.663 . . . . 0.0 110.829 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 96.71 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.16 0.886 . . . . 0.0 112.771 170.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 57.29 18.52 4.35 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.352 1.461 . . . . 0.0 112.56 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -150.8 143.5 24.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.75 2.02 . . . . 0.0 105.783 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.81 150.89 30.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.819 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.0 131.64 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.437 1.095 . . . . 0.0 108.441 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.95 134.04 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.955 1.702 . . . . 0.0 107.337 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.1 m -132.72 137.42 46.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.704 1.202 . . . . 0.0 107.986 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 t -127.09 140.12 52.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.975 1.71 . . . . 0.0 107.737 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -123.35 116.7 23.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.05 159.97 56.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.27 -4.39 14.27 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.008 1.805 . . . . 0.0 112.445 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -119.42 29.11 7.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.233 1.413 . . . . 0.0 110.932 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 127.83 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.303 3.441 . . . . 0.0 110.389 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 p -108.79 138.08 45.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.2 135.71 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.336 1.454 . . . . 0.0 108.099 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -144.43 151.4 39.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 111.524 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.17 140.98 9.26 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.557 1.543 . . . . 0.0 109.751 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -124.91 151.64 45.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.868 1.267 . . . . 0.0 109.828 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -166.2 152.99 9.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.24 0.543 . . . . 0.0 110.984 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -122.42 144.52 48.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.434 1.894 . . . . 0.0 108.016 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.34 131.73 46.76 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.343 0.257 . . . . 0.0 111.476 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.26 50.34 51.45 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -160.46 139.27 10.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.47 142.28 49.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.97 150.67 27.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.649 0.779 . . . . 0.0 109.892 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -89.43 132.38 35.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.303 1.041 . . . . 0.0 109.219 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.74 147.14 25.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.319 1.048 . . . . 0.0 108.273 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.454 -0.238 0 C-N-CA 124.945 1.298 . . . . 0.0 107.975 -175.199 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 121.187 0.517 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.7 -173.8 2.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.536 2.334 . . . . 0.0 107.633 166.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.81 146.33 37.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.79 0.836 . . . . 0.0 110.68 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.9 p -166.23 162.6 17.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.777 1.231 . . . . 0.0 109.094 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -116.26 61.31 0.72 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 111.894 -173.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.63 138.06 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.381 1.073 . . . . 0.0 112.396 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -151.22 153.96 35.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.291 1.037 . . . . 0.0 110.303 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -85.15 125.49 32.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.059 1.344 . . . . 0.0 108.906 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.28 -68.38 0.8 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.212 1.005 . . . . 0.0 109.387 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -164.51 88.52 0.5 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.93 24.23 64.52 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.198 0.904 . . . . 0.0 112.797 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -157.43 138.8 13.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 109.337 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.37 139.79 36.37 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.2 t -133.45 139.58 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.228 1.411 . . . . 0.0 107.376 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.82 156.11 37.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -143.56 141.49 30.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.309 1.044 . . . . 0.0 109.049 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 t -151.55 166.94 29.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.868 1.267 . . . . 0.0 107.883 163.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -85.72 12.32 9.17 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.157 0.983 . . . . 0.0 111.857 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -126.97 -30.33 2.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.21 1.804 . . . . 0.0 109.854 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -157.12 157.24 34.13 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.913 0.885 . . . . 0.0 109.682 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -136.15 150.91 49.26 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -143.95 92.67 2.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.369 1.468 . . . . 0.0 108.07 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -130.3 124.16 31.7 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.68 139.8 11.8 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -121.07 136.02 55.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.944 2.098 . . . . 0.0 107.948 -172.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.0 133.72 56.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -160.84 127.7 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.628 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.34 -96.34 0.48 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.138 0.875 . . . . 0.0 110.949 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -138.8 18.46 2.67 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.251 1.02 . . . . 0.0 110.757 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -148.65 130.92 15.55 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.4 ptp -123.97 155.56 37.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.428 1.091 . . . . 0.0 111.488 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.55 131.7 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -131.61 140.54 49.43 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.29 0.636 . . . . 0.0 110.898 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -131.17 129.34 41.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.982 1.713 . . . . 0.0 108.181 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 48.0 mm -123.48 152.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 53.2 m -134.99 145.84 48.49 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 163.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -130.5 105.44 7.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 170.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -15.69 89.05 0.01 OUTLIER Glycine 0 C--N 1.342 0.864 0 C-N-CA 128.562 2.982 . . . . 0.0 115.016 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.8 -47.88 0.95 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.93 137.35 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 109.183 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 36.6 m -120.19 133.51 55.48 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.172 1.389 . . . . 0.0 109.179 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 118' ' ' LEU . 2.5 mp -119.92 140.12 51.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.951 2.101 . . . . 0.0 108.73 -170.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.19 141.73 40.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm85 -162.77 160.72 25.67 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 109.761 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -135.64 143.91 45.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.457 1.103 . . . . 0.0 109.344 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 m -133.21 155.73 48.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.427 1.091 . . . . 0.0 109.417 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -124.71 142.11 51.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.074 1.35 . . . . 0.0 108.158 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -65.95 141.75 58.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.554 0.741 . . . . 0.0 109.859 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 C--O 1.251 1.18 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 CA--C 1.527 0.095 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 p -48.34 112.06 0.54 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.281 1.433 . . . . 0.0 110.793 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.58 -177.31 41.48 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -119.28 140.62 49.98 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.842 1.257 . . . . 0.0 107.922 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -142.29 150.26 40.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.007 0.923 . . . . 0.0 109.759 -163.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -137.33 121.63 18.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -53.25 117.31 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.214 1.006 . . . . 0.0 108.613 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.11 -35.06 9.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.525 0.73 . . . . 0.0 110.209 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 147.08 39.68 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.507 1.123 . . . . 0.0 108.652 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.8 147.08 22.59 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.005 0.922 . . . . 0.0 109.99 -175.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.74 155.73 36.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.296 0.57 . . . . 0.0 111.532 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.22 35.11 25.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.237 1.815 . . . . 0.0 110.494 -169.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -99.88 -45.41 5.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.866 1.666 . . . . 0.0 110.139 -167.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.25 -40.03 46.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.008 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.29 -48.31 82.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.493 1.117 . . . . 0.0 110.772 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.47 -46.5 89.86 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 122.889 0.476 . . . . 0.0 110.828 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.56 -45.37 85.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.662 0.21 . . . . 0.0 111.136 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -65.51 -34.48 78.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.984 0.514 . . . . 0.0 111.74 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.73 -25.35 67.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.79 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.4 mt -76.46 170.49 16.29 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.088 0.858 . . . . 0.0 110.64 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.54 94.27 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.74 1.216 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 139.85 97.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 111.516 -173.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.47 169.01 17.58 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.914 3.076 . . . . 0.0 111.191 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -48.92 -41.0 32.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.275 1.43 . . . . 0.0 112.631 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -53.85 -38.52 64.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.881 0.473 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.62 -24.12 19.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.607 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -32.56 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.832 1.196 . . . . 0.0 109.62 170.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -50.94 -43.27 60.17 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.336 1.054 . . . . 0.0 110.551 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 56.7 mtt -69.65 -52.18 28.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.244 0.618 . . . . 0.0 110.046 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.46 -35.7 70.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.768 0.827 . . . . 0.0 112.832 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -32.05 67.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.885 0.874 . . . . 0.0 111.186 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -119.39 49.03 1.4 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.175 0.99 . . . . 0.0 109.353 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.39 146.59 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 126.042 1.737 . . . . 0.0 106.472 165.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 106.5 40.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.334 1.054 . . . . 0.0 109.547 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.05 113.49 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.378 2.052 . . . . 0.0 109.392 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.31 139.29 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.06 148.36 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.598 1.559 . . . . 0.0 108.306 -171.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.87 130.11 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -109.1 129.14 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -119.14 101.4 7.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -126.12 141.76 51.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.639 1.176 . . . . 0.0 109.351 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -145.96 73.12 1.32 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.929 0.892 . . . . 0.0 108.953 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.89 -115.09 3.95 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.19 -42.67 88.53 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.53 0.732 . . . . 0.0 111.208 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -76.68 131.83 39.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.449 0.7 . . . . 0.0 110.432 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -129.84 120.85 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.058 1.743 . . . . 0.0 108.16 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -109.53 131.96 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.05 135.23 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -134.48 142.15 46.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.8 t -144.45 137.19 26.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.958 0.503 . . . . 0.0 109.804 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -124.1 153.84 40.86 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.736 1.214 . . . . 0.0 109.514 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.08 159.21 29.23 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.72 39.93 0.92 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.407 2.738 . . . . 0.0 111.577 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -144.55 -41.6 0.25 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.49 1.516 . . . . 0.0 110.129 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.0 169.82 23.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.206 1.802 . . . . 0.0 109.217 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.4 m -150.41 143.33 24.74 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.987 1.315 . . . . 0.0 107.681 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.16 146.56 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.59 1.156 . . . . 0.0 109.711 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.5 m -134.21 145.65 49.39 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.121 1.768 . . . . 0.0 107.529 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.85 130.52 24.17 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.556 1.542 . . . . 0.0 106.847 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 p -125.01 127.29 46.77 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.475 1.11 . . . . 0.0 109.249 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -164.39 -176.46 4.4 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.458 0.703 . . . . 0.0 110.613 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.5 m -140.25 148.22 41.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.131 1.372 . . . . 0.0 107.847 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 165.54 25.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.109 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.24 -29.05 5.35 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.055 0.836 . . . . 0.0 112.84 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -121.81 -177.03 3.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.144 1.378 . . . . 0.0 109.345 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.71 142.57 57.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.453 0.701 . . . . 0.0 109.791 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.4 125.64 16.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.367 1.067 . . . . 0.0 108.871 -175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.33 139.16 32.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.599 0.76 . . . . 0.0 109.27 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.2 mt -135.39 142.07 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.6 m . . . . . 0 CA--C 1.532 0.27 0 C-N-CA 125.779 1.632 . . . . 0.0 108.771 -177.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 mttm . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.915 0.388 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.15 168.08 24.19 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.229 1.412 . . . . 0.0 109.993 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -118.14 144.33 45.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.87 1.268 . . . . 0.0 108.994 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.4 p -157.79 150.1 22.42 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.489 1.115 . . . . 0.0 109.182 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.5 m -88.08 87.34 7.3 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.14 132.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.434 0.694 . . . . 0.0 109.518 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -150.37 164.53 35.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.812 1.245 . . . . 0.0 108.637 172.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.83 127.16 52.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.663 1.185 . . . . 0.0 108.105 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.25 142.54 25.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.427 1.091 . . . . 0.0 109.537 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.72 41.63 31.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.923 1.289 . . . . 0.0 111.781 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.43 31.44 79.51 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.133 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -154.79 151.6 28.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.98 0.89 . . . . 0.0 110.387 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.51 141.41 50.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.43 129.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.25 28.31 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -157.45 143.18 17.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.827 0.851 . . . . 0.0 109.192 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -109.82 -118.36 0.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.57 -47.8 5.23 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.463 1.505 . . . . 0.0 108.945 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 -44.25 2.11 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.9 1.28 . . . . 0.0 111.186 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -70.7 139.87 51.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 m -141.04 162.92 34.36 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.272 0.629 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.04 123.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.946 1.299 . . . . 0.0 107.877 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -136.69 110.84 8.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -118.98 120.2 36.56 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -121.02 150.96 40.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.338 1.455 . . . . 0.0 109.406 -170.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.45 136.19 57.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 125.792 1.637 . . . . 0.0 109.534 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.91 103.41 2.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.31 1.044 . . . . 0.0 109.931 170.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.64 -105.83 1.1 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.419 1.009 . . . . 0.0 111.429 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -122.58 24.65 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.931 1.293 . . . . 0.0 110.25 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -143.8 135.0 25.73 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 122.891 0.476 . . . . 0.0 110.723 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 mmt -100.74 129.23 46.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.1 123.51 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -135.87 141.94 44.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.241 -174.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -134.97 143.17 46.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.84 0.856 . . . . 0.0 109.414 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.41 142.83 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.843 1.657 . . . . 0.0 106.779 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.4 m -113.62 144.71 42.44 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.63 108.4 4.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.37 -125.3 39.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.21 29.11 13.23 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.03 0.824 . . . . 0.0 111.848 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.88 145.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 C-N-CA 124.906 1.282 . . . . 0.0 107.616 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.4 m -123.56 149.78 44.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.701 1.201 . . . . 0.0 107.89 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.0 133.67 53.62 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.64 128.82 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 ptt-85 -158.64 168.11 27.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.341 0.591 . . . . 0.0 111.048 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -138.39 132.8 32.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.353 -171.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 162.24 15.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.971 0.908 . . . . 0.0 110.139 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -126.52 147.57 49.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.332 1.453 . . . . 0.0 109.471 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -63.08 105.97 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.918 0.887 . . . . 0.0 110.045 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--O 1.253 1.244 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.078 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 119.796 -0.145 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 p -50.72 116.23 1.85 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.815 1.646 . . . . 0.0 111.022 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.84 -178.99 40.92 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -118.91 130.66 55.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -134.42 144.69 48.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.777 1.631 . . . . 0.0 109.166 -167.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -119.53 118.96 32.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -52.87 124.62 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.067 0.947 . . . . 0.0 108.966 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -103.49 -44.14 5.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.772 1.629 . . . . 0.0 109.777 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 155.5 41.64 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.095 0.958 . . . . 0.0 109.439 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -151.31 122.4 7.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.401 1.08 . . . . 0.0 109.319 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.87 136.52 38.78 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.772 0.829 . . . . 0.0 111.582 -165.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 65.02 14.75 9.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.808 2.443 . . . . 0.0 112.022 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -81.21 -50.98 8.91 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.509 1.524 . . . . 0.0 110.663 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.54 -47.75 75.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.374 0.67 . . . . 0.0 110.854 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -59.73 -47.41 85.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.58 1.552 . . . . 0.0 110.134 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -55.16 -53.11 60.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.034 0.533 . . . . 0.0 111.899 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.93 -41.35 82.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -62.24 -38.77 90.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.242 0.617 . . . . 0.0 110.974 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.89 -20.15 61.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.716 0.806 . . . . 0.0 112.218 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.0 tp -75.34 -59.35 2.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.756 0.707 . . . . 0.0 111.22 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.03 -46.0 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.905 1.282 . . . . 0.0 110.097 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.65 135.56 71.44 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.643 1.177 . . . . 0.0 110.848 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -79.29 169.77 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.461 2.774 . . . . 0.0 110.639 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -44.56 -38.09 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.115 1.766 . . . . 0.0 112.474 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.1 -46.04 68.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.299 1.04 . . . . 0.0 111.757 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -81.15 -34.66 32.29 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.335 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.03 -22.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 118.815 0.734 . . . . 0.0 112.036 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.44 -33.16 19.98 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.855 0.862 . . . . 0.0 111.904 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.4 ttp -60.87 -30.56 70.21 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 123.607 0.763 . . . . 0.0 112.095 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.99 -36.14 9.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.897 1.279 . . . . 0.0 111.387 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -34.88 18.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.753 2.021 . . . . 0.0 113.561 -170.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -120.08 6.92 10.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.417 1.087 . . . . 0.0 111.859 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.98 122.91 71.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -106.33 100.73 31.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.354 1.462 . . . . 0.0 108.182 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.12 156.32 51.64 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.685 2.257 . . . . 0.0 110.96 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 tt -83.46 147.96 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -131.87 151.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.038 1.735 . . . . 0.0 108.316 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -154.47 127.94 8.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.53 148.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 125.108 1.363 . . . . 0.0 107.714 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.45 141.05 37.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.13 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.82 152.08 0.33 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.469 1.908 . . . . 0.0 110.64 172.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -135.25 58.42 1.76 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.322 1.449 . . . . 0.0 107.786 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.66 -131.98 6.12 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.729 1.157 . . . . 0.0 110.23 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.86 -33.84 76.95 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.926 1.29 . . . . 0.0 113.349 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.72 171.92 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.485 0.714 . . . . 0.0 110.843 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -157.56 121.56 4.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.641 1.576 . . . . 0.0 108.463 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.8 129.89 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 158.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.44 130.49 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.522 1.529 . . . . 0.0 107.221 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.1 m -128.68 145.81 51.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.238 1.415 . . . . 0.0 108.155 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.7 t -139.87 136.21 33.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -123.25 134.59 54.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -130.57 151.51 78.79 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 125.694 1.598 . . . . 0.0 107.125 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.43 -19.09 49.75 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.788 2.325 . . . . 0.0 114.068 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -138.79 32.4 2.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.087 0.858 . . . . 0.0 111.941 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -171.31 156.2 4.53 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.629 1.172 . . . . 0.0 108.871 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.3 m -148.2 143.97 27.4 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.33 151.5 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 109.519 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.4 m -148.31 146.27 28.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.456 1.102 . . . . 0.0 108.665 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.31 155.14 42.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.396 1.478 . . . . 0.0 108.893 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 p -138.6 145.7 40.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.682 0.793 . . . . 0.0 109.93 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -163.03 172.71 14.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.955 1.302 . . . . 0.0 109.429 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -144.6 139.12 27.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.21 152.54 44.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.25 0.547 . . . . 0.0 111.715 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.69 75.31 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.071 1.32 . . . . 0.0 112.049 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -160.01 157.69 29.22 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.416 1.108 . . . . 0.0 111.576 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.74 144.55 50.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.912 1.685 . . . . 0.0 111.048 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.87 161.73 42.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.867 1.267 . . . . 0.0 109.385 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.7 144.85 25.64 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.4 mt -129.3 136.19 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 109.054 -175.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.4 3.66 2.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.547 1.139 . . . . 0.0 113.193 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 69.72 134.22 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.0 2.12 . . . . 0.0 112.759 171.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.7 125.3 13.27 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.928 1.291 . . . . 0.0 110.214 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -91.7 104.35 16.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.857 1.663 . . . . 0.0 108.719 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.11 150.47 3.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.077 0.951 . . . . 0.0 110.145 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -150.8 167.12 28.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.435 1.494 . . . . 0.0 109.117 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.91 115.16 16.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.57 -114.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.015 1.326 . . . . 0.0 110.555 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -83.91 56.95 3.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.426 1.49 . . . . 0.0 110.639 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.47 37.37 94.69 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -140.32 140.55 35.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.671 1.188 . . . . 0.0 107.946 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 tt -79.3 109.71 13.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.8 t -119.24 117.25 53.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 m -123.89 152.13 42.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.508 1.523 . . . . 0.0 109.404 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -128.9 135.44 49.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.352 1.461 . . . . 0.0 108.32 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t -110.17 168.27 9.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.695 1.198 . . . . 0.0 108.748 170.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.46 -43.47 84.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 111.045 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -96.68 -23.71 16.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.822 0.849 . . . . 0.0 113.162 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.9 -168.3 3.0 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.44 1.018 . . . . 0.0 112.373 -168.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -143.9 162.27 36.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.596 1.159 . . . . 0.0 111.502 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -149.54 120.9 7.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.589 1.556 . . . . 0.0 108.336 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -128.48 133.57 48.51 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.68 1.192 . . . . 0.0 108.423 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -152.07 135.95 16.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -165.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.0 152.78 30.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.385 0.274 . . . . 0.0 110.446 -166.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.3 t -119.3 139.36 46.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.854 1.261 . . . . 0.0 108.817 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -133.77 101.63 5.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.172 1.789 . . . . 0.0 109.321 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.71 -101.84 0.57 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.27 11.14 10.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.203 1.401 . . . . 0.0 111.377 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -114.88 145.74 41.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.322 1.449 . . . . 0.0 107.45 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.2 ttt -127.72 133.4 49.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.2 t -115.56 136.96 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.47 119.26 21.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.3 1.44 . . . . 0.0 108.657 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -129.28 114.57 16.41 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.84 140.27 44.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.9 t -119.68 172.23 7.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.065 0.393 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -158.11 103.17 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.86 1.664 . . . . 0.0 107.503 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.02 -113.71 5.36 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.03 28.44 13.01 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.17 0.89 . . . . 0.0 112.084 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.14 118.96 51.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -120.33 128.44 53.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.965 0.906 . . . . 0.0 109.246 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.91 138.78 50.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 107.861 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.81 130.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -151.95 164.57 36.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -151.69 155.89 39.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.0 m -136.13 166.05 24.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.558 1.143 . . . . 0.0 109.549 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -132.45 137.48 47.28 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.021 0.928 . . . . 0.0 109.341 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -58.13 132.55 53.85 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.508 0.723 . . . . 0.0 109.479 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.3 178.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 p -51.94 116.81 2.35 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.0 111.156 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.09 177.73 42.56 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.3 m -118.41 138.54 52.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.172 1.389 . . . . 0.0 107.669 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -143.48 155.18 44.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.53 1.132 . . . . 0.0 109.761 -163.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -142.39 128.17 19.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.63 134.14 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 124.042 0.937 . . . . 0.0 109.61 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -109.61 -33.97 6.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.435 0.694 . . . . 0.0 111.339 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.51 46.58 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.137 0.575 . . . . 0.0 110.828 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -148.79 144.3 26.9 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 109.09 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -156.65 144.12 19.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.222 1.009 . . . . 0.0 109.645 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.9 26.05 12.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.035 1.334 . . . . 0.0 110.855 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -99.98 -48.44 4.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.69 2.396 . . . . 0.0 107.711 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.02 -43.65 50.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.126 1.37 . . . . 0.0 110.572 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -60.13 -50.3 74.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.891 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD2' HD21 ' A' ' 118' ' ' LEU . 8.9 t80 -57.61 -50.03 74.49 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.297 0.639 . . . . 0.0 110.934 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.45 -44.25 95.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -62.87 -30.57 71.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.046 0.539 . . . . 0.0 111.626 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.47 66.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 0.0 111.389 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.02 -176.94 5.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.375 0.534 . . . . 0.0 110.094 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.12 -32.99 37.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.528 1.531 . . . . 0.0 113.606 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.48 111.38 1.8 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.104 1.362 . . . . 0.0 111.013 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.81 167.89 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.075 2.517 . . . . 0.0 110.065 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -46.04 -36.66 5.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.772 1.629 . . . . 0.0 113.059 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -72.4 -57.46 4.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.288 1.035 . . . . 0.0 111.622 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.28 -33.74 63.35 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.342 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.433 ' O ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -63.72 -39.52 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -33.67 18.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.518 0.599 . . . . 0.0 112.267 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.22 -55.77 5.27 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.81 65.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.57 1.148 . . . . 0.0 112.9 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -45.34 -39.55 6.87 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.75 1.62 . . . . 0.0 111.974 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -118.2 47.36 1.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.334 1.054 . . . . 0.0 109.238 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.0 mt -127.12 135.16 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -109.47 99.15 35.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.868 1.667 . . . . 0.0 108.354 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.49 145.23 26.32 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.123 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.5 tp -80.81 137.13 21.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.95 148.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.285 1.434 . . . . 0.0 108.078 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -153.26 123.56 7.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mp -110.16 140.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -129.37 137.26 50.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.177 1.391 . . . . 0.0 107.393 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.77 166.66 32.82 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.514 0.726 . . . . 0.0 109.529 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -156.17 65.84 0.57 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.363 0.665 . . . . 0.0 109.54 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.1 -85.3 1.04 Allowed Glycine 0 C--N 1.337 0.631 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -92.88 -49.48 6.03 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.501 0.72 . . . . 0.0 111.709 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.64 142.73 31.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.273 0.488 . . . . 0.0 110.485 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.83 142.34 48.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.924 1.689 . . . . 0.0 108.424 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.2 t -130.3 126.97 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.774 1.63 . . . . 0.0 106.77 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.3 t -110.41 126.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.9 m -132.26 141.07 48.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.448 1.099 . . . . 0.0 108.533 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.1 m -142.85 134.13 26.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 108.157 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -123.48 146.84 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 108.651 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.4 HG22 ' HD2' ' A' ' 54' ' ' PRO . 1.3 m -144.59 151.73 51.1 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' HG22 ' A' ' 53' ' ' THR . 42.8 Cg_endo -63.78 -13.38 36.62 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.448 2.099 . . . . 0.0 113.27 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -144.1 41.56 1.4 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.859 0.864 . . . . 0.0 111.365 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -177.19 154.98 1.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.224 1.41 . . . . 0.0 108.143 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.6 m -154.53 130.8 10.4 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 167.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -127.18 131.26 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 107.864 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -140.02 133.53 30.14 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.268 1.027 . . . . 0.0 108.333 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.12 158.81 37.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.42 1.488 . . . . 0.0 109.609 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.3 p -152.27 159.96 43.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.465 0.706 . . . . 0.0 110.529 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -167.4 171.21 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.66 1.184 . . . . 0.0 109.061 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.1 m -139.93 155.13 47.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.566 1.146 . . . . 0.0 107.959 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.0 mt -59.05 112.37 1.66 Allowed 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.686 0.394 . . . . 0.0 111.883 -171.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.8 41.03 95.87 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.787 1.184 . . . . 0.0 111.251 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -130.87 132.09 44.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.548 0.739 . . . . 0.0 110.183 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.48 124.81 12.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.886 1.675 . . . . 0.0 110.754 172.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.81 173.88 13.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.887 1.275 . . . . 0.0 110.107 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -116.31 146.84 42.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.044 1.738 . . . . 0.0 108.162 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.29 136.26 60.55 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 173.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 N--CA 1.454 -0.26 0 C-N-CA 123.503 0.721 . . . . 0.0 109.484 -172.323 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.557 0.218 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp -144.84 13.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.284 1.034 . . . . 0.0 113.093 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 66.51 143.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.928 2.091 . . . . 0.0 113.357 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.9 t -155.66 147.42 23.14 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.636 -0.665 . . . . 0.0 110.748 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 m -156.21 71.97 0.74 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.719 0.808 . . . . 0.0 111.036 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.26 -161.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.793 0.724 . . . . 0.0 111.173 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -157.79 -174.88 5.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.584 1.554 . . . . 0.0 111.884 -161.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -104.89 139.55 39.46 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 109.345 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.16 112.91 5.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.838 1.255 . . . . 0.0 108.918 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 56.58 64.99 1.52 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.053 1.341 . . . . 0.0 111.394 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.88 37.23 77.05 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.716 1.151 . . . . 0.0 113.117 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -154.75 118.33 4.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.11 0.964 . . . . 0.0 108.497 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.63 122.05 44.2 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.502 1.121 . . . . 0.0 108.302 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.73 70.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.451 -163.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.45 127.2 32.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -144.98 152.13 39.69 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.072 0.949 . . . . 0.0 110.16 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -141.63 -164.88 1.87 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.697 1.199 . . . . 0.0 109.799 -174.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -46.93 -57.27 5.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.24 1.816 . . . . 0.0 112.045 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -127.84 -24.59 3.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.296 1.038 . . . . 0.0 111.648 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -72.87 145.9 46.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.162 0.437 . . . . 0.0 110.117 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.9 m -134.65 152.17 51.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.374 1.07 . . . . 0.0 108.287 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -146.07 93.41 2.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -107.0 105.73 15.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.045 1.738 . . . . 0.0 106.956 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 125.55 50.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.314 1.046 . . . . 0.0 109.104 -170.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -122.37 130.46 53.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.563 1.545 . . . . 0.0 107.723 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -121.46 149.48 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 109.304 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -143.22 -150.3 0.31 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.018 1.327 . . . . 0.0 108.414 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.76 -65.96 2.1 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -126.73 31.45 5.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.602 1.161 . . . . 0.0 109.958 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -155.44 143.78 20.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.161 0.984 . . . . 0.0 108.716 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 11.4 ttt -146.66 124.07 11.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.69 1.196 . . . . 0.0 108.101 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.75 137.29 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.666 1.186 . . . . 0.0 107.932 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -132.61 125.87 31.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.032 0.933 . . . . 0.0 108.779 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -132.68 122.65 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mm -119.12 157.02 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -134.05 149.26 51.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.58 112.98 5.28 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.623 1.169 . . . . 0.0 108.748 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.5 -91.24 0.25 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 124.333 0.968 . . . . 0.0 111.028 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.46 37.19 1.49 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.837 1.208 . . . . 0.0 110.152 172.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.44 144.89 35.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 106.956 174.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -121.49 134.74 55.07 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.836 1.254 . . . . 0.0 108.038 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -120.28 141.53 49.91 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.61 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -161.71 161.29 29.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.017 0.927 . . . . 0.0 108.684 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -139.95 143.61 36.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.1 m -119.08 163.74 16.56 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.408 1.483 . . . . 0.0 110.618 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -123.32 151.13 42.76 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.16 1.384 . . . . 0.0 108.342 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -71.92 146.34 47.88 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.406 0.683 . . . . 0.0 109.618 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--O 1.255 1.349 0 CA-C-O 116.857 -1.544 . . . . 0.0 106.92 174.453 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 119.051 -0.499 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.3 p -43.62 112.92 0.44 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 126.116 1.766 . . . . 0.0 111.261 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.85 -175.79 39.97 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -120.5 142.69 49.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -142.56 139.39 31.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.201 1.0 . . . . 0.0 109.622 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -120.6 109.46 15.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.49 1.116 . . . . 0.0 108.521 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.24 137.54 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.592 1.157 . . . . 0.0 109.618 167.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -125.03 -52.7 1.65 Allowed 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.607 0.763 . . . . 0.0 109.38 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.09 148.29 25.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.987 0.915 . . . . 0.0 110.284 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.44 147.61 12.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.618 1.167 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -147.53 143.49 27.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.973 0.909 . . . . 0.0 109.263 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.46 28.2 17.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.507 1.523 . . . . 0.0 111.092 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -89.71 -61.55 1.67 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.034 2.134 . . . . 0.0 109.524 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -55.28 -36.87 66.59 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.196 0.999 . . . . 0.0 111.098 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.29 -39.8 71.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.162 0.985 . . . . 0.0 110.635 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.64 -52.89 63.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.459 171.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.89 -42.45 75.98 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 123.244 0.34 . . . . 0.0 110.548 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.78 -43.39 98.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.784 0.434 . . . . 0.0 111.108 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.29 -17.19 61.89 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.7 tp -69.57 -70.3 0.29 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.841 0.746 . . . . 0.0 112.311 -165.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.82 -58.0 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.381 1.072 . . . . 0.0 110.482 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.48 154.34 44.62 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.203 1.001 . . . . 0.0 111.84 -176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.94 165.25 28.71 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.502 2.135 . . . . 0.0 111.227 -172.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.16 -23.83 62.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.029 1.331 . . . . 0.0 112.17 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.04 -37.55 83.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.931 0.492 . . . . 0.0 111.355 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.41 -29.57 26.05 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.426 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -36.53 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.487 1.04 . . . . 0.0 110.217 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.39 -41.38 76.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.951 1.3 . . . . 0.0 110.246 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 ttt -68.64 -38.97 80.91 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.669 0.213 . . . . 0.0 111.252 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.49 -18.05 49.78 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.288 1.035 . . . . 0.0 113.189 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -38.69 -60.79 0.79 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.174 2.19 . . . . 0.0 114.427 -165.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.447 ' C ' HD12 ' A' ' 34' ' ' ILE . 37.5 m-20 -119.31 34.49 5.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.268 1.027 . . . . 0.0 109.505 -171.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.447 HD12 ' C ' ' A' ' 33' ' ' ASP . 1.8 mp -116.46 126.87 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -104.04 98.23 13.19 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 126.176 1.79 . . . . 0.0 108.396 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.29 124.31 10.33 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.065 2.51 . . . . 0.0 110.005 -172.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.37 141.63 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.89 144.93 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.078 1.351 . . . . 0.0 109.037 -169.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -135.8 132.47 36.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.325 1.05 . . . . 0.0 109.02 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mm -110.6 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.014 1.726 . . . . 0.0 106.911 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 -179.72 2.31 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.109 1.364 . . . . 0.0 110.856 168.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -152.67 39.8 0.56 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.615 0.766 . . . . 0.0 110.365 168.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.04 -133.8 3.53 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.67 -31.19 72.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.855 1.262 . . . . 0.0 112.731 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.16 156.98 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.188 0.595 . . . . 0.0 109.688 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -148.64 110.14 4.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.752 1.621 . . . . 0.0 107.101 173.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.38 141.47 24.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.35 133.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.553 1.141 . . . . 0.0 108.063 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -126.27 143.31 51.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.636 1.175 . . . . 0.0 108.435 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.8 p -124.81 141.74 51.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.571 1.148 . . . . 0.0 108.989 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -133.5 137.27 45.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.87 1.268 . . . . 0.0 108.519 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -153.12 148.41 20.08 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.22 32.51 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.64 2.226 . . . . 0.0 112.402 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -174.6 20.27 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.947 2.099 . . . . 0.0 111.403 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.97 147.08 0.44 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.517 1.127 . . . . 0.0 108.952 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.9 t -170.06 152.58 4.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.184 0.594 . . . . 0.0 109.639 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -162.44 164.34 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.517 1.127 . . . . 0.0 109.078 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 m -136.79 146.14 45.36 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.487 1.115 . . . . 0.0 108.52 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.64 155.94 45.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.083 1.353 . . . . 0.0 110.417 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.6 p -138.6 121.97 17.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.65 1.58 . . . . 0.0 109.009 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -144.51 175.11 10.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.639 0.775 . . . . 0.0 110.487 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -153.18 148.49 26.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.7 0.8 . . . . 0.0 110.24 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.65 123.52 21.1 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.857 0.863 . . . . 0.0 110.791 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.96 37.46 93.24 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.367 0.984 . . . . 0.0 111.885 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -160.3 175.3 13.01 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -50.73 140.09 15.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.741 1.216 . . . . 0.0 111.638 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.69 91.06 2.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 110.097 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.7 130.65 41.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 mt -129.84 140.94 47.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 123.342 0.657 . . . . 0.0 109.437 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.366 4.9 t . . . . . 0 CA--C 1.533 0.314 0 C-N-CA 128.119 2.567 . . . . 0.0 115.362 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.34 -179.89 4.1 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.418 1.487 . . . . 0.0 109.708 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -153.46 120.73 5.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.693 1.597 . . . . 0.0 107.541 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.3 m -136.08 -172.13 3.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.633 1.173 . . . . 0.0 109.241 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.0 m -135.68 85.37 2.16 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.92 132.14 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.689 0.796 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -144.44 151.93 39.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.192 1.397 . . . . 0.0 108.368 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tp -92.24 137.88 31.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.032 0.933 . . . . 0.0 108.703 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.7 72.06 1.46 Allowed 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.312 1.445 . . . . 0.0 108.911 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.6 t30 65.47 75.42 0.35 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.662 1.585 . . . . 0.0 111.286 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.38 32.68 84.99 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.961 0.791 . . . . 0.0 113.198 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -157.84 139.89 14.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.721 0.76 . . . . 0.0 110.828 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.1 mp -78.42 146.14 34.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.595 1.158 . . . . 0.0 108.651 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -143.29 138.51 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.242 1.017 . . . . 0.0 109.214 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.0 p -144.82 169.73 17.48 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.673 1.589 . . . . 0.0 109.863 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -144.58 141.86 29.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.515 1.126 . . . . 0.0 108.197 158.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -120.06 -159.05 0.77 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 107.999 164.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.32 -50.21 68.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.415 0.686 . . . . 0.0 111.158 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -127.58 -25.78 3.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.036 1.334 . . . . 0.0 111.581 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -91.08 144.05 26.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 109.321 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.7 m -149.29 125.36 10.68 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -109.0 112.08 24.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.857 1.663 . . . . 0.0 109.195 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -137.26 128.89 28.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.983 1.313 . . . . 0.0 108.542 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -162.15 149.35 13.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.82 157.44 46.78 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.744 1.218 . . . . 0.0 111.094 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.67 140.72 47.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.695 1.198 . . . . 0.0 109.488 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.87 162.26 30.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.013 1.725 . . . . 0.0 107.858 165.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -10.4 -79.87 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 128.368 2.89 . . . . 0.0 115.077 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -123.69 29.13 6.66 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.503 1.121 . . . . 0.0 111.184 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -152.01 115.76 4.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 ttt -101.92 141.41 34.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.959 1.304 . . . . 0.0 107.574 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.49 138.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.55 151.91 47.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.357 0.663 . . . . 0.0 110.739 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 152.45 51.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.085 0.954 . . . . 0.0 108.782 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.47 138.36 29.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.1 m -97.97 154.37 17.73 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.572 1.149 . . . . 0.0 109.143 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.28 67.27 1.08 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.577 1.551 . . . . 0.0 107.24 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.73 8.38 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.728 1.156 . . . . 0.0 110.937 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.05 15.36 27.79 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.296 -0.724 . . . . 0.0 113.046 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.6 154.1 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.28 1.432 . . . . 0.0 107.534 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -136.46 160.64 38.15 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.56 1.144 . . . . 0.0 108.75 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.55 143.52 50.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.478 1.511 . . . . 0.0 107.323 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.19 143.88 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 160.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -141.07 161.73 37.16 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.952 0.901 . . . . 0.0 109.476 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -141.81 138.45 32.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.924 0.89 . . . . 0.0 109.708 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.6 m -134.38 159.93 39.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.947 1.699 . . . . 0.0 110.712 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -122.71 148.99 44.66 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.269 1.428 . . . . 0.0 109.207 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -66.02 147.34 53.5 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.234 0.614 . . . . 0.0 110.171 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.8 1.64 . . . . 0.0 107.025 169.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.267 0.079 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.49 -6.64 6.96 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.802 0.841 . . . . 0.0 113.208 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -51.75 131.08 30.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.462 1.105 . . . . 0.0 111.506 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.58 -173.88 35.64 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.9 m -120.85 148.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -143.94 155.8 44.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.74 1.216 . . . . 0.0 109.05 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -138.96 130.45 27.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.378 1.071 . . . . 0.0 108.227 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.57 136.7 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.389 1.076 . . . . 0.0 110.132 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.26 -57.17 2.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.796 1.639 . . . . 0.0 109.922 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.31 172.28 16.13 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.702 0.801 . . . . 0.0 110.617 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.67 143.86 26.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.269 1.028 . . . . 0.0 110.651 -170.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -141.39 118.38 11.21 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.074 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 62.8 6.12 2.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.722 2.009 . . . . 0.0 113.342 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -62.87 -47.79 81.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.913 0.885 . . . . 0.0 110.093 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -33.46 76.09 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.074 0.55 . . . . 0.0 111.526 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -67.71 -43.13 80.77 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.333 0.653 . . . . 0.0 110.232 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.4 -53.25 60.3 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.731 0.812 . . . . 0.0 110.994 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.71 -39.78 85.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.768 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -75.35 -23.72 57.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.048 0.84 . . . . 0.0 112.567 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -34.26 74.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.279 0.49 . . . . 0.0 110.283 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.9 tp -73.37 162.01 29.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.677 1.191 . . . . 0.0 108.719 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.69 -34.49 26.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.481 1.113 . . . . 0.0 113.038 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -44.3 111.92 1.29 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.119 1.768 . . . . 0.0 110.637 174.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' HD23 ' A' ' 23' ' ' LEU . 71.4 Cg_endo -80.17 149.64 19.81 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.197 2.598 . . . . 0.0 110.192 -169.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -54.85 -32.3 60.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.22 -47.85 71.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.709 0.803 . . . . 0.0 111.889 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.7 mt -80.54 -31.52 36.99 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.589 -0.719 . . . . 0.0 111.984 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.15 -29.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.57 1.077 . . . . 0.0 111.246 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -53.43 -29.93 37.76 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 111.591 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 90.4 mtp -61.4 -66.93 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 171.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.88 -39.07 65.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.029 1.331 . . . . 0.0 112.769 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -43.34 -49.08 6.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.838 2.055 . . . . 0.0 112.25 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -123.8 40.74 3.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.905 0.882 . . . . 0.0 110.71 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.4 mt -130.99 136.93 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -112.79 97.72 42.36 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 107.906 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.13 159.42 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.334 2.69 . . . . 0.0 112.893 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.1 mm -75.29 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.138 0.975 . . . . 0.0 109.159 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.4 t -128.61 144.55 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 126.023 1.729 . . . . 0.0 107.19 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -156.04 143.28 19.17 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.343 0.657 . . . . 0.0 110.072 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.74 142.82 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.455 1.102 . . . . 0.0 110.383 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -118.81 107.23 13.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.45 1.9 . . . . 0.0 108.412 173.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -89.31 134.69 33.95 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.28 1.432 . . . . 0.0 108.061 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -151.33 59.54 0.9 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.1 81.55 0.24 Allowed Glycine 0 C--N 1.339 0.721 0 C-N-CA 124.076 0.846 . . . . 0.0 112.029 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 76.93 -43.96 0.45 Allowed 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.071 2.148 . . . . 0.0 112.657 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.6 146.03 25.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -160.64 163.06 32.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.799 0.439 . . . . 0.0 111.17 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.18 139.66 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.391 1.076 . . . . 0.0 108.714 -171.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.03 137.4 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 125.902 1.681 . . . . 0.0 106.812 174.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.1 m -131.08 135.53 47.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 t -129.04 144.79 51.31 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.288 1.035 . . . . 0.0 109.144 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -122.76 122.23 38.21 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 p -122.94 154.56 64.35 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.59 56.37 6.02 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.548 2.832 . . . . 0.0 110.732 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -162.35 -41.89 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.564 . . . . 0.0 110.173 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -161.96 157.38 23.64 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.31 1.044 . . . . 0.0 109.127 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.0 p -109.77 140.93 43.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.015 0.926 . . . . 0.0 109.049 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.2 t -136.2 149.13 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.328 1.051 . . . . 0.0 109.968 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 m -144.98 146.9 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.337 1.455 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.35 151.79 33.42 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 p -122.14 153.07 39.23 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.654 1.982 . . . . 0.0 110.947 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.29 169.22 10.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.073 0.949 . . . . 0.0 110.625 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.1 m -141.75 145.56 34.95 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.938 1.295 . . . . 0.0 109.091 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.19 136.5 53.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.338 0.655 . . . . 0.0 111.544 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.83 45.38 95.82 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.607 1.099 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -157.43 148.97 21.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.165 0.482 . . . . 0.0 110.168 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.07 124.28 23.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.641 1.176 . . . . 0.0 109.163 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.76 147.72 47.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.295 1.038 . . . . 0.0 110.477 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.1 132.66 36.42 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.687 1.195 . . . . 0.0 108.48 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.8 tt -133.59 153.77 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 124.976 1.31 . . . . 0.0 109.137 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.9 m -124.72 126.31 45.47 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 124.362 1.065 . . . . 0.0 109.559 -171.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -70.22 152.24 44.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.134 0.973 . . . . 0.0 109.706 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 48.3 ttm -51.47 -42.86 61.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.033 1.333 . . . . 0.0 113.101 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.43 -49.21 78.46 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.053 0.541 . . . . 0.0 110.986 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.98 66.88 0.1 OUTLIER Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -139.54 116.25 10.8 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.154 0.982 . . . . 0.0 108.396 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -74.75 149.19 39.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.851 0.358 . . . . 0.0 111.035 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.1 -175.32 5.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.72 1.608 . . . . 0.0 107.851 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 157.51 43.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.915 0.325 . . . . 0.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.5 p -159.79 160.94 34.47 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.499 1.119 . . . . 0.0 109.807 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -84.03 112.48 20.23 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.5 t -84.9 136.52 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -154.98 159.19 40.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.255 1.022 . . . . 0.0 110.266 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -124.86 128.66 49.02 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 126.861 2.064 . . . . 0.0 108.645 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.08 -134.02 0.34 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.232 1.413 . . . . 0.0 108.89 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.97 79.98 2.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.137 0.975 . . . . 0.0 110.641 -176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.51 40.27 77.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.292 0.949 . . . . 0.0 111.642 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.96 126.34 6.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.774 0.83 . . . . 0.0 109.892 -174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.0 mt -74.19 142.57 45.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.78 127.63 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.02 152.5 46.3 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.385 1.074 . . . . 0.0 109.242 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.21 140.25 41.59 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.495 1.118 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 t -125.27 -160.61 0.97 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.896 1.278 . . . . 0.0 108.642 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.35 -54.08 42.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.498 1.119 . . . . 0.0 110.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -133.99 -6.09 2.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.745 1.218 . . . . 0.0 112.764 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.69 153.03 19.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.713 0.805 . . . . 0.0 109.334 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 p -145.82 160.23 42.07 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -143.79 121.84 12.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -137.1 107.18 6.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.441 1.096 . . . . 0.0 108.837 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.04 145.38 40.96 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.533 1.133 . . . . 0.0 108.988 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.99 145.88 29.88 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.051 0.541 . . . . 0.0 110.422 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.97 134.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 C-N-CA 125.127 1.371 . . . . 0.0 108.951 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 133.76 19.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.125 1.37 . . . . 0.0 108.69 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.85 -112.03 4.04 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.084 0.85 . . . . 0.0 111.638 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.32 37.02 4.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.895 1.278 . . . . 0.0 109.146 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -142.9 145.46 33.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.289 1.036 . . . . 0.0 109.112 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 ttt -138.88 116.47 11.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.136 1.374 . . . . 0.0 108.335 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.5 t -99.95 137.12 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -128.7 93.02 3.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.868 1.267 . . . . 0.0 108.839 -169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.4 m -97.02 139.4 33.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.879 1.272 . . . . 0.0 109.604 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.5 mt -143.13 147.89 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.682 1.193 . . . . 0.0 107.945 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 165.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -131.5 84.07 2.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.381 1.872 . . . . 0.0 107.395 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.72 -117.34 9.88 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.32 11.39 58.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.481 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.2 t -128.19 138.23 55.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 118.649 1.225 . . . . 0.0 108.009 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.8 m -123.04 136.11 54.7 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.745 1.218 . . . . 0.0 107.764 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.2 163.33 32.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.03 0.532 . . . . 0.0 111.835 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.7 139.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -138.02 157.7 45.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.04 145.97 47.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.747 1.219 . . . . 0.0 109.376 -169.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.1 m -143.42 161.86 37.27 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.115 1.366 . . . . 0.0 109.798 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -131.7 145.79 51.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.61 1.564 . . . . 0.0 109.483 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -71.66 146.74 48.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.869 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 C--O 1.25 1.108 0 C-N-CA 126.085 1.754 . . . . 0.0 107.505 174.055 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -65.12 -50.29 66.62 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.495 0.718 . . . . 0.0 110.053 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t 50.77 75.63 0.18 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.566 1.547 . . . . 0.0 112.226 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.4 -167.22 37.09 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.6 m -117.69 147.64 42.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -142.42 138.65 31.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.517 1.127 . . . . 0.0 109.584 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -112.65 112.03 23.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.06 139.72 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -125.62 -34.65 2.63 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.456 0.702 . . . . 0.0 111.726 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.95 144.06 50.56 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.703 0.801 . . . . 0.0 110.43 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -144.83 121.28 11.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.551 1.541 . . . . 0.0 107.908 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -140.34 139.96 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.913 0.885 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.24 18.32 10.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.702 1.601 . . . . 0.0 111.758 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -84.46 -47.33 10.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.008 1.323 . . . . 0.0 109.721 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.75 -36.89 67.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.601 0.761 . . . . 0.0 111.79 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.7 -46.64 89.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.429 1.092 . . . . 0.0 110.47 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.46 ' CG ' HD11 ' A' ' 118' ' ' LEU . 65.5 t80 -63.41 -50.77 68.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.937 0.495 . . . . 0.0 111.072 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.7 mt -55.2 -40.92 71.32 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.903 0.319 . . . . 0.0 111.076 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.05 -37.5 85.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.248 0.619 . . . . 0.0 111.122 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.13 66.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.057 -0.497 . . . . 0.0 111.851 173.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -75.76 171.27 14.65 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 121.579 0.704 . . . . 0.0 110.752 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.56 76.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.147 1.379 . . . . 0.0 112.959 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.91 130.62 92.7 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 119.63 -0.224 . . . . 0.0 110.574 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.16 168.17 23.64 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.389 2.726 . . . . 0.0 110.897 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -48.24 -36.69 14.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.425 1.49 . . . . 0.0 113.487 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.72 -38.26 81.16 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.929 0.492 . . . . 0.0 111.596 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.87 -31.67 20.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.567 -0.73 . . . . 0.0 112.027 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.86 -36.94 77.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.597 1.09 . . . . 0.0 109.817 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -52.83 -38.09 60.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 111.559 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 66.8 mtt -72.35 -17.94 61.8 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.248 0.619 . . . . 0.0 112.43 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.86 26.52 4.3 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.525 1.13 . . . . 0.0 111.801 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -69.45 -70.69 0.26 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.427 0.691 . . . . 0.0 109.765 -174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -121.59 52.08 1.27 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.343 1.457 . . . . 0.0 107.111 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.16 124.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -107.7 93.68 10.78 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 125.883 1.673 . . . . 0.0 108.249 -165.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.32 172.28 16.25 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.119 2.546 . . . . 0.0 112.686 -164.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.61 135.43 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.8 t -124.69 143.15 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.928 1.291 . . . . 0.0 107.66 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -152.36 113.48 4.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -171.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mp -109.6 140.21 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -140.59 139.53 34.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -115.76 166.94 11.38 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.134 0.973 . . . . 0.0 111.089 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -147.7 56.25 1.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.87 -143.79 16.06 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.45 1.5 . . . . 0.0 109.799 -173.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.03 -35.98 78.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.567 1.147 . . . . 0.0 111.357 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.5 138.14 46.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.02 157.28 37.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.914 0.759 . . . . 0.0 112.561 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.47 138.71 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.395 -167.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -108.62 126.22 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.518 1.927 . . . . 0.0 106.553 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.3 m -123.65 138.22 54.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.607 1.163 . . . . 0.0 107.965 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.3 m -133.57 129.06 36.5 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.465 1.506 . . . . 0.0 108.703 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -123.9 121.46 35.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.66 1.184 . . . . 0.0 108.113 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -122.28 155.29 61.98 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.19 40.42 0.97 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.425 2.75 . . . . 0.0 111.292 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -142.94 -50.72 0.35 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.899 2.079 . . . . 0.0 108.088 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -159.17 159.8 34.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.298 1.439 . . . . 0.0 108.981 -175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -111.87 146.47 37.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.065 0.946 . . . . 0.0 109.721 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.3 t -141.25 146.55 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.125 1.37 . . . . 0.0 108.419 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -149.92 157.81 43.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.247 0.619 . . . . 0.0 110.098 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -153.13 150.42 29.07 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.186 0.994 . . . . 0.0 109.923 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -122.53 150.52 42.45 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.145 1.778 . . . . 0.0 110.603 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -164.67 -179.52 5.95 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.188 0.995 . . . . 0.0 110.205 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.6 m -136.3 134.66 38.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.516 1.126 . . . . 0.0 108.877 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.17 142.69 50.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.489 0.316 . . . . 0.0 110.551 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.23 -39.99 2.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.001 1.286 . . . . 0.0 112.207 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -124.39 177.85 5.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.598 1.159 . . . . 0.0 111.292 -170.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -73.76 155.75 38.56 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.713 0.805 . . . . 0.0 111.009 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.14 149.48 28.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.28 1.032 . . . . 0.0 109.176 171.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -85.11 138.3 32.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.484 0.713 . . . . 0.0 109.167 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -127.99 147.65 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.798 1.239 . . . . 0.0 107.843 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.1 m -116.23 134.65 54.68 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.706 1.202 . . . . 0.0 108.662 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -65.03 -80.64 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.602 0.761 . . . . 0.0 110.495 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 92.8 mtp -150.58 -66.4 0.2 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.487 1.115 . . . . 0.0 109.275 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -68.65 -71.64 0.21 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.747 1.219 . . . . 0.0 110.651 -173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.75 50.35 0.07 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -121.03 75.28 1.14 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -75.06 150.47 38.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.027 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.95 178.47 8.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.549 1.94 . . . . 0.0 108.462 -175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.34 158.16 35.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.302 0.641 . . . . 0.0 110.393 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.7 p -157.98 160.84 37.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.759 1.223 . . . . 0.0 109.155 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.6 m -74.62 100.17 3.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.5 t -74.38 97.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -133.89 153.5 51.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.724 0.81 . . . . 0.0 109.756 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -135.44 131.54 36.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.368 1.067 . . . . 0.0 109.269 -165.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.11 88.97 3.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.559 1.543 . . . . 0.0 109.606 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.95 67.06 0.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.901 1.28 . . . . 0.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.17 31.93 82.29 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.283 0.944 . . . . 0.0 113.077 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.01 112.13 5.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.083 0.953 . . . . 0.0 108.559 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -74.9 125.67 29.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.53 114.37 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.1 p -130.11 162.78 28.05 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.844 0.858 . . . . 0.0 109.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -156.1 142.94 18.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 168.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 t -137.67 168.56 19.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.026 1.73 . . . . 0.0 108.103 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -84.77 50.05 1.84 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.454 0.702 . . . . 0.0 110.695 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? 178.51 -23.0 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.948 2.099 . . . . 0.0 111.429 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -150.24 161.56 42.2 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.886 0.766 . . . . 0.0 111.049 -166.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.9 t -149.01 141.94 24.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.379 1.071 . . . . 0.0 108.842 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -122.9 102.46 8.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.453 1.901 . . . . 0.0 106.513 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -121.72 94.35 4.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.29 1.436 . . . . 0.0 109.51 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -121.71 112.33 18.27 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.67 147.83 45.37 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.51 0.724 . . . . 0.0 110.255 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.47 149.95 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.605 1.162 . . . . 0.0 109.915 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -125.12 -155.09 0.65 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.147 . . . . 0.0 108.287 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.48 -59.36 8.93 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.616 0.627 . . . . 0.0 111.884 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -136.22 22.3 3.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.378 1.071 . . . . 0.0 111.207 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -142.53 155.0 44.97 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.066 0.946 . . . . 0.0 108.976 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.7 ttt -146.03 133.78 21.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.667 1.187 . . . . 0.0 108.731 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.2 t -102.86 122.44 55.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.64 91.93 3.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.289 1.836 . . . . 0.0 108.441 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.8 m -103.46 133.75 47.99 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.818 0.847 . . . . 0.0 109.11 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 34.2 mm -125.63 153.29 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.0 m -133.08 143.59 49.43 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -129.61 92.47 3.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 106.337 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -9.13 83.81 0.0 OUTLIER Glycine 0 C--N 1.342 0.867 0 C-N-CA 129.296 3.331 . . . . 0.0 115.068 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.19 -46.24 1.02 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.232 0.92 . . . . 0.0 110.947 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.69 150.78 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 125.417 1.487 . . . . 0.0 108.767 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -122.39 155.96 34.98 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.313 1.445 . . . . 0.0 108.987 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 17' ' ' PHE . 2.0 mp -125.44 136.03 52.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.74 115.43 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 165.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -126.92 156.33 41.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.958 1.703 . . . . 0.0 106.637 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -141.62 147.0 36.9 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.771 0.429 . . . . 0.0 110.365 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -134.64 160.83 36.89 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.435 1.494 . . . . 0.0 110.83 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -121.96 144.95 48.57 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.26 1.424 . . . . 0.0 109.539 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -75.21 140.45 43.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.656 1.182 . . . . 0.0 110.862 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.432 1.493 . . . . 0.0 107.932 177.131 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.221 0.058 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -64.31 -34.0 77.13 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.262 0.625 . . . . 0.0 111.269 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.3 p -51.09 135.12 25.9 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.138 0.975 . . . . 0.0 111.127 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.06 -170.65 35.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 m -121.69 146.09 47.36 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.763 1.225 . . . . 0.0 108.704 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -145.0 161.9 38.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.95 1.3 . . . . 0.0 110.062 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.45 123.87 23.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.938 1.295 . . . . 0.0 107.781 172.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.71 137.63 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -122.63 -43.66 2.26 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.043 0.937 . . . . 0.0 110.707 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.01 146.91 46.19 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.631 0.772 . . . . 0.0 110.685 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.28 138.18 21.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.5 1.92 . . . . 0.0 107.808 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -151.41 139.6 20.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.508 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t30 64.64 28.13 13.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.586 2.354 . . . . 0.0 112.164 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -79.91 -50.54 10.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 109.977 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -53.99 -38.76 65.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 111.729 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -57.65 -52.57 64.88 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.095 0.958 . . . . 0.0 110.482 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.14 -46.77 89.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.039 0.536 . . . . 0.0 111.453 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.4 mt -55.69 -42.39 75.1 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.604 0.362 . . . . 0.0 111.406 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -65.89 -38.54 89.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.221 0.208 . . . . 0.0 110.669 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -23.17 65.75 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.86 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.78 -71.82 0.2 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.311 0.96 . . . . 0.0 109.596 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.47 -54.53 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.291 1.036 . . . . 0.0 110.527 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.9 134.93 47.66 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.238 1.015 . . . . 0.0 111.774 -170.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.06 168.05 23.98 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.491 2.794 . . . . 0.0 111.196 -171.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -50.43 -35.32 28.07 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 113.531 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.76 -36.94 82.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.486 0.714 . . . . 0.0 112.001 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.0 mt -86.84 -33.14 19.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.716 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -35.34 69.51 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 119.647 1.112 . . . . 0.0 110.434 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -46.98 -44.19 19.93 Favored 'General case' 0 C--N 1.345 0.403 0 C-N-CA 124.508 1.123 . . . . 0.0 111.192 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.6 ttt -71.21 -16.59 62.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.142 0.977 . . . . 0.0 112.008 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.71 -34.79 9.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.657 1.183 . . . . 0.0 111.12 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.75 -57.65 1.86 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 127.023 2.129 . . . . 0.0 111.821 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.421 ' C ' HD12 ' A' ' 34' ' ' ILE . 19.8 t70 -118.14 35.41 4.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.853 0.861 . . . . 0.0 109.981 -172.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 33' ' ' ASP . 1.9 mp -118.59 122.64 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -112.22 100.05 48.26 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.399 1.08 . . . . 0.0 109.255 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.72 166.65 23.41 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.281 -166.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mm -68.25 140.97 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.07 147.1 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -148.47 128.55 13.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.59 143.52 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.99 1.316 . . . . 0.0 107.931 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -141.61 77.06 1.57 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.549 1.14 . . . . 0.0 108.901 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -81.55 128.93 34.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.926 0.89 . . . . 0.0 108.906 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -125.99 79.68 1.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.03 -120.28 5.25 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.095 0.855 . . . . 0.0 111.497 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -68.95 -40.7 78.78 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.168 0.987 . . . . 0.0 111.69 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.76 138.07 39.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.058 0.543 . . . . 0.0 109.876 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -127.51 117.31 21.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.138 1.775 . . . . 0.0 107.572 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.1 t -110.04 126.21 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.27 141.6 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.173 1.389 . . . . 0.0 108.028 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.2 m -141.86 152.41 43.61 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 108.812 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.7 p -147.93 143.32 27.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.372 1.069 . . . . 0.0 109.093 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -125.8 136.93 53.68 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.28 1.032 . . . . 0.0 109.402 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.52 168.73 12.34 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.957 1.303 . . . . 0.0 108.175 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.07 -25.01 32.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.429 2.086 . . . . 0.0 113.0 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -138.17 33.59 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.504 0.722 . . . . 0.0 110.566 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.81 173.16 1.97 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.091 . . . . 0.0 109.588 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.6 t -170.63 151.47 3.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 108.295 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -144.58 148.42 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.088 1.355 . . . . 0.0 108.872 -173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 156.89 43.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.966 0.906 . . . . 0.0 110.381 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -150.67 143.93 24.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.253 1.421 . . . . 0.0 109.422 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m -130.86 130.33 43.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.847 1.259 . . . . 0.0 109.639 -172.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -158.19 173.64 16.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.974 0.91 . . . . 0.0 110.032 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 m -145.28 147.71 32.66 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.549 1.139 . . . . 0.0 108.463 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.91 168.87 19.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 111.644 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.87 -39.99 3.03 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.89 0.757 . . . . 0.0 113.207 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -120.28 -173.34 2.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.491 1.116 . . . . 0.0 109.887 -168.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -57.66 145.12 35.22 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.508 1.123 . . . . 0.0 109.997 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -146.86 105.16 3.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.444 0.698 . . . . 0.0 110.338 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.08 127.86 34.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 165.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.7 tt -144.73 144.59 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.874 0.47 . . . . 0.0 110.365 174.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 m -90.35 146.47 24.16 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.139 0.976 . . . . 0.0 109.502 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.5 p -64.77 -177.64 0.35 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.055 0.942 . . . . 0.0 110.443 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.91 78.65 1.64 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.3 t0 62.43 83.91 0.15 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.313 1.845 . . . . 0.0 110.642 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.52 -85.13 0.06 OUTLIER Glycine 0 C--N 1.339 0.724 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.871 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -149.13 158.87 44.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.973 0.909 . . . . 0.0 109.557 -165.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -91.76 149.86 21.39 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.323 0.649 . . . . 0.0 111.64 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.23 162.82 34.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.517 1.527 . . . . 0.0 109.304 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -103.92 140.67 37.37 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.353 1.061 . . . . 0.0 109.048 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.6 p -152.27 174.99 13.11 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.705 1.202 . . . . 0.0 108.812 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.9 m -110.12 97.62 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.71 137.58 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -151.54 157.22 41.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 109.628 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.86 123.05 49.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.18 -68.56 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.001 0.921 . . . . 0.0 110.434 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -156.96 78.1 0.9 Allowed 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.27 28.95 65.12 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.12 0.867 . . . . 0.0 112.089 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -152.27 140.75 20.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.111 2.164 . . . . 0.0 106.559 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.71 135.54 33.65 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.54 122.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 p -133.68 142.11 47.88 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -150.62 145.27 25.78 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.644 0.378 . . . . 0.0 110.874 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -126.16 -168.6 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.611 1.565 . . . . 0.0 108.542 166.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -36.41 68.4 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.166 0.986 . . . . 0.0 113.211 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -133.75 -37.12 0.93 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.548 1.139 . . . . 0.0 112.407 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.65 149.69 47.83 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.9 m -150.24 157.92 43.6 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.107 0.963 . . . . 0.0 108.951 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -166.69 149.37 6.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -154.98 123.59 6.07 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -118.2 141.47 48.47 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.793 0.837 . . . . 0.0 109.499 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -141.5 127.2 19.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.278 1.431 . . . . 0.0 107.759 -173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.08 133.84 64.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 124.531 1.133 . . . . 0.0 108.574 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.53 164.38 29.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.073 2.149 . . . . 0.0 107.838 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -5.98 -85.9 0.01 OUTLIER Glycine 0 C--N 1.344 0.987 0 C-N-CA 128.337 2.875 . . . . 0.0 115.119 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -125.59 40.59 3.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.271 1.028 . . . . 0.0 110.008 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -152.03 128.41 10.62 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 ttt -122.26 121.07 35.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.996 1.318 . . . . 0.0 108.591 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.77 135.04 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -130.85 89.29 2.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.923 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.9 m -95.44 133.87 38.92 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.419 0.687 . . . . 0.0 109.441 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.63 143.68 38.08 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.9 m -136.13 133.87 37.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.61 1.164 . . . . 0.0 108.669 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -123.78 72.02 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.509 1.923 . . . . 0.0 107.207 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 14.43 67.93 0.01 OUTLIER Glycine 0 C--N 1.344 1.014 0 C-N-CA 129.063 3.22 . . . . 0.0 115.407 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.4 -43.34 1.1 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.38 148.53 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.4 t -121.19 164.67 16.56 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 124.32 1.048 . . . . 0.0 110.323 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -145.44 140.97 27.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.002 1.321 . . . . 0.0 108.183 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -124.77 129.32 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -111.68 146.49 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 165.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -135.56 128.89 32.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.4 m -121.58 156.07 33.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.994 1.318 . . . . 0.0 110.788 -174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -121.37 137.95 54.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.111 1.764 . . . . 0.0 107.809 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -70.46 145.31 51.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.553 0.216 . . . . 0.0 111.098 -170.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.545 1.538 . . . . 0.0 107.754 179.397 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 120.009 -0.043 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -131.2 0.53 4.15 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.095 0.958 . . . . 0.0 113.054 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 t -53.44 114.03 1.37 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.504 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 -177.55 43.43 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.0 m -120.5 156.07 32.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.882 1.273 . . . . 0.0 108.923 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -149.59 152.94 36.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.224 1.41 . . . . 0.0 109.893 -169.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -129.59 120.13 24.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.321 1.448 . . . . 0.0 107.311 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.15 121.14 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.333 0.653 . . . . 0.0 109.545 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -89.58 -51.34 5.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.815 1.646 . . . . 0.0 109.735 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.06 161.99 37.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.135 0.574 . . . . 0.0 110.581 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -156.23 137.55 13.87 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.009 1.324 . . . . 0.0 109.422 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -151.77 142.01 22.35 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.965 0.906 . . . . 0.0 110.54 -171.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 53.46 31.46 12.25 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.944 1.698 . . . . 0.0 111.415 -167.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -94.78 -49.65 5.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.609 1.963 . . . . 0.0 108.627 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -53.55 -34.48 58.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.716 1.207 . . . . 0.0 111.677 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -57.49 -49.86 74.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.608 0.763 . . . . 0.0 111.089 171.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -68.34 -42.84 78.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.915 0.325 . . . . 0.0 111.428 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.01 -42.4 85.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.53 0.332 . . . . 0.0 110.853 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.08 -41.28 99.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 110.754 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.61 -25.85 66.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.151 0.58 . . . . 0.0 112.157 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -78.82 172.3 13.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.477 0.581 . . . . 0.0 110.709 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.93 76.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.267 1.427 . . . . 0.0 113.283 -175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.12 132.97 90.12 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.913 -175.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.45 164.39 34.06 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.195 2.597 . . . . 0.0 110.578 -174.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -54.16 -31.28 52.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.713 1.205 . . . . 0.0 112.216 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -56.71 -44.11 81.25 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.056 0.942 . . . . 0.0 111.39 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 mt -83.92 -29.7 26.92 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.18 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.74 -34.11 60.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 119.501 1.046 . . . . 0.0 109.716 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -52.66 -37.07 58.06 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.037 0.935 . . . . 0.0 111.618 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.73 -58.4 3.51 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.33 61.55 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.546 1.138 . . . . 0.0 112.595 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -53.26 -34.48 57.38 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.119 1.367 . . . . 0.0 112.008 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -121.04 40.23 3.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.28 1.032 . . . . 0.0 110.547 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.0 mt -125.68 134.96 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 166.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -102.87 102.28 26.27 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.451 1.1 . . . . 0.0 108.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 138.3 20.85 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.062 1.841 . . . . 0.0 109.996 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.43 141.46 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 166.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.8 t -123.88 147.17 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.34 144.11 25.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.76 144.64 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -141.9 143.75 33.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 170.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.83 152.08 27.95 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.092 0.557 . . . . 0.0 109.977 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -147.05 58.04 1.16 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.734 0.814 . . . . 0.0 109.072 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.74 -135.72 12.9 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.84 -27.9 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.251 1.02 . . . . 0.0 112.001 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.11 140.07 43.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.222 1.409 . . . . 0.0 110.856 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -141.49 127.37 19.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.824 1.249 . . . . 0.0 108.234 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.73 138.04 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.56 128.9 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.1 m -124.56 151.95 44.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.384 1.474 . . . . 0.0 109.274 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 p -125.29 151.42 46.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.788 1.635 . . . . 0.0 108.415 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -136.65 107.36 6.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.35 140.39 14.81 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.11 -9.65 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.959 2.439 . . . . 0.0 113.637 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -128.77 10.7 6.06 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.106 0.962 . . . . 0.0 111.917 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -166.21 79.82 0.26 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.022 0.828 . . . . 0.0 110.426 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.9 m -110.81 101.52 10.12 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -136.78 152.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.913 1.285 . . . . 0.0 110.126 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.7 m -124.74 147.65 48.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.507 1.523 . . . . 0.0 109.981 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.19 131.6 38.78 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 126.726 2.01 . . . . 0.0 107.018 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 p -122.41 132.03 54.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.241 1.016 . . . . 0.0 109.761 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -160.75 176.35 11.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 111.609 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -145.43 145.03 30.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.8 1.64 . . . . 0.0 107.936 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.84 137.41 55.29 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.986 0.514 . . . . 0.0 110.842 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.82 48.14 84.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -157.74 166.38 32.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.631 0.772 . . . . 0.0 109.123 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -60.19 116.78 4.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.58 101.58 7.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.159 0.984 . . . . 0.0 109.225 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -79.72 112.73 17.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.336 1.054 . . . . 0.0 109.583 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -127.35 140.53 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.228 1.011 . . . . 0.0 108.415 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 m -77.52 136.31 38.3 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.901 0.881 . . . . 0.0 109.872 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 t -61.88 -49.67 75.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.606 0.362 . . . . 0.0 111.094 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.16 -69.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.702 1.201 . . . . 0.0 108.929 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -65.14 -55.87 16.21 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.867 1.267 . . . . 0.0 111.888 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.84 54.93 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -147.43 115.1 6.39 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 152.86 23.67 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -169.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 153.66 51.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.379 1.472 . . . . 0.0 109.107 170.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -89.43 142.6 27.52 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.985 0.914 . . . . 0.0 109.99 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.6 m -142.79 175.17 10.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 109.589 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 m -132.18 84.91 2.19 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.7 1.2 . . . . 0.0 107.845 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.63 149.89 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.922 0.889 . . . . 0.0 110.602 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -134.62 157.72 45.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.458 1.503 . . . . 0.0 108.513 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.35 112.29 24.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.42 -66.26 0.93 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.885 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.66 83.82 0.61 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.2 35.03 82.63 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.558 0.599 . . . . 0.0 111.709 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -161.52 141.38 10.43 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.75 0.82 . . . . 0.0 110.004 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.42 133.89 34.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.05 136.64 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 108.065 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 m -148.27 148.63 30.67 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.6 1.16 . . . . 0.0 108.353 -172.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -144.89 154.52 42.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.948 1.299 . . . . 0.0 109.634 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 -172.48 3.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.721 1.608 . . . . 0.0 107.328 167.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -63.03 -56.49 16.5 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.561 0.744 . . . . 0.0 110.141 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -96.76 -36.89 10.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.562 1.145 . . . . 0.0 111.268 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -99.75 156.7 16.96 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.234 1.014 . . . . 0.0 110.823 -170.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.7 t -147.36 156.2 42.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.052 0.941 . . . . 0.0 108.54 165.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.17 127.99 8.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -172.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -147.19 120.86 9.18 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.15 131.08 54.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.314 1.046 . . . . 0.0 108.865 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.41 129.99 54.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.48 2.312 . . . . 0.0 107.447 -175.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.5 t -120.51 144.79 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.955 0.902 . . . . 0.0 109.42 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -137.09 -176.06 4.25 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.186 1.795 . . . . 0.0 108.582 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.29 -61.32 6.74 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.623 1.106 . . . . 0.0 113.403 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -129.55 31.92 4.71 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.772 1.229 . . . . 0.0 110.905 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -159.49 150.11 19.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 16.0 ttt -144.93 134.61 23.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.786 1.234 . . . . 0.0 107.903 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.22 139.22 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -134.63 137.08 43.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.191 0.996 . . . . 0.0 108.94 -170.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -143.32 133.31 24.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.789 0.836 . . . . 0.0 109.239 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.47 152.66 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.2 m -136.47 137.33 40.28 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -133.09 95.04 3.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.81 1.644 . . . . 0.0 106.566 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.66 -125.29 39.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.14 24.84 23.06 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.078 -0.845 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.6 136.71 58.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.9 m -121.53 145.27 48.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.158 1.383 . . . . 0.0 107.98 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.93 131.59 54.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -125.56 136.03 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -157.07 174.89 14.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -157.69 150.81 23.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m -130.83 162.34 29.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.93 1.292 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -122.65 139.6 53.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.463 1.505 . . . . 0.0 108.415 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -70.88 148.62 47.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.678 0.791 . . . . 0.0 111.072 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 C--O 1.252 1.235 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.474 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 119.662 -0.209 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -152.26 -55.18 0.13 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.296 1.039 . . . . 0.0 108.934 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.7 p -52.92 100.29 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.11 1.364 . . . . 0.0 110.669 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.32 -168.48 36.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.5 m -119.51 151.73 38.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.187 1.395 . . . . 0.0 108.69 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -148.85 129.41 13.99 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 110.208 -162.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -113.07 106.8 15.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.567 1.547 . . . . 0.0 109.17 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.52 117.96 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.121 0.968 . . . . 0.0 109.551 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -99.51 -40.67 7.72 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.811 0.844 . . . . 0.0 111.09 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.41 148.2 43.5 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.927 0.891 . . . . 0.0 110.625 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.49 134.97 14.29 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.544 1.538 . . . . 0.0 108.346 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -156.14 137.87 14.26 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.099 0.959 . . . . 0.0 109.483 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.31 -35.66 0.33 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.459 1.904 . . . . 0.0 111.352 -172.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -32.23 -49.69 0.2 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.428 2.691 . . . . 0.0 112.115 156.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -57.79 -52.03 67.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.835 0.854 . . . . 0.0 111.016 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.94 -41.5 91.95 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.161 . . . . 0.0 110.664 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.28 -50.37 74.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.329 0.652 . . . . 0.0 111.584 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.94 -42.78 85.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.094 0.406 . . . . 0.0 111.123 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -38.44 80.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -27.25 67.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.957 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.01 -65.17 0.73 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.445 0.566 . . . . 0.0 111.348 -167.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.99 -58.31 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.427 1.091 . . . . 0.0 109.466 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -55.9 130.53 72.9 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.189 0.596 . . . . 0.0 110.508 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.75 170.12 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.299 2.666 . . . . 0.0 111.332 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.57 -28.57 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.876 1.67 . . . . 0.0 113.282 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.14 -42.51 96.77 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.433 0.693 . . . . 0.0 111.868 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.5 mt -83.98 -34.1 24.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.771 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.46 -26.71 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.276 0.944 . . . . 0.0 111.047 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -49.11 -35.88 17.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 111.629 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.5 mtt -71.24 -60.23 2.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.23 -41.76 69.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.525 1.13 . . . . 0.0 112.168 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -51.36 -37.26 47.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.465 1.506 . . . . 0.0 111.521 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.28 37.58 4.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.032 0.933 . . . . 0.0 110.934 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.5 mt -133.15 136.92 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 168.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -103.1 89.57 2.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.615 1.166 . . . . 0.0 108.293 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.33 148.23 88.2 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.052 1.835 . . . . 0.0 110.923 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 tp -96.26 124.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 t -123.76 136.89 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -168.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -126.97 121.02 30.52 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.795 1.238 . . . . 0.0 108.46 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 98.4 mt -110.62 135.13 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -124.12 88.7 2.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.655 1.582 . . . . 0.0 108.627 -171.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -85.18 128.78 34.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 166.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -132.2 77.72 1.77 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 163.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.82 -128.33 8.44 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.846 1.212 . . . . 0.0 111.174 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.1 -33.05 74.63 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.544 1.138 . . . . 0.0 112.06 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.38 142.46 28.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.185 0.994 . . . . 0.0 110.85 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -133.65 137.01 45.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.458 1.903 . . . . 0.0 108.264 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -131.35 124.4 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.26 125.79 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -122.64 135.78 54.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.771 1.228 . . . . 0.0 108.239 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -125.77 128.87 48.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -124.88 114.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 165.79 31.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.78 -3.54 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.277 1.985 . . . . 0.0 113.223 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -139.77 -17.93 0.96 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -130.17 98.6 4.78 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.592 1.157 . . . . 0.0 109.151 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -110.91 113.4 25.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 172.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.16 150.25 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.229 . . . . 0.0 109.394 -173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -135.93 147.06 47.95 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.833 1.253 . . . . 0.0 109.615 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -132.76 149.25 52.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.668 1.187 . . . . 0.0 109.875 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -128.07 138.79 52.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.371 1.868 . . . . 0.0 109.738 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.42 176.33 11.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.082 0.953 . . . . 0.0 110.132 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.2 m -138.39 146.27 42.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.052 1.341 . . . . 0.0 108.196 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 pp -66.8 148.78 51.48 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.967 0.167 . . . . 0.0 111.269 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.43 43.23 44.15 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.855 1.217 . . . . 0.0 112.877 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -156.37 140.15 16.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.11 116.79 7.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.481 0.712 . . . . 0.0 110.566 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.31 160.22 25.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.133 1.373 . . . . 0.0 109.327 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.11 139.74 38.23 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 tt -137.25 168.21 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.523 1.529 . . . . 0.0 108.17 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.6 m -137.05 144.56 43.24 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.36 0.664 . . . . 0.0 109.849 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -67.22 -177.35 0.66 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.946 1.298 . . . . 0.0 110.771 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -70.72 85.1 0.65 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.311 0.644 . . . . 0.0 109.402 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 52.9 63.41 2.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.442 1.897 . . . . 0.0 110.671 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.14 -104.27 0.46 Allowed Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.481 -0.647 . . . . 0.0 111.481 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -128.06 155.87 43.67 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.626 1.171 . . . . 0.0 110.308 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.95 160.06 18.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.471 1.109 . . . . 0.0 111.605 -177.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -156.75 161.27 39.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.87 1.268 . . . . 0.0 109.136 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -89.07 154.3 20.3 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.336 0.654 . . . . 0.0 109.797 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p -155.05 165.66 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.397 1.079 . . . . 0.0 109.939 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.1 m -135.32 76.73 1.63 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.75 137.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -150.95 153.23 34.83 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.947 0.899 . . . . 0.0 109.44 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.49 162.0 19.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.178 0.991 . . . . 0.0 110.274 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.63 49.3 0.87 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.585 1.154 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.9 t30 68.09 95.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.578 1.951 . . . . 0.0 111.979 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.79 24.54 75.53 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.105 0.86 . . . . 0.0 112.854 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -163.06 147.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.203 . . . . 0.0 108.694 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -103.68 151.25 23.2 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.035 1.334 . . . . 0.0 108.205 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.3 t -121.63 95.08 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -71.25 144.81 49.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.736 0.814 . . . . 0.0 109.526 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -164.86 128.2 2.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.933 0.493 . . . . 0.0 111.928 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m -141.71 -149.03 0.26 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.269 2.228 . . . . 0.0 106.115 166.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.64 -73.92 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -78.76 -37.7 40.5 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 111.723 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -95.71 81.76 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.579 0.752 . . . . 0.0 111.054 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.6 p -140.91 144.17 35.05 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.212 1.005 . . . . 0.0 110.904 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 180.0 -145.74 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.17 1.788 . . . . 0.0 110.124 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.78 170.41 15.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.439 1.496 . . . . 0.0 110.378 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -160.0 127.51 4.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 109.615 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -122.27 149.73 43.3 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.801 1.64 . . . . 0.0 109.86 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.02 146.39 33.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.026 0.931 . . . . 0.0 110.422 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -136.55 171.7 14.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.516 1.926 . . . . 0.0 108.474 168.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -3.22 -76.0 0.01 OUTLIER Glycine 0 C--N 1.343 0.929 0 C-N-CA 128.906 3.146 . . . . 0.0 116.264 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.58 35.43 2.93 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.47 1.108 . . . . 0.0 110.269 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.21 147.29 31.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.201 0.6 . . . . 0.0 110.884 -172.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.14 130.24 38.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.593 1.557 . . . . 0.0 108.63 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.71 116.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -129.8 136.8 50.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 109.794 -169.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 t -142.3 157.73 44.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.201 0.524 . . . . 0.0 110.645 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.4 128.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.78 171.55 9.88 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -150.81 80.68 1.33 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.51 -113.19 5.58 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -175.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.95 68.64 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.37 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.98 160.41 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.745 1.218 . . . . 0.0 107.871 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.2 m -134.39 155.46 50.24 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.274 1.03 . . . . 0.0 110.311 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 mp -127.1 129.04 47.19 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 158.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.94 142.57 39.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 164.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -158.18 147.93 19.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -128.26 136.08 50.54 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 t -125.04 162.93 23.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.525 1.13 . . . . 0.0 110.583 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.71 133.96 50.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.52 1.528 . . . . 0.0 107.499 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 ttp85 -68.82 150.92 47.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.054 0.541 . . . . 0.0 109.918 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--O 1.249 1.038 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 172.654 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.62 -52.99 4.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.277 1.031 . . . . 0.0 112.151 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.3 p -168.7 155.01 6.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.58 1.152 . . . . 0.0 110.026 -173.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.34 -169.76 16.74 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.161 0.886 . . . . 0.0 112.449 165.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 m -121.95 134.13 54.84 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.939 1.295 . . . . 0.0 108.849 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -144.02 165.0 29.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.167 0.987 . . . . 0.0 111.281 -166.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -148.15 122.64 9.75 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.762 1.225 . . . . 0.0 108.943 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.01 139.63 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.67 1.188 . . . . 0.0 109.783 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -124.06 -37.67 2.55 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.331 0.652 . . . . 0.0 112.187 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.51 149.4 51.71 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 110.161 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -161.38 148.46 14.77 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.7 0.8 . . . . 0.0 111.536 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -151.08 140.54 21.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.334 1.454 . . . . 0.0 108.184 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 59.24 89.96 0.06 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.381 1.472 . . . . 0.0 109.268 -171.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -148.64 -51.41 0.17 Allowed 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -47.65 -50.73 23.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.049 1.34 . . . . 0.0 111.375 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -57.84 -47.49 82.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.819 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -61.66 -53.36 57.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.948 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -62.99 -35.37 79.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.948 0.34 . . . . 0.0 111.51 -174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -75.81 -36.3 59.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.291 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.84 65.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.314 0.506 . . . . 0.0 111.147 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -74.11 -64.52 1.0 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.424 1.089 . . . . 0.0 109.543 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.11 -65.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.353 0.661 . . . . 0.0 111.135 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -56.33 136.77 75.66 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.7 0.8 . . . . 0.0 112.684 -165.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.48 171.47 16.77 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.572 2.848 . . . . 0.0 111.889 -171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.22 -34.63 4.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.842 2.057 . . . . 0.0 113.532 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.43 -31.85 71.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.949 0.9 . . . . 0.0 112.104 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -93.78 -32.17 14.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.8 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pp -66.89 -20.7 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 119.078 0.854 . . . . 0.0 111.296 173.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -49.87 -38.31 34.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.61 0.641 . . . . 0.0 110.582 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -96.2 46.75 1.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.362 1.065 . . . . 0.0 109.683 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -156.9 -52.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.321 1.048 . . . . 0.0 110.634 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -52.46 -46.38 66.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.62 1.968 . . . . 0.0 112.341 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -120.51 35.21 4.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 109.328 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.82 144.73 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -111.88 90.32 12.98 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.64 137.29 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.184 1.923 . . . . 0.0 109.426 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.55 137.52 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.36 142.02 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.38 129.75 22.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.171 1.388 . . . . 0.0 108.11 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.14 138.43 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.289 1.436 . . . . 0.0 108.505 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -126.15 125.49 42.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.32 1.048 . . . . 0.0 108.648 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.95 142.99 29.0 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.62 1.568 . . . . 0.0 111.559 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -140.85 42.09 1.83 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.858 1.663 . . . . 0.0 110.829 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 96.71 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.16 0.886 . . . . 0.0 112.771 170.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 57.29 18.52 4.35 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.352 1.461 . . . . 0.0 112.56 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -150.8 143.5 24.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.75 2.02 . . . . 0.0 105.783 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.81 150.89 30.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.819 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.0 131.64 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.437 1.095 . . . . 0.0 108.441 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.95 134.04 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.955 1.702 . . . . 0.0 107.337 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.1 m -132.72 137.42 46.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.704 1.202 . . . . 0.0 107.986 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 t -127.09 140.12 52.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.975 1.71 . . . . 0.0 107.737 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -123.35 116.7 23.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.05 159.97 56.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.27 -4.39 14.27 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.008 1.805 . . . . 0.0 112.445 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -119.42 29.11 7.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.233 1.413 . . . . 0.0 110.932 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 127.83 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 130.303 3.441 . . . . 0.0 110.389 168.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 p -108.79 138.08 45.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.2 135.71 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.336 1.454 . . . . 0.0 108.099 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -144.43 151.4 39.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 111.524 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.17 140.98 9.26 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.557 1.543 . . . . 0.0 109.751 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -124.91 151.64 45.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.868 1.267 . . . . 0.0 109.828 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -166.2 152.99 9.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.24 0.543 . . . . 0.0 110.984 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -122.42 144.52 48.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.434 1.894 . . . . 0.0 108.016 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.34 131.73 46.76 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.343 0.257 . . . . 0.0 111.476 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.26 50.34 51.45 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -160.46 139.27 10.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.47 142.28 49.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.97 150.67 27.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.649 0.779 . . . . 0.0 109.892 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -89.43 132.38 35.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.303 1.041 . . . . 0.0 109.219 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.74 147.14 25.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.319 1.048 . . . . 0.0 108.273 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 m -113.03 95.95 5.68 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.945 1.298 . . . . 0.0 107.975 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 m -149.09 47.44 0.99 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.191 0.451 . . . . 0.0 110.579 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 54.3 mtm -148.05 56.57 1.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.639 0.776 . . . . 0.0 109.599 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 56.37 67.69 0.96 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.445 0.698 . . . . 0.0 109.485 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.76 39.99 78.59 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.145 1.355 . . . . 0.0 113.164 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -139.28 143.33 37.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.4 143.31 27.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.285 -161.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.7 -173.8 2.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.536 2.334 . . . . 0.0 107.633 166.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.81 146.33 37.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.79 0.836 . . . . 0.0 110.68 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.9 p -166.23 162.6 17.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.777 1.231 . . . . 0.0 109.094 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -116.26 61.31 0.72 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.872 0.844 . . . . 0.0 111.894 -173.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.63 138.06 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.381 1.073 . . . . 0.0 112.396 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -151.22 153.96 35.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.291 1.037 . . . . 0.0 110.303 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.6 tp -85.15 125.49 32.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.059 1.344 . . . . 0.0 108.906 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.28 -68.38 0.8 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.212 1.005 . . . . 0.0 109.387 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -164.51 88.52 0.5 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.93 24.23 64.52 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.198 0.904 . . . . 0.0 112.797 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -157.43 138.8 13.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 109.337 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.37 139.79 36.37 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.2 t -133.45 139.58 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.228 1.411 . . . . 0.0 107.376 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.82 156.11 37.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -143.56 141.49 30.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.309 1.044 . . . . 0.0 109.049 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 t -151.55 166.94 29.62 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.868 1.267 . . . . 0.0 107.883 163.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -85.72 12.32 9.17 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.157 0.983 . . . . 0.0 111.857 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -126.97 -30.33 2.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.21 1.804 . . . . 0.0 109.854 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -157.12 157.24 34.13 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.913 0.885 . . . . 0.0 109.682 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -136.15 150.91 49.26 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -143.95 92.67 2.36 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.369 1.468 . . . . 0.0 108.07 -169.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -130.3 124.16 31.7 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.68 139.8 11.8 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -121.07 136.02 55.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.944 2.098 . . . . 0.0 107.948 -172.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.0 133.72 56.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -160.84 127.7 4.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.628 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.34 -96.34 0.48 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.138 0.875 . . . . 0.0 110.949 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -138.8 18.46 2.67 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.251 1.02 . . . . 0.0 110.757 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -148.65 130.92 15.55 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.4 ptp -123.97 155.56 37.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.428 1.091 . . . . 0.0 111.488 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.55 131.7 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -131.61 140.54 49.43 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.29 0.636 . . . . 0.0 110.898 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -131.17 129.34 41.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.982 1.713 . . . . 0.0 108.181 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 48.0 mm -123.48 152.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 53.2 m -134.99 145.84 48.49 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 163.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -130.5 105.44 7.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 170.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -15.69 89.05 0.01 OUTLIER Glycine 0 C--N 1.342 0.864 0 C-N-CA 128.562 2.982 . . . . 0.0 115.016 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.8 -47.88 0.95 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.93 137.35 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 109.183 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 36.6 m -120.19 133.51 55.48 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.172 1.389 . . . . 0.0 109.179 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 118' ' ' LEU . 2.5 mp -119.92 140.12 51.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.951 2.101 . . . . 0.0 108.73 -170.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.19 141.73 40.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm85 -162.77 160.72 25.67 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 109.761 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -135.64 143.91 45.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.457 1.103 . . . . 0.0 109.344 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 m -133.21 155.73 48.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.427 1.091 . . . . 0.0 109.417 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -124.71 142.11 51.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.074 1.35 . . . . 0.0 108.158 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -65.95 141.75 58.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.554 0.741 . . . . 0.0 109.859 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 C--O 1.251 1.18 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 120.221 0.058 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.62 -50.37 0.72 Allowed 'General case' 0 C--N 1.339 0.11 0 C-N-CA 124.498 1.119 . . . . 0.0 109.72 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 p -48.34 112.06 0.54 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.281 1.433 . . . . 0.0 110.793 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.58 -177.31 41.48 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -119.28 140.62 49.98 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.842 1.257 . . . . 0.0 107.922 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -142.29 150.26 40.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.007 0.923 . . . . 0.0 109.759 -163.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -137.33 121.63 18.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -53.25 117.31 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.214 1.006 . . . . 0.0 108.613 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.11 -35.06 9.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.525 0.73 . . . . 0.0 110.209 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 147.08 39.68 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.507 1.123 . . . . 0.0 108.652 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.8 147.08 22.59 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.005 0.922 . . . . 0.0 109.99 -175.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.74 155.73 36.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.296 0.57 . . . . 0.0 111.532 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.22 35.11 25.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.237 1.815 . . . . 0.0 110.494 -169.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -99.88 -45.41 5.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.866 1.666 . . . . 0.0 110.139 -167.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.25 -40.03 46.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.008 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.29 -48.31 82.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.493 1.117 . . . . 0.0 110.772 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.47 -46.5 89.86 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 122.889 0.476 . . . . 0.0 110.828 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.56 -45.37 85.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.662 0.21 . . . . 0.0 111.136 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -65.51 -34.48 78.36 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.984 0.514 . . . . 0.0 111.74 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.73 -25.35 67.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.79 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.4 mt -76.46 170.49 16.29 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.088 0.858 . . . . 0.0 110.64 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.54 94.27 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.74 1.216 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 139.85 97.03 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.078 0.551 . . . . 0.0 111.516 -173.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.47 169.01 17.58 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.914 3.076 . . . . 0.0 111.191 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -48.92 -41.0 32.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.275 1.43 . . . . 0.0 112.631 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -53.85 -38.52 64.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.881 0.473 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.62 -24.12 19.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.607 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -32.56 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.832 1.196 . . . . 0.0 109.62 170.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -50.94 -43.27 60.17 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.336 1.054 . . . . 0.0 110.551 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 56.7 mtt -69.65 -52.18 28.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.244 0.618 . . . . 0.0 110.046 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.46 -35.7 70.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.768 0.827 . . . . 0.0 112.832 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -32.05 67.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.885 0.874 . . . . 0.0 111.186 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -119.39 49.03 1.4 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.175 0.99 . . . . 0.0 109.353 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.39 146.59 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 126.042 1.737 . . . . 0.0 106.472 165.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 106.5 40.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.334 1.054 . . . . 0.0 109.547 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.05 113.49 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.378 2.052 . . . . 0.0 109.392 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.31 139.29 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.06 148.36 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.598 1.559 . . . . 0.0 108.306 -171.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.87 130.11 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.1 mm -109.1 129.14 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -119.14 101.4 7.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -126.12 141.76 51.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.639 1.176 . . . . 0.0 109.351 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -145.96 73.12 1.32 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.929 0.892 . . . . 0.0 108.953 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.89 -115.09 3.95 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -66.19 -42.67 88.53 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.53 0.732 . . . . 0.0 111.208 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -76.68 131.83 39.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.449 0.7 . . . . 0.0 110.432 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -129.84 120.85 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.058 1.743 . . . . 0.0 108.16 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -109.53 131.96 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.05 135.23 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -134.48 142.15 46.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.8 t -144.45 137.19 26.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.958 0.503 . . . . 0.0 109.804 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -124.1 153.84 40.86 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.736 1.214 . . . . 0.0 109.514 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.08 159.21 29.23 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.72 39.93 0.92 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.407 2.738 . . . . 0.0 111.577 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -144.55 -41.6 0.25 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.49 1.516 . . . . 0.0 110.129 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.0 169.82 23.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.206 1.802 . . . . 0.0 109.217 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.4 m -150.41 143.33 24.74 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.987 1.315 . . . . 0.0 107.681 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.16 146.56 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.59 1.156 . . . . 0.0 109.711 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.5 m -134.21 145.65 49.39 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.121 1.768 . . . . 0.0 107.529 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.85 130.52 24.17 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.556 1.542 . . . . 0.0 106.847 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 p -125.01 127.29 46.77 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.475 1.11 . . . . 0.0 109.249 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -164.39 -176.46 4.4 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.458 0.703 . . . . 0.0 110.613 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.5 m -140.25 148.22 41.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.131 1.372 . . . . 0.0 107.847 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 165.54 25.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.109 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.24 -29.05 5.35 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.055 0.836 . . . . 0.0 112.84 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -121.81 -177.03 3.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.144 1.378 . . . . 0.0 109.345 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.71 142.57 57.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.453 0.701 . . . . 0.0 109.791 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.4 125.64 16.47 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.367 1.067 . . . . 0.0 108.871 -175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.33 139.16 32.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.599 0.76 . . . . 0.0 109.27 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.2 mt -135.39 142.07 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.6 m -102.83 120.59 40.88 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.779 1.632 . . . . 0.0 108.771 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 m -73.48 152.22 40.79 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -79.79 55.74 2.12 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.135 0.974 . . . . 0.0 110.826 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -159.03 23.78 0.21 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.996 1.718 . . . . 0.0 109.715 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.27 53.83 42.56 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.115 0.864 . . . . 0.0 112.171 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -145.52 118.45 8.76 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.66 0.784 . . . . 0.0 108.95 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -91.12 162.95 14.46 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.817 0.447 . . . . 0.0 111.798 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.15 168.08 24.19 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.229 1.412 . . . . 0.0 109.993 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -118.14 144.33 45.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.87 1.268 . . . . 0.0 108.994 173.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.4 p -157.79 150.1 22.42 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.489 1.115 . . . . 0.0 109.182 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.5 m -88.08 87.34 7.3 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.14 132.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.434 0.694 . . . . 0.0 109.518 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -150.37 164.53 35.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.812 1.245 . . . . 0.0 108.637 172.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.83 127.16 52.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.663 1.185 . . . . 0.0 108.105 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.25 142.54 25.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.427 1.091 . . . . 0.0 109.537 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.72 41.63 31.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.923 1.289 . . . . 0.0 111.781 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.43 31.44 79.51 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.133 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -154.79 151.6 28.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.98 0.89 . . . . 0.0 110.387 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.51 141.41 50.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.43 129.76 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.25 28.31 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -157.45 143.18 17.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.827 0.851 . . . . 0.0 109.192 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -109.82 -118.36 0.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.57 -47.8 5.23 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.463 1.505 . . . . 0.0 108.945 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 -44.25 2.11 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.9 1.28 . . . . 0.0 111.186 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -70.7 139.87 51.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 m -141.04 162.92 34.36 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.272 0.629 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.04 123.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.946 1.299 . . . . 0.0 107.877 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -136.69 110.84 8.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -118.98 120.2 36.56 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -121.02 150.96 40.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.338 1.455 . . . . 0.0 109.406 -170.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.45 136.19 57.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 125.792 1.637 . . . . 0.0 109.534 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.91 103.41 2.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.31 1.044 . . . . 0.0 109.931 170.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.64 -105.83 1.1 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.419 1.009 . . . . 0.0 111.429 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -122.58 24.65 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.931 1.293 . . . . 0.0 110.25 -173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -143.8 135.0 25.73 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 122.891 0.476 . . . . 0.0 110.723 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.9 mmt -100.74 129.23 46.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.1 123.51 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -135.87 141.94 44.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.241 -174.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -134.97 143.17 46.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.84 0.856 . . . . 0.0 109.414 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.41 142.83 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.843 1.657 . . . . 0.0 106.779 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.4 m -113.62 144.71 42.44 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.63 108.4 4.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.37 -125.3 39.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.21 29.11 13.23 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.03 0.824 . . . . 0.0 111.848 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.88 145.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 C-N-CA 124.906 1.282 . . . . 0.0 107.616 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.4 m -123.56 149.78 44.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.701 1.201 . . . . 0.0 107.89 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.0 133.67 53.62 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.64 128.82 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 ptt-85 -158.64 168.11 27.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.341 0.591 . . . . 0.0 111.048 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -138.39 132.8 32.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.353 -171.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 162.24 15.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.971 0.908 . . . . 0.0 110.139 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -126.52 147.57 49.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.332 1.453 . . . . 0.0 109.471 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -63.08 105.97 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.918 0.887 . . . . 0.0 110.045 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--O 1.253 1.244 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.078 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.305 0.098 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -73.0 -19.31 61.23 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.051 0.94 . . . . 0.0 110.757 168.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 p -50.72 116.23 1.85 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.815 1.646 . . . . 0.0 111.022 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.84 -178.99 40.92 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -118.91 130.66 55.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -134.42 144.69 48.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.777 1.631 . . . . 0.0 109.166 -167.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -119.53 118.96 32.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -52.87 124.62 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.067 0.947 . . . . 0.0 108.966 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -103.49 -44.14 5.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.772 1.629 . . . . 0.0 109.777 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 155.5 41.64 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.095 0.958 . . . . 0.0 109.439 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -151.31 122.4 7.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.401 1.08 . . . . 0.0 109.319 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.87 136.52 38.78 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.772 0.829 . . . . 0.0 111.582 -165.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 65.02 14.75 9.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.808 2.443 . . . . 0.0 112.022 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -81.21 -50.98 8.91 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.509 1.524 . . . . 0.0 110.663 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.54 -47.75 75.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.374 0.67 . . . . 0.0 110.854 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -59.73 -47.41 85.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.58 1.552 . . . . 0.0 110.134 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -55.16 -53.11 60.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.034 0.533 . . . . 0.0 111.899 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.93 -41.35 82.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -62.24 -38.77 90.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.242 0.617 . . . . 0.0 110.974 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.89 -20.15 61.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.716 0.806 . . . . 0.0 112.218 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.0 tp -75.34 -59.35 2.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.756 0.707 . . . . 0.0 111.22 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.03 -46.0 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.905 1.282 . . . . 0.0 110.097 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.65 135.56 71.44 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.643 1.177 . . . . 0.0 110.848 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -79.29 169.77 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.461 2.774 . . . . 0.0 110.639 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -44.56 -38.09 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.115 1.766 . . . . 0.0 112.474 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.1 -46.04 68.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.299 1.04 . . . . 0.0 111.757 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -81.15 -34.66 32.29 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.335 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.03 -22.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 118.815 0.734 . . . . 0.0 112.036 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.44 -33.16 19.98 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.855 0.862 . . . . 0.0 111.904 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.4 ttp -60.87 -30.56 70.21 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 123.607 0.763 . . . . 0.0 112.095 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.99 -36.14 9.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.897 1.279 . . . . 0.0 111.387 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -34.88 18.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.753 2.021 . . . . 0.0 113.561 -170.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -120.08 6.92 10.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.417 1.087 . . . . 0.0 111.859 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.98 122.91 71.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -106.33 100.73 31.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.354 1.462 . . . . 0.0 108.182 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.12 156.32 51.64 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.685 2.257 . . . . 0.0 110.96 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 tt -83.46 147.96 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -131.87 151.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.038 1.735 . . . . 0.0 108.316 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -154.47 127.94 8.55 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.53 148.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 125.108 1.363 . . . . 0.0 107.714 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.45 141.05 37.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.13 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.82 152.08 0.33 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.469 1.908 . . . . 0.0 110.64 172.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -135.25 58.42 1.76 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.322 1.449 . . . . 0.0 107.786 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.66 -131.98 6.12 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.729 1.157 . . . . 0.0 110.23 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.86 -33.84 76.95 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.926 1.29 . . . . 0.0 113.349 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.72 171.92 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.485 0.714 . . . . 0.0 110.843 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -157.56 121.56 4.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.641 1.576 . . . . 0.0 108.463 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.8 129.89 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 158.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.44 130.49 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.522 1.529 . . . . 0.0 107.221 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.1 m -128.68 145.81 51.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.238 1.415 . . . . 0.0 108.155 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.7 t -139.87 136.21 33.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -123.25 134.59 54.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -130.57 151.51 78.79 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 125.694 1.598 . . . . 0.0 107.125 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.43 -19.09 49.75 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.788 2.325 . . . . 0.0 114.068 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -138.79 32.4 2.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.087 0.858 . . . . 0.0 111.941 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -171.31 156.2 4.53 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.629 1.172 . . . . 0.0 108.871 176.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.3 m -148.2 143.97 27.4 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.33 151.5 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.463 1.105 . . . . 0.0 109.519 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.4 m -148.31 146.27 28.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.456 1.102 . . . . 0.0 108.665 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.31 155.14 42.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.396 1.478 . . . . 0.0 108.893 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 p -138.6 145.7 40.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.682 0.793 . . . . 0.0 109.93 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -163.03 172.71 14.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.955 1.302 . . . . 0.0 109.429 -173.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -144.6 139.12 27.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.21 152.54 44.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.25 0.547 . . . . 0.0 111.715 -173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.69 75.31 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.071 1.32 . . . . 0.0 112.049 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -160.01 157.69 29.22 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.416 1.108 . . . . 0.0 111.576 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.74 144.55 50.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.912 1.685 . . . . 0.0 111.048 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.87 161.73 42.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.867 1.267 . . . . 0.0 109.385 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.7 144.85 25.64 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 168.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.4 mt -129.3 136.19 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.3 m -80.75 89.35 5.77 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 109.054 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.4 m -81.52 154.79 26.1 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.439 1.096 . . . . 0.0 109.844 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -54.11 152.43 6.0 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.488 1.515 . . . . 0.0 111.156 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.2 t70 63.58 33.43 13.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.166 1.386 . . . . 0.0 111.024 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 49.23 69.85 0.92 Allowed Glycine 0 C--N 1.343 0.934 0 C-N-CA 126.293 1.901 . . . . 0.0 113.529 170.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -146.81 160.62 42.05 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.696 0.748 . . . . 0.0 112.208 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -116.25 138.69 51.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.237 1.415 . . . . 0.0 108.544 170.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.4 3.66 2.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.547 1.139 . . . . 0.0 113.193 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 69.72 134.22 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.0 2.12 . . . . 0.0 112.759 171.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.7 125.3 13.27 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.928 1.291 . . . . 0.0 110.214 -172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -91.7 104.35 16.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.857 1.663 . . . . 0.0 108.719 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.11 150.47 3.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.077 0.951 . . . . 0.0 110.145 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -150.8 167.12 28.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.435 1.494 . . . . 0.0 109.117 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.91 115.16 16.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.57 -114.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.015 1.326 . . . . 0.0 110.555 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -83.91 56.95 3.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.426 1.49 . . . . 0.0 110.639 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.47 37.37 94.69 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -140.32 140.55 35.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.671 1.188 . . . . 0.0 107.946 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 tt -79.3 109.71 13.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.8 t -119.24 117.25 53.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 m -123.89 152.13 42.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.508 1.523 . . . . 0.0 109.404 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -128.9 135.44 49.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.352 1.461 . . . . 0.0 108.32 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t -110.17 168.27 9.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.695 1.198 . . . . 0.0 108.748 170.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.46 -43.47 84.01 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 111.045 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -96.68 -23.71 16.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.822 0.849 . . . . 0.0 113.162 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.9 -168.3 3.0 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.44 1.018 . . . . 0.0 112.373 -168.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -143.9 162.27 36.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.596 1.159 . . . . 0.0 111.502 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -149.54 120.9 7.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.589 1.556 . . . . 0.0 108.336 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -128.48 133.57 48.51 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.68 1.192 . . . . 0.0 108.423 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -152.07 135.95 16.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -165.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.0 152.78 30.93 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.385 0.274 . . . . 0.0 110.446 -166.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.3 t -119.3 139.36 46.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.854 1.261 . . . . 0.0 108.817 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -133.77 101.63 5.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.172 1.789 . . . . 0.0 109.321 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.71 -101.84 0.57 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.27 11.14 10.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.203 1.401 . . . . 0.0 111.377 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -114.88 145.74 41.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.322 1.449 . . . . 0.0 107.45 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.2 ttt -127.72 133.4 49.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.2 t -115.56 136.96 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -131.47 119.26 21.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.3 1.44 . . . . 0.0 108.657 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.7 m -129.28 114.57 16.41 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.84 140.27 44.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.9 t -119.68 172.23 7.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.065 0.393 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -158.11 103.17 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.86 1.664 . . . . 0.0 107.503 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.02 -113.71 5.36 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.03 28.44 13.01 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.17 0.89 . . . . 0.0 112.084 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.14 118.96 51.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -120.33 128.44 53.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.965 0.906 . . . . 0.0 109.246 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.91 138.78 50.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.658 1.183 . . . . 0.0 107.861 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.81 130.59 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -151.95 164.57 36.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -151.69 155.89 39.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.0 m -136.13 166.05 24.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.558 1.143 . . . . 0.0 109.549 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -132.45 137.48 47.28 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.021 0.928 . . . . 0.0 109.341 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -58.13 132.55 53.85 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.508 0.723 . . . . 0.0 109.479 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.3 178.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -89.62 -10.04 47.44 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.501 0.72 . . . . 0.0 111.944 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 p -51.94 116.81 2.35 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.0 111.156 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.09 177.73 42.56 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.3 m -118.41 138.54 52.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.172 1.389 . . . . 0.0 107.669 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -143.48 155.18 44.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.53 1.132 . . . . 0.0 109.761 -163.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -142.39 128.17 19.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.63 134.14 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 124.042 0.937 . . . . 0.0 109.61 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -109.61 -33.97 6.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.435 0.694 . . . . 0.0 111.339 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.51 46.58 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.137 0.575 . . . . 0.0 110.828 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -148.79 144.3 26.9 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 109.09 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -156.65 144.12 19.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.222 1.009 . . . . 0.0 109.645 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.9 26.05 12.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.035 1.334 . . . . 0.0 110.855 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -99.98 -48.44 4.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.69 2.396 . . . . 0.0 107.711 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.02 -43.65 50.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.126 1.37 . . . . 0.0 110.572 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -60.13 -50.3 74.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.03 1.332 . . . . 0.0 110.891 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD2' HD21 ' A' ' 118' ' ' LEU . 8.9 t80 -57.61 -50.03 74.49 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.297 0.639 . . . . 0.0 110.934 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.45 -44.25 95.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -62.87 -30.57 71.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.046 0.539 . . . . 0.0 111.626 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.28 -27.47 66.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.287 0.494 . . . . 0.0 111.389 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.02 -176.94 5.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.375 0.534 . . . . 0.0 110.094 172.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.12 -32.99 37.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.528 1.531 . . . . 0.0 113.606 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 mt -48.48 111.38 1.8 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.104 1.362 . . . . 0.0 111.013 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.81 167.89 23.15 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.075 2.517 . . . . 0.0 110.065 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -46.04 -36.66 5.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.772 1.629 . . . . 0.0 113.059 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -72.4 -57.46 4.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.288 1.035 . . . . 0.0 111.622 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.28 -33.74 63.35 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.342 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.433 ' O ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -63.72 -39.52 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -33.67 18.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.518 0.599 . . . . 0.0 112.267 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.22 -55.77 5.27 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.81 65.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.57 1.148 . . . . 0.0 112.9 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -45.34 -39.55 6.87 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.75 1.62 . . . . 0.0 111.974 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -118.2 47.36 1.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.334 1.054 . . . . 0.0 109.238 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.0 mt -127.12 135.16 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -109.47 99.15 35.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.868 1.667 . . . . 0.0 108.354 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.49 145.23 26.32 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.123 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.5 tp -80.81 137.13 21.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.95 148.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.285 1.434 . . . . 0.0 108.078 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -153.26 123.56 7.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mp -110.16 140.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -129.37 137.26 50.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.177 1.391 . . . . 0.0 107.393 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.77 166.66 32.82 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.514 0.726 . . . . 0.0 109.529 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -156.17 65.84 0.57 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.363 0.665 . . . . 0.0 109.54 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.1 -85.3 1.04 Allowed Glycine 0 C--N 1.337 0.631 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -92.88 -49.48 6.03 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.501 0.72 . . . . 0.0 111.709 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.64 142.73 31.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.273 0.488 . . . . 0.0 110.485 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.83 142.34 48.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.924 1.689 . . . . 0.0 108.424 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.2 t -130.3 126.97 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.774 1.63 . . . . 0.0 106.77 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.3 t -110.41 126.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.9 m -132.26 141.07 48.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.448 1.099 . . . . 0.0 108.533 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.1 m -142.85 134.13 26.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 108.157 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -123.48 146.84 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 108.651 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.4 HG22 ' HD2' ' A' ' 54' ' ' PRO . 1.3 m -144.59 151.73 51.1 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' HG22 ' A' ' 53' ' ' THR . 42.8 Cg_endo -63.78 -13.38 36.62 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.448 2.099 . . . . 0.0 113.27 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -144.1 41.56 1.4 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.859 0.864 . . . . 0.0 111.365 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -177.19 154.98 1.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.224 1.41 . . . . 0.0 108.143 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.6 m -154.53 130.8 10.4 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 167.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.8 t -127.18 131.26 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 107.864 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -140.02 133.53 30.14 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.268 1.027 . . . . 0.0 108.333 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.12 158.81 37.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.42 1.488 . . . . 0.0 109.609 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.3 p -152.27 159.96 43.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.465 0.706 . . . . 0.0 110.529 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -167.4 171.21 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.66 1.184 . . . . 0.0 109.061 -176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.1 m -139.93 155.13 47.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.566 1.146 . . . . 0.0 107.959 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.0 mt -59.05 112.37 1.66 Allowed 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.686 0.394 . . . . 0.0 111.883 -171.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.8 41.03 95.87 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.787 1.184 . . . . 0.0 111.251 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -130.87 132.09 44.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.548 0.739 . . . . 0.0 110.183 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.48 124.81 12.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.886 1.675 . . . . 0.0 110.754 172.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.81 173.88 13.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.887 1.275 . . . . 0.0 110.107 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -116.31 146.84 42.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.044 1.738 . . . . 0.0 108.162 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.29 136.26 60.55 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 173.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m -85.1 103.49 14.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.503 0.721 . . . . 0.0 109.484 -172.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -65.08 153.68 40.09 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.605 1.162 . . . . 0.0 108.999 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 58.3 mtt -78.6 50.35 0.96 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.803 0.841 . . . . 0.0 110.654 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -152.8 37.09 0.5 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.751 1.621 . . . . 0.0 108.716 169.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 47.87 46.85 25.58 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.717 2.103 . . . . 0.0 114.869 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -160.67 -177.27 6.06 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.052 0.941 . . . . 0.0 109.166 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.34 171.4 10.45 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 124.532 1.133 . . . . 0.0 110.7 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp -144.84 13.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.284 1.034 . . . . 0.0 113.093 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 66.51 143.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.928 2.091 . . . . 0.0 113.357 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.9 t -155.66 147.42 23.14 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.636 -0.665 . . . . 0.0 110.748 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 m -156.21 71.97 0.74 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.719 0.808 . . . . 0.0 111.036 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.26 -161.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 118.793 0.724 . . . . 0.0 111.173 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -157.79 -174.88 5.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.584 1.554 . . . . 0.0 111.884 -161.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -104.89 139.55 39.46 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 127.47 2.308 . . . . 0.0 109.345 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.16 112.91 5.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.838 1.255 . . . . 0.0 108.918 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 56.58 64.99 1.52 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.053 1.341 . . . . 0.0 111.394 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.88 37.23 77.05 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.716 1.151 . . . . 0.0 113.117 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -154.75 118.33 4.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.11 0.964 . . . . 0.0 108.497 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.63 122.05 44.2 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.502 1.121 . . . . 0.0 108.302 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.73 70.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.451 -163.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.45 127.2 32.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -144.98 152.13 39.69 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.072 0.949 . . . . 0.0 110.16 -168.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -141.63 -164.88 1.87 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.697 1.199 . . . . 0.0 109.799 -174.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -46.93 -57.27 5.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.24 1.816 . . . . 0.0 112.045 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -127.84 -24.59 3.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.296 1.038 . . . . 0.0 111.648 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -72.87 145.9 46.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.162 0.437 . . . . 0.0 110.117 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.9 m -134.65 152.17 51.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.374 1.07 . . . . 0.0 108.287 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -146.07 93.41 2.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -107.0 105.73 15.91 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.045 1.738 . . . . 0.0 106.956 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 125.55 50.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.314 1.046 . . . . 0.0 109.104 -170.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -122.37 130.46 53.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.563 1.545 . . . . 0.0 107.723 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -121.46 149.48 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 109.304 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -143.22 -150.3 0.31 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.018 1.327 . . . . 0.0 108.414 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.76 -65.96 2.1 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -126.73 31.45 5.32 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.602 1.161 . . . . 0.0 109.958 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -155.44 143.78 20.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.161 0.984 . . . . 0.0 108.716 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 11.4 ttt -146.66 124.07 11.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.69 1.196 . . . . 0.0 108.101 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.75 137.29 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.666 1.186 . . . . 0.0 107.932 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -132.61 125.87 31.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.032 0.933 . . . . 0.0 108.779 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -132.68 122.65 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mm -119.12 157.02 21.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.2 m -134.05 149.26 51.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -148.58 112.98 5.28 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.623 1.169 . . . . 0.0 108.748 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.5 -91.24 0.25 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 124.333 0.968 . . . . 0.0 111.028 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.46 37.19 1.49 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.837 1.208 . . . . 0.0 110.152 172.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.44 144.89 35.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 106.956 174.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -121.49 134.74 55.07 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.836 1.254 . . . . 0.0 108.038 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -120.28 141.53 49.91 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.61 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -161.71 161.29 29.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.017 0.927 . . . . 0.0 108.684 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -139.95 143.61 36.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.1 m -119.08 163.74 16.56 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.408 1.483 . . . . 0.0 110.618 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -123.32 151.13 42.76 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.16 1.384 . . . . 0.0 108.342 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.7 ttp85 -71.92 146.34 47.88 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.406 0.683 . . . . 0.0 109.618 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--O 1.255 1.349 0 CA-C-O 116.857 -1.544 . . . . 0.0 106.92 174.453 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 119.814 -0.136 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -72.85 -18.95 61.4 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 119.051 -0.499 . . . . 0.0 109.688 168.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.3 p -43.62 112.92 0.44 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 126.116 1.766 . . . . 0.0 111.261 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.85 -175.79 39.97 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -120.5 142.69 49.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -142.56 139.39 31.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.201 1.0 . . . . 0.0 109.622 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -120.6 109.46 15.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.49 1.116 . . . . 0.0 108.521 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.24 137.54 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 124.592 1.157 . . . . 0.0 109.618 167.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -125.03 -52.7 1.65 Allowed 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.607 0.763 . . . . 0.0 109.38 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.09 148.29 25.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.987 0.915 . . . . 0.0 110.284 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.44 147.61 12.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.618 1.167 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -147.53 143.49 27.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.973 0.909 . . . . 0.0 109.263 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.46 28.2 17.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.507 1.523 . . . . 0.0 111.092 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -89.71 -61.55 1.67 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.034 2.134 . . . . 0.0 109.524 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -55.28 -36.87 66.59 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.196 0.999 . . . . 0.0 111.098 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.29 -39.8 71.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.162 0.985 . . . . 0.0 110.635 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.64 -52.89 63.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 122.868 0.467 . . . . 0.0 110.459 171.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.89 -42.45 75.98 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 123.244 0.34 . . . . 0.0 110.548 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.78 -43.39 98.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.784 0.434 . . . . 0.0 111.108 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.29 -17.19 61.89 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.7 tp -69.57 -70.3 0.29 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.841 0.746 . . . . 0.0 112.311 -165.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.82 -58.0 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.381 1.072 . . . . 0.0 110.482 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.48 154.34 44.62 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.203 1.001 . . . . 0.0 111.84 -176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.94 165.25 28.71 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.502 2.135 . . . . 0.0 111.227 -172.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.16 -23.83 62.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.029 1.331 . . . . 0.0 112.17 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.04 -37.55 83.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.931 0.492 . . . . 0.0 111.355 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.41 -29.57 26.05 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.426 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -36.53 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.487 1.04 . . . . 0.0 110.217 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.39 -41.38 76.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.951 1.3 . . . . 0.0 110.246 168.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 ttt -68.64 -38.97 80.91 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.669 0.213 . . . . 0.0 111.252 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.49 -18.05 49.78 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.288 1.035 . . . . 0.0 113.189 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -38.69 -60.79 0.79 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.174 2.19 . . . . 0.0 114.427 -165.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.447 ' C ' HD12 ' A' ' 34' ' ' ILE . 37.5 m-20 -119.31 34.49 5.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.268 1.027 . . . . 0.0 109.505 -171.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.447 HD12 ' C ' ' A' ' 33' ' ' ASP . 1.8 mp -116.46 126.87 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -104.04 98.23 13.19 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 126.176 1.79 . . . . 0.0 108.396 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.29 124.31 10.33 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.065 2.51 . . . . 0.0 110.005 -172.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.37 141.63 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -123.89 144.93 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.078 1.351 . . . . 0.0 109.037 -169.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -135.8 132.47 36.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.325 1.05 . . . . 0.0 109.02 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mm -110.6 142.57 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 126.014 1.726 . . . . 0.0 106.911 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 -179.72 2.31 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.109 1.364 . . . . 0.0 110.856 168.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -152.67 39.8 0.56 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.615 0.766 . . . . 0.0 110.365 168.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.04 -133.8 3.53 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.67 -31.19 72.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.855 1.262 . . . . 0.0 112.731 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -73.16 156.98 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.188 0.595 . . . . 0.0 109.688 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -148.64 110.14 4.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.752 1.621 . . . . 0.0 107.101 173.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.38 141.47 24.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.35 133.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.553 1.141 . . . . 0.0 108.063 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -126.27 143.31 51.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.636 1.175 . . . . 0.0 108.435 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.8 p -124.81 141.74 51.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.571 1.148 . . . . 0.0 108.989 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -133.5 137.27 45.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.87 1.268 . . . . 0.0 108.519 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -153.12 148.41 20.08 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.22 32.51 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.64 2.226 . . . . 0.0 112.402 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -174.6 20.27 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.947 2.099 . . . . 0.0 111.403 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.97 147.08 0.44 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.517 1.127 . . . . 0.0 108.952 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.9 t -170.06 152.58 4.34 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.184 0.594 . . . . 0.0 109.639 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -162.44 164.34 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.517 1.127 . . . . 0.0 109.078 173.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 m -136.79 146.14 45.36 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.487 1.115 . . . . 0.0 108.52 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.64 155.94 45.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.083 1.353 . . . . 0.0 110.417 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.6 p -138.6 121.97 17.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.65 1.58 . . . . 0.0 109.009 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -144.51 175.11 10.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.639 0.775 . . . . 0.0 110.487 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -153.18 148.49 26.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.7 0.8 . . . . 0.0 110.24 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.65 123.52 21.1 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.857 0.863 . . . . 0.0 110.791 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.96 37.46 93.24 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.367 0.984 . . . . 0.0 111.885 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -160.3 175.3 13.01 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -50.73 140.09 15.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.741 1.216 . . . . 0.0 111.638 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.69 91.06 2.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 110.097 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.7 130.65 41.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 mt -129.84 140.94 47.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 123.342 0.657 . . . . 0.0 109.437 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . 0.366 4.9 t 47.89 -171.68 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 128.119 2.567 . . . . 0.0 115.362 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 73' ' ' MET . 6.5 t 168.73 -78.1 0.0 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.935 2.894 . . . . 0.0 109.315 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.489 ' H ' HG23 ' A' ' 72' ' ' THR . 18.0 ttt -91.22 62.1 4.66 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.125 0.97 . . . . 0.0 109.939 -170.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -171.33 -68.48 0.02 OUTLIER 'General case' 0 C--N 1.338 0.102 0 C-N-CA 126.284 1.834 . . . . 0.0 107.283 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.9 -98.34 1.32 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -163.15 119.17 1.78 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -51.1 138.92 19.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.503 1.121 . . . . 0.0 109.811 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.34 -179.89 4.1 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.418 1.487 . . . . 0.0 109.708 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -153.46 120.73 5.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.693 1.597 . . . . 0.0 107.541 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 90.3 m -136.08 -172.13 3.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.633 1.173 . . . . 0.0 109.241 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.0 m -135.68 85.37 2.16 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.92 132.14 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.689 0.796 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -144.44 151.93 39.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.192 1.397 . . . . 0.0 108.368 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tp -92.24 137.88 31.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.032 0.933 . . . . 0.0 108.703 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.7 72.06 1.46 Allowed 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.312 1.445 . . . . 0.0 108.911 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.6 t30 65.47 75.42 0.35 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.662 1.585 . . . . 0.0 111.286 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.38 32.68 84.99 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.961 0.791 . . . . 0.0 113.198 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -157.84 139.89 14.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.721 0.76 . . . . 0.0 110.828 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.1 mp -78.42 146.14 34.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.595 1.158 . . . . 0.0 108.651 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -143.29 138.51 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.242 1.017 . . . . 0.0 109.214 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.0 p -144.82 169.73 17.48 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.673 1.589 . . . . 0.0 109.863 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -144.58 141.86 29.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.515 1.126 . . . . 0.0 108.197 158.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -120.06 -159.05 0.77 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.13 1.372 . . . . 0.0 107.999 164.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.32 -50.21 68.71 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.415 0.686 . . . . 0.0 111.158 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -127.58 -25.78 3.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.036 1.334 . . . . 0.0 111.581 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -91.08 144.05 26.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 109.321 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.7 m -149.29 125.36 10.68 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -109.0 112.08 24.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.857 1.663 . . . . 0.0 109.195 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -137.26 128.89 28.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.983 1.313 . . . . 0.0 108.542 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -162.15 149.35 13.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.82 157.44 46.78 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.744 1.218 . . . . 0.0 111.094 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.67 140.72 47.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.695 1.198 . . . . 0.0 109.488 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.87 162.26 30.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.013 1.725 . . . . 0.0 107.858 165.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -10.4 -79.87 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 128.368 2.89 . . . . 0.0 115.077 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -123.69 29.13 6.66 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.503 1.121 . . . . 0.0 111.184 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -152.01 115.76 4.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 ttt -101.92 141.41 34.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.959 1.304 . . . . 0.0 107.574 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.49 138.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.55 151.91 47.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.357 0.663 . . . . 0.0 110.739 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 152.45 51.63 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.085 0.954 . . . . 0.0 108.782 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.47 138.36 29.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 170.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.1 m -97.97 154.37 17.73 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.572 1.149 . . . . 0.0 109.143 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.28 67.27 1.08 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.577 1.551 . . . . 0.0 107.24 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.73 8.38 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.728 1.156 . . . . 0.0 110.937 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.05 15.36 27.79 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.296 -0.724 . . . . 0.0 113.046 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.6 154.1 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.28 1.432 . . . . 0.0 107.534 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -136.46 160.64 38.15 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.56 1.144 . . . . 0.0 108.75 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.55 143.52 50.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.478 1.511 . . . . 0.0 107.323 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.19 143.88 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 160.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -141.07 161.73 37.16 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.952 0.901 . . . . 0.0 109.476 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -141.81 138.45 32.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.924 0.89 . . . . 0.0 109.708 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.6 m -134.38 159.93 39.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.947 1.699 . . . . 0.0 110.712 -169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -122.71 148.99 44.66 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.269 1.428 . . . . 0.0 109.207 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -66.02 147.34 53.5 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.234 0.614 . . . . 0.0 110.171 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.8 1.64 . . . . 0.0 107.025 169.916 . . . . . . . . 0 0 . 1 stop_ save_